data_6lci_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6lci _Structure_validation_residue.Date_analyzed 2020-11-27 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.705 0.288 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.42 154.04 34.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.26 156.44 39.68 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.57 142.87 29.54 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -135.3 7.71 3.37 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -102.79 69.02 1.04 Allowed 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -73.82 -23.87 59.71 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -88.76 148.45 23.94 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 t -146.43 138.9 25.18 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -116.4 170.37 8.6 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -91.14 161.13 15.22 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 121.971 0.891 . . . . 0.0 108.768 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -84.17 159.86 58.62 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -55.32 140.65 82.03 Favored 'Trans proline' 0 CA--C 1.5 -1.178 0 C-N-CA 121.826 1.684 . . . . 0.0 112.589 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -83.82 155.54 22.92 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.756 0.789 . . . . 0.0 109.092 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.19 -164.73 37.03 Favored Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.41 ' HB3' HD21 ' A' ' 55' ' ' LEU . 47.4 m0 -80.57 145.99 31.48 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.24 161.99 40.2 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -117.65 135.83 53.73 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.4 mt -100.82 106.03 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -104.71 129.59 52.88 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.449 0.642 . . . . 0.0 109.381 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.01 119.95 24.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -62.08 -32.5 73.06 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.9 t -65.16 -43.02 93.12 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 121.594 -0.691 . . . . 0.0 111.101 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -100.02 -21.84 15.47 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.298 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.12 19.56 78.41 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 10.7 m-30 -109.8 162.27 14.63 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 28' ' ' LEU . 1.4 p -116.02 154.29 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 1.9 mp -61.6 133.71 55.97 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.998 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -144.77 166.35 25.48 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.519 ' CG1' ' H ' ' A' ' 34' ' ' SER . 2.6 p -70.79 179.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -55.13 -47.91 74.41 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.289 -0.882 . . . . 0.0 111.479 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -173.85 74.77 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.588 -0.845 . . . . 0.0 108.829 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 52.43 44.73 29.61 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.519 ' H ' ' CG1' ' A' ' 30' ' ' VAL . 57.2 m -103.08 118.84 37.7 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -93.64 -1.5 55.24 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -80.04 142.04 35.32 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t -75.56 149.07 38.42 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.48 5.83 60.09 Favored Glycine 0 C--N 1.355 1.614 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.3 m -83.97 138.22 40.18 Favored Pre-proline 0 N--CA 1.438 -1.032 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.565 ' HA ' HG13 ' A' ' 87' ' ' VAL . 56.8 Cg_endo -70.31 155.25 64.53 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.597 1.531 . . . . 0.0 112.338 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.0 mm -94.36 131.63 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 20.6 m -133.93 169.03 22.54 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.7 143.15 27.21 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.66 151.59 37.49 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.4 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 9.1 t -65.34 153.5 41.01 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 139.42 57.62 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.109 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -106.78 138.58 42.68 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.3 m -66.04 -34.82 78.95 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -137.07 160.61 38.44 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 60.31 41.86 15.79 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -100.0 15.78 26.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.46 77.74 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.7 p -72.01 -13.12 61.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -101.65 2.94 39.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 16' ' ' TRP . 62.4 mt -98.61 133.53 42.82 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -126.84 152.73 46.59 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -134.93 150.05 50.34 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -99.13 115.14 28.36 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 94.1 m-20 -83.08 154.96 67.44 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 31.9 Cg_exo -59.52 -18.95 49.69 Favored 'Trans proline' 0 CA--C 1.496 -1.401 0 C-N-CA 122.386 2.057 . . . . 0.0 113.598 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.1 m -73.56 -16.25 61.27 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.23 15.4 21.66 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.07 158.07 21.72 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 118.427 1.113 . . . . 0.0 108.851 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.2 mp -105.0 124.34 49.36 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.6 t -113.95 138.4 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -75.34 132.06 40.69 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -62.59 -43.36 99.0 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.063 -0.398 . . . . 0.0 111.357 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -78.06 -52.35 8.89 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 121.81 -0.556 . . . . 0.0 111.421 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.6 m -68.4 -39.76 81.55 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.42 4.58 90.39 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 105.783 -2.927 . . . . 0.0 105.783 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.6 163.63 12.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 64' ' ' LEU . 2.2 p -115.28 154.56 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.1 mtt -66.66 137.32 56.62 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -153.03 172.1 17.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.98 142.8 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.25 79.74 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.325 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -72.21 -33.27 67.47 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.41 -8.54 79.65 Favored Glycine 0 CA--C 1.495 -1.176 0 N-CA-C 105.924 -2.87 . . . . 0.0 105.924 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.5 m -119.7 124.01 28.23 Favored Pre-proline 0 N--CA 1.437 -1.089 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.4 116.53 4.73 Favored 'Trans proline' 0 CA--C 1.497 -1.375 0 C-N-CA 121.04 1.16 . . . . 0.0 112.901 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -136.27 161.82 34.72 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.68 131.2 40.68 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.69 7.85 83.68 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 p -72.75 143.38 14.0 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-N 118.652 1.226 . . . . 0.0 108.35 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -80.49 154.6 27.47 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 121.482 0.658 . . . . 0.0 109.267 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.7 mm -111.43 127.85 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' A' ' 40' ' ' PRO . 33.9 m -131.47 161.4 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -84.91 139.33 31.93 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -141.8 168.48 19.65 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.4 m -62.68 150.54 40.75 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.3 150.54 46.25 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.34 156.31 35.65 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.8 -166.82 42.62 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.5 p -88.01 7.46 31.11 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -93.79 7.38 45.11 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.52 123.52 71.26 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -67.25 144.0 56.17 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.38 -22.5 66.8 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.07 -3.87 57.7 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -117.81 10.25 13.2 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -99.64 139.11 35.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -91.78 -7.91 48.26 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -81.22 -7.84 59.64 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.34 129.77 35.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -123.97 154.48 39.74 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -116.29 153.7 17.29 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 106.858 -2.497 . . . . 0.0 106.858 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 tt -131.34 125.99 34.13 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 81.4 p -91.98 159.75 37.21 Favored Pre-proline 0 CA--C 1.506 -0.744 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.3 -19.82 59.68 Favored 'Trans proline' 0 CA--C 1.501 -1.171 0 C-N-CA 122.246 1.964 . . . . 0.0 112.986 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.57 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 97.9 m-85 -76.63 -12.92 60.08 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 7.6 58.16 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.57 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 75.8 m80 -83.6 139.44 32.84 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.7 mt -109.4 124.72 66.32 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.713 ' HB3' HG23 ' A' ' 122' ' ' ILE . 1.4 p90 -135.59 175.85 9.21 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' A' ' 118' ' ' LYS . 7.5 mt -84.68 147.68 26.8 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.83 -23.14 60.73 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -102.77 -19.65 14.64 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.556 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.593 ' HB2' HD13 ' A' ' 115' ' ' LEU . 1.3 mptm? -134.46 83.51 43.03 Favored Pre-proline 0 CA--C 1.496 -1.102 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.99 -9.32 24.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.491 2.127 . . . . 0.0 113.246 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 88.1 p -86.06 -14.66 43.7 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.4 mp -102.22 131.18 48.93 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.713 HG23 ' HB3' ' A' ' 114' ' ' TYR . 28.6 pt -134.58 167.46 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.44 137.7 35.62 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.13 176.63 34.3 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.9 pp -131.94 160.34 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -122.44 147.09 46.74 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -68.96 156.25 38.89 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.6 t -103.87 164.48 11.66 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -64.72 -37.14 86.59 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -97.79 7.17 46.85 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 51.05 47.81 24.2 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.985 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -83.44 110.24 18.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -74.02 -21.31 60.01 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -91.46 90.46 7.66 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 129.95 7.76 3.61 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.3 127.85 33.42 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.519 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -90.61 154.66 19.42 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.518 0.675 . . . . 0.0 109.543 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.21 145.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -147.84 165.93 29.12 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 89.7 mt -83.26 129.28 34.99 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -129.67 141.92 50.82 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 120' ' ' SER . 1.3 mp -73.02 150.81 42.09 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.446 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.14 137.87 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 CA-C-O 121.917 0.865 . . . . 0.0 110.051 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -115.29 78.35 1.16 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -64.19 -18.45 64.5 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.06 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -68.06 -26.14 65.7 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -139.36 86.32 2.11 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.08 4.11 44.43 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -95.62 12.95 27.88 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -88.06 138.54 31.36 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -69.71 -22.82 63.37 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.19 -28.38 65.25 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -90.76 1.05 57.22 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -113.75 137.53 51.51 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.811 0.815 . . . . 0.0 109.17 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -119.64 143.39 47.72 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -118.01 143.22 46.58 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -112.41 135.54 52.98 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.0 145.49 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.76 152.24 42.79 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.52 151.13 70.42 Favored 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 121.728 1.619 . . . . 0.0 113.089 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.6 t 63.25 73.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.263 1.801 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.196 0.522 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.98 95.25 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.63 154.38 35.23 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 7' ' ' GLU . . . -99.58 131.19 45.74 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -20.24 30.74 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -106.46 33.88 3.66 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 24.9 pt-20 -72.11 -21.94 61.41 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -146.6 163.66 35.12 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.8 p -130.22 158.34 39.99 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -122.82 153.23 39.85 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.24 161.69 17.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -73.0 147.75 88.63 Favored Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.81 -30.9 32.98 Favored 'Trans proline' 0 CA--C 1.501 -1.171 0 C-N-CA 121.939 1.759 . . . . 0.0 114.205 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -142.82 159.45 42.21 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.67 -42.74 97.13 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -94.58 134.35 37.23 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -163.3 161.15 24.53 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -117.73 134.66 54.68 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 80.3 mt -98.21 115.25 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -113.0 131.11 55.89 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -84.98 121.4 27.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -61.81 -28.88 69.78 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.1 t -63.83 -43.68 95.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 121.443 -0.785 . . . . 0.0 110.87 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -104.55 -21.1 13.48 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.226 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.39 20.26 77.21 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -107.96 165.25 11.6 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.85 161.25 15.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.29 134.24 47.77 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.605 0.717 . . . . 0.0 109.895 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 34.9 ttp -146.37 165.01 30.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.4 t -70.4 164.84 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -49.81 -43.03 48.37 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 122.016 -0.427 . . . . 0.0 110.599 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -164.51 57.04 0.14 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 54.57 47.93 21.55 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.7 m -87.88 127.45 35.35 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -93.32 -1.7 55.7 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -91.85 148.54 22.15 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.6 m -82.06 157.27 24.2 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.13 -3.83 64.64 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.4 m -82.92 143.71 46.62 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.58 155.41 54.73 Favored 'Trans proline' 0 CA--C 1.496 -1.42 0 C-N-CA 121.671 1.58 . . . . 0.0 112.793 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.8 mm -92.88 131.19 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 25.7 m -130.91 164.35 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.2 mt -93.03 143.18 26.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.99 151.33 38.42 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -66.86 155.04 39.4 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.2 139.47 58.11 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.8 147.65 51.59 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.5 m -83.97 -10.47 57.89 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -123.46 146.06 48.33 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 58.38 42.16 21.84 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -91.03 -1.85 57.74 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.04 89.64 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.9 p -75.04 -12.6 60.36 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -101.12 0.85 38.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.1 mt -95.96 136.11 36.83 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -127.63 156.49 42.23 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -149.59 165.7 31.48 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -119.76 134.61 55.17 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 119.129 -1.028 . . . . 0.0 108.283 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.463 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 98.3 m-20 -75.24 162.05 74.57 Favored Pre-proline 0 N--CA 1.44 -0.966 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 59' ' ' ASP . 18.9 Cg_endo -58.54 -18.8 41.5 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.491 1.461 . . . . 0.0 113.198 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.6 m -84.12 -8.84 58.98 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.6 31.23 10.51 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -104.43 134.71 47.18 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.73 130.16 36.41 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.38 137.37 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -79.98 131.54 35.83 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.89 -43.05 99.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 122.06 -0.4 . . . . 0.0 111.348 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.42 -51.8 9.51 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 121.755 -0.591 . . . . 0.0 111.423 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -68.23 -39.49 82.31 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.49 4.89 90.3 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 106.094 -2.802 . . . . 0.0 106.094 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -96.28 167.23 11.31 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.1 m -117.22 161.35 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.5 mtt -72.76 139.94 47.44 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -154.12 169.43 23.58 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.45 142.41 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.29 84.82 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -70.62 -34.07 71.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.83 -5.78 84.41 Favored Glycine 0 CA--C 1.495 -1.178 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.5 m -123.12 117.18 28.39 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.35 118.63 5.53 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 121.343 1.362 . . . . 0.0 112.831 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.25 161.46 42.4 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.01 133.22 41.7 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.13 8.29 64.84 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.3 t -81.69 131.84 32.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 CA-C-N 118.793 1.297 . . . . 0.0 108.151 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -72.43 149.13 44.51 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.435 ' HA ' HD11 ' A' ' 86' ' ' ILE . 48.8 mm -103.82 128.25 57.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.6 163.76 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -91.44 141.13 29.08 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -147.03 178.65 8.2 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -72.14 169.13 16.74 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -82.13 148.69 28.38 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.81 -143.15 0.24 Allowed 'General case' 0 C--N 1.357 0.932 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.49 -175.19 37.85 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.7 m -63.37 -40.15 96.46 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -155.38 69.75 0.71 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.0 t -119.34 124.92 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -67.34 145.99 54.53 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -68.82 -19.26 64.27 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -90.23 -6.38 55.29 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.6 mt -116.99 10.82 14.11 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -83.35 131.46 35.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -92.52 -5.46 51.71 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -72.75 -9.63 58.86 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -75.6 126.72 31.56 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.99 148.51 42.91 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.26 164.26 24.55 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 105.868 -2.893 . . . . 0.0 105.868 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -146.32 137.15 24.25 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 118.929 -1.108 . . . . 0.0 108.481 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.0 p -84.75 162.63 49.59 Favored Pre-proline 0 N--CA 1.442 -0.833 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.41 -16.93 37.83 Favored 'Trans proline' 0 CA--C 1.502 -1.102 0 C-N-CA 122.511 2.141 . . . . 0.0 113.295 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.478 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 82.9 m-85 -72.93 -16.18 61.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.42 21.37 19.88 Favored Glycine 0 C--N 1.355 1.604 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.478 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 75.7 m80 -100.41 130.8 46.55 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.2 mt -101.93 127.28 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.503 ' HB3' HG22 ' A' ' 122' ' ' ILE . 4.9 p90 -140.06 171.88 13.56 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 118' ' ' LYS . 4.2 mt -83.54 145.88 28.65 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.66 84.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.607 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -96.04 -14.28 23.07 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.296 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -134.56 83.09 43.66 Favored Pre-proline 0 CA--C 1.496 -1.131 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.88 -9.62 26.19 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.385 2.057 . . . . 0.0 112.952 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 85.0 p -88.88 -15.76 33.63 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.81 130.25 45.24 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.503 HG22 ' HB3' ' A' ' 114' ' ' TYR . 39.7 pt -141.44 164.26 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.12 146.09 33.38 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.5 -169.49 24.87 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 106.258 -2.737 . . . . 0.0 106.258 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.03 173.47 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -119.07 111.06 17.81 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.64 137.56 36.35 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.8 t -150.0 174.31 12.86 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -71.47 -30.79 66.41 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.96 33.76 3.64 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' HD23 ' A' ' 136' ' ' LEU . . . -90.09 78.82 6.59 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.481 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 31.8 tpt180 -63.7 131.93 49.45 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.89 -35.73 77.41 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.481 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 30.6 mt-10 -84.55 84.48 7.65 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.4 3.29 2.76 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.648 HD23 ' HB1' ' A' ' 131' ' ' ALA . 8.6 mt -67.52 118.59 11.04 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 118.937 1.368 . . . . 0.0 107.415 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -85.06 156.0 21.28 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.31 136.89 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.16 141.63 49.69 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.1 tp -80.77 114.69 19.83 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -115.35 151.74 34.08 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 120' ' ' SER . 1.0 OUTLIER -88.67 151.13 22.64 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.6 m -66.43 150.09 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.019 0.914 . . . . 0.0 109.22 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -148.0 102.26 3.37 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -66.6 -20.48 66.01 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.277 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -80.36 -11.11 59.74 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.405 ' HB3' ' HD3' ' A' ' 150' ' ' ARG . 65.2 m170 -126.11 53.42 1.62 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.8 mt -91.06 4.06 53.11 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -92.96 12.2 24.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.405 ' HD3' ' HB3' ' A' ' 147' ' ' HIS . 2.1 mpt_? -90.12 125.27 35.38 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -69.32 -21.84 63.82 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.2 -20.0 63.97 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -92.68 -3.34 55.04 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -93.3 132.52 37.43 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -125.37 140.41 52.83 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -122.36 153.76 38.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -119.08 139.03 52.43 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 t -124.75 144.38 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.7 mt -109.43 155.24 41.55 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.28 139.98 91.62 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 122.035 1.823 . . . . 0.0 113.143 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 162' ' ' VAL . 11.8 p -146.5 145.57 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 161' ' ' VAL . 50.7 t . . . . . 0 C--O 1.261 1.685 0 CA-C-O 117.634 -1.174 . . . . 0.0 108.416 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttm . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.887 0.375 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.08 154.91 34.47 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.64 151.25 34.65 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.22 89.48 4.78 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 75.6 mtm -89.58 -14.48 34.95 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.25 76.87 1.07 Allowed 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -73.17 -24.03 60.51 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.1 151.98 22.75 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.2 t -146.02 139.16 25.9 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -95.21 170.19 9.57 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.07 161.47 14.72 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -89.72 154.71 48.14 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.4 158.99 54.45 Favored 'Trans proline' 0 CA--C 1.5 -1.213 0 C-N-CA 122.012 1.808 . . . . 0.0 112.902 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -77.14 157.86 30.74 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 121.721 0.772 . . . . 0.0 109.08 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.0 -168.15 38.8 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 107.104 -2.399 . . . . 0.0 107.104 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -89.76 178.54 6.22 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -164.09 162.77 23.15 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -118.66 134.7 54.92 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.0 mt -102.61 112.23 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -110.71 131.2 55.25 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.84 125.12 33.05 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -65.05 -21.38 66.82 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.5 t -63.33 -44.11 95.83 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.432 -0.793 . . . . 0.0 111.204 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -121.34 -6.61 9.32 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.789 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.72 25.01 75.07 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -106.0 164.55 11.88 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.38 160.87 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.452 HD23 HG21 ' A' ' 138' ' ' VAL . 2.5 mp -67.47 132.0 46.76 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.8 ttp -146.33 165.72 28.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.0 t -69.81 158.26 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 42.5 t0 -53.38 -40.65 65.18 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.765 -0.584 . . . . 0.0 110.668 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -156.26 27.06 0.35 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.307 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 61.44 45.48 8.42 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 m -85.99 117.46 24.85 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -88.05 -2.47 58.63 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -82.09 -7.13 59.6 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t 70.9 -176.05 0.19 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.97 25.48 69.11 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.1 m -124.69 146.66 53.49 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HA ' HG12 ' A' ' 87' ' ' VAL . 71.8 Cg_endo -74.81 158.41 42.92 Favored 'Trans proline' 0 CA--C 1.496 -1.397 0 C-N-CA 121.959 1.773 . . . . 0.0 113.024 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.09 131.31 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 20.0 m -130.64 166.72 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD12 HG21 ' A' ' 125' ' ' ILE . 87.9 mt -94.95 142.33 27.6 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.19 34.85 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -60.7 145.08 50.65 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 139.5 57.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.478 0.656 . . . . 0.0 109.301 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -105.42 140.68 38.16 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -66.54 -34.58 78.23 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -135.27 159.93 39.99 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 60.59 41.74 15.0 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -99.5 16.74 22.28 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.66 84.51 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.2 m -70.6 -16.65 62.86 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -97.81 2.22 49.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.3 mt -99.49 135.8 40.36 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -127.95 154.99 44.95 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -139.34 154.46 47.88 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -108.56 135.53 49.66 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -84.05 163.45 48.26 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.28 -23.34 45.41 Favored 'Trans proline' 0 CA--C 1.501 -1.146 0 C-N-CA 121.729 1.619 . . . . 0.0 112.46 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 p -84.29 -3.26 58.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.89 23.03 51.23 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -96.68 133.33 41.35 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.36 127.81 35.85 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.4 t -119.59 138.18 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -73.24 132.31 43.01 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -61.93 -40.94 97.21 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 122.102 -0.374 . . . . 0.0 111.294 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -84.89 -51.92 6.38 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.393 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.9 m -67.95 -39.05 83.49 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.916 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.46 5.21 89.74 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 106.401 -2.68 . . . . 0.0 106.401 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -92.93 161.29 14.53 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 m -115.58 161.18 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.5 mtt -73.31 140.48 46.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -157.26 168.02 28.63 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.0 143.0 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.05 -42.05 81.12 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.444 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.14 -33.4 70.04 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.13 -6.25 83.71 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 105.913 -2.875 . . . . 0.0 105.913 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.0 m -124.53 128.7 24.89 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.74 112.7 3.32 Favored 'Trans proline' 0 CA--C 1.498 -1.325 0 C-N-CA 121.19 1.26 . . . . 0.0 113.038 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -129.42 157.53 41.72 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.34 130.64 40.6 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.77 8.25 82.99 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.61 144.52 13.88 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-N 118.583 1.192 . . . . 0.0 108.199 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -85.62 155.85 20.96 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.428 HG23 HD12 ' A' ' 86' ' ' ILE . 48.9 mm -108.94 129.39 63.66 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 40' ' ' PRO . 35.3 m -129.74 170.05 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.34 141.49 28.5 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -142.85 169.08 18.24 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.2 m -73.25 149.15 43.0 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -67.78 153.19 44.25 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -131.86 -154.9 0.65 Allowed 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.57 -14.86 53.7 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.5 p -70.55 -37.59 74.04 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -130.72 17.81 5.21 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.85 130.75 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -61.39 139.08 58.26 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.49 -18.59 65.11 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -90.29 -4.75 56.95 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.8 mt -120.41 10.8 11.29 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -94.55 128.32 41.08 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -83.5 -7.25 59.57 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.316 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -75.84 -6.99 53.37 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -82.18 126.1 31.68 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -117.51 151.83 36.31 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.89 153.89 16.91 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.8 tp -114.6 120.66 40.95 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.433 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 10.5 t -80.87 137.21 50.39 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.58 -9.59 26.54 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.91 1.74 . . . . 0.0 112.782 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.66 -4.0 57.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.41 43.42 3.2 Favored Glycine 0 C--N 1.355 1.613 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -134.21 154.16 51.42 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -117.33 127.21 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.679 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -133.14 172.66 12.36 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.594 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 16.2 mt -84.19 150.34 25.55 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.94 -19.95 56.75 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -101.12 -28.75 12.52 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.594 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 14.1 mptt -131.86 85.17 51.89 Favored Pre-proline 0 CA--C 1.496 -1.109 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.32 -6.08 15.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.462 2.108 . . . . 0.0 112.458 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.9 m -86.84 -12.51 47.68 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.477 HD13 HD12 ' A' ' 140' ' ' LEU . 50.3 mt -106.44 130.68 54.2 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' A' ' 114' ' ' TYR . 29.0 pt -134.3 164.72 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.11 139.73 37.99 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.32 174.84 39.62 Favored Glycine 0 CA--C 1.494 -1.252 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.2 pp -134.39 159.36 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -96.35 116.86 29.71 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.95 125.76 29.82 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -150.68 146.83 26.72 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -92.34 -6.02 51.04 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -110.63 11.25 22.84 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -106.57 -6.45 18.03 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 70.85 129.89 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.849 0.833 . . . . 0.0 109.255 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -64.02 -36.89 85.46 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -87.9 85.46 7.01 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.32 3.7 0.85 Allowed Glycine 0 N--CA 1.435 -1.407 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.94 122.56 16.32 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.553 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -86.09 153.53 22.03 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.726 0.774 . . . . 0.0 109.947 -177.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.452 HG21 HD23 ' A' ' 28' ' ' LEU . 35.8 t -96.79 140.51 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -146.51 167.47 23.59 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.477 HD12 HD13 ' A' ' 121' ' ' LEU . 89.2 mt -91.55 120.93 32.78 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -108.32 140.68 41.22 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.06 135.11 48.94 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.31 143.45 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.247 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -147.61 104.23 3.6 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -67.14 -19.18 65.57 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.092 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -67.41 -24.68 65.68 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -131.69 79.72 1.89 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.6 mt -104.51 4.3 32.9 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -96.06 13.95 25.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -83.36 126.01 32.27 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -69.4 -24.77 63.9 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -73.12 -21.09 60.8 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -103.52 2.63 33.81 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.3 tpt85 -95.38 131.71 41.21 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -120.4 137.01 54.54 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -113.49 144.27 43.12 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -115.23 136.06 53.51 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.4 t -128.93 143.52 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt -108.8 151.22 41.67 Favored Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.75 148.48 65.25 Favored 'Trans proline' 0 CA--C 1.497 -1.344 0 C-N-CA 121.738 1.626 . . . . 0.0 113.057 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.54 158.06 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 C--O 1.262 1.723 0 CA-C-O 117.685 -1.15 . . . . 0.0 108.581 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.849 0.357 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.12 155.9 36.24 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.81 153.65 39.46 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.87 128.11 45.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.0 ptp -131.51 8.02 4.56 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.5 88.06 2.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -73.98 -23.35 59.46 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -81.67 138.56 35.27 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m -134.56 145.04 48.33 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -127.87 170.42 12.83 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -102.28 156.35 17.63 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-O 122.033 0.92 . . . . 0.0 108.747 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -90.33 157.77 44.43 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.49 156.29 66.74 Favored 'Trans proline' 0 CA--C 1.498 -1.306 0 C-N-CA 121.491 1.461 . . . . 0.0 111.953 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -113.47 164.89 13.04 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.19 -161.08 34.03 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -80.75 138.2 36.29 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -159.98 164.59 33.19 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -121.28 139.99 52.67 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 88.4 mt -108.78 120.32 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.281 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' HB3' HG12 ' A' ' 27' ' ' VAL . 11.6 ptmt -122.44 147.38 46.39 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 121.997 0.903 . . . . 0.0 109.09 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -93.21 121.89 35.04 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.93 -25.95 63.92 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -63.64 -42.88 98.1 Favored 'General case' 0 CA--C 1.504 -0.795 0 O-C-N 121.222 -0.924 . . . . 0.0 110.628 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -106.82 -23.04 12.51 Favored 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.155 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.65 17.41 78.93 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -103.02 164.04 11.85 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' A' ' 20' ' ' LYS . 22.5 m -114.45 159.35 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-O 121.557 0.694 . . . . 0.0 109.221 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mp -67.73 132.55 47.66 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.915 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.413 ' HG2' ' H ' ' A' ' 30' ' ' VAL . 26.8 ttp -146.1 166.91 24.73 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.413 ' H ' ' HG2' ' A' ' 29' ' ' MET . 40.7 t -69.94 162.22 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.42 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 36.0 t70 -54.25 -40.51 67.81 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.85 -0.531 . . . . 0.0 110.578 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -161.92 45.36 0.16 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 55.73 47.54 20.26 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.5 m -87.8 98.94 11.75 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -75.9 -11.33 59.95 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -80.27 -6.66 58.27 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t 70.1 -169.38 0.17 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.61 25.06 75.06 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -131.42 148.98 72.26 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.536 ' HA ' HG13 ' A' ' 87' ' ' VAL . 71.8 Cg_endo -74.61 161.58 39.42 Favored 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 122.252 1.968 . . . . 0.0 112.977 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.9 mm -88.6 131.03 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 23.2 m -130.09 167.2 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.981 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.26 143.57 26.55 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.19 149.33 34.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -60.86 144.23 53.21 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.4 139.26 57.23 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -117.94 147.21 43.37 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.6 m -83.67 -19.49 35.23 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -126.49 149.39 49.37 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 58.69 42.89 19.61 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -93.37 5.18 52.46 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.56 87.74 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.4 p -73.09 -12.32 60.86 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -102.45 2.55 36.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.5 mt -98.31 138.54 35.42 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -127.23 151.23 48.98 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -128.54 131.72 48.25 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -92.94 113.26 25.49 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -76.55 154.75 83.74 Favored Pre-proline 0 N--CA 1.439 -0.986 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.28 -17.82 61.91 Favored 'Trans proline' 0 CA--C 1.497 -1.351 0 C-N-CA 121.872 1.714 . . . . 0.0 112.858 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -73.87 -18.94 60.86 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.54 14.64 17.38 Favored Glycine 0 C--N 1.358 1.768 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 103' ' ' GLN . 1.9 m-85 -107.34 160.3 15.73 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 118.22 1.01 . . . . 0.0 108.732 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.9 mt -110.05 128.83 55.65 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.1 t -115.67 136.5 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -80.84 128.87 34.15 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.59 -42.34 99.5 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 121.947 -0.471 . . . . 0.0 111.352 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -65.71 -50.43 64.9 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.3 p -89.14 -29.57 19.25 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.554 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.68 5.49 89.82 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -96.57 165.9 11.93 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.7 m -113.09 156.82 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 23.4 ptp -86.58 140.85 29.48 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -162.42 -177.86 5.92 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.8 142.34 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.981 0 CA-C-O 121.669 0.747 . . . . 0.0 109.005 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.49 72.32 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.631 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -71.13 -32.9 69.56 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.92 -5.22 85.18 Favored Glycine 0 CA--C 1.494 -1.242 0 N-CA-C 105.802 -2.919 . . . . 0.0 105.802 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -123.66 127.42 25.5 Favored Pre-proline 0 N--CA 1.435 -1.207 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.05 117.42 5.15 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 C-N-CA 121.236 1.291 . . . . 0.0 113.135 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -135.93 162.27 33.31 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.68 128.92 35.58 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.95 11.51 81.27 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.85 143.54 14.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 CA-C-N 118.391 1.095 . . . . 0.0 108.414 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -82.0 157.42 24.22 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 121.494 0.664 . . . . 0.0 109.621 -178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.413 HG23 HD13 ' A' ' 86' ' ' ILE . 48.6 mm -112.82 127.77 69.88 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.536 HG13 ' HA ' ' A' ' 40' ' ' PRO . 33.3 m -132.0 170.42 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -99.69 143.49 29.87 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -146.08 -178.01 5.91 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 t -71.17 168.15 17.84 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.943 0.878 . . . . 0.0 108.877 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -84.35 134.97 34.48 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -101.75 -158.57 0.68 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.51 -13.78 59.56 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.1 p -68.62 -37.49 79.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -144.99 28.54 1.24 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.8 t -126.84 128.79 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -63.36 142.5 58.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -66.83 -19.8 65.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -90.03 -4.75 57.22 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.76 9.14 12.9 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -91.66 132.22 36.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.0 -7.69 48.17 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.464 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 35.3 mt-30 -70.23 -21.59 62.98 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.37 129.69 39.96 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -120.02 157.09 29.6 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.57 160.21 13.31 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.8 tp -135.19 129.81 34.34 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.8 p -102.12 159.3 29.79 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.91 -20.52 67.3 Favored 'Trans proline' 0 CA--C 1.499 -1.229 0 C-N-CA 122.323 2.015 . . . . 0.0 112.969 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.529 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 98.2 m-85 -75.89 -13.75 60.26 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.39 5.69 60.28 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.529 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 75.2 m80 -82.72 138.62 34.01 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.12 124.72 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.748 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.9 OUTLIER -132.91 179.01 6.44 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.715 HD12 ' HB2' ' A' ' 118' ' ' LYS . 13.8 mt -85.55 149.03 25.65 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.17 -23.4 61.27 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -104.34 -17.73 14.7 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.734 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.715 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -134.55 84.28 40.36 Favored Pre-proline 0 CA--C 1.493 -1.231 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.71 -7.17 18.66 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.444 2.096 . . . . 0.0 112.466 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 71.0 m -88.65 -12.51 42.29 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 140' ' ' LEU . 46.4 mt -106.75 130.5 54.45 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.748 HG23 ' HB3' ' A' ' 114' ' ' TYR . 25.3 pt -134.07 165.0 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.28 138.95 35.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.82 176.06 39.14 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 107.146 -2.381 . . . . 0.0 107.146 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.7 pp -130.26 159.22 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -116.12 144.86 43.58 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -69.54 147.26 51.04 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.0 t -98.16 163.46 12.73 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -64.59 -37.1 86.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -96.78 5.09 51.28 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 51.4 45.02 28.59 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.952 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -77.47 104.86 8.25 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -65.34 -36.64 84.63 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -83.11 89.38 6.93 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 134.17 5.64 2.65 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.402 HD13 HD12 ' A' ' 125' ' ' ILE . 79.7 mt -67.61 125.8 27.33 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -89.0 154.43 20.22 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.474 0.654 . . . . 0.0 109.417 -177.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 p -97.66 144.99 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -146.73 166.52 26.36 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.512 HD13 HD12 ' A' ' 121' ' ' LEU . 86.6 mt -88.76 117.18 27.55 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -102.45 138.15 39.74 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.72 137.54 46.0 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.077 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.85 147.58 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.132 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -145.53 107.33 4.29 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -64.89 -23.2 67.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.982 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -64.4 -28.18 69.51 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -140.45 85.9 2.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -106.48 3.95 27.75 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -98.38 16.48 21.49 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.4 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 97.9 mtt180 -76.93 135.62 38.77 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -70.82 -22.96 62.28 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' A' ' 150' ' ' ARG . 8.3 pt-20 -72.05 -21.2 61.56 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -100.75 0.67 39.29 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -92.78 132.02 37.33 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -126.71 144.48 50.92 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -130.87 156.46 45.0 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -118.7 142.18 47.91 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.98 144.25 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.8 mt -108.67 155.75 40.05 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.98 141.67 98.56 Favored 'Trans proline' 0 CA--C 1.5 -1.189 0 C-N-CA 121.92 1.747 . . . . 0.0 113.401 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.6 t 61.0 63.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.263 1.774 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.455 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.147 0.499 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.66 156.06 37.18 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.23 136.99 52.35 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.4 95.09 7.44 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.0 ptp -81.09 -17.96 48.21 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.598 ' HB3' ' HH ' ' A' ' 114' ' ' TYR . 88.4 m-85 -111.19 86.89 2.41 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -84.29 -35.6 23.23 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.86 142.05 37.17 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.7 m -133.15 145.76 50.96 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -101.55 170.99 7.83 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.29 162.39 25.59 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -90.15 146.92 35.86 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.86 -24.93 20.58 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.057 1.838 . . . . 0.0 113.843 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.94 150.74 49.41 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.06 -43.14 93.98 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -91.0 135.24 33.87 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -165.62 163.96 19.21 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -116.28 137.36 52.21 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.98 120.6 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 29.8 pttt -125.68 146.62 49.65 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -87.82 130.93 34.71 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -64.67 -26.85 68.56 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 122.203 -0.311 . . . . 0.0 111.425 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 t -65.32 -42.02 93.41 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 121.79 -0.569 . . . . 0.0 110.672 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -104.98 -23.69 12.93 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.593 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.88 17.35 80.17 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 107.402 -2.279 . . . . 0.0 107.402 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -107.86 159.58 16.41 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 12.6 m -107.6 158.91 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -91.86 139.4 30.7 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.066 0.936 . . . . 0.0 109.468 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.6 ptm -147.57 178.7 8.24 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.5 156.49 5.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.507 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 43.0 t0 -57.36 -39.47 76.06 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.567 -0.708 . . . . 0.0 110.75 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -160.94 50.26 0.25 Allowed 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.861 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 53.9 51.95 13.83 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.1 t -89.81 113.78 25.4 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -92.65 -4.62 53.01 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -91.36 0.47 57.51 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 t 69.56 -172.29 0.18 Allowed 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.61 29.26 72.82 Favored Glycine 0 C--N 1.355 1.605 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 28.4 t -128.59 129.37 23.53 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HA ' HG13 ' A' ' 87' ' ' VAL . 36.1 Cg_exo -61.7 155.3 54.69 Favored 'Trans proline' 0 CA--C 1.5 -1.219 0 C-N-CA 122.434 2.089 . . . . 0.0 113.433 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.0 mm -87.63 129.45 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 31' ' ' ASP . 14.8 m -130.99 163.15 37.71 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 CA-C-O 121.851 0.834 . . . . 0.0 109.474 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.448 HD13 ' HB2' ' A' ' 136' ' ' LEU . 94.2 mt -82.72 144.45 30.21 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.232 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.99 148.35 29.65 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.3 t -66.87 154.73 40.22 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.83 138.65 58.51 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.41 147.87 52.39 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -86.62 -4.87 59.24 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -118.77 138.3 52.77 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 57.52 44.36 21.29 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -84.17 -5.5 59.26 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.63 84.72 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.0 m -69.07 -20.58 64.1 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -99.29 4.27 46.45 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mt -99.6 136.53 39.4 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -126.2 148.69 49.4 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -124.26 128.52 49.29 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -91.36 109.86 21.15 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 95.3 m-20 -75.15 155.53 86.2 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 44.2 Cg_exo -58.78 -23.53 67.15 Favored 'Trans proline' 0 CA--C 1.498 -1.318 0 C-N-CA 122.037 1.825 . . . . 0.0 113.3 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.9 m -74.41 -15.64 60.91 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.35 11.75 30.66 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.77 155.25 17.45 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 118.4 1.1 . . . . 0.0 108.456 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.3 mt -107.8 123.91 49.27 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' CG2' HG12 ' A' ' 72' ' ' VAL . 92.7 t -109.72 136.85 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -80.97 125.67 30.43 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.45 -39.72 94.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.988 -0.445 . . . . 0.0 111.237 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -66.34 -50.9 62.0 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.1 p -90.82 -27.79 18.63 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.793 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.02 3.91 90.21 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.53 167.81 11.26 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 HG12 ' CG2' ' A' ' 65' ' ' VAL . 27.1 m -115.1 153.45 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.1 ptp -76.82 143.64 39.63 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -156.75 175.62 13.82 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.07 143.13 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.32 -43.21 74.19 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.763 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -71.89 -33.12 68.09 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.64 -7.29 81.54 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 105.652 -2.979 . . . . 0.0 105.652 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.2 m -114.05 119.19 41.22 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.33 113.53 3.8 Favored 'Trans proline' 0 CA--C 1.497 -1.328 0 C-N-CA 121.213 1.275 . . . . 0.0 112.922 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.67 165.03 30.81 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.15 138.3 43.75 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.66 6.87 82.56 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.453 ' HB ' HD12 ' A' ' 140' ' ' LEU . 83.8 t -83.05 133.45 29.05 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-N 119.13 1.465 . . . . 0.0 107.893 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.36 156.31 37.21 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.441 0.639 . . . . 0.0 109.592 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.401 HG23 HD12 ' A' ' 86' ' ' ILE . 49.4 mm -110.3 127.53 67.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 40' ' ' PRO . 33.1 m -133.24 162.48 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -81.93 147.71 29.12 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -145.02 169.35 18.27 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.9 m -68.8 148.61 50.04 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -69.94 156.57 38.9 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.69 -159.92 1.01 Allowed 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.91 -18.86 48.63 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.4 m -67.92 -41.8 82.05 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -131.89 24.44 4.63 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.2 t -124.7 128.66 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -60.21 146.16 44.61 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.22 -20.53 66.1 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.46 -2.7 57.94 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -115.57 7.11 14.78 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.35 125.28 34.15 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -97.53 -8.13 29.82 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -83.08 -4.84 58.77 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.99 124.41 26.92 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.8 154.23 34.55 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -116.92 150.7 18.48 Favored Glycine 0 C--N 1.352 1.438 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.6 tp -111.51 120.36 41.87 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.43 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 8.8 t -77.7 143.78 67.95 Favored Pre-proline 0 N--CA 1.441 -0.912 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 108' ' ' SER . 40.1 Cg_exo -58.99 -20.38 53.04 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.029 1.819 . . . . 0.0 112.801 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.543 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 97.5 m-85 -85.26 -2.87 58.54 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.83 6.32 59.4 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.543 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 74.8 m80 -84.69 147.49 26.89 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.8 mt -111.85 124.01 68.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.598 ' HH ' ' HB3' ' A' ' 6' ' ' PHE . 1.1 p90 -132.27 171.18 14.02 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.523 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 2.3 mt -87.55 147.53 25.3 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.16 82.67 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.616 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -94.38 -17.3 22.68 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.281 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.523 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 0.6 OUTLIER -134.71 82.5 44.33 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -64.65 -15.02 47.9 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.595 2.197 . . . . 0.0 113.141 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 92.3 p -83.09 -17.17 44.06 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.5 mt -98.41 130.68 45.04 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.563 HG22 ' HB3' ' A' ' 114' ' ' TYR . 36.4 pt -135.49 164.22 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.27 142.6 30.99 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.92 -173.14 32.25 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 106.564 -2.614 . . . . 0.0 106.564 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -136.54 161.64 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.535 ' O ' HD23 ' A' ' 136' ' ' LEU . 40.1 ttmt -110.18 143.41 40.32 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.77 149.4 46.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -107.71 157.2 18.31 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -60.8 -45.64 93.64 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -89.06 1.76 55.09 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 50.81 47.12 25.13 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.16 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -82.37 113.16 19.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.13 -35.72 80.35 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.6 85.66 6.95 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.88 -3.18 1.5 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 126' ' ' LYS . 88.1 mt -68.99 125.17 25.83 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.582 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -92.48 157.74 16.4 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.524 0.678 . . . . 0.0 109.486 -177.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.09 135.4 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.98 142.38 47.65 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.453 HD12 ' HB ' ' A' ' 84' ' ' VAL . 83.7 mt -79.68 128.85 33.91 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -119.91 152.48 37.31 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.52 139.29 30.63 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.715 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.18 144.24 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.862 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -149.82 103.86 3.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -67.43 -19.7 65.41 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.077 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.98 -24.94 66.09 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -133.96 82.43 1.98 Allowed 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.8 mt -103.05 4.7 37.5 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -93.45 15.81 14.99 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -87.43 115.5 24.9 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.562 ' HA ' ' HE ' ' A' ' 154' ' ' ARG . 60.9 pttt -66.06 -20.59 66.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.893 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -74.74 -18.29 60.52 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -96.91 -1.72 45.26 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.562 ' HE ' ' HA ' ' A' ' 151' ' ' LYS . 79.4 mtm180 -99.94 133.75 43.86 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -118.52 140.56 49.68 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -112.81 157.1 21.78 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -128.29 143.66 51.04 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.4 145.14 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.8 mt -107.77 151.59 41.2 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.83 149.1 72.33 Favored 'Trans proline' 0 CA--C 1.496 -1.399 0 C-N-CA 121.752 1.635 . . . . 0.0 113.058 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.673 HG12 HG23 ' A' ' 162' ' ' VAL . 67.4 t -119.94 124.81 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.673 HG23 HG12 ' A' ' 161' ' ' VAL . 59.5 t . . . . . 0 C--O 1.262 1.741 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.81 0.338 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.73 94.94 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.39 33.98 3.93 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.43 58.49 2.42 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.7 ttt -93.82 62.04 3.14 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 65.62 50.48 1.62 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -71.15 -19.4 62.43 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -119.74 159.36 24.65 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m -129.38 145.45 51.4 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -90.6 170.08 10.47 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -93.9 137.42 33.15 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' HB2' ' CD2' ' A' ' 58' ' ' HIS . 71.3 m-85 -78.53 157.38 77.45 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 12' ' ' PHE . 38.8 Cg_endo -66.71 149.33 83.77 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 C-N-CA 121.288 1.325 . . . . 0.0 112.069 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -98.75 164.27 12.29 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.89 -166.76 41.32 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.485 ' HB3' HD21 ' A' ' 55' ' ' LEU . 52.3 m0 -76.82 141.63 40.61 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -155.94 162.27 40.4 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -119.59 140.67 50.2 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.8 mt -103.18 115.84 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -110.9 131.63 54.88 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -88.57 122.24 31.81 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -62.8 -20.06 64.65 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 t -63.62 -45.67 89.25 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 119.357 0.98 . . . . 0.0 110.916 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -116.94 -13.14 10.65 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.319 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.26 19.14 72.64 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -97.58 163.87 12.67 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.29 160.13 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 138' ' ' VAL . 3.1 mp -67.61 133.18 48.92 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.468 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 37.3 ttp -145.28 163.66 33.79 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.92 161.13 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -49.31 -38.09 26.43 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 122.188 -0.32 . . . . 0.0 111.015 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -161.26 48.57 0.21 Allowed 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.726 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 55.41 47.02 22.11 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -96.53 130.23 43.75 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -92.45 -3.21 55.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -85.44 142.37 29.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.5 p -72.6 161.03 31.3 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.52 7.58 69.09 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 54.1 m -92.45 128.73 43.43 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' HG13 ' A' ' 87' ' ' VAL . 35.9 Cg_exo -60.0 151.8 69.47 Favored 'Trans proline' 0 CA--C 1.499 -1.242 0 C-N-CA 122.16 1.907 . . . . 0.0 113.127 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.0 mm -93.93 129.27 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 29.9 m -131.57 164.07 35.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.7 mt -94.51 142.6 27.25 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.11 150.33 35.72 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -60.46 145.22 49.08 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 139.58 57.23 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.24 146.3 47.4 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.7 m -85.53 -16.02 40.81 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -123.27 147.04 47.37 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 57.84 42.66 22.89 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -90.58 2.41 55.85 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 -36.79 84.74 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 m -69.72 -18.84 63.56 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -98.21 2.75 48.69 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 16' ' ' TRP . 48.6 mt -98.61 136.22 39.01 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -126.1 150.12 48.44 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -128.58 130.89 48.0 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.434 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 52.0 t-80 -89.9 117.9 29.07 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -80.34 158.36 71.8 Favored Pre-proline 0 C--N 1.359 0.998 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.58 -17.68 55.55 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 121.77 1.647 . . . . 0.0 112.348 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -85.34 -2.52 58.17 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 58' ' ' HIS . . . 86.64 22.48 46.61 Favored Glycine 0 C--N 1.356 1.693 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -104.41 134.96 46.74 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.28 123.17 37.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.2 t -110.6 135.33 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -79.29 128.0 32.77 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -63.27 -40.17 96.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.9 -0.5 . . . . 0.0 111.195 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -70.38 -50.29 40.36 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.962 -0.461 . . . . 0.0 112.116 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 88.5 p -87.43 -29.59 21.33 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.806 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.83 3.88 90.47 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -91.05 165.12 13.69 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.2 m -116.94 160.29 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 mtt -70.08 139.58 52.59 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -159.04 172.29 18.44 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.95 143.53 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.73 -44.56 81.24 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.788 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -73.26 -32.79 64.9 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.4 -7.91 80.68 Favored Glycine 0 CA--C 1.496 -1.118 0 N-CA-C 105.703 -2.959 . . . . 0.0 105.703 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.9 m -113.49 119.99 40.61 Favored Pre-proline 0 N--CA 1.436 -1.155 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HG3' ' CE2' ' A' ' 102' ' ' PHE . 72.3 Cg_endo -74.09 117.89 5.19 Favored 'Trans proline' 0 CA--C 1.496 -1.422 0 C-N-CA 121.291 1.327 . . . . 0.0 113.131 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -150.54 161.23 42.95 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.13 138.68 47.89 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.67 8.09 77.45 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' A' ' 140' ' ' LEU . 80.3 t -85.54 133.59 29.15 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-N 118.978 1.389 . . . . 0.0 107.648 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -73.74 153.8 39.88 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.593 0.711 . . . . 0.0 109.614 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.5 mm -107.61 128.4 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 40' ' ' PRO . 29.1 m -133.65 161.91 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -87.21 137.78 32.05 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -139.67 174.33 10.63 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -72.21 166.03 23.21 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -80.08 157.08 26.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -134.81 162.1 33.32 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.57 -22.05 0.41 Allowed Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.8 m -64.68 -40.81 96.04 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -128.61 16.75 6.43 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.87 127.97 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -65.09 140.32 58.8 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.61 -18.54 65.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -89.4 -5.7 57.2 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.7 mt -119.41 10.62 11.94 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -92.86 123.9 36.47 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' A' ' 80' ' ' PRO . 67.4 m-85 -77.65 -7.58 56.64 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.945 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -71.59 -12.21 61.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -76.7 126.8 31.61 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -117.3 155.56 29.3 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.3 151.61 18.08 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.0 tp -111.94 121.95 46.43 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.438 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.9 t -82.03 138.37 46.14 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.01 -8.97 25.07 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.768 1.645 . . . . 0.0 112.99 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.15 -0.3 57.68 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.3 41.55 4.51 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -132.18 151.13 51.96 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.9 mt -116.79 126.66 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.9 OUTLIER -132.14 173.63 11.04 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 118' ' ' LYS . 13.7 mt -85.71 149.16 25.49 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.22 -21.04 59.97 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -102.25 -24.68 13.87 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.396 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.597 ' HB2' HD13 ' A' ' 115' ' ' LEU . 3.6 mptp? -133.46 85.06 44.42 Favored Pre-proline 0 CA--C 1.492 -1.264 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -66.35 -8.8 21.69 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.437 2.091 . . . . 0.0 112.591 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.3 m -82.92 -26.18 31.71 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.07 131.35 38.16 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.586 HG22 ' HB3' ' A' ' 114' ' ' TYR . 38.9 pt -136.62 162.81 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.54 134.56 40.72 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.4 -169.02 19.37 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 106.988 -2.445 . . . . 0.0 106.988 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.8 pt -139.21 173.05 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.153 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -117.05 112.96 21.65 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -85.39 131.65 34.36 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.5 t -150.39 160.39 43.78 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.71 -30.93 68.68 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -100.78 34.63 2.4 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 136' ' ' LEU . . . -119.66 99.45 6.66 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.456 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 16.8 tpt180 -62.22 131.54 49.76 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -62.55 -36.12 81.64 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.456 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 29.9 mt-10 -83.76 86.0 7.21 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.94 10.22 1.81 Allowed Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.418 HD23 ' HB1' ' A' ' 131' ' ' ALA . 18.7 mt -63.6 121.09 13.05 Favored 'General case' 0 C--N 1.363 1.155 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -83.12 155.37 23.85 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.546 0.689 . . . . 0.0 109.398 -178.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.498 HG21 HD23 ' A' ' 28' ' ' LEU . 57.5 t -80.27 134.16 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -130.09 139.6 50.92 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.498 HD13 ' HB ' ' A' ' 84' ' ' VAL . 77.0 mt -75.49 125.73 29.59 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -123.67 143.68 50.11 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.41 148.99 26.29 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.68 151.67 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-O 121.767 0.794 . . . . 0.0 109.232 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -147.51 100.11 3.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -68.79 -20.07 64.32 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.794 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -68.39 -23.99 64.72 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -135.19 83.91 2.06 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.3 4.87 42.08 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -95.89 20.81 9.42 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -92.96 120.26 33.09 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -68.39 -22.93 64.61 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -70.97 -20.41 62.43 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -96.9 -1.68 45.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -98.84 133.13 43.57 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -123.19 140.35 53.11 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -123.51 156.2 36.09 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.7 141.02 49.0 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.06 144.68 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -108.38 152.75 42.15 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.4 149.19 74.84 Favored 'Trans proline' 0 CA--C 1.497 -1.347 0 C-N-CA 121.729 1.619 . . . . 0.0 113.053 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.677 HG12 HG23 ' A' ' 162' ' ' VAL . 65.6 t -120.02 124.55 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.677 HG23 HG12 ' A' ' 161' ' ' VAL . 60.5 t . . . . . 0 C--O 1.263 1.79 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.109 0.481 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.6 152.16 32.5 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.45 144.98 39.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.57 106.05 18.2 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.2 mtm -66.3 -38.87 88.74 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -95.2 64.32 2.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -65.66 -43.56 88.97 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -87.17 161.13 18.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -145.76 143.64 29.84 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -101.27 170.67 8.08 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -115.49 162.82 16.64 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -79.21 126.51 81.46 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.22 -23.22 24.66 Favored 'Trans proline' 0 CA--C 1.499 -1.247 0 C-N-CA 121.892 1.728 . . . . 0.0 114.131 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.64 162.36 18.53 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.35 -56.42 2.03 Favored Glycine 0 CA--C 1.494 -1.256 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -90.51 132.35 35.73 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -162.92 162.32 26.16 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -117.84 137.37 52.81 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.52 HG22 ' CE3' ' A' ' 155' ' ' TRP . 80.4 mt -104.9 116.36 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -110.75 131.99 54.58 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -85.89 123.15 30.91 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.35 -16.33 63.98 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 122.27 -0.269 . . . . 0.0 111.532 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.2 t -63.16 -43.88 97.06 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 121.34 -0.85 . . . . 0.0 110.708 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -123.37 -5.68 8.25 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.623 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.25 21.93 76.99 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.9 m-30 -107.58 163.0 13.44 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -110.65 159.94 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -83.26 144.36 29.8 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 122.306 1.05 . . . . 0.0 108.994 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.455 ' HB3' ' HE2' ' A' ' 29' ' ' MET . 6.9 tmm? -144.71 175.38 10.21 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.8 t -68.93 170.22 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -56.83 -40.8 76.7 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.318 -0.864 . . . . 0.0 110.487 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -166.59 58.67 0.09 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 53.97 48.06 22.01 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.0 m -88.44 128.2 35.52 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -92.92 -2.69 55.6 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -93.98 147.96 22.61 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.3 p -78.07 163.4 25.93 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.63 8.23 77.32 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -89.36 125.04 63.01 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' HA ' HG12 ' A' ' 87' ' ' VAL . 44.1 Cg_exo -58.97 149.93 75.94 Favored 'Trans proline' 0 CA--C 1.499 -1.264 0 C-N-CA 122.114 1.876 . . . . 0.0 113.221 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.2 mm -89.96 129.41 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 23.9 m -131.58 162.54 39.24 Favored 'Isoleucine or valine' 0 C--N 1.359 0.999 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -89.47 145.45 25.3 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.606 0.717 . . . . 0.0 109.136 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.25 148.77 32.81 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t -63.16 156.99 23.55 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.74 137.1 56.41 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.698 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -145.85 129.31 16.91 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.6 m -60.69 -36.24 78.29 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -75.9 141.8 42.24 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 60.5 42.18 14.68 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.415 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -71.85 -27.41 62.86 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.71 90.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.1 m -67.9 -23.81 65.15 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -99.73 3.85 45.16 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 16.0 mt -99.5 135.39 40.98 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-O 121.894 0.855 . . . . 0.0 108.841 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.478 ' HB3' HD11 ' A' ' 64' ' ' LEU . 79.1 m95 -127.8 155.83 43.46 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -146.35 160.37 42.12 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -111.73 136.21 51.3 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -178.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 99.9 m-20 -84.78 161.04 54.53 Favored Pre-proline 0 N--CA 1.436 -1.148 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 59' ' ' ASP . 18.1 Cg_endo -60.01 -18.72 52.03 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.431 1.421 . . . . 0.0 112.97 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -82.43 -11.06 58.78 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.76 14.44 43.36 Favored Glycine 0 C--N 1.358 1.754 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -92.98 146.44 23.62 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 56' ' ' TRP . 3.0 mm? -92.7 132.17 37.15 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 72' ' ' VAL . 67.0 t -124.67 137.24 58.05 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -81.11 129.78 34.72 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -62.5 -39.51 93.74 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 122.14 -0.35 . . . . 0.0 110.911 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -76.91 -54.89 6.0 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.882 -0.511 . . . . 0.0 111.043 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.0 m -68.85 -39.64 79.78 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.48 5.01 89.91 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 105.933 -2.867 . . . . 0.0 105.933 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -97.88 169.44 9.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG12 ' CG2' ' A' ' 65' ' ' VAL . 32.7 m -116.55 160.95 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 63.6 mtt -72.8 140.71 47.85 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -156.3 167.93 28.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.09 142.93 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.73 86.79 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.836 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -72.46 -32.92 66.65 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.01 -6.11 82.87 Favored Glycine 0 CA--C 1.495 -1.195 0 N-CA-C 105.736 -2.946 . . . . 0.0 105.736 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.7 m -117.89 122.92 30.07 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.73 117.16 5.0 Favored 'Trans proline' 0 CA--C 1.497 -1.374 0 C-N-CA 121.196 1.264 . . . . 0.0 112.945 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.39 166.36 26.58 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.47 135.9 39.37 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.0 4.27 82.1 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.89 131.02 35.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-N 119.099 1.45 . . . . 0.0 108.598 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -73.07 154.48 40.41 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-O 121.534 0.683 . . . . 0.0 109.447 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.413 ' HA ' HD11 ' A' ' 86' ' ' ILE . 47.9 mm -106.84 130.25 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.614 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.9 m -131.14 161.02 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -86.3 140.05 30.43 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -144.25 169.31 18.13 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 m -67.31 150.37 49.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -69.02 156.96 37.73 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.47 -155.07 0.67 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.65 -14.89 57.57 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.8 p -69.45 -36.93 77.09 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -143.63 31.32 1.32 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.2 t -125.49 129.22 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -62.42 145.19 54.7 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.24 -20.21 66.32 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -89.64 -3.48 58.24 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -115.93 8.06 14.58 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.55 121.13 27.81 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -98.35 -7.46 28.81 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -80.47 -8.88 59.72 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -77.43 126.22 30.56 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -116.32 154.02 30.94 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.45 161.89 12.63 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 106.541 -2.623 . . . . 0.0 106.541 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.5 tp -132.25 132.29 42.91 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 83.4 p -113.47 155.26 44.99 Favored Pre-proline 0 N--CA 1.443 -0.796 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 56.4 Cg_endo -70.51 -8.14 22.92 Favored 'Trans proline' 0 CA--C 1.499 -1.237 0 C-N-CA 122.132 1.888 . . . . 0.0 112.849 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -82.53 -3.75 56.45 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.44 23.02 52.55 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -110.42 136.5 49.48 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.8 mt -108.31 124.19 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.654 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.33 177.28 7.45 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 118' ' ' LYS . 4.8 mt -86.98 150.95 23.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.18 86.37 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.714 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -97.75 -11.91 22.87 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.543 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.635 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.92 84.68 37.04 Favored Pre-proline 0 CA--C 1.493 -1.229 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -68.45 -9.82 27.16 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.255 1.97 . . . . 0.0 112.395 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 68.2 m -85.61 -27.59 25.35 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 140' ' ' LEU . 57.2 mt -92.21 130.78 37.84 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.654 HG23 ' HB3' ' A' ' 114' ' ' TYR . 36.1 pt -136.39 164.99 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.2 mt -82.06 141.2 33.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.98 178.12 41.89 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 107.286 -2.326 . . . . 0.0 107.286 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -129.36 158.81 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -104.89 135.26 46.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -97.53 135.3 39.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.1 t -150.09 155.67 40.27 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -69.72 -26.58 64.4 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -102.17 30.59 4.41 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.34 99.41 4.83 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.537 ' HG2' ' H ' ' A' ' 134' ' ' GLU . 54.6 ttt85 -62.7 145.25 55.14 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -59.98 -34.34 73.17 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.537 ' H ' ' HG2' ' A' ' 132' ' ' ARG . 88.8 tt0 -88.24 84.68 6.86 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.39 5.42 1.31 Allowed Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.6 mt -63.0 127.7 32.43 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -87.7 153.42 21.38 Favored 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 121.621 0.724 . . . . 0.0 109.46 -177.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.64 138.36 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -145.52 163.83 33.5 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -90.41 126.2 35.81 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -126.77 161.86 27.19 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' SER . 1.1 mp -91.45 152.41 20.39 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.753 0.787 . . . . 0.0 109.207 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.75 155.57 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.919 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -141.1 101.23 3.99 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -66.18 -23.99 66.56 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.928 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -67.01 -25.95 66.55 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -141.85 85.84 1.96 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.6 mt -98.75 3.76 47.62 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -99.28 18.46 17.55 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -76.01 128.65 35.47 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -69.55 -23.27 63.55 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.17 -20.73 60.12 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -99.97 0.41 41.03 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -100.72 132.61 46.03 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 19' ' ' ILE . 96.2 m95 -122.28 138.89 54.34 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -112.15 149.28 32.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.85 138.02 51.55 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.7 t -127.22 144.64 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.9 mt -109.54 152.66 42.9 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.91 150.66 73.54 Favored 'Trans proline' 0 CA--C 1.497 -1.364 0 C-N-CA 121.818 1.679 . . . . 0.0 112.86 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -117.7 125.23 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.262 1.723 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.749 0.309 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.17 134.63 55.22 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.7 156.93 34.23 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.89 64.06 7.05 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 98.5 mtp -95.99 60.39 2.06 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 65.2 60.71 0.77 Allowed 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.209 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.85 -39.97 83.73 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.29 149.48 33.52 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -143.3 157.62 44.32 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -119.32 171.91 7.98 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.83 162.28 13.03 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.473 ' HB2' ' CD2' ' A' ' 58' ' ' HIS . 75.2 m-85 -87.45 157.67 52.65 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 12' ' ' PHE . 39.9 Cg_endo -66.65 152.07 81.42 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 121.536 1.491 . . . . 0.0 112.209 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -97.52 164.31 12.49 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.4 -170.18 42.34 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 107.749 -2.141 . . . . 0.0 107.749 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -76.36 141.89 41.36 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -157.06 163.77 38.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.437 ' CE2' HD21 ' A' ' 46' ' ' LEU . 41.4 m-85 -120.4 138.89 53.52 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.6 mt -102.51 114.77 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -112.01 131.44 55.41 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -88.51 127.33 35.53 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.48 -19.86 65.83 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.404 ' HA ' ' HG3' ' A' ' 151' ' ' LYS . 38.6 t -63.56 -44.01 95.37 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 119.114 0.87 . . . . 0.0 111.285 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -123.5 -7.51 8.07 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.822 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.14 20.25 79.3 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -100.15 166.88 10.79 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.66 160.56 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mp -67.25 133.77 50.35 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.638 0.732 . . . . 0.0 109.956 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -145.46 166.16 26.47 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 31' ' ' ASP . 16.0 t -69.28 171.44 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 105.161 -2.162 . . . . 0.0 105.161 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.428 ' H ' ' CG1' ' A' ' 30' ' ' VAL . 35.8 t70 -54.8 -42.01 71.3 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.721 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -170.24 65.94 0.05 OUTLIER 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.815 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 53.16 46.82 25.8 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.0 m -97.44 123.76 41.4 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -94.27 -0.9 54.75 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.47 145.1 26.41 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.7 m -77.13 155.57 32.26 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.51 62.87 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.2 m -91.05 138.64 25.87 Favored Pre-proline 0 N--CA 1.438 -1.039 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HA ' HG13 ' A' ' 87' ' ' VAL . 57.1 Cg_endo -70.3 154.09 65.89 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 121.67 1.58 . . . . 0.0 112.694 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mm -92.6 131.13 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 24.6 m -131.95 167.44 26.37 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.79 144.03 26.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.26 36.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 m -61.03 143.93 54.41 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -59.83 139.69 57.14 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -108.73 142.22 39.57 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.7 m -66.8 -34.35 77.62 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -137.58 159.72 41.17 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.6 t0 61.64 46.05 7.53 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -105.97 17.49 23.54 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.26 86.47 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.7 p -71.56 -12.67 61.48 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -101.14 2.38 40.12 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 mt -98.28 137.39 37.08 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.37 150.67 48.43 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -130.05 134.67 47.55 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 12' ' ' PHE . 55.9 t-80 -95.43 112.42 24.14 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 94.9 m-20 -80.81 155.88 72.9 Favored Pre-proline 0 N--CA 1.439 -1.003 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 36.8 Cg_exo -58.65 -19.69 46.76 Favored 'Trans proline' 0 CA--C 1.497 -1.363 0 C-N-CA 122.274 1.983 . . . . 0.0 113.675 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -71.91 -19.59 61.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.67 15.21 19.48 Favored Glycine 0 C--N 1.355 1.622 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -108.32 159.63 16.49 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 118.212 1.006 . . . . 0.0 108.726 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.94 125.78 51.41 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.5 t -114.48 134.05 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -76.46 129.79 37.04 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.01 -41.05 99.47 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 121.939 -0.475 . . . . 0.0 110.853 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -74.62 -53.92 8.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 122.052 -0.405 . . . . 0.0 111.088 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.0 m -70.32 -39.94 74.48 Favored 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.859 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.01 7.04 88.38 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 105.818 -2.913 . . . . 0.0 105.818 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.82 168.04 9.9 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.446 HG21 ' HG2' ' A' ' 103' ' ' GLN . 21.9 m -116.75 162.2 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 mtt -71.8 140.69 49.54 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -156.44 169.39 24.74 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.415 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -88.41 143.87 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.037 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.94 -42.19 85.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -71.65 -33.89 69.28 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 89.55 -8.29 80.13 Favored Glycine 0 CA--C 1.496 -1.147 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.5 m -126.25 124.46 24.49 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.65 130.94 41.28 Favored 'Trans proline' 0 CA--C 1.497 -1.339 0 C-N-CA 121.416 1.411 . . . . 0.0 112.99 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -149.27 150.15 32.09 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.16 130.09 40.58 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.1 7.92 82.75 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.06 144.11 13.8 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 CA-C-N 118.473 1.137 . . . . 0.0 108.302 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.29 156.35 20.97 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 86' ' ' ILE . 48.8 mm -108.57 129.14 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 40' ' ' PRO . 34.6 m -130.78 163.27 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -87.53 139.57 30.41 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -142.49 173.34 11.62 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -73.32 168.62 18.8 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -83.75 151.34 25.27 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.06 156.79 20.93 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.51 -166.74 42.83 Favored Glycine 0 C--N 1.349 1.291 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.3 p -89.91 7.08 39.1 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -101.97 17.43 23.18 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 p -100.05 142.32 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.4 tptp -66.07 141.72 58.05 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.64 -15.96 62.25 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -89.79 -6.82 55.58 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.3 mt -115.87 11.53 15.56 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -89.61 98.48 11.79 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -98.2 -7.39 29.42 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.274 -177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.446 ' HG2' HG21 ' A' ' 72' ' ' VAL . 26.6 mp0 -71.22 -18.55 62.45 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -70.76 135.36 48.15 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -129.43 152.68 48.71 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.08 163.79 12.38 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 106.635 -2.586 . . . . 0.0 106.635 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 67.0 tp -125.79 118.82 26.35 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.0 t -79.18 138.75 56.25 Favored Pre-proline 0 N--CA 1.441 -0.909 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.32 -9.55 26.26 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.802 1.668 . . . . 0.0 112.715 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -90.27 -0.77 57.78 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.62 40.29 4.75 Favored Glycine 0 C--N 1.356 1.675 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -129.55 149.69 51.21 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.1 mt -115.8 126.81 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.68 ' HB3' HG23 ' A' ' 122' ' ' ILE . 1.2 p90 -131.25 173.99 10.5 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 118' ' ' LYS . 14.4 mt -83.92 150.58 25.59 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.05 -23.65 61.4 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -104.59 -19.98 13.81 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.767 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.61 ' HB2' HD12 ' A' ' 115' ' ' LEU . 1.3 mptm? -134.15 85.44 39.44 Favored Pre-proline 0 CA--C 1.495 -1.14 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.91 -9.19 23.98 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.605 2.204 . . . . 0.0 112.877 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.29 -29.46 28.35 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 mt -89.18 130.89 35.53 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.68 HG23 ' HB3' ' A' ' 114' ' ' TYR . 24.6 pt -134.27 162.92 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.09 136.6 35.95 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.64 175.96 38.16 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.647 HD13 HD13 ' A' ' 136' ' ' LEU . 1.9 pp -128.37 158.22 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.524 ' O ' HD23 ' A' ' 136' ' ' LEU . 47.9 tttt -107.19 147.79 29.69 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -124.53 144.91 49.86 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.8 t -149.97 161.82 41.56 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -69.15 -27.2 65.33 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -102.74 28.9 5.71 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -132.73 98.92 4.46 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -64.09 153.95 35.97 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HA ' ' HG ' ' A' ' 136' ' ' LEU . 99.6 mtt180 -70.39 -16.84 63.01 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.15 84.59 5.7 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 131.1 13.68 1.92 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.647 HD13 HD13 ' A' ' 125' ' ' ILE . 82.5 mt -64.57 127.73 32.74 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -90.3 151.08 21.65 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.5 p -95.27 144.04 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -147.27 166.98 25.43 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 115' ' ' LEU . 90.1 mt -90.85 119.92 31.46 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -118.25 143.21 46.74 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.03 146.29 43.85 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.053 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.503 HG12 HD13 ' A' ' 122' ' ' ILE . 17.5 m -64.09 155.46 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.272 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -145.57 100.43 3.43 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -67.13 -20.23 65.74 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.027 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -67.8 -24.66 65.33 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -136.42 84.93 2.11 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.1 mt -101.3 5.18 42.28 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -93.43 17.46 11.39 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -90.56 109.48 20.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.404 ' HG3' ' HA ' ' A' ' 23' ' ' SER . 10.7 ptmt -66.47 -20.1 65.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.749 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -70.44 -19.25 62.99 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -95.31 -1.61 50.99 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -101.95 135.07 44.13 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -118.48 138.47 52.48 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -112.97 148.63 34.65 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.86 138.19 51.69 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.0 t -128.99 143.84 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.7 mt -108.41 152.48 42.04 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.2 149.96 76.49 Favored 'Trans proline' 0 CA--C 1.496 -1.401 0 C-N-CA 121.826 1.684 . . . . 0.0 113.234 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.9 t -119.22 125.71 74.69 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.262 1.728 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttm . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.154 0.502 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.78 148.58 28.03 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.89 154.66 28.28 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.69 76.55 8.05 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.4 mtt -70.47 -29.84 66.49 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.97 89.39 3.05 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -72.34 -23.24 61.12 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -81.06 146.97 30.36 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.3 p -140.11 150.73 44.64 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -134.81 171.34 14.52 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.29 159.55 15.31 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -83.53 157.18 64.94 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.45 141.31 89.98 Favored 'Trans proline' 0 CA--C 1.499 -1.241 0 C-N-CA 121.903 1.736 . . . . 0.0 112.891 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -90.48 155.83 18.63 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.89 -158.82 33.74 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.452 ' HB3' HD21 ' A' ' 55' ' ' LEU . 47.6 m0 -80.72 141.18 35.1 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -156.63 162.14 39.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -120.92 140.01 52.43 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.1 mt -97.64 117.31 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.36 127.49 53.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.508 0.67 . . . . 0.0 109.992 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -87.33 114.38 23.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -60.12 -35.19 74.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 t -63.72 -43.86 95.3 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.685 -0.634 . . . . 0.0 111.5 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -99.36 -21.39 16.04 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.374 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.46 20.14 77.24 Favored Glycine 0 C--N 1.346 1.115 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -112.07 171.9 7.23 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.1 160.77 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -69.18 133.81 48.45 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.592 0.711 . . . . 0.0 109.62 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.6 ttp -145.32 164.38 31.61 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.543 HG23 ' HG ' ' A' ' 39' ' ' SER . 1.3 p -69.41 172.32 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.501 ' H ' HG23 ' A' ' 30' ' ' VAL . 19.0 t70 -53.22 -48.86 67.8 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.645 -0.659 . . . . 0.0 111.455 -176.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -172.55 75.21 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.04 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 51.75 47.72 24.24 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.503 ' H ' ' CG1' ' A' ' 30' ' ' VAL . 67.5 m -102.12 121.96 43.22 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.84 -1.51 49.38 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -82.77 150.4 26.67 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.0 t -80.65 149.45 29.81 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.57 8.73 60.71 Favored Glycine 0 C--N 1.355 1.625 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.543 ' HG ' HG23 ' A' ' 30' ' ' VAL . 35.5 t -83.46 124.61 75.48 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' HA ' HG12 ' A' ' 87' ' ' VAL . 44.5 Cg_exo -59.2 148.75 84.52 Favored 'Trans proline' 0 CA--C 1.498 -1.324 0 C-N-CA 122.061 1.841 . . . . 0.0 113.016 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.59 131.89 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.1 m -132.39 167.98 25.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.0 mt -96.45 144.24 26.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.85 149.77 33.95 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -62.8 144.06 56.91 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.85 138.98 57.02 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -117.98 138.16 52.37 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.1 m -64.52 -29.17 70.2 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.344 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -129.65 160.39 33.49 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 57.89 42.23 23.4 Favored 'General case' 0 C--N 1.361 1.076 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -98.25 11.55 37.53 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.55 87.7 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.0 p -73.73 -12.21 60.64 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -101.12 1.92 39.73 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 16' ' ' TRP . 31.5 mt -99.58 137.5 37.98 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -128.57 154.85 45.76 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -138.44 153.91 48.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -105.0 118.55 36.81 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -85.05 156.44 60.48 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.26 -19.48 50.42 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 122.396 2.064 . . . . 0.0 113.742 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -73.23 -16.24 61.41 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.4 14.44 25.84 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -111.62 160.8 16.89 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 118.153 0.977 . . . . 0.0 108.667 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.77 135.39 47.29 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.4 t -120.65 140.45 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -88.92 123.42 33.26 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -63.34 -37.51 87.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 121.695 -0.628 . . . . 0.0 111.793 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -62.87 -49.41 74.96 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.977 -0.452 . . . . 0.0 111.383 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 87.7 p -91.07 -30.18 16.9 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.313 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.82 5.79 89.05 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 107.222 -2.351 . . . . 0.0 107.222 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -99.04 166.41 11.28 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 m -116.17 164.15 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.0 139.16 50.44 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -156.97 170.84 21.61 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.44 143.22 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.37 83.63 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.346 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -71.28 -33.53 69.83 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.14 -8.12 80.39 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.6 m -123.06 127.17 25.77 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.33 126.91 13.45 Favored 'Trans proline' 0 CA--C 1.496 -1.411 0 C-N-CA 120.974 1.116 . . . . 0.0 112.906 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.0 157.81 43.87 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.88 132.65 43.79 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.51 7.11 85.07 Favored Glycine 0 C--N 1.345 1.034 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 p -71.82 143.77 13.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 CA-C-N 118.608 1.204 . . . . 0.0 108.094 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -84.13 154.49 23.1 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.3 mm -109.14 127.84 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.3 m -131.17 161.18 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -84.6 137.84 33.06 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -144.41 172.97 12.21 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.8 m -65.36 149.35 50.14 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -69.22 156.22 39.1 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.36 148.4 47.06 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.85 -161.76 37.11 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -88.66 4.06 48.47 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -99.76 16.42 23.68 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.1 t -113.99 124.04 70.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -66.26 164.26 16.24 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.863 0.84 . . . . 0.0 109.972 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.98 -20.44 61.02 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -90.25 -5.04 56.79 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -113.06 6.59 17.7 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -88.97 98.56 11.82 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -96.79 -8.0 32.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -82.2 -9.87 59.35 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.95 128.83 34.13 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -117.48 152.24 35.46 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.51 152.75 17.33 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 105.971 -2.852 . . . . 0.0 105.971 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.2 tp -130.32 121.65 26.46 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 79.0 p -91.1 156.27 44.13 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 43.7 Cg_endo -68.25 -15.16 42.13 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 121.725 1.617 . . . . 0.0 112.451 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.487 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 85.1 m-85 -72.68 -26.03 61.47 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.61 12.12 17.59 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.487 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 80.2 m80 -94.98 134.61 37.47 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.1 mt -107.35 125.3 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.742 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.8 p90 -135.71 176.1 8.99 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' A' ' 118' ' ' LYS . 3.5 mt -85.33 150.17 24.94 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.77 88.69 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.702 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -96.35 -11.12 26.25 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.569 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.625 ' HB2' HD13 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -135.25 84.9 34.47 Favored Pre-proline 0 CA--C 1.493 -1.213 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.8 -9.69 26.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.289 1.992 . . . . 0.0 112.205 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 79.7 p -88.64 -17.47 29.98 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.423 HD13 HD13 ' A' ' 140' ' ' LEU . 55.2 mt -102.91 129.95 49.79 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.742 HG22 ' HB3' ' A' ' 114' ' ' TYR . 37.9 pt -135.58 165.19 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.249 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.9 mt -77.74 138.51 39.07 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.68 176.94 36.37 Favored Glycine 0 CA--C 1.495 -1.216 0 N-CA-C 107.466 -2.254 . . . . 0.0 107.466 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.88 160.51 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -110.61 126.24 54.26 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -96.56 134.84 39.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.4 t -149.9 157.42 43.16 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -69.77 -26.58 64.36 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.13 31.41 3.96 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.96 103.02 6.3 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.529 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 27.9 tpt180 -62.0 137.51 58.26 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.422 ' HA ' ' HG ' ' A' ' 136' ' ' LEU . 99.5 mtt180 -61.47 -35.27 77.17 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.529 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 94.9 mt-10 -85.85 86.37 7.36 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.28 10.57 1.46 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.422 ' HG ' ' HA ' ' A' ' 133' ' ' ARG . 80.1 mt -64.53 126.74 28.82 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.22 151.2 25.76 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 121.696 0.76 . . . . 0.0 109.726 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.44 139.15 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -146.52 166.42 26.5 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 115' ' ' LEU . 90.6 mt -88.49 121.17 30.58 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -112.49 140.9 46.85 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.68 138.91 53.35 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 119.116 -1.033 . . . . 0.0 108.821 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.3 134.18 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.349 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -119.26 88.18 2.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.483 ' HA ' HD22 ' A' ' 148' ' ' LEU . 23.5 pttp -63.65 -20.13 65.44 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.996 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.503 ' HG3' ' CD2' ' A' ' 147' ' ' HIS . 17.9 ptm180 -68.04 -21.47 65.01 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.503 ' CD2' ' HG3' ' A' ' 146' ' ' ARG . 99.4 m-70 -139.05 86.64 2.15 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 145' ' ' LYS . 95.2 mt -100.91 4.52 42.71 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -95.1 10.92 34.0 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -83.36 140.11 32.61 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -71.17 -23.96 62.15 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.33 -26.54 62.87 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -89.57 -1.06 57.91 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.34 133.72 52.7 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.67 0.747 . . . . 0.0 109.051 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -122.84 144.58 49.1 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -126.24 163.82 22.35 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -126.79 144.15 51.04 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.64 144.35 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -109.58 154.94 42.12 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.97 140.58 92.7 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 122.019 1.813 . . . . 0.0 113.198 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.6 t -118.61 125.86 74.72 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--O 1.263 1.782 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 121.205 0.526 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.73 40.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.78 149.13 32.75 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.79 143.63 23.73 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.7 tpp -83.28 -20.6 34.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 75.74 55.84 0.06 Allowed 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.31 -22.23 61.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -81.41 144.57 31.33 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.6 m -125.16 143.94 50.69 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -124.66 171.8 9.77 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 158.52 16.44 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.405 ' HB3' ' HD2' ' A' ' 13' ' ' PRO . 81.3 m-85 -90.56 156.91 44.98 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 12' ' ' PHE . 38.7 Cg_endo -66.17 150.92 84.74 Favored 'Trans proline' 0 CA--C 1.498 -1.279 0 C-N-CA 121.53 1.487 . . . . 0.0 112.166 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -102.4 158.68 16.03 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.27 -165.39 31.4 Favored Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.469 ' HB3' HD21 ' A' ' 55' ' ' LEU . 50.1 m0 -77.3 140.36 40.0 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -158.41 164.49 36.23 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -120.59 139.99 52.17 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.47 HD11 HD12 ' A' ' 64' ' ' LEU . 84.5 mt -102.26 115.52 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -114.06 131.55 56.34 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -85.5 124.25 31.86 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.15 -36.29 79.39 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.1 t -64.07 -42.68 96.89 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.601 -0.687 . . . . 0.0 111.214 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -96.52 -24.16 16.2 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.052 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.03 17.61 78.72 Favored Glycine 0 C--N 1.347 1.158 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -109.69 166.27 11.04 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.73 160.76 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.43 HD22 HG11 ' A' ' 138' ' ' VAL . 1.8 mp -70.68 135.19 48.14 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.54 0.686 . . . . 0.0 109.661 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.5 ttp -145.58 164.67 30.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.525 ' CG1' ' H ' ' A' ' 34' ' ' SER . 4.0 p -70.53 174.37 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.21 -48.03 71.47 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.713 -0.617 . . . . 0.0 111.317 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -171.85 74.1 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 119.564 -0.854 . . . . 0.0 108.888 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 51.94 47.37 24.9 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.525 ' H ' ' CG1' ' A' ' 30' ' ' VAL . 66.8 m -99.17 117.71 34.24 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -91.86 -2.36 56.89 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -87.39 141.41 28.65 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.1 m -74.73 154.37 38.42 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.77 7.78 61.19 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 10.2 p -93.94 141.97 24.4 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.543 ' HA ' HG13 ' A' ' 87' ' ' VAL . 35.6 Cg_exo -61.89 153.53 67.66 Favored 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 122.527 2.151 . . . . 0.0 113.945 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.8 mm -96.78 129.89 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 27.6 m -133.71 166.37 29.25 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.207 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 125' ' ' ILE . 91.5 mt -90.36 144.54 25.72 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.66 148.63 31.26 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.4 t -67.69 156.3 37.23 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.99 139.24 58.21 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.01 148.03 52.7 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -83.46 -10.45 58.36 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -125.14 146.79 49.32 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.96 42.67 22.46 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -91.94 -2.06 56.96 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.39 90.95 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.0 p -72.78 -13.22 61.27 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.18 1.82 42.37 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 16' ' ' TRP . 30.0 mt -98.28 138.41 35.58 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.6 150.99 48.57 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -127.59 133.39 49.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -89.18 110.47 21.21 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.34 141.6 83.46 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.1 -19.32 40.61 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 121.823 1.682 . . . . 0.0 114.076 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -73.67 -17.73 61.11 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.4 10.39 17.5 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.93 164.9 11.44 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 118.607 1.203 . . . . 0.0 108.25 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.47 HD12 HD11 ' A' ' 19' ' ' ILE . 91.9 mt -112.73 129.94 56.24 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.4 t -114.8 134.04 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -77.8 129.34 35.33 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.58 -41.61 99.04 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 122.035 -0.416 . . . . 0.0 110.996 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -75.29 -53.68 8.36 Favored 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 122.039 -0.413 . . . . 0.0 111.171 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.6 m -70.34 -39.77 74.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.58 90.07 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -96.73 166.76 11.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.52 160.68 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.5 mtt -70.5 139.66 51.69 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -157.07 170.09 23.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.17 143.54 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.74 -42.26 86.52 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.29 -33.44 69.72 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.9 -7.73 81.17 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.1 m -124.88 128.72 24.8 Favored Pre-proline 0 N--CA 1.436 -1.135 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.53 126.59 13.65 Favored 'Trans proline' 0 CA--C 1.494 -1.476 0 C-N-CA 120.91 1.073 . . . . 0.0 112.865 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.7 167.09 23.01 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.03 128.1 33.08 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.21 76.52 Favored Glycine 0 C--N 1.345 1.037 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.34 143.31 14.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.71 155.98 25.26 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-O 121.46 0.648 . . . . 0.0 109.466 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.1 mm -113.71 128.78 70.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.543 HG13 ' HA ' ' A' ' 40' ' ' PRO . 33.3 m -133.22 161.58 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -85.72 137.68 32.64 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -142.38 175.22 9.94 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -71.83 165.18 24.64 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -84.53 156.98 21.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.05 159.01 44.35 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.26 -27.72 0.19 Allowed Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.8 t -64.19 -42.49 96.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -118.51 17.96 13.62 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -125.74 127.51 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -62.64 146.49 51.96 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -65.79 -19.38 65.87 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.36 -2.26 57.97 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -115.51 7.92 15.05 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -83.29 110.11 17.82 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -89.32 -7.96 54.27 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -80.11 -8.98 59.67 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -76.23 128.26 34.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.88 155.16 30.64 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.56 159.95 13.45 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 105.898 -2.881 . . . . 0.0 105.898 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 67.6 tp -132.98 125.25 29.34 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 97.8 p -93.02 157.57 38.93 Favored Pre-proline 0 N--CA 1.442 -0.841 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 56.5 Cg_endo -70.96 -8.5 23.76 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 C-N-CA 121.747 1.631 . . . . 0.0 112.539 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.457 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 90.3 m-85 -87.52 -5.23 58.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.93 9.61 60.74 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.457 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 79.8 m80 -93.15 136.98 32.91 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -110.63 127.11 67.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.486 ' HB3' ' CG2' ' A' ' 122' ' ' ILE . 1.0 OUTLIER -133.8 178.52 6.88 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 4.3 mt -86.81 149.65 24.69 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.97 -36.42 84.34 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.765 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -99.8 -9.7 22.67 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.412 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.489 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.92 83.39 40.63 Favored Pre-proline 0 CA--C 1.493 -1.225 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -69.15 -8.73 24.39 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.206 1.938 . . . . 0.0 111.987 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.5 m -86.92 -14.65 41.24 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 140' ' ' LEU . 75.6 mt -109.19 131.25 55.24 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.486 ' CG2' ' HB3' ' A' ' 114' ' ' TYR . 25.1 pt -134.22 166.5 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.504 HD21 HD13 ' A' ' 140' ' ' LEU . 84.7 mt -78.94 137.05 37.44 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.4 171.87 34.13 Favored Glycine 0 CA--C 1.494 -1.274 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.612 HG21 HD11 ' A' ' 43' ' ' LEU . 1.6 pp -135.36 160.19 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -118.35 141.89 48.07 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -134.75 149.69 50.47 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.3 t -149.99 -179.52 7.22 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -71.67 -29.04 64.16 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.48 37.25 2.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.55 101.83 6.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.522 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 29.2 tpt180 -65.13 135.76 55.88 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -61.7 -35.86 79.26 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.522 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 14.8 mt-10 -85.55 86.02 7.39 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.55 4.64 1.62 Allowed Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.86 129.31 39.34 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.51 ' O ' HG23 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -92.32 155.68 17.76 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.542 0.687 . . . . 0.0 109.399 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.43 HG11 HD22 ' A' ' 28' ' ' LEU . 2.1 p -101.11 146.92 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -146.6 166.4 26.64 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.504 HD13 HD21 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -91.12 114.22 26.69 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -103.95 142.93 33.56 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 tp -70.3 137.06 50.36 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.66 143.21 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.36 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -138.03 96.56 3.23 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.08 -18.46 63.41 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.192 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -66.45 -27.79 68.09 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -133.53 84.7 2.15 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.4 mt -107.8 4.38 25.47 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -97.72 19.94 12.79 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -83.2 136.46 34.41 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -70.41 -22.19 62.76 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.15 -26.03 61.94 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -92.32 -0.79 57.37 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -92.52 132.97 36.38 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -124.54 140.12 53.24 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -123.92 155.75 37.56 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -118.06 139.25 51.48 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 t -127.93 144.15 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.116 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.0 mt -108.56 152.28 42.05 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.63 150.41 74.64 Favored 'Trans proline' 0 CA--C 1.497 -1.346 0 C-N-CA 121.745 1.63 . . . . 0.0 113.136 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.4 t -118.77 125.95 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.263 1.793 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 121.267 0.556 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.69 150.11 29.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.24 153.51 30.75 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.23 76.6 7.62 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 75.7 mtm -87.76 -11.78 47.09 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.24 85.24 2.32 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.43 -20.95 59.85 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -78.07 142.81 37.91 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -146.67 139.48 25.26 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -133.71 171.46 14.1 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.13 162.5 32.34 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -82.09 124.81 78.43 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.43 -21.84 19.24 Favored 'Trans proline' 0 CA--C 1.499 -1.234 0 C-N-CA 121.818 1.679 . . . . 0.0 113.043 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 155.07 17.43 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.98 -53.27 2.89 Favored Glycine 0 CA--C 1.494 -1.239 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -94.06 134.22 36.72 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -163.32 162.73 25.26 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -118.86 138.87 52.43 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 80.9 mt -105.67 118.0 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -116.63 131.24 57.0 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -86.23 128.8 34.96 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -65.48 -24.64 67.21 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.0 p -67.47 -38.09 83.89 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 121.357 -0.84 . . . . 0.0 111.471 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -112.33 -20.1 11.95 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.043 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.32 22.07 76.58 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -109.81 163.15 13.79 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 m -115.04 161.25 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mp -68.13 132.28 46.91 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.609 0.719 . . . . 0.0 109.438 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.7 ttp -145.71 163.67 34.19 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.23 157.04 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.424 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 36.2 t70 -49.39 -39.9 34.04 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 122.133 -0.354 . . . . 0.0 111.714 -177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -150.94 36.13 0.61 Allowed 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.342 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 61.84 42.93 9.91 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 m -91.6 119.31 31.39 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -78.55 -12.13 60.0 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -86.07 145.96 26.83 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.8 m -76.34 162.23 28.06 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.07 11.26 34.69 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.0 p -117.68 147.69 41.48 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.07 162.35 34.48 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.214 1.943 . . . . 0.0 113.401 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.9 mm -94.38 131.71 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 23.6 m -132.2 170.24 20.31 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.6 mt -99.14 143.46 29.39 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.53 150.95 36.53 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 m -59.99 145.26 46.85 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 139.84 58.2 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -126.8 147.61 50.0 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -88.5 -7.49 56.43 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.22 140.13 52.45 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.5 t0 57.6 44.96 20.05 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -86.49 -2.19 58.25 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.47 84.06 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.5 p -72.15 -14.74 61.9 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -103.07 3.32 35.88 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.5 mt -97.16 135.41 39.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -128.83 154.74 46.15 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -136.54 152.34 50.39 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -103.11 116.41 32.45 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.59 157.05 67.85 Favored Pre-proline 0 N--CA 1.441 -0.913 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.64 -24.08 60.71 Favored 'Trans proline' 0 CA--C 1.498 -1.287 0 C-N-CA 122.296 1.997 . . . . 0.0 113.867 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -71.24 -19.58 62.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.54 10.37 31.29 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.459 ' CD2' ' HB2' ' A' ' 103' ' ' GLN . 2.1 m-85 -97.7 159.37 14.97 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.18 129.57 55.18 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.94 136.17 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -76.71 132.49 39.35 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -62.59 -42.81 99.79 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.053 -0.404 . . . . 0.0 111.184 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.9 -51.63 9.42 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.812 -0.555 . . . . 0.0 111.386 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.3 m -68.37 -39.76 81.67 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.43 5.38 90.01 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 106.422 -2.671 . . . . 0.0 106.422 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -99.39 161.46 13.6 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' A' ' 91' ' ' GLN . 1.1 m -108.05 165.98 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 63.3 mtt -80.2 133.2 36.0 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -152.04 175.93 12.03 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 118.876 -1.129 . . . . 0.0 108.913 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.94 142.25 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.73 -43.1 80.78 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.895 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -71.96 -33.04 67.86 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.14 -6.79 82.45 Favored Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 105.77 -2.932 . . . . 0.0 105.77 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.7 m -115.62 120.84 35.38 Favored Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.13 115.78 4.45 Favored 'Trans proline' 0 CA--C 1.497 -1.361 0 C-N-CA 121.211 1.274 . . . . 0.0 112.918 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.9 168.04 21.8 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.53 137.57 39.67 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.94 2.36 88.46 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.54 132.71 32.92 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 CA-C-N 119.355 1.577 . . . . 0.0 108.228 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -73.71 154.81 39.49 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 121.518 0.675 . . . . 0.0 109.74 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.405 HG22 HD12 ' A' ' 86' ' ' ILE . 48.5 mm -105.19 128.43 59.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.898 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.6 166.3 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -100.95 141.83 33.28 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.32 169.97 13.58 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.3 m -73.17 129.18 37.49 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.588 ' HB2' HG21 ' A' ' 72' ' ' VAL . 97.1 mm-40 -131.25 161.59 31.91 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.485 0.66 . . . . 0.0 110.141 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 72.98 -159.41 0.09 Allowed 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.37 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.3 -166.21 37.59 Favored Glycine 0 CA--C 1.487 -1.662 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -68.82 -23.95 64.32 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -160.12 71.12 0.45 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.425 ' CG1' HD22 ' A' ' 101' ' ' ASN . 9.3 p -81.91 142.06 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 141.84 57.28 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -74.47 -15.53 60.88 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.38 -5.09 57.75 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -116.37 13.32 15.49 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.425 HD22 ' CG1' ' A' ' 96' ' ' VAL . 1.0 OUTLIER -84.66 97.99 9.95 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -98.87 -9.95 23.55 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.459 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -94.37 -1.68 53.33 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -72.17 125.36 27.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -115.81 151.77 34.59 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.64 141.88 17.27 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 105.78 -2.928 . . . . 0.0 105.78 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.1 tp -105.6 124.92 50.36 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.417 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 0.9 OUTLIER -93.99 140.53 22.96 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.31 -8.17 22.96 Favored 'Trans proline' 0 CA--C 1.5 -1.214 0 C-N-CA 121.998 1.799 . . . . 0.0 112.916 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.425 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 98.2 m-85 -86.8 0.11 55.4 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.69 35.0 8.04 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.425 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 80.6 m80 -127.08 147.99 50.15 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -118.51 126.86 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.058 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.644 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -137.74 174.03 11.02 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 118' ' ' LYS . 13.3 mt -83.44 150.67 25.89 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.03 -22.91 58.16 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -104.69 -21.91 13.31 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.915 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.589 ' HB2' HD12 ' A' ' 115' ' ' LEU . 13.8 mptt -132.39 84.82 50.51 Favored Pre-proline 0 CA--C 1.498 -1.056 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -67.12 -9.24 24.39 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.542 2.161 . . . . 0.0 112.827 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.6 p -84.99 -14.76 46.46 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.405 HD22 HD11 ' A' ' 142' ' ' LEU . 80.4 mt -104.83 130.42 52.95 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' A' ' 114' ' ' TYR . 32.0 pt -135.27 166.47 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.6 mt -83.9 139.23 32.75 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.31 179.22 35.97 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 107.555 -2.218 . . . . 0.0 107.555 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.428 ' O ' HD12 ' A' ' 125' ' ' ILE . 2.0 pp -132.67 160.55 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -108.76 125.29 51.77 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -96.33 135.1 38.63 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.5 t -149.92 157.32 43.06 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -69.76 -26.63 64.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.12 32.14 3.63 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.07 103.67 6.65 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.532 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 28.0 tpt180 -61.73 136.38 57.97 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HA ' ' HG ' ' A' ' 136' ' ' LEU . 90.7 mtm180 -61.84 -35.37 78.05 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.532 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 94.5 mt-10 -84.87 86.53 7.35 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.16 12.12 1.7 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 133' ' ' ARG . 76.5 mt -64.76 127.86 33.32 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -84.17 151.83 24.63 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 121.746 0.784 . . . . 0.0 109.763 -177.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.3 t -94.94 140.12 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -146.63 165.78 28.5 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.99 122.94 26.8 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -110.97 139.11 46.58 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 142' ' ' LEU . 3.7 tp -78.34 135.62 37.53 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 118.684 -1.206 . . . . 0.0 108.075 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.87 146.68 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.225 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -137.86 96.35 3.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -64.17 -19.59 65.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.664 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -70.12 -24.0 63.12 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -139.06 85.25 2.06 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -100.79 4.51 42.99 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.14 21.09 10.33 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -83.26 130.35 35.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -68.01 -22.24 64.99 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.48 -36.12 73.67 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -89.49 -1.41 58.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -94.76 131.41 40.63 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -119.62 137.88 53.59 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -112.09 154.77 24.92 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -128.57 143.43 50.96 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.99 144.69 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.64 153.76 42.04 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -58.08 141.06 96.15 Favored 'Trans proline' 0 CA--C 1.499 -1.271 0 C-N-CA 122.076 1.85 . . . . 0.0 113.14 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.8 t -118.73 125.73 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 C--O 1.262 1.727 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.201 0.524 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.98 154.11 35.38 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.22 153.96 34.83 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 64.84 53.76 1.42 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -76.61 -8.21 56.77 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -92.1 67.57 5.08 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.74 -22.21 61.65 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -99.62 152.33 20.17 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 t -146.21 138.42 25.17 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -94.55 170.9 9.14 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -104.78 162.67 13.11 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.4 ' HB3' ' HD2' ' A' ' 13' ' ' PRO . 89.3 m-85 -83.3 156.83 66.01 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 12' ' ' PHE . 39.4 Cg_endo -66.49 151.5 82.88 Favored 'Trans proline' 0 CA--C 1.498 -1.286 0 C-N-CA 121.604 1.536 . . . . 0.0 112.395 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -88.61 156.7 18.9 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.777 0.798 . . . . 0.0 108.993 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.75 -168.42 37.75 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.467 ' HB3' HD21 ' A' ' 55' ' ' LEU . 46.5 m0 -77.73 146.1 36.15 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.17 160.83 41.2 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -119.62 139.52 52.06 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.493 HG23 ' CE3' ' A' ' 155' ' ' TRP . 89.5 mt -107.27 114.65 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -109.99 132.7 53.92 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -83.47 122.95 29.21 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -61.83 -34.61 76.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 t -63.7 -43.55 96.29 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 121.653 -0.655 . . . . 0.0 111.399 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -101.62 -21.84 14.6 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.49 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.7 19.68 78.86 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -110.52 167.02 10.53 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 m -115.0 159.44 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.421 ' CD2' ' HB ' ' A' ' 19' ' ' ILE . 2.5 pt? -85.03 144.22 28.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.221 1.01 . . . . 0.0 109.259 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.572 ' HG2' ' H ' ' A' ' 30' ' ' VAL . 33.4 ttp -145.6 173.88 11.66 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.572 ' H ' ' HG2' ' A' ' 29' ' ' MET . 21.5 t -68.42 163.98 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.428 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 36.3 t70 -54.94 -40.47 69.95 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.741 -0.599 . . . . 0.0 110.433 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -160.2 48.32 0.26 Allowed 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 55.01 46.55 24.03 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.5 m -81.7 129.14 34.61 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -90.72 -2.12 57.83 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -97.54 152.44 19.02 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.0 p -80.29 166.73 21.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.6 12.51 75.07 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.2 t -94.18 123.51 58.75 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.569 ' HA ' HG12 ' A' ' 87' ' ' VAL . 42.8 Cg_exo -59.17 148.94 83.49 Favored 'Trans proline' 0 CA--C 1.499 -1.267 0 C-N-CA 122.167 1.912 . . . . 0.0 113.414 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.1 mm -88.06 129.71 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 24.7 m -131.92 161.41 41.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -86.65 145.85 26.55 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.99 152.16 38.95 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -63.65 144.45 57.01 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.46 139.32 57.77 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -123.5 146.91 47.71 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 m -86.9 -14.4 42.04 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -125.41 147.27 49.25 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 58.49 41.27 22.92 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -90.37 0.35 57.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.03 85.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 t -67.48 -24.43 65.59 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.97 3.36 55.03 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 16' ' ' TRP . 38.4 mt -98.1 138.01 36.04 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.948 0.88 . . . . 0.0 108.924 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -130.69 156.22 45.29 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -142.22 153.71 44.21 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.453 ' CD2' ' O ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -107.46 135.92 48.12 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.004 0.907 . . . . 0.0 108.754 -178.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 98.7 m-20 -86.35 158.92 54.3 Favored Pre-proline 0 N--CA 1.436 -1.152 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 59' ' ' ASP . 20.8 Cg_endo -61.0 -18.15 56.01 Favored 'Trans proline' 0 CA--C 1.499 -1.26 0 C-N-CA 121.616 1.544 . . . . 0.0 113.162 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.2 m -80.22 -13.08 59.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.6 39.97 Favored Glycine 0 C--N 1.358 1.763 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -96.77 147.68 23.68 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.46 134.38 43.5 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.16 137.56 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -76.82 130.95 38.36 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -62.55 -42.61 99.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.203 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -77.95 -52.36 8.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.845 -0.534 . . . . 0.0 111.418 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.7 m -70.4 -39.09 74.7 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.88 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.37 5.14 89.83 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 106.251 -2.739 . . . . 0.0 106.251 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -96.56 167.44 11.14 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.9 m -116.53 161.18 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 61.6 mtt -73.49 140.52 46.48 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -159.22 169.85 23.22 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.93 143.44 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.51 76.63 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.624 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HZ2' ' HG3' ' A' ' 81' ' ' LYS . 58.6 mtpt -72.33 -32.84 66.86 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.15 -7.99 80.61 Favored Glycine 0 CA--C 1.495 -1.216 0 N-CA-C 105.871 -2.892 . . . . 0.0 105.871 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.6 m -119.67 126.23 27.04 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.59 117.21 5.03 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 121.17 1.247 . . . . 0.0 113.069 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.438 ' HG3' ' HZ2' ' A' ' 77' ' ' LYS . 75.8 mmtt -137.07 162.73 32.56 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.68 129.8 37.69 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.68 8.65 82.56 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.45 142.22 15.75 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 CA-C-N 118.619 1.21 . . . . 0.0 108.235 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -82.3 155.32 24.87 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.466 0.65 . . . . 0.0 109.495 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 86' ' ' ILE . 48.3 mm -109.49 129.36 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.9 m -132.92 166.73 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -81.78 141.01 33.89 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -142.13 170.68 15.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.6 m -70.3 148.3 48.66 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -68.31 137.54 54.74 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.63 -158.74 0.69 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.56 -16.13 56.69 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.2 p -70.24 -39.36 75.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -133.3 21.0 4.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.7 t -126.67 129.32 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -62.07 141.93 57.83 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -69.23 -17.12 63.74 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -89.71 -6.25 56.26 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.5 mt -119.55 10.05 11.68 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -94.56 132.06 39.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.45 -6.78 49.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.78 -10.57 59.47 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.12 128.49 33.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.22 154.77 32.86 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.85 158.89 14.04 Favored Glycine 0 C--N 1.353 1.48 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.3 tp -118.43 120.07 36.46 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.443 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.1 t -82.07 140.55 46.25 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.48 -9.36 25.07 Favored 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 121.832 1.688 . . . . 0.0 112.768 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.402 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 96.7 m-85 -90.68 2.34 56.03 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.98 20.25 40.08 Favored Glycine 0 C--N 1.356 1.684 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.402 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 76.6 m80 -108.91 150.23 28.01 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.7 mt -116.2 126.13 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.663 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -131.78 174.33 10.25 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.563 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 14.0 mt -84.11 150.01 25.83 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.38 -23.5 61.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -106.83 -18.86 13.81 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.149 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.563 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 13.9 mptt -132.18 84.94 51.12 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.6 -9.22 24.69 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.506 2.137 . . . . 0.0 112.58 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 88.6 p -83.99 -15.99 45.66 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 140' ' ' LEU . 73.3 mt -106.63 131.02 54.26 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.663 HG22 ' HB3' ' A' ' 114' ' ' TYR . 32.0 pt -134.21 164.44 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.7 mt -81.47 138.48 35.51 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.7 -179.52 38.1 Favored Glycine 0 CA--C 1.494 -1.25 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -130.35 161.41 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.516 ' O ' HD23 ' A' ' 136' ' ' LEU . 39.9 ttmt -113.75 144.42 43.0 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -66.95 156.82 34.88 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -110.97 160.47 16.78 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -65.26 -36.1 83.06 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -95.59 3.41 54.08 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 50.7 44.63 27.63 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.088 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -86.07 114.75 23.19 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -74.61 -20.12 60.03 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -91.32 90.05 7.55 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 134.06 2.46 3.41 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 126' ' ' LYS . 89.9 mt -66.96 131.18 45.34 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.609 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -90.85 156.62 17.89 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.602 0.715 . . . . 0.0 109.598 -177.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.67 139.55 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -148.14 167.59 24.65 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.635 HD13 HD12 ' A' ' 121' ' ' LEU . 90.7 mt -89.2 118.86 29.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -104.07 138.48 40.52 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.27 135.02 45.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 118.924 -1.11 . . . . 0.0 108.115 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.72 141.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.189 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -131.35 101.88 5.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -64.78 -28.73 69.77 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.553 ' HG3' ' CD2' ' A' ' 147' ' ' HIS . 37.9 ptt180 -68.8 -18.42 64.18 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.553 ' CD2' ' HG3' ' A' ' 146' ' ' ARG . 97.4 m-70 -132.97 77.29 1.73 Allowed 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.6 mt -99.99 3.74 44.44 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -97.35 31.79 2.41 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -102.3 116.57 32.91 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -68.33 -20.42 64.73 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.951 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -72.33 -19.37 61.66 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -96.91 -0.98 46.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -98.19 133.6 42.4 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.493 ' CE3' HG23 ' A' ' 19' ' ' ILE . 94.9 m95 -118.36 139.02 52.0 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -110.27 144.45 38.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -112.04 135.43 52.69 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.4 t -128.79 144.46 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.57 153.03 41.61 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.67 149.49 79.08 Favored 'Trans proline' 0 CA--C 1.496 -1.4 0 C-N-CA 121.764 1.643 . . . . 0.0 113.278 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.7 t -120.88 126.34 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.265 1.87 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.107 0.479 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 152.95 32.7 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.54 153.55 32.62 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.71 99.64 11.45 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 tpp -66.08 -40.11 90.59 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.07 88.51 2.9 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -72.69 -23.55 60.89 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.5 146.57 30.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -146.31 138.91 25.33 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -97.78 163.32 12.86 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -90.63 138.28 31.69 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -75.03 155.71 86.36 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.6 141.81 95.44 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 121.922 1.748 . . . . 0.0 112.691 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.55 157.48 16.18 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.25 -162.81 37.02 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.459 ' HB3' HD21 ' A' ' 55' ' ' LEU . 49.0 m0 -79.67 142.94 35.08 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -158.04 163.01 38.14 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -119.8 139.82 51.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.7 mt -102.3 113.94 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -114.42 131.06 56.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -83.86 126.27 32.8 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -63.35 -28.28 69.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.8 p -71.0 -36.99 72.68 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 121.354 -0.841 . . . . 0.0 111.396 -176.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -105.05 -23.8 12.89 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.373 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.83 18.46 80.11 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -108.0 165.31 11.56 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -117.57 160.42 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.8 mp -68.63 133.76 48.94 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.956 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.6 ttp -145.43 163.25 35.22 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.74 164.08 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 18.6 t70 -53.62 -39.18 64.74 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 121.871 -0.518 . . . . 0.0 110.294 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -161.62 50.93 0.23 Allowed 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 54.87 41.59 31.78 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.9 m -75.19 132.96 41.5 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -96.81 1.38 50.66 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -103.02 150.27 23.73 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -77.01 158.42 30.59 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.66 8.59 62.11 Favored Glycine 0 C--N 1.356 1.661 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 32.2 t -93.35 126.14 51.61 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HA ' HG13 ' A' ' 87' ' ' VAL . 42.5 Cg_exo -59.23 150.63 72.92 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 122.251 1.968 . . . . 0.0 113.278 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.9 mm -90.62 130.09 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 25.6 m -132.19 164.2 35.49 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 121.701 0.762 . . . . 0.0 108.971 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.518 HD13 ' HB2' ' A' ' 136' ' ' LEU . 95.8 mt -85.42 145.29 27.52 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.95 148.73 32.04 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -62.91 143.5 57.6 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.4 139.45 57.67 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -121.35 146.56 46.73 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 p -87.34 -16.37 35.23 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -124.3 147.03 48.42 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 58.11 42.69 21.93 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -91.18 3.16 55.53 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.35 -37.41 87.16 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m -69.32 -17.37 63.71 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -100.64 3.88 42.85 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' A' ' 16' ' ' TRP . 25.8 mt -98.66 136.57 38.54 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -128.53 153.83 46.78 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -137.23 151.05 48.3 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -99.38 116.77 32.32 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -80.95 155.39 72.82 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.03 -15.75 45.56 Favored 'Trans proline' 0 CA--C 1.498 -1.286 0 C-N-CA 122.004 1.803 . . . . 0.0 113.256 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -77.94 -12.69 60.0 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.66 21.06 15.18 Favored Glycine 0 C--N 1.356 1.693 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -117.14 159.02 23.25 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 118.392 1.096 . . . . 0.0 108.215 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.01 126.29 52.02 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 72' ' ' VAL . 98.1 t -115.57 137.34 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -74.07 131.3 41.21 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.21 -40.75 98.35 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 122.021 -0.424 . . . . 0.0 110.852 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -78.43 -56.33 4.52 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.305 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.0 m -70.22 -38.43 75.25 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.86 9.57 85.26 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -94.27 157.59 15.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.725 HG22 HG23 ' A' ' 65' ' ' VAL . 13.7 t -106.79 150.07 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 mtt -69.97 138.92 52.68 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -157.61 172.73 18.01 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.104 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -88.87 143.72 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.24 -42.8 88.11 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.44 -33.79 69.69 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 89.68 -8.42 79.85 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.5 m -124.73 122.29 25.68 Favored Pre-proline 0 N--CA 1.436 -1.159 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.03 129.21 32.03 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 121.389 1.392 . . . . 0.0 113.028 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 155.08 42.19 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.63 130.25 39.2 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.38 8.78 80.52 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.61 144.99 11.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -87.19 168.9 12.82 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.1 mm -116.92 128.64 74.27 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.538 HG13 ' HA ' ' A' ' 40' ' ' PRO . 34.2 m -130.24 160.08 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -86.22 138.41 31.89 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -140.16 167.88 21.11 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 m -68.81 159.7 31.94 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.2 151.46 43.42 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.67 147.92 49.97 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.02 -167.02 43.29 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.8 p -85.63 1.59 48.6 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -98.82 21.25 11.74 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.2 t -115.08 123.25 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -65.25 150.11 48.79 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.7 -19.08 65.68 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -90.78 -2.31 57.8 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.8 mt -114.14 7.54 16.68 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -83.76 97.96 9.43 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -91.63 -6.64 51.88 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.289 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -74.26 -11.64 60.33 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -72.59 138.58 46.91 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -129.09 154.28 46.83 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.7 143.54 17.71 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 106.489 -2.644 . . . . 0.0 106.489 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.4 tp -109.54 123.95 50.28 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.473 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.6 t -89.15 139.16 28.69 Favored Pre-proline 0 N--CA 1.438 -1.047 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.93 -9.06 23.55 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.72 1.613 . . . . 0.0 112.722 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -88.07 -0.24 56.81 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.98 16.58 40.84 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -107.8 149.16 28.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.29 127.19 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.642 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -129.13 -178.67 4.74 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' A' ' 118' ' ' LYS . 15.2 mt -91.97 151.29 20.57 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.2 -22.98 60.34 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -104.39 -21.78 13.43 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.765 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.631 ' HB2' HD13 ' A' ' 115' ' ' LEU . 4.2 mptp? -133.39 85.59 43.27 Favored Pre-proline 0 CA--C 1.493 -1.232 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -66.89 -8.54 21.85 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.415 2.077 . . . . 0.0 112.281 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 90.0 p -87.19 -15.64 37.68 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.2 mt -103.59 130.98 51.11 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.642 HG22 ' HB3' ' A' ' 114' ' ' TYR . 32.7 pt -133.61 160.36 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD21 HG11 ' A' ' 138' ' ' VAL . 6.1 mp -82.69 138.15 34.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.28 179.85 38.18 Favored Glycine 0 CA--C 1.494 -1.234 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 137' ' ' HIS . 1.9 pp -125.2 160.78 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.464 ' O ' HD22 ' A' ' 136' ' ' LEU . 86.8 tttt -118.02 145.85 44.47 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -75.55 164.67 26.1 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.9 p -128.88 167.54 17.24 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -65.52 -36.0 82.52 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.28 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -90.12 -1.64 57.97 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 48.57 48.33 19.7 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.752 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -84.18 110.26 18.39 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -75.69 -19.01 59.42 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.98 88.2 6.49 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 131.69 6.61 3.26 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.518 ' HB2' HD13 ' A' ' 43' ' ' LEU . 82.1 mt -65.64 129.22 38.99 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.55 ' O ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -90.87 155.49 18.72 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 121.663 0.744 . . . . 0.0 109.426 -177.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.509 HG11 HD21 ' A' ' 123' ' ' LEU . 30.9 t -94.33 140.28 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -147.18 167.66 23.62 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.51 126.56 44.11 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -119.63 154.7 33.59 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 120' ' ' SER . 1.1 tp -75.63 136.57 40.45 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.562 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.22 144.89 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.59 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -139.13 97.59 3.33 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -64.45 -18.5 64.81 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.802 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -69.74 -22.41 63.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -133.87 83.81 2.07 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.6 mt -100.37 5.15 44.35 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -94.05 21.48 6.72 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -90.52 110.78 21.9 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.04 -21.13 65.93 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.903 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -74.39 -16.95 60.87 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -99.22 -0.53 41.25 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -98.42 133.88 42.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -116.73 137.85 51.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -112.38 146.25 38.66 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 136.31 52.1 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.6 t -127.35 145.0 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.1 mt -108.96 152.46 42.43 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.42 149.3 74.82 Favored 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 121.709 1.606 . . . . 0.0 113.114 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.55 158.83 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 C--O 1.262 1.727 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.728 0.299 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.96 98.31 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.74 47.07 8.36 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.42 71.52 10.79 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -106.47 12.92 29.09 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -120.84 91.57 3.56 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -86.54 -34.19 20.03 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -83.59 146.43 28.3 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.3 t -146.41 138.17 24.75 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.29 171.47 9.04 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.65 161.3 14.99 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.16 155.76 46.74 Favored Pre-proline 0 N--CA 1.441 -0.924 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.5 148.96 79.81 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 121.386 1.391 . . . . 0.0 112.17 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -91.94 157.83 16.61 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.815 0.817 . . . . 0.0 108.92 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.57 -165.65 35.47 Favored Glycine 0 CA--C 1.495 -1.18 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.463 ' HB3' HD21 ' A' ' 55' ' ' LEU . 52.7 m0 -75.83 141.91 42.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -156.1 162.34 40.27 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -120.05 137.16 54.27 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.404 HD11 HD13 ' A' ' 64' ' ' LEU . 86.9 mt -99.62 114.94 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -113.33 131.36 55.98 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -83.77 126.21 32.7 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -61.47 -35.98 79.14 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -67.1 -41.61 85.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.672 -0.642 . . . . 0.0 111.294 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -97.26 -24.6 15.61 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.331 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.28 17.8 79.0 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -111.0 168.57 9.39 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.18 161.11 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 mp -74.34 137.68 42.98 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.531 0.681 . . . . 0.0 110.874 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.4 ptm -147.09 176.06 10.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.4 t -74.41 162.66 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -56.01 -39.16 71.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 121.485 -0.76 . . . . 0.0 110.282 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -158.49 53.73 0.43 Allowed 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.054 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 51.64 48.93 21.91 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.0 m -98.23 127.48 44.19 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -92.59 -2.61 56.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -87.58 151.6 22.86 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.5 m -77.85 158.67 29.37 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.37 5.52 65.29 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.1 t -93.85 124.55 56.23 Favored Pre-proline 0 N--CA 1.438 -1.039 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -59.0 150.84 70.2 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 122.117 1.878 . . . . 0.0 113.433 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 mm -90.8 130.28 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 30.8 m -131.76 164.34 34.87 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.15 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.3 mt -91.57 147.74 22.79 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.04 151.6 29.52 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -66.11 159.56 25.87 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.023 0.916 . . . . 0.0 108.756 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.25 139.67 57.35 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.687 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.8 mmm-85 -127.65 147.17 50.37 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 m -87.85 -11.46 47.76 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -122.62 145.02 48.73 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 57.35 42.83 24.32 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 34.8 p90 -86.91 -1.38 57.78 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.08 89.59 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -70.65 -19.09 62.84 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 51' ' ' TYR . 8.4 mm100 -94.56 0.11 54.97 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 16' ' ' TRP . 68.6 mt -99.86 140.53 33.94 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-O 121.936 0.874 . . . . 0.0 109.793 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -129.78 152.49 49.22 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -136.44 133.1 36.28 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -96.41 128.5 43.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.97 160.42 66.15 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.19 -27.91 58.76 Favored 'Trans proline' 0 CA--C 1.499 -1.255 0 C-N-CA 121.935 1.757 . . . . 0.0 113.675 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.4 m -73.65 -16.56 61.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.22 12.83 32.68 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -89.08 150.18 22.87 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.404 HD13 HD11 ' A' ' 19' ' ' ILE . 88.7 mt -105.47 129.06 53.84 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.0 t -114.58 135.21 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -84.33 128.31 34.5 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.38 -40.39 96.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.921 -0.487 . . . . 0.0 111.31 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -64.79 -49.63 69.95 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -89.52 -31.37 17.67 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.576 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.08 3.39 90.4 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 107.247 -2.341 . . . . 0.0 107.247 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -93.09 170.62 9.51 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.8 m -118.37 162.45 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.1 mtt -71.12 139.94 50.46 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -157.68 166.61 32.35 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.99 142.68 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.52 84.91 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.425 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.5 -33.27 69.1 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.02 84.06 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.2 m -124.25 126.84 25.47 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.91 116.7 4.79 Favored 'Trans proline' 0 CA--C 1.496 -1.399 0 C-N-CA 121.115 1.21 . . . . 0.0 112.765 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -136.69 162.54 32.89 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.56 130.34 38.67 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.17 8.28 78.73 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 140' ' ' LEU . 12.1 p -71.74 145.21 12.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 118.586 1.193 . . . . 0.0 108.144 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -91.23 158.52 16.55 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.481 0.658 . . . . 0.0 109.25 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.8 mm -109.45 129.94 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 m -132.28 164.66 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -76.7 141.04 41.05 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -152.73 160.84 43.13 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 m -64.88 146.48 54.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -71.38 156.57 39.33 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.09 -154.3 0.54 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.03 -13.97 57.31 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.6 t -64.71 -45.08 88.08 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -136.78 21.69 3.09 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.4 t -125.11 130.23 73.14 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -61.22 141.76 57.28 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -67.75 -19.22 65.1 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.27 -5.03 56.78 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.3 mt -118.38 10.08 12.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -91.55 121.64 33.41 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -75.51 -8.57 57.09 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.275 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -73.55 -13.09 60.97 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -74.43 129.75 38.35 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -116.07 151.71 35.02 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.33 151.66 17.76 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.5 tp -118.91 121.85 40.93 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.424 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 8.6 t -84.81 140.62 37.76 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.85 -10.18 25.83 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.676 1.584 . . . . 0.0 112.689 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.414 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 95.8 m-85 -86.87 -2.45 58.6 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.01 12.08 50.78 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.414 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 80.6 m80 -99.81 144.62 28.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.51 126.38 73.04 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.593 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.97 177.22 7.6 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 118' ' ' LYS . 15.4 mt -87.41 150.59 23.7 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.24 -20.91 58.97 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -104.7 -24.39 12.95 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.561 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.613 ' HB2' HD13 ' A' ' 115' ' ' LEU . 13.8 mptt -131.9 84.45 53.9 Favored Pre-proline 0 CA--C 1.496 -1.099 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.05 -9.18 24.12 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.515 2.143 . . . . 0.0 113.014 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 88.2 p -83.22 -22.3 33.16 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.4 HD13 HD21 ' A' ' 140' ' ' LEU . 61.1 mt -96.24 131.68 42.47 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' A' ' 114' ' ' TYR . 22.7 pt -133.27 163.76 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.628 HD21 HD11 ' A' ' 140' ' ' LEU . 85.4 mt -81.52 139.67 35.0 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.71 176.34 40.55 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 106.909 -2.477 . . . . 0.0 106.909 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 138' ' ' VAL . 1.9 pp -129.39 159.19 41.7 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -102.04 145.77 28.85 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -116.77 140.6 49.24 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.4 t -149.35 155.87 41.18 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -69.52 -27.63 65.34 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.08 30.74 4.64 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -135.82 103.6 5.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -65.87 160.67 22.79 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -72.51 -13.11 61.34 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -95.62 89.25 5.29 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 127.31 7.81 4.74 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.46 133.55 49.74 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 118.987 1.394 . . . . 0.0 107.262 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -95.46 154.24 17.3 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.46 ' HA ' HG21 ' A' ' 125' ' ' ILE . 1.4 p -94.12 143.59 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -144.39 163.76 32.83 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.628 HD11 HD21 ' A' ' 123' ' ' LEU . 5.1 mp -94.33 124.22 38.22 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -122.11 156.24 34.02 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 120' ' ' SER . 1.0 OUTLIER -80.36 149.69 30.15 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.165 -178.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.42 HG13 HD13 ' A' ' 122' ' ' ILE . 7.3 m -63.13 155.8 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.57 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -139.22 100.14 3.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -66.59 -21.53 66.14 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.004 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -67.29 -25.42 66.03 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -142.51 88.44 2.07 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.0 mt -100.78 3.77 42.4 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -99.32 25.31 7.05 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -83.46 125.63 31.93 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.7 -22.9 62.4 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -74.02 -21.88 59.8 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.71 2.17 38.28 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.1 ttp85 -102.81 132.38 49.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -119.59 142.89 47.98 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.541 0.686 . . . . 0.0 109.226 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -120.43 152.89 37.33 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.98 140.18 50.11 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.64 144.75 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.5 mt -109.86 152.46 42.98 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.41 149.06 74.7 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.731 1.621 . . . . 0.0 113.084 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.4 p -145.98 144.74 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.5 t . . . . . 0 C--O 1.262 1.75 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mmm . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.037 0.446 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.8 151.67 29.82 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.15 -169.04 0.15 Allowed 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.51 144.88 20.99 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -112.5 0.31 15.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.86 77.15 1.1 Allowed 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -71.32 -23.38 61.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -78.68 145.11 34.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.3 p -146.5 154.88 42.07 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -136.44 170.36 16.18 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -106.14 161.52 14.44 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' A' ' 13' ' ' PRO . 82.0 m-85 -90.39 156.69 45.56 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 12' ' ' PHE . 38.0 Cg_endo -65.86 148.96 86.83 Favored 'Trans proline' 0 CA--C 1.499 -1.251 0 C-N-CA 121.411 1.407 . . . . 0.0 112.516 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -95.02 158.57 15.41 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.76 -161.53 28.35 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.445 ' HB3' HD21 ' A' ' 55' ' ' LEU . 43.1 m0 -83.61 143.62 30.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.546 ' HZ ' HD21 ' A' ' 64' ' ' LEU . 52.4 p90 -157.04 163.71 38.75 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -121.76 139.76 53.18 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.7 mt -106.86 119.2 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 27.9 pttt -122.66 147.05 46.9 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.644 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -89.24 127.98 35.8 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -62.9 -18.19 62.69 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.5 t -62.29 -46.06 90.48 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 119.1 0.864 . . . . 0.0 110.883 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -125.8 -7.67 6.72 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.85 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.2 12.07 84.38 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -84.68 156.18 21.62 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 22.2 m -111.9 159.29 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.624 0.726 . . . . 0.0 109.495 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mp -66.38 131.6 46.44 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.566 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.418 ' HG2' ' H ' ' A' ' 30' ' ' VAL . 27.0 ttp -145.88 166.39 26.11 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.418 ' H ' ' HG2' ' A' ' 29' ' ' MET . 46.8 t -67.92 159.42 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.423 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 36.6 t70 -52.71 -40.61 63.15 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.926 -0.484 . . . . 0.0 110.68 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -163.27 50.64 0.16 Allowed 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.536 -0.866 . . . . 0.0 108.777 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 55.88 49.13 16.6 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -94.45 109.32 21.2 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -91.12 -3.52 57.02 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -83.18 -6.4 59.46 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 t 69.07 -172.65 0.18 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.69 24.82 76.23 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.6 m -127.66 149.05 69.27 Favored Pre-proline 0 CA--C 1.501 -0.929 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.474 ' HA ' HG13 ' A' ' 87' ' ' VAL . 68.7 Cg_endo -72.6 158.58 50.56 Favored 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 122.161 1.908 . . . . 0.0 113.321 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 mm -88.0 131.41 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 24.5 m -130.84 166.13 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 125' ' ' ILE . 88.9 mt -95.99 142.77 27.81 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.37 151.25 39.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 m -58.71 145.66 39.39 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.99 131.67 46.78 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -137.23 140.71 41.87 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -64.93 -36.09 83.25 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -75.19 142.37 43.49 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 60.32 43.22 13.85 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.415 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -70.17 -31.44 68.93 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.61 91.71 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.2 m -70.36 -22.05 62.82 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -100.43 4.23 43.65 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 16' ' ' TRP . 24.0 mt -102.3 138.74 38.83 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -125.42 151.54 46.05 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -128.51 135.24 49.16 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -91.58 112.99 25.14 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -85.42 156.38 59.43 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.94 -13.7 36.6 Favored 'Trans proline' 0 CA--C 1.497 -1.351 0 C-N-CA 122.216 1.944 . . . . 0.0 113.263 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.3 m -70.48 -20.58 62.85 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.15 8.82 33.08 Favored Glycine 0 C--N 1.356 1.674 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -121.95 161.97 21.93 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 118.513 1.156 . . . . 0.0 109.24 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.546 HD21 ' HZ ' ' A' ' 17' ' ' PHE . 58.2 mt -99.81 135.14 41.69 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -177.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 72' ' ' VAL . 92.4 t -117.18 136.66 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -76.68 127.91 33.68 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -64.42 -37.33 87.14 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.321 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -75.54 -54.33 7.18 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.669 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.4 m -70.88 -39.96 72.52 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.67 10.25 84.54 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 105.932 -2.867 . . . . 0.0 105.932 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -98.99 162.62 12.97 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 65' ' ' VAL . 11.7 t -110.96 150.9 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.8 mtt -69.83 139.81 53.19 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -157.68 169.8 23.82 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.211 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.75 142.88 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.36 -41.11 76.98 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.476 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.45 -33.56 71.43 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.4 -6.79 83.06 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.9 m -123.82 125.88 25.82 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.41 115.83 4.23 Favored 'Trans proline' 0 CA--C 1.497 -1.365 0 C-N-CA 121.022 1.148 . . . . 0.0 112.758 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -135.75 162.65 32.18 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.21 38.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.34 7.42 82.72 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.83 142.9 15.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 CA-C-N 118.534 1.167 . . . . 0.0 107.942 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.21 155.39 20.74 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 86' ' ' ILE . 49.0 mm -106.59 128.01 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 40' ' ' PRO . 34.1 m -130.59 168.48 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -80.33 142.08 34.82 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -145.21 171.24 14.83 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -71.45 169.18 15.93 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -84.04 156.47 22.21 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.49 150.99 42.77 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.7 -171.57 48.16 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 84.8 p -85.5 1.7 47.8 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -99.04 13.03 34.25 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.91 123.29 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -65.56 150.05 49.05 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.62 -20.4 66.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -90.66 -1.62 57.86 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.38 6.14 18.56 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.17 112.0 19.86 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -85.07 -10.74 56.56 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -84.26 -11.44 56.44 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.76 131.04 45.75 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.47 154.62 33.48 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.88 158.47 14.26 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.6 tp -129.53 130.91 46.38 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 91.7 p -104.16 155.92 36.5 Favored Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 57.3 Cg_endo -70.69 -8.5 23.76 Favored 'Trans proline' 0 CA--C 1.499 -1.239 0 C-N-CA 121.856 1.704 . . . . 0.0 112.61 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.426 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 99.7 m-85 -82.62 -9.71 59.27 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.61 12.61 55.57 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.426 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 78.8 m80 -101.12 137.41 39.52 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.95 124.91 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.464 ' HB3' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -127.0 -179.62 4.93 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.608 HD13 ' HB2' ' A' ' 118' ' ' LYS . 7.7 mt -89.6 149.11 22.98 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.22 -24.23 61.36 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.27 -19.57 14.43 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.897 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HB2' HD13 ' A' ' 115' ' ' LEU . 13.4 mptt -132.53 84.17 51.89 Favored Pre-proline 0 N--CA 1.438 -1.055 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -68.52 -9.75 26.98 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.605 2.203 . . . . 0.0 113.012 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.8 m -83.51 -22.88 32.35 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.505 HD13 HD12 ' A' ' 140' ' ' LEU . 54.4 mt -97.28 131.35 44.07 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.465 HG21 HG13 ' A' ' 143' ' ' VAL . 26.8 pt -133.19 163.21 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.9 mt -79.38 137.99 37.5 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.16 176.81 37.7 Favored Glycine 0 CA--C 1.493 -1.309 0 N-CA-C 107.415 -2.274 . . . . 0.0 107.415 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 137' ' ' HIS . 1.4 pp -135.92 159.82 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.488 ' O ' HD23 ' A' ' 136' ' ' LEU . 88.2 tttt -108.48 145.59 34.46 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -134.54 144.71 48.15 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 t -150.5 175.84 11.5 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -71.61 -28.58 63.9 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.9 37.51 2.04 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.77 104.46 8.65 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 32.2 tpt180 -63.68 129.93 42.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HA ' ' HG ' ' A' ' 136' ' ' LEU . 99.5 mtt180 -63.16 -36.13 82.58 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 93.5 mt-10 -83.19 86.69 6.99 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.14 8.73 1.54 Allowed Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 126' ' ' LYS . 84.2 mt -63.98 127.73 32.67 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -87.99 153.83 20.98 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.66 0.743 . . . . 0.0 109.706 -177.373 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.5 t -97.01 139.75 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -147.39 167.4 24.47 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.505 HD12 HD13 ' A' ' 121' ' ' LEU . 89.5 mt -91.91 125.02 36.45 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -116.74 142.18 47.25 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tp -74.9 146.14 42.1 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.465 HG13 HG21 ' A' ' 122' ' ' ILE . 32.6 m -61.84 153.94 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 121.87 0.843 . . . . 0.0 109.443 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -148.24 102.16 3.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -70.08 -18.27 63.26 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.867 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -67.65 -25.58 65.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -135.6 84.24 2.07 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -102.55 4.36 38.41 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -97.78 22.31 9.31 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -90.9 115.33 27.86 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -68.5 -20.59 64.6 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -73.9 -17.32 61.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -100.63 0.88 40.05 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.55 133.35 39.67 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -118.43 139.8 50.85 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -123.14 158.28 31.09 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -119.91 142.37 48.76 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.2 t -128.58 144.12 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -109.49 152.64 42.85 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.74 150.13 73.86 Favored 'Trans proline' 0 CA--C 1.495 -1.453 0 C-N-CA 121.735 1.623 . . . . 0.0 113.07 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.7 t -118.71 125.83 74.74 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.261 1.7 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 ttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.784 0.326 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.16 142.4 46.13 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.24 156.95 36.51 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.35 101.85 14.54 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 60.4 ttm -65.21 -40.57 94.32 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -117.53 84.34 2.14 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.87 -22.16 61.56 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -99.48 148.0 24.7 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.9 m -139.14 145.45 39.43 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -103.46 162.15 13.27 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.9 161.02 17.71 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.978 0.894 . . . . 0.0 108.986 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.405 ' HB3' ' HD2' ' A' ' 13' ' ' PRO . 83.2 m-85 -86.18 157.91 56.0 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 12' ' ' PHE . 37.3 Cg_endo -65.75 148.96 87.23 Favored 'Trans proline' 0 CA--C 1.499 -1.235 0 C-N-CA 121.321 1.348 . . . . 0.0 112.281 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.31 156.83 19.46 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.824 0.821 . . . . 0.0 109.179 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.52 -168.81 38.56 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.488 ' HB3' HD21 ' A' ' 55' ' ' LEU . 49.4 m0 -75.72 144.48 41.49 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.42 161.07 41.91 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -119.59 138.65 53.08 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 85.6 mt -99.87 113.76 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -110.48 131.39 55.09 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.378 0.609 . . . . 0.0 109.429 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -83.66 123.95 30.34 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -61.03 -36.22 78.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 t -65.3 -43.32 91.48 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 121.557 -0.715 . . . . 0.0 111.56 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -99.18 -23.13 15.33 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.495 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.31 18.62 79.94 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -107.23 167.09 10.15 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 26.8 m -118.25 160.94 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.572 HD22 HG21 ' A' ' 138' ' ' VAL . 2.5 mp -67.86 132.43 47.36 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.908 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.2 ttp -145.76 163.15 35.87 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -68.33 165.57 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -49.37 -41.54 39.42 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 122.103 -0.373 . . . . 0.0 110.812 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -162.21 51.53 0.21 Allowed 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 56.65 43.93 24.63 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -88.17 128.93 35.45 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -93.35 -2.0 55.28 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -88.31 142.32 27.83 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.7 m -74.98 156.57 36.13 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.18 7.26 62.42 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.3 m -93.03 137.23 23.84 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.28 154.36 65.76 Favored 'Trans proline' 0 CA--C 1.496 -1.398 0 C-N-CA 121.661 1.574 . . . . 0.0 112.831 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.2 mm -91.81 130.84 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 27.6 m -131.65 164.39 34.65 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' CD1' HG21 ' A' ' 125' ' ' ILE . 92.8 mt -92.82 142.22 27.57 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.24 150.24 36.33 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 t -64.22 155.27 32.4 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.49 139.53 58.78 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.62 147.18 49.93 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -87.73 -12.15 46.09 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.29 143.92 48.91 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 57.66 40.08 26.89 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -85.68 -4.34 59.14 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.78 81.24 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -72.82 -13.4 61.29 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -102.31 2.49 36.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 16' ' ' TRP . 56.5 mt -98.02 138.07 35.88 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -126.51 149.94 49.06 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -133.01 129.6 38.34 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -92.25 129.39 38.21 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.13 159.8 56.09 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.29 -26.66 62.84 Favored 'Trans proline' 0 CA--C 1.499 -1.25 0 C-N-CA 122.021 1.814 . . . . 0.0 113.825 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.9 m -72.14 -19.55 61.76 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.88 11.25 28.73 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 103' ' ' GLN . 2.6 m-85 -92.81 147.27 23.0 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.1 128.36 50.04 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -114.23 135.44 53.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -75.73 131.02 39.57 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -62.18 -41.4 98.29 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 122.048 -0.407 . . . . 0.0 111.279 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -80.43 -52.09 8.07 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 121.691 -0.631 . . . . 0.0 111.379 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.6 m -68.24 -39.85 82.15 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.691 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.04 2.15 90.63 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -93.32 167.02 12.01 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 m -119.18 163.83 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.8 mtt -71.01 139.29 50.46 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -154.24 169.7 23.0 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -93.39 143.66 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.33 87.2 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -72.5 -33.01 66.64 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.32 -8.86 79.1 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 105.959 -2.856 . . . . 0.0 105.959 -177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.9 m -121.26 125.38 26.94 Favored Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.36 120.18 6.6 Favored 'Trans proline' 0 CA--C 1.497 -1.359 0 C-N-CA 121.205 1.27 . . . . 0.0 113.251 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -138.58 162.58 34.22 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.12 131.33 39.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.37 15.36 71.72 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.23 150.89 4.47 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -90.03 153.03 20.88 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 86' ' ' ILE . 48.8 mm -109.8 128.25 66.03 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.29 161.32 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -86.3 142.95 28.15 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.87 178.72 9.36 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 m -76.07 150.05 37.36 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -76.48 156.2 33.21 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -102.38 -148.08 0.38 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.81 -6.03 62.22 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.9 p -67.96 -38.25 82.54 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -155.31 31.02 0.39 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.35 147.97 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.22 157.02 38.42 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.81 0.814 . . . . 0.0 108.905 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -78.18 -21.54 50.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.44 -10.36 52.14 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -109.69 9.75 24.91 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -93.54 131.7 38.54 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -86.88 -7.72 57.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.464 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 33.5 mt-30 -70.16 -18.03 63.19 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -71.99 128.6 36.24 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.45 156.98 34.49 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.85 163.92 25.24 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 106.303 -2.719 . . . . 0.0 106.303 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -145.65 152.63 39.95 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 85.2 p -105.77 160.65 25.37 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.88 -14.61 33.46 Favored 'Trans proline' 0 CA--C 1.499 -1.268 0 C-N-CA 122.513 2.142 . . . . 0.0 113.424 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.44 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 96.9 m-85 -74.79 -11.45 60.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.95 27.78 11.97 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.44 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 77.0 m80 -112.53 134.75 53.89 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -107.47 127.13 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.727 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.1 p90 -134.46 178.4 7.02 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.584 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 7.0 mt -89.23 146.67 24.6 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.59 -24.11 61.85 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -102.71 -19.19 14.86 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.657 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.584 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -134.57 82.71 44.62 Favored Pre-proline 0 N--CA 1.437 -1.116 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.54 -11.78 32.03 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.474 2.116 . . . . 0.0 113.05 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 88.9 p -79.94 -23.5 41.66 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.6 mt -95.81 131.79 41.74 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.727 HG22 ' HB3' ' A' ' 114' ' ' TYR . 23.8 pt -133.21 163.58 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.3 mt -81.68 141.99 33.11 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.78 -175.6 35.69 Favored Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 106.732 -2.547 . . . . 0.0 106.732 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 137' ' ' HIS . 1.6 pp -135.45 161.02 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.401 ' O ' HD23 ' A' ' 136' ' ' LEU . 40.0 ttmt -117.32 143.09 46.3 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.98 151.54 44.54 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.8 m -104.51 166.48 10.36 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -65.14 -37.07 86.23 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -94.71 3.53 54.93 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 49.73 49.31 20.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.112 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -85.15 116.01 23.27 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.435 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -77.41 -22.57 51.36 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -90.49 87.4 6.74 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.5 6.1 2.15 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 126' ' ' LYS . 80.8 mt -66.37 125.48 25.79 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.527 ' O ' HG23 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -89.02 154.87 19.86 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 121.491 0.662 . . . . 0.0 109.644 -177.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.572 HG21 HD22 ' A' ' 28' ' ' LEU . 52.5 t -79.16 136.28 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.91 140.58 44.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.5 mt -85.31 129.38 34.82 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -124.36 152.47 43.13 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -81.66 152.79 26.95 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -61.19 141.03 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 121.808 0.813 . . . . 0.0 109.42 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -126.57 86.02 2.46 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.47 -20.52 66.39 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -71.34 -22.12 61.95 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -133.73 83.95 2.09 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.31 4.0 52.61 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -95.93 27.65 3.48 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -98.89 108.54 21.25 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -69.78 -21.53 63.41 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -69.82 -19.84 63.46 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -100.59 3.0 42.3 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -99.3 136.74 38.81 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -124.47 141.78 51.82 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -121.42 155.5 34.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.86 139.08 51.62 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.93 145.42 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.35 152.44 42.66 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.55 149.64 74.37 Favored 'Trans proline' 0 CA--C 1.496 -1.404 0 C-N-CA 121.809 1.673 . . . . 0.0 113.267 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.6 t -121.18 126.22 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--O 1.263 1.785 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.575 0.226 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.95 44.35 2.03 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.65 152.41 32.78 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.48 130.27 21.62 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.0 mtm -67.06 -37.46 84.08 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -112.34 74.73 0.88 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -72.53 -22.7 60.98 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -79.11 141.1 37.6 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.6 m -135.19 146.09 48.35 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -126.15 171.53 10.79 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 161.95 36.1 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -90.3 122.36 67.51 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.22 -24.61 23.08 Favored 'Trans proline' 0 CA--C 1.501 -1.135 0 C-N-CA 121.4 1.4 . . . . 0.0 112.492 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 pm0 -83.61 160.97 21.29 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.53 -61.99 0.87 Allowed Glycine 0 C--N 1.351 1.364 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -86.86 138.2 31.76 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -163.73 162.82 24.17 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -119.15 138.12 53.13 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.01 117.69 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -117.08 129.6 56.1 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -85.33 127.16 34.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -67.16 -16.58 64.4 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 122.244 -0.285 . . . . 0.0 111.535 -177.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.8 t -62.93 -43.97 97.34 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 121.478 -0.764 . . . . 0.0 110.947 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -124.03 -6.52 7.82 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.535 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.46 23.75 76.46 Favored Glycine 0 C--N 1.349 1.305 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -103.33 162.96 12.57 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.81 160.81 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mp -68.54 131.9 46.03 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.595 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.423 ' HG2' ' H ' ' A' ' 30' ' ' VAL . 34.7 ttp -145.85 166.5 25.76 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' A' ' 29' ' ' MET . 24.0 t -68.03 164.94 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -53.54 -40.97 65.95 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.747 -0.596 . . . . 0.0 110.458 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -164.78 55.07 0.13 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 53.79 48.38 21.53 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.1 m -86.68 130.74 34.36 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.49 -2.01 52.49 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -94.02 152.34 18.88 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.9 m -81.36 157.89 24.87 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.78 8.39 65.39 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 33.0 t -88.53 124.68 65.45 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.618 ' HA ' HG13 ' A' ' 87' ' ' VAL . 44.7 Cg_exo -58.77 148.72 81.87 Favored 'Trans proline' 0 CA--C 1.497 -1.329 0 C-N-CA 122.094 1.863 . . . . 0.0 113.163 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.41 129.63 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 24.6 m -131.56 166.48 28.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.957 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.4 mt -94.36 141.65 28.33 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.11 151.81 40.09 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -60.44 146.28 45.15 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.3 139.07 58.73 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -127.66 140.85 51.83 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 90.2 m -66.47 -34.96 79.11 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.56 154.23 17.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 61.4 44.51 9.43 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 48' ' ' THR . 5.9 m-85 -67.15 -30.36 70.33 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.82 -38.05 84.08 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.891 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -70.95 -16.98 62.69 Favored 'General case' 0 CA--C 1.5 -0.98 0 O-C-N 121.897 -0.502 . . . . 0.0 109.723 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -109.29 7.64 25.3 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 mt -100.46 136.8 39.78 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -125.49 147.97 49.03 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -125.94 129.47 49.33 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.407 ' HD1' ' CD1' ' A' ' 64' ' ' LEU . 70.0 t60 -90.38 114.84 27.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -80.99 159.77 67.64 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.45 -21.73 55.39 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 122.135 1.89 . . . . 0.0 112.445 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.6 p -82.78 -2.84 55.6 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.46 20.4 54.58 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -100.82 138.93 37.21 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.407 ' CD1' ' HD1' ' A' ' 58' ' ' HIS . 5.9 mp -97.42 119.39 35.88 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.85 135.0 45.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -84.86 126.07 33.15 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -61.77 -40.64 95.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 122.011 -0.43 . . . . 0.0 111.514 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -65.09 -50.16 67.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 121.977 -0.452 . . . . 0.0 112.041 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.3 p -88.48 -29.66 19.97 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.333 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.19 4.37 90.24 Favored Glycine 0 C--N 1.352 1.445 0 N-CA-C 107.219 -2.352 . . . . 0.0 107.219 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -94.69 168.18 10.99 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.83 162.47 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.9 mtt -69.04 139.36 54.91 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -155.11 173.23 16.89 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.11 143.23 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.05 86.1 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.401 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.98 -33.05 67.82 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.27 -8.16 80.29 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 105.899 -2.88 . . . . 0.0 105.899 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.0 m -124.14 127.2 25.42 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.32 120.26 6.85 Favored 'Trans proline' 0 CA--C 1.495 -1.427 0 C-N-CA 121.115 1.21 . . . . 0.0 113.25 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -136.54 162.23 33.68 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.98 129.43 37.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.38 81.76 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 p -72.79 143.13 14.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-N 118.539 1.169 . . . . 0.0 108.268 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.5 154.69 24.96 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-O 121.468 0.651 . . . . 0.0 109.425 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.82 127.06 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 40' ' ' PRO . 34.0 m -132.08 160.86 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -84.43 139.63 32.08 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -146.87 171.59 14.97 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -66.51 149.43 50.45 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -69.67 156.41 39.0 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.35 148.04 45.7 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.35 -160.47 35.94 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 107.375 -2.29 . . . . 0.0 107.375 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.7 m -89.99 6.95 39.97 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -102.12 16.1 27.1 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.7 t -111.88 127.06 69.28 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -61.05 149.52 36.7 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -67.27 -18.47 65.22 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -90.36 -3.53 57.67 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.9 mt -114.6 6.78 15.87 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -87.1 98.63 11.4 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -96.0 -7.74 35.57 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.728 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -77.19 -9.33 58.71 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -77.52 125.47 29.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -118.51 152.77 35.32 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.51 145.09 17.24 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 106.86 -2.496 . . . . 0.0 106.86 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.0 tp -113.27 125.66 54.55 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . 86.5 p -89.81 158.38 45.0 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 53.2 Cg_endo -70.18 -8.48 23.7 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.659 1.573 . . . . 0.0 112.509 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.438 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 98.7 m-85 -89.99 -4.12 57.62 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.39 4.96 65.74 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.438 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 76.5 m80 -89.65 145.05 25.5 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.8 mt -112.59 127.07 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.68 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -130.35 176.99 7.68 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.57 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 15.4 mt -82.37 150.08 27.35 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.66 -17.52 55.82 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -104.09 -26.12 12.7 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.379 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.57 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -133.27 86.02 42.68 Favored Pre-proline 0 N--CA 1.436 -1.137 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.98 -8.27 19.42 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.781 2.321 . . . . 0.0 113.236 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.6 m -88.23 -8.71 54.85 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.24 130.93 54.68 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.68 HG23 ' HB3' ' A' ' 114' ' ' TYR . 27.0 pt -134.93 168.2 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.66 138.78 37.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.06 177.8 34.62 Favored Glycine 0 CA--C 1.495 -1.17 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.2 pt -134.02 168.64 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -117.11 120.11 37.31 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -107.27 137.66 44.91 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.439 ' H ' ' HB3' ' A' ' 131' ' ' ALA . 86.3 p -150.9 172.34 15.82 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -69.9 -27.97 65.24 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -99.57 23.45 9.46 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.439 ' HB3' ' H ' ' A' ' 128' ' ' SER . . . -123.91 91.92 3.57 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -64.73 152.37 42.7 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -68.89 -14.55 63.1 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.043 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -92.73 85.03 5.1 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 126.9 13.57 2.96 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 mt -64.33 123.02 18.09 Favored 'General case' 0 C--N 1.36 1.058 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -90.0 152.72 21.05 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 121.515 0.674 . . . . 0.0 109.311 -177.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 p -99.38 144.9 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -147.79 166.95 25.99 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.8 mt -85.99 130.24 34.6 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -128.64 144.44 51.16 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.79 141.15 55.26 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.25 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.66 129.77 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.29 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -124.18 92.08 3.59 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -67.2 -20.61 65.73 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.521 ' HG3' ' CD2' ' A' ' 147' ' ' HIS . 17.0 ptp180 -69.7 -19.29 63.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.521 ' CD2' ' HG3' ' A' ' 146' ' ' ARG . 98.0 m-70 -128.39 77.46 1.77 Allowed 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.6 mt -103.55 4.41 35.76 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.02 22.23 9.64 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -98.92 125.65 44.41 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -68.51 -21.48 64.58 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -76.43 -19.61 57.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -92.16 -3.38 55.7 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.88 133.49 44.17 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -117.46 137.77 52.3 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.37 146.94 37.43 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -119.07 138.86 52.58 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.81 145.35 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.1 mt -109.71 154.58 42.4 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -58.39 141.21 96.86 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 C-N-CA 122.061 1.841 . . . . 0.0 113.08 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.8 t -119.93 126.12 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.261 1.702 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.643 0.259 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.26 155.76 39.45 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.69 156.29 41.63 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.93 108.65 19.84 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -128.54 9.53 6.02 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -105.01 70.89 0.93 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -73.08 -24.74 60.7 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -87.51 147.93 25.14 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 t -146.35 138.55 25.07 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -101.09 170.59 8.16 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -98.38 160.06 14.53 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -90.53 158.94 42.27 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.83 146.06 87.83 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 122.076 1.851 . . . . 0.0 112.687 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.67 156.74 16.4 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.47 -160.84 33.38 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.483 ' HB3' HD21 ' A' ' 55' ' ' LEU . 49.0 m0 -81.97 141.42 33.3 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -160.74 165.29 30.67 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -119.4 138.55 53.02 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.24 119.26 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HB3' HG12 ' A' ' 27' ' ' VAL . 11.1 ptmt -121.46 147.3 45.94 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.939 0.876 . . . . 0.0 108.986 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -91.41 123.65 35.0 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -59.33 -22.41 61.23 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.8 t -63.16 -45.55 91.31 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.278 -0.889 . . . . 0.0 110.882 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -114.05 -19.34 11.43 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.416 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.99 6.73 88.06 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.41 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 13.1 m-30 -83.8 160.14 21.27 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' A' ' 20' ' ' LYS . 29.9 m -114.71 160.12 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -177.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.07 132.72 48.45 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.458 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.0 ttp -145.4 163.02 35.88 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 t -67.62 162.7 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -48.65 -42.22 33.77 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 122.072 -0.393 . . . . 0.0 111.01 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -165.43 57.03 0.12 Allowed 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 119.555 -0.858 . . . . 0.0 108.708 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 54.23 49.25 19.02 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.7 m -97.07 126.93 42.57 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -91.47 -3.32 56.72 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -88.19 142.12 28.01 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 97.1 p -75.2 162.84 28.12 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.72 6.43 72.91 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.3 m -90.47 135.71 29.12 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.536 ' HA ' HG13 ' A' ' 87' ' ' VAL . 55.8 Cg_endo -69.51 154.14 69.13 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 C-N-CA 121.509 1.473 . . . . 0.0 112.763 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 mm -90.9 131.57 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 31.4 m -130.53 165.62 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.49 140.24 31.42 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.67 146.18 32.11 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.41 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 11.4 t -62.85 157.42 21.45 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.53 138.5 58.29 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -119.2 144.69 46.58 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -75.77 -16.55 60.1 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -118.04 154.26 32.32 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 61.54 48.85 5.48 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -68.58 -30.8 69.64 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.52 85.06 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 120.719 0.295 . . . . 0.0 110.563 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.1 m -66.86 -23.96 66.08 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -103.38 6.72 37.97 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 16' ' ' TRP . 20.6 mt -99.94 137.38 38.47 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.901 0.857 . . . . 0.0 108.85 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -128.68 157.49 41.19 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -139.32 154.92 47.98 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -109.01 117.72 34.92 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.71 154.39 78.41 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.11 -17.86 58.71 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 121.867 1.712 . . . . 0.0 113.401 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -74.31 -19.01 60.62 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.36 19.26 10.09 Favored Glycine 0 C--N 1.357 1.705 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -109.7 154.79 22.38 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 118.296 1.048 . . . . 0.0 108.544 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -102.97 131.56 49.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.3 t -119.75 136.15 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -79.87 130.08 35.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.78 -40.68 98.06 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 122.062 -0.399 . . . . 0.0 111.203 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -75.09 -53.11 9.44 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.076 -176.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.4 m -69.63 -40.03 76.81 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.1 5.26 89.84 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 105.754 -2.938 . . . . 0.0 105.754 -177.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.01 166.1 11.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.11 163.11 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.4 mtt -72.3 138.7 47.56 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -153.85 169.22 23.92 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.504 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -85.94 145.27 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.52 91.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.624 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -78.42 -31.7 48.31 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.504 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.56 -10.37 74.76 Favored Glycine 0 CA--C 1.495 -1.213 0 N-CA-C 105.903 -2.879 . . . . 0.0 105.903 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -116.02 122.91 31.69 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.22 128.79 16.09 Favored 'Trans proline' 0 CA--C 1.496 -1.383 0 C-N-CA 121.017 1.145 . . . . 0.0 113.158 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.02 158.96 44.09 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.16 133.41 44.06 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.88 84.63 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 140' ' ' LEU . 8.5 p -74.7 142.54 14.52 Favored 'Isoleucine or valine' 0 C--N 1.358 0.942 0 CA-C-N 118.687 1.244 . . . . 0.0 108.191 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.89 155.46 24.08 Favored 'General case' 0 C--N 1.358 0.976 0 CA-C-O 121.427 0.632 . . . . 0.0 109.522 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.05 129.11 65.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.536 HG13 ' HA ' ' A' ' 40' ' ' PRO . 33.0 m -130.64 161.68 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -83.24 142.55 31.06 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.52 175.3 12.45 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.4 m -69.36 148.6 49.44 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.6 pm0 -70.84 156.48 39.51 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.06 -154.06 0.61 Allowed 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.458 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 95.73 3.97 60.67 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -95.88 -51.43 4.48 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -104.86 6.82 34.12 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.458 HG13 ' H ' ' A' ' 93' ' ' GLY . 9.4 p -133.74 147.26 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -64.11 142.47 58.4 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.61 -21.59 64.49 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.44 -7.45 58.42 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.42 9.79 18.2 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -87.86 129.51 35.19 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -85.74 -7.35 58.83 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -74.89 -11.02 60.03 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -78.26 128.18 33.34 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.16 153.89 33.08 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.45 155.17 16.51 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 106.623 -2.591 . . . . 0.0 106.623 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.5 tp -115.54 122.31 45.3 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.458 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.1 t -83.8 141.56 41.38 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 108' ' ' SER . 33.9 Cg_exo -59.46 -19.55 52.23 Favored 'Trans proline' 0 CA--C 1.503 -1.056 0 C-N-CA 122.036 1.824 . . . . 0.0 113.063 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.484 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 96.8 m-85 -83.05 -3.51 57.34 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.17 10.8 55.69 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.484 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 76.1 m80 -94.51 147.18 23.52 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.6 mt -113.62 125.13 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.694 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -130.02 176.43 8.07 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.709 HD13 ' HB2' ' A' ' 118' ' ' LYS . 12.5 mt -85.45 151.12 24.22 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.07 -27.35 64.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -105.04 -15.7 15.02 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.277 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.709 ' HB2' HD13 ' A' ' 115' ' ' LEU . 3.7 mptp? -133.32 84.93 45.58 Favored Pre-proline 0 CA--C 1.494 -1.197 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.99 -8.56 23.01 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.432 2.088 . . . . 0.0 112.337 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 88.7 p -86.42 -15.88 38.93 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.565 HD13 HD21 ' A' ' 140' ' ' LEU . 57.0 mt -105.43 130.77 53.45 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.694 HG23 ' HB3' ' A' ' 114' ' ' TYR . 34.1 pt -134.51 164.18 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.9 mt -82.71 139.74 33.48 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.77 177.49 39.59 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.569 HD13 HD13 ' A' ' 136' ' ' LEU . 1.8 pp -131.88 159.3 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.471 ' O ' HD22 ' A' ' 136' ' ' LEU . 88.2 tttt -103.64 145.27 30.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.67 131.56 56.69 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.2 t -150.1 155.76 40.41 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -70.17 -26.52 63.95 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.15 32.74 3.36 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -129.77 107.35 9.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.421 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 32.0 tpt180 -59.74 130.55 47.33 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.406 ' HA ' ' HG ' ' A' ' 136' ' ' LEU . 82.2 mtp180 -63.12 -35.99 82.13 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 34.2 mt-10 -85.78 85.57 7.39 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 105.761 -1.941 . . . . 0.0 105.761 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.2 11.56 1.19 Allowed Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.569 HD13 HD13 ' A' ' 125' ' ' ILE . 82.6 mt -62.99 129.09 38.86 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -84.57 153.73 23.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 121.701 0.762 . . . . 0.0 109.592 -177.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.04 137.75 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -146.62 165.86 28.27 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.565 HD21 HD13 ' A' ' 121' ' ' LEU . 1.5 mp -88.22 130.63 35.02 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -117.78 150.79 38.54 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 120' ' ' SER . 1.7 tp -80.02 137.95 36.92 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.44 135.75 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.185 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -129.97 95.29 3.91 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -64.8 -19.56 65.9 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.02 -22.87 63.06 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -132.26 83.44 2.08 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -100.21 5.45 44.7 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -95.41 20.4 9.49 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -91.65 108.31 19.82 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -66.44 -20.52 66.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -73.82 -17.29 61.09 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -100.99 0.36 38.03 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -96.17 133.83 40.0 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -119.73 143.44 47.79 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -124.95 163.76 21.59 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -126.7 145.75 50.47 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.1 t -130.66 144.22 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.3 mt -107.56 152.29 41.35 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.9 150.35 73.27 Favored 'Trans proline' 0 CA--C 1.496 -1.406 0 C-N-CA 121.773 1.648 . . . . 0.0 113.18 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.0 t 61.96 73.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 80.0 t . . . . . 0 C--O 1.261 1.696 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mmt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.943 0.401 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.27 154.26 34.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.66 154.06 35.63 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.96 144.97 37.32 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.51 10.81 18.24 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -85.63 62.2 7.32 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -74.2 -22.9 59.19 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -78.9 140.51 38.09 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -126.27 144.28 50.85 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -126.0 171.74 10.53 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.96 161.12 14.48 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -90.19 157.44 45.26 Favored Pre-proline 0 N--CA 1.44 -0.955 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.4 145.93 92.04 Favored 'Trans proline' 0 CA--C 1.499 -1.231 0 C-N-CA 122.064 1.843 . . . . 0.0 112.688 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -95.8 161.35 14.05 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.5 -160.35 37.76 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.476 ' HB3' HD21 ' A' ' 55' ' ' LEU . 47.7 m0 -82.13 142.48 32.21 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -160.01 163.6 33.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -120.92 139.09 53.71 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.4 mt -108.86 119.81 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 34.8 pttt -126.58 149.79 49.23 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.64 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.79 130.85 34.62 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.34 -33.55 75.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.091 -0.381 . . . . 0.0 110.229 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -65.18 -37.73 88.28 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 122.125 -0.359 . . . . 0.0 111.938 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -107.56 -23.12 12.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.141 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.06 19.65 79.76 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -108.63 154.92 21.29 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 14.1 m -106.8 158.44 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 121.798 0.808 . . . . 0.0 109.553 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.574 HD22 HG21 ' A' ' 138' ' ' VAL . 3.4 mp -71.65 133.7 45.85 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.39 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.2 ptm -147.02 175.47 10.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.9 155.08 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.456 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 40.1 p-10 -52.28 -31.68 33.89 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.651 -0.656 . . . . 0.0 111.968 -177.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -162.81 45.3 0.13 Allowed 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 54.67 49.24 18.51 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.1 m -84.29 120.1 25.84 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -79.52 -11.62 59.89 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -93.23 142.63 27.09 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.6 p -78.82 167.24 21.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.55 8.77 58.23 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.6 p -105.13 148.55 36.39 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.437 ' HA ' HG13 ' A' ' 87' ' ' VAL . 56.0 Cg_endo -70.69 155.29 63.16 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 C-N-CA 122.042 1.828 . . . . 0.0 113.612 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.0 mm -94.04 132.88 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 23.1 m -130.9 163.78 35.85 Favored 'Isoleucine or valine' 0 C--N 1.36 1.027 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.4 mt -96.56 146.37 24.88 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.08 151.44 33.22 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -60.78 144.73 51.89 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.26 139.62 58.11 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -127.07 149.21 50.02 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -84.13 -9.45 58.57 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -124.6 145.73 49.45 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 58.53 39.32 25.02 Favored 'General case' 0 C--N 1.361 1.088 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -86.62 -4.93 59.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.48 -36.41 83.66 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -73.34 -14.43 61.29 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -101.03 2.02 40.09 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 16' ' ' TRP . 26.5 mt -96.66 137.6 35.5 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -128.74 158.74 37.77 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -140.05 156.3 46.67 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -109.97 114.74 28.52 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.94 154.14 86.81 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.3 -16.75 56.48 Favored 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 121.948 1.765 . . . . 0.0 112.983 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -76.48 -16.52 59.64 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.61 23.54 8.28 Favored Glycine 0 C--N 1.356 1.681 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -115.39 154.6 28.92 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.695 1.247 . . . . 0.0 108.793 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.0 131.14 44.11 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.4 t -124.78 137.8 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -77.61 130.04 36.37 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -61.94 -44.01 97.66 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 121.915 -0.491 . . . . 0.0 111.337 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -79.72 -50.75 10.14 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.858 -0.526 . . . . 0.0 111.681 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 t -69.76 -39.72 76.54 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.94 3.28 90.56 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 107.253 -2.339 . . . . 0.0 107.253 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -94.8 164.38 12.96 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 91' ' ' GLN . 11.5 m -115.79 160.77 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -178.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.2 mtt -72.47 138.98 47.42 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -157.03 174.0 16.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.74 143.25 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.63 -43.53 76.12 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.835 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -72.8 -32.52 65.61 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.1 -7.43 80.92 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 105.704 -2.958 . . . . 0.0 105.704 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.5 m -115.34 120.59 36.24 Favored Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.44 106.76 2.32 Favored 'Trans proline' 0 CA--C 1.496 -1.384 0 C-N-CA 121.363 1.375 . . . . 0.0 113.559 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -137.8 165.46 26.4 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.41 136.56 46.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.61 4.58 79.67 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.5 t -81.48 132.8 30.67 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 CA-C-N 119.314 1.557 . . . . 0.0 108.055 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.71 151.94 41.93 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 121.526 0.679 . . . . 0.0 109.317 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.409 HD12 HD23 ' A' ' 140' ' ' LEU . 48.0 mm -104.19 127.88 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 40' ' ' PRO . 33.6 m -131.33 162.17 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -89.48 137.69 32.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.23 168.04 20.72 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 m -73.6 147.57 43.71 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.4 ' HB3' HG11 ' A' ' 72' ' ' VAL . 26.0 pt20 -71.57 156.52 39.31 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.26 157.34 42.98 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.48 -29.96 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.18 0 N-CA-C 107.876 -2.09 . . . . 0.0 107.876 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.0 m -64.19 -40.96 97.18 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.73 16.54 17.4 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.09 127.22 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -63.45 146.62 53.24 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.28 -20.64 66.51 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.63 -2.11 57.86 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.0 mt -114.05 7.47 16.78 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.64 121.32 26.2 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -97.67 -8.7 28.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -3.23 48.55 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -75.33 140.34 43.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.42 151.19 51.98 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.58 153.24 17.38 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 106.388 -2.685 . . . . 0.0 106.388 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.5 tp -129.31 122.55 29.81 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.5 p -92.8 158.92 37.11 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.11 -19.98 68.24 Favored 'Trans proline' 0 CA--C 1.501 -1.137 0 C-N-CA 122.414 2.076 . . . . 0.0 113.031 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.519 ' HB2' ' HD1' ' A' ' 112' ' ' HIS . 96.3 m-85 -78.28 -10.89 59.85 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.94 7.38 58.69 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.519 ' HD1' ' HB2' ' A' ' 110' ' ' TYR . 75.7 m80 -85.23 134.96 34.12 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.3 mt -108.08 123.02 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.58 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.9 OUTLIER -129.43 179.65 5.68 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.575 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 7.9 mt -85.89 148.51 25.76 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.86 -25.29 61.89 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -98.74 -22.61 15.79 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.651 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.575 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 1.7 mptm? -134.26 85.46 38.75 Favored Pre-proline 0 CA--C 1.496 -1.1 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -64.91 -11.01 27.51 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.648 2.232 . . . . 0.0 113.286 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 89.0 p -86.84 -15.19 39.89 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 mp -98.06 131.88 44.09 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.58 HG22 ' HB3' ' A' ' 114' ' ' TYR . 26.8 pt -134.07 164.48 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -85.48 141.73 29.71 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.41 -176.14 32.18 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.85 160.29 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.023 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -93.06 143.55 26.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -119.66 127.66 53.11 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.7 t -150.57 156.55 41.61 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.24 -26.9 64.06 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -102.35 35.47 2.41 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -129.93 105.9 8.3 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.442 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 16.7 tpt180 -61.6 131.13 49.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -62.44 -36.81 83.58 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 13.6 mt-10 -82.93 85.82 7.07 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.73 7.88 1.54 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.0 mt -66.06 127.46 32.19 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -88.81 154.73 20.03 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 121.517 0.675 . . . . 0.0 109.354 -177.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.574 HG21 HD22 ' A' ' 28' ' ' LEU . 50.6 t -77.78 135.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -130.92 137.06 49.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.409 HD23 HD12 ' A' ' 86' ' ' ILE . 72.3 mt -76.0 133.17 40.48 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -133.1 155.07 49.93 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.3 mp -94.11 151.91 19.14 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.23 154.1 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-O 121.821 0.819 . . . . 0.0 109.076 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -142.58 99.0 3.4 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -66.99 -20.61 65.91 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.045 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.76 -25.86 65.83 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -138.79 86.58 2.16 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.3 mt -100.82 4.65 43.05 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -96.28 21.32 9.15 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -88.07 124.7 34.03 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -68.17 -22.88 64.82 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -72.17 -20.34 61.61 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -96.02 -0.56 50.36 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -102.0 133.59 46.57 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -119.49 138.54 53.09 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -115.47 147.61 40.42 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -113.52 137.57 51.38 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.69 144.04 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 96.7 mt -108.87 154.93 41.56 Favored Pre-proline 0 N--CA 1.44 -0.943 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 159' ' ' LEU . 50.6 Cg_exo -57.5 140.85 94.54 Favored 'Trans proline' 0 CA--C 1.499 -1.237 0 C-N-CA 122.032 1.821 . . . . 0.0 113.266 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.5 p -143.53 143.68 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.0 t . . . . . 0 C--O 1.262 1.76 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.976 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.926 0.393 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.87 156.8 36.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.03 148.55 31.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 60.77 60.59 1.86 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 99.1 mtp -68.22 -28.28 67.1 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -134.97 90.48 2.64 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -73.01 -24.05 60.7 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -83.03 143.21 30.76 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 t -146.69 139.01 24.89 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -97.01 171.73 8.3 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -109.5 161.94 14.85 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -91.06 156.66 43.9 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.26 156.07 65.72 Favored 'Trans proline' 0 CA--C 1.501 -1.151 0 C-N-CA 121.797 1.665 . . . . 0.0 112.906 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 pm0 -75.57 159.78 30.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.62 -165.73 42.68 Favored Glycine 0 C--N 1.352 1.423 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -90.09 175.85 7.0 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -168.26 165.14 13.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -118.01 135.23 54.29 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.6 mt -99.1 114.18 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -113.73 131.96 56.0 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.5 127.47 35.24 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.37 -21.55 66.67 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.1 p -68.22 -39.04 82.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 119.478 1.035 . . . . 0.0 111.704 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -116.86 -16.98 10.55 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.236 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.83 20.72 75.82 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 107.601 -2.199 . . . . 0.0 107.601 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -102.65 163.48 12.2 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.25 160.45 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -67.03 133.49 50.01 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.793 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.5 ttp -145.82 163.01 36.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -68.08 164.33 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 177.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -48.58 -44.32 36.69 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 122.042 -0.411 . . . . 0.0 110.946 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -167.37 62.41 0.08 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.582 -0.847 . . . . 0.0 108.734 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 54.39 47.64 22.43 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.6 m -95.41 124.71 39.58 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -93.28 -1.69 55.79 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -88.62 148.83 23.85 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.1 m -81.78 157.56 24.45 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.83 62.63 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.4 m -92.21 141.47 25.1 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HA ' HG13 ' A' ' 87' ' ' VAL . 59.1 Cg_endo -71.3 154.66 61.28 Favored 'Trans proline' 0 CA--C 1.497 -1.364 0 C-N-CA 121.643 1.562 . . . . 0.0 112.861 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.5 mm -91.14 131.47 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 28.8 m -131.39 165.77 30.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -94.77 143.8 26.16 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.83 150.24 35.8 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 m -61.59 144.97 53.54 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.77 139.53 57.89 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -115.54 145.07 42.99 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -82.21 -20.31 38.0 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -128.84 149.58 50.69 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 59.13 44.28 16.13 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -97.22 10.3 39.85 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.18 86.3 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -73.06 -13.74 61.27 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -100.35 2.01 42.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.4 mt -97.41 136.08 38.37 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -127.97 158.7 37.15 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.9 ptm180 -141.88 158.44 43.79 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -111.52 115.41 29.15 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.92 154.47 86.86 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.02 -16.75 56.36 Favored 'Trans proline' 0 CA--C 1.496 -1.413 0 C-N-CA 121.871 1.714 . . . . 0.0 112.966 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.8 m -74.28 -20.17 60.23 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.23 21.15 8.19 Favored Glycine 0 C--N 1.356 1.679 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.37 155.81 25.6 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 118.724 1.262 . . . . 0.0 109.151 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -95.17 132.79 39.73 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.6 t -125.75 137.47 57.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -78.56 130.81 36.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -63.42 -41.67 98.72 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.939 -0.476 . . . . 0.0 111.503 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -73.3 -51.18 18.47 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.794 -0.566 . . . . 0.0 112.373 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.6 p -84.32 -29.64 26.18 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.565 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.06 4.6 90.49 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -89.61 166.1 13.84 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 91' ' ' GLN . 32.5 m -118.12 160.81 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.1 mtt -72.55 140.86 48.36 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -154.94 169.46 24.01 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.417 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -91.56 143.55 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.33 87.78 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.32 -33.82 70.02 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 89.87 -8.49 79.72 Favored Glycine 0 CA--C 1.494 -1.219 0 N-CA-C 106.3 -2.72 . . . . 0.0 106.3 -178.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.3 m -124.59 121.57 25.8 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.39 128.43 27.34 Favored 'Trans proline' 0 CA--C 1.495 -1.429 0 C-N-CA 121.394 1.396 . . . . 0.0 112.837 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.42 153.51 38.64 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.62 132.74 44.13 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.07 16.41 69.77 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.8 149.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -90.8 153.09 20.49 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.64 128.73 64.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.924 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 40' ' ' PRO . 34.2 m -131.53 161.47 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -89.04 140.96 28.91 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -145.45 171.67 14.3 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 m -71.17 150.92 44.89 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.413 ' HB3' HG11 ' A' ' 72' ' ' VAL . 25.5 pt20 -70.95 157.26 38.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.95 162.35 38.9 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.58 -26.55 0.21 Allowed Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.1 m -64.9 -40.05 94.48 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -121.97 18.51 10.91 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 97' ' ' LYS . 84.1 t -126.37 129.01 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.402 ' O ' HG12 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -66.79 159.96 26.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -77.51 -16.96 58.4 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -89.55 -11.97 41.25 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.5 mt -112.05 11.58 20.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -91.68 115.29 27.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -97.82 -6.32 32.87 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.921 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -80.01 -7.81 59.02 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.97 127.04 31.48 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -119.42 153.5 35.13 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.66 148.84 17.69 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.7 tp -112.73 122.27 47.16 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.46 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 8.8 t -86.78 139.22 33.06 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.61 -9.81 27.21 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 C-N-CA 121.897 1.731 . . . . 0.0 113.006 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.51 -0.81 57.61 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.09 38.83 5.31 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -129.71 148.76 51.63 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.0 mt -118.71 126.17 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.605 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -130.88 176.6 8.09 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 118' ' ' LYS . 12.1 mt -86.98 150.22 24.22 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.6 -25.21 61.24 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -103.33 -20.49 14.07 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.889 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.618 ' HB2' HD12 ' A' ' 115' ' ' LEU . 13.7 mptt -131.79 84.27 54.93 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.66 -9.23 24.78 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.542 2.162 . . . . 0.0 113.087 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 86.3 p -87.31 -16.95 33.6 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -97.14 130.72 44.36 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.605 HG22 ' HB3' ' A' ' 114' ' ' TYR . 25.0 pt -134.62 163.39 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.4 143.1 33.74 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.66 -173.73 36.02 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.47 161.04 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.474 ' O ' HD22 ' A' ' 136' ' ' LEU . 39.7 ttmt -104.49 137.7 41.96 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -107.24 131.08 54.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.8 t -149.56 155.33 40.14 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -69.99 -24.87 63.38 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -101.02 25.95 7.52 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.03 100.48 5.45 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.586 ' HG2' ' H ' ' A' ' 134' ' ' GLU . 71.7 ttt180 -61.08 139.09 58.16 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.422 ' HA ' ' HG ' ' A' ' 136' ' ' LEU . 14.6 ptm180 -62.83 -21.77 66.17 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.586 ' H ' ' HG2' ' A' ' 132' ' ' ARG . 15.2 mt-10 -94.01 86.53 5.05 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 131.72 11.84 2.06 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 126' ' ' LYS . 78.7 mt -63.89 126.57 28.08 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -85.56 153.51 22.37 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.639 0.733 . . . . 0.0 109.7 -177.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.0 t -76.7 134.52 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.75 136.52 40.84 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -177.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 85.4 mt -83.55 132.31 34.93 Favored 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.757 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -125.22 152.87 43.99 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 120' ' ' SER . 1.4 mp -83.23 150.75 26.0 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.22 151.51 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 121.805 0.812 . . . . 0.0 109.474 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -140.59 94.61 2.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -70.48 -20.91 62.82 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -71.18 -19.71 62.37 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -142.49 85.36 1.9 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.8 mt -98.26 5.37 48.43 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -89.65 17.43 6.49 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -85.62 108.89 18.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -65.6 -20.23 66.23 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.784 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -74.1 -19.06 60.72 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -96.94 -1.49 45.61 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -98.24 133.4 42.72 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -119.83 139.46 52.33 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -117.48 160.25 21.52 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.81 142.86 51.18 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.25 143.3 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.0 mt -106.61 150.99 40.28 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.69 150.37 68.53 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 121.849 1.699 . . . . 0.0 112.934 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.4 t -118.26 125.56 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 C--O 1.261 1.668 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.705 0.288 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.42 154.04 34.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.26 156.44 39.68 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.57 142.87 29.54 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -135.3 7.71 3.37 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -102.79 69.02 1.04 Allowed 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -73.82 -23.87 59.71 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -88.76 148.45 23.94 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 t -146.43 138.9 25.18 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -116.4 170.37 8.6 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -91.14 161.13 15.22 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 121.971 0.891 . . . . 0.0 108.768 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -84.17 159.86 58.62 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -55.32 140.65 82.03 Favored 'Trans proline' 0 CA--C 1.5 -1.178 0 C-N-CA 121.826 1.684 . . . . 0.0 112.589 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -83.82 155.54 22.92 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.756 0.789 . . . . 0.0 109.092 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.19 -164.73 37.03 Favored Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.618 ' HB3' HD22 ' A' ' 55' ' ' LEU . 47.4 m0 -80.57 145.99 31.48 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.24 161.99 40.2 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 31.5 m-85 -117.65 135.83 53.73 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.456 HD11 ' CD2' ' A' ' 64' ' ' LEU . 82.4 mt -100.82 106.03 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -104.71 129.59 52.88 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.449 0.642 . . . . 0.0 109.381 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.01 119.95 24.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -62.08 -32.5 73.06 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.9 t -65.16 -43.02 93.12 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 121.594 -0.691 . . . . 0.0 111.101 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -100.02 -21.84 15.47 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.298 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.12 19.56 78.41 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 10.7 m-30 -109.8 162.27 14.63 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 28' ' ' LEU . 1.4 p -116.02 154.29 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.842 HD23 HG21 ' A' ' 41' ' ' ILE . 1.9 mp -61.6 133.71 55.97 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.998 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -144.77 166.35 25.48 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.661 HG11 ' H ' ' A' ' 34' ' ' SER . 2.6 p -70.79 179.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.633 ' H ' HG22 ' A' ' 30' ' ' VAL . 36.0 t70 -55.13 -47.91 74.41 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.289 -0.882 . . . . 0.0 111.479 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.411 ' H ' HG13 ' A' ' 30' ' ' VAL . 65.2 t30 -173.85 74.77 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.588 -0.845 . . . . 0.0 108.829 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 52.43 44.73 29.61 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.661 ' H ' HG11 ' A' ' 30' ' ' VAL . 57.2 m -103.08 118.84 37.7 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -93.64 -1.5 55.24 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -80.04 142.04 35.32 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t -75.56 149.07 38.42 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.48 5.83 60.09 Favored Glycine 0 C--N 1.355 1.614 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.3 m -83.97 138.22 40.18 Favored Pre-proline 0 N--CA 1.438 -1.032 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HA ' HG12 ' A' ' 87' ' ' VAL . 56.8 Cg_endo -70.31 155.25 64.53 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.597 1.531 . . . . 0.0 112.338 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.842 HG21 HD23 ' A' ' 28' ' ' LEU . 23.0 mm -94.36 131.63 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 20.6 m -133.93 169.03 22.54 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 125' ' ' ILE . 89.7 mt -95.7 143.15 27.21 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.66 151.59 37.49 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.405 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 9.1 t -65.34 153.5 41.01 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 139.42 57.62 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.109 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -106.78 138.58 42.68 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.3 m -66.04 -34.82 78.95 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -137.07 160.61 38.44 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 60.31 41.86 15.79 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -100.0 15.78 26.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.46 77.74 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.7 p -72.01 -13.12 61.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -101.65 2.94 39.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 16' ' ' TRP . 62.4 mt -98.61 133.53 42.82 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -126.84 152.73 46.59 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -134.93 150.05 50.34 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -99.13 115.14 28.36 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -83.08 154.96 67.44 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.52 -18.95 49.69 Favored 'Trans proline' 0 CA--C 1.496 -1.401 0 C-N-CA 122.386 2.057 . . . . 0.0 113.598 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.1 m -73.56 -16.25 61.27 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.23 15.4 21.66 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.07 158.07 21.72 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 118.427 1.113 . . . . 0.0 108.851 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.462 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.2 mp -105.0 124.34 49.36 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.6 t -113.95 138.4 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -75.34 132.06 40.69 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -62.59 -43.36 99.0 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.063 -0.398 . . . . 0.0 111.357 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -78.06 -52.35 8.89 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 121.81 -0.556 . . . . 0.0 111.421 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.6 m -68.4 -39.76 81.55 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.42 4.58 90.39 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 105.783 -2.927 . . . . 0.0 105.783 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.6 163.63 12.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 64' ' ' LEU . 2.2 p -115.28 154.56 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.404 ' N ' HG22 ' A' ' 72' ' ' VAL . 65.1 mtt -66.66 137.32 56.62 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -153.03 172.1 17.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.414 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -87.98 142.8 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.25 79.74 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.325 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -72.21 -33.27 67.47 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.41 -8.54 79.65 Favored Glycine 0 CA--C 1.495 -1.176 0 N-CA-C 105.924 -2.87 . . . . 0.0 105.924 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.5 m -119.7 124.01 28.23 Favored Pre-proline 0 N--CA 1.437 -1.089 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.4 116.53 4.73 Favored 'Trans proline' 0 CA--C 1.497 -1.375 0 C-N-CA 121.04 1.16 . . . . 0.0 112.901 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -136.27 161.82 34.72 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.68 131.2 40.68 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.69 7.85 83.68 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.489 ' CG1' HD12 ' A' ' 140' ' ' LEU . 9.4 p -72.75 143.38 14.0 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-N 118.652 1.226 . . . . 0.0 108.35 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -80.49 154.6 27.47 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 121.482 0.658 . . . . 0.0 109.267 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.492 HD11 ' HG ' ' A' ' 140' ' ' LEU . 47.7 mm -111.43 127.85 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.9 m -131.47 161.4 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -84.91 139.33 31.93 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -141.8 168.48 19.65 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.4 m -62.68 150.54 40.75 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.3 150.54 46.25 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.34 156.31 35.65 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.8 -166.82 42.62 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.5 p -88.01 7.46 31.11 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -93.79 7.38 45.11 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.52 123.52 71.26 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -67.25 144.0 56.17 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.38 -22.5 66.8 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.07 -3.87 57.7 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -117.81 10.25 13.2 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -99.64 139.11 35.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -91.78 -7.91 48.26 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -81.22 -7.84 59.64 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.34 129.77 35.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -123.97 154.48 39.74 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -116.29 153.7 17.29 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 106.858 -2.497 . . . . 0.0 106.858 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 tt -131.34 125.99 34.13 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 81.4 p -91.98 159.75 37.21 Favored Pre-proline 0 CA--C 1.506 -0.744 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.3 -19.82 59.68 Favored 'Trans proline' 0 CA--C 1.501 -1.171 0 C-N-CA 122.246 1.964 . . . . 0.0 112.986 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.63 -12.92 60.08 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 7.6 58.16 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -83.6 139.44 32.84 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.7 mt -109.4 124.72 66.32 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.711 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.4 p90 -135.59 175.85 9.21 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.633 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 7.5 mt -84.68 147.68 26.8 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.83 -23.14 60.73 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -102.77 -19.65 14.64 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.556 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.633 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 1.3 mptm? -134.46 83.51 43.03 Favored Pre-proline 0 CA--C 1.496 -1.102 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.99 -9.32 24.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.491 2.127 . . . . 0.0 113.246 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 88.1 p -86.06 -14.66 43.7 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.574 HD23 ' HB3' ' A' ' 140' ' ' LEU . 6.4 mp -102.22 131.18 48.93 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 114' ' ' TYR . 28.6 pt -134.58 167.46 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.44 137.7 35.62 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.13 176.63 34.3 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.9 pp -131.94 160.34 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -122.44 147.09 46.74 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -68.96 156.25 38.89 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.6 t -103.87 164.48 11.66 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -64.72 -37.14 86.59 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -97.79 7.17 46.85 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 51.05 47.81 24.2 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.985 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -83.44 110.24 18.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -74.02 -21.31 60.01 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -91.46 90.46 7.66 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 129.95 7.76 3.61 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.3 127.85 33.42 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -90.61 154.66 19.42 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.518 0.675 . . . . 0.0 109.543 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.21 145.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -147.84 165.93 29.12 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.574 ' HB3' HD23 ' A' ' 121' ' ' LEU . 89.7 mt -83.26 129.28 34.99 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -129.67 141.92 50.82 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.02 150.81 42.09 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.446 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.14 137.87 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 CA-C-O 121.917 0.865 . . . . 0.0 110.051 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -115.29 78.35 1.16 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -64.19 -18.45 64.5 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.06 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -68.06 -26.14 65.7 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -139.36 86.32 2.11 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.08 4.11 44.43 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -95.62 12.95 27.88 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -88.06 138.54 31.36 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -69.71 -22.82 63.37 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.19 -28.38 65.25 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -90.76 1.05 57.22 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -113.75 137.53 51.51 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.811 0.815 . . . . 0.0 109.17 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -119.64 143.39 47.72 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -118.01 143.22 46.58 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -112.41 135.54 52.98 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.0 145.49 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.76 152.24 42.79 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.52 151.13 70.42 Favored 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 121.728 1.619 . . . . 0.0 113.089 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.6 t 63.25 73.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.263 1.801 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.196 0.522 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.98 95.25 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.63 154.38 35.23 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 7' ' ' GLU . . . -99.58 131.19 45.74 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -20.24 30.74 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -106.46 33.88 3.66 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 24.9 pt-20 -72.11 -21.94 61.41 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -146.6 163.66 35.12 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.8 p -130.22 158.34 39.99 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -122.82 153.23 39.85 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.24 161.69 17.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -73.0 147.75 88.63 Favored Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.81 -30.9 32.98 Favored 'Trans proline' 0 CA--C 1.501 -1.171 0 C-N-CA 121.939 1.759 . . . . 0.0 114.205 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -142.82 159.45 42.21 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.67 -42.74 97.13 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -94.58 134.35 37.23 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -163.3 161.15 24.53 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -117.73 134.66 54.68 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 80.3 mt -98.21 115.25 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -113.0 131.11 55.89 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -84.98 121.4 27.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -61.81 -28.88 69.78 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.1 t -63.83 -43.68 95.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 121.443 -0.785 . . . . 0.0 110.87 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -104.55 -21.1 13.48 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.226 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.39 20.26 77.21 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -107.96 165.25 11.6 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.85 161.25 15.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.884 HD23 HG21 ' A' ' 41' ' ' ILE . 2.5 mp -70.29 134.24 47.77 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.605 0.717 . . . . 0.0 109.895 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 34.9 ttp -146.37 165.01 30.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 31' ' ' ASP . 32.4 t -70.4 164.84 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.569 ' N ' HG12 ' A' ' 30' ' ' VAL . 19.4 t70 -49.81 -43.03 48.37 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 122.016 -0.427 . . . . 0.0 110.599 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -164.51 57.04 0.14 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 54.57 47.93 21.55 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.7 m -87.88 127.45 35.35 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -93.32 -1.7 55.7 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -91.85 148.54 22.15 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.6 m -82.06 157.27 24.2 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.13 -3.83 64.64 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.4 m -82.92 143.71 46.62 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.58 155.41 54.73 Favored 'Trans proline' 0 CA--C 1.496 -1.42 0 C-N-CA 121.671 1.58 . . . . 0.0 112.793 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.884 HG21 HD23 ' A' ' 28' ' ' LEU . 26.8 mm -92.88 131.19 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 25.7 m -130.91 164.35 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.2 mt -93.03 143.18 26.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.99 151.33 38.42 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -66.86 155.04 39.4 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.2 139.47 58.11 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.8 147.65 51.59 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.5 m -83.97 -10.47 57.89 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -123.46 146.06 48.33 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 58.38 42.16 21.84 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -91.03 -1.85 57.74 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.04 89.64 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.9 p -75.04 -12.6 60.36 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -101.12 0.85 38.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 55' ' ' LEU . 9.1 mt -95.96 136.11 36.83 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -127.63 156.49 42.23 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -149.59 165.7 31.48 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -119.76 134.61 55.17 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 119.129 -1.028 . . . . 0.0 108.283 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 98.3 m-20 -75.24 162.05 74.57 Favored Pre-proline 0 N--CA 1.44 -0.966 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 59' ' ' ASP . 18.9 Cg_endo -58.54 -18.8 41.5 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.491 1.461 . . . . 0.0 113.198 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.6 m -84.12 -8.84 58.98 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.6 31.23 10.51 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -104.43 134.71 47.18 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.73 130.16 36.41 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.953 HG22 HG12 ' A' ' 72' ' ' VAL . 61.1 t -128.38 137.37 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -79.98 131.54 35.83 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.89 -43.05 99.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 122.06 -0.4 . . . . 0.0 111.348 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.42 -51.8 9.51 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 121.755 -0.591 . . . . 0.0 111.423 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -68.23 -39.49 82.31 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.49 4.89 90.3 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 106.094 -2.802 . . . . 0.0 106.094 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -96.28 167.23 11.31 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.953 HG12 HG22 ' A' ' 65' ' ' VAL . 20.1 m -117.22 161.35 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.5 mtt -72.76 139.94 47.44 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -154.12 169.43 23.58 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.45 142.41 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.29 84.82 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -70.62 -34.07 71.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.83 -5.78 84.41 Favored Glycine 0 CA--C 1.495 -1.178 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.5 m -123.12 117.18 28.39 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.35 118.63 5.53 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 121.343 1.362 . . . . 0.0 112.831 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.25 161.46 42.4 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -75.01 133.22 41.7 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.13 8.29 64.84 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.3 t -81.69 131.84 32.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 CA-C-N 118.793 1.297 . . . . 0.0 108.151 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -72.43 149.13 44.51 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.862 HD11 HD13 ' A' ' 140' ' ' LEU . 48.8 mm -103.82 128.25 57.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.6 163.76 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -91.44 141.13 29.08 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -147.03 178.65 8.2 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -72.14 169.13 16.74 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -82.13 148.69 28.38 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.81 -143.15 0.24 Allowed 'General case' 0 C--N 1.357 0.932 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.49 -175.19 37.85 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.7 m -63.37 -40.15 96.46 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -155.38 69.75 0.71 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.0 t -119.34 124.92 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -67.34 145.99 54.53 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -68.82 -19.26 64.27 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -90.23 -6.38 55.29 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.6 mt -116.99 10.82 14.11 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -83.35 131.46 35.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -92.52 -5.46 51.71 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -72.75 -9.63 58.86 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -75.6 126.72 31.56 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.99 148.51 42.91 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.26 164.26 24.55 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 105.868 -2.893 . . . . 0.0 105.868 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -146.32 137.15 24.25 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 118.929 -1.108 . . . . 0.0 108.481 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.0 p -84.75 162.63 49.59 Favored Pre-proline 0 N--CA 1.442 -0.833 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.41 -16.93 37.83 Favored 'Trans proline' 0 CA--C 1.502 -1.102 0 C-N-CA 122.511 2.141 . . . . 0.0 113.295 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -72.93 -16.18 61.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.42 21.37 19.88 Favored Glycine 0 C--N 1.355 1.604 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -100.41 130.8 46.55 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.2 mt -101.93 127.28 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.503 ' HB3' HG22 ' A' ' 122' ' ' ILE . 4.9 p90 -140.06 171.88 13.56 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' A' ' 118' ' ' LYS . 4.2 mt -83.54 145.88 28.65 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.66 84.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.607 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -96.04 -14.28 23.07 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.296 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -134.56 83.09 43.66 Favored Pre-proline 0 CA--C 1.496 -1.131 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.88 -9.62 26.19 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.385 2.057 . . . . 0.0 112.952 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 85.0 p -88.88 -15.76 33.63 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.661 HD12 ' HG ' ' A' ' 140' ' ' LEU . 4.6 mm? -98.81 130.25 45.24 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.503 HG22 ' HB3' ' A' ' 114' ' ' TYR . 39.7 pt -141.44 164.26 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.631 HD22 ' H ' ' A' ' 123' ' ' LEU . 1.3 mm? -79.12 146.09 33.38 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.5 -169.49 24.87 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 106.258 -2.737 . . . . 0.0 106.258 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.03 173.47 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -119.07 111.06 17.81 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.64 137.56 36.35 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.474 ' H ' ' HB2' ' A' ' 131' ' ' ALA . 10.8 t -150.0 174.31 12.86 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -71.47 -30.79 66.41 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.96 33.76 3.64 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.779 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -90.09 78.82 6.59 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.501 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 31.8 tpt180 -63.7 131.93 49.45 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.89 -35.73 77.41 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 30.6 mt-10 -84.55 84.48 7.65 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.4 3.29 2.76 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.779 HD21 ' HB1' ' A' ' 131' ' ' ALA . 8.6 mt -67.52 118.59 11.04 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 118.937 1.368 . . . . 0.0 107.415 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -85.06 156.0 21.28 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.491 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.521 HG13 ' HB ' ' A' ' 86' ' ' ILE . 0.4 OUTLIER -86.31 136.89 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.16 141.63 49.69 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.862 HD13 HD11 ' A' ' 86' ' ' ILE . 5.1 tp -80.77 114.69 19.83 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -115.35 151.74 34.08 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.563 HD12 HD13 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -88.67 151.13 22.64 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.6 m -66.43 150.09 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.019 0.914 . . . . 0.0 109.22 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -148.0 102.26 3.37 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -66.6 -20.48 66.01 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.277 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -80.36 -11.11 59.74 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.2 m170 -126.11 53.42 1.62 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.8 mt -91.06 4.06 53.11 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -92.96 12.2 24.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -90.12 125.27 35.38 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -69.32 -21.84 63.82 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.2 -20.0 63.97 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -92.68 -3.34 55.04 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -93.3 132.52 37.43 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -125.37 140.41 52.83 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -122.36 153.76 38.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -119.08 139.03 52.43 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 t -124.75 144.38 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.7 mt -109.43 155.24 41.55 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.28 139.98 91.62 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 122.035 1.823 . . . . 0.0 113.143 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 162' ' ' VAL . 11.8 p -146.5 145.57 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.508 HG23 HG22 ' A' ' 161' ' ' VAL . 50.7 t . . . . . 0 C--O 1.261 1.685 0 CA-C-O 117.634 -1.174 . . . . 0.0 108.416 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttm . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.887 0.375 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.08 154.91 34.47 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.64 151.25 34.65 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.22 89.48 4.78 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 75.6 mtm -89.58 -14.48 34.95 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.25 76.87 1.07 Allowed 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -73.17 -24.03 60.51 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.1 151.98 22.75 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.2 t -146.02 139.16 25.9 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -95.21 170.19 9.57 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.07 161.47 14.72 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -89.72 154.71 48.14 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.4 158.99 54.45 Favored 'Trans proline' 0 CA--C 1.5 -1.213 0 C-N-CA 122.012 1.808 . . . . 0.0 112.902 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -77.14 157.86 30.74 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 121.721 0.772 . . . . 0.0 109.08 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.0 -168.15 38.8 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 107.104 -2.399 . . . . 0.0 107.104 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.497 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.5 m95 -89.76 178.54 6.22 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -164.09 162.77 23.15 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.579 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 51.6 m-85 -118.66 134.7 54.92 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.0 mt -102.61 112.23 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -110.71 131.2 55.25 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.84 125.12 33.05 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -65.05 -21.38 66.82 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.5 t -63.33 -44.11 95.83 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.432 -0.793 . . . . 0.0 111.204 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -121.34 -6.61 9.32 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.789 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.72 25.01 75.07 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -106.0 164.55 11.88 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.38 160.87 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.0 HD23 HG21 ' A' ' 41' ' ' ILE . 2.5 mp -67.47 132.0 46.76 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.8 ttp -146.33 165.72 28.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 31' ' ' ASP . 75.0 t -69.81 158.26 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' N ' HG12 ' A' ' 30' ' ' VAL . 42.5 t0 -53.38 -40.65 65.18 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.765 -0.584 . . . . 0.0 110.668 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -156.26 27.06 0.35 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.307 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 61.44 45.48 8.42 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 m -85.99 117.46 24.85 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -88.05 -2.47 58.63 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -82.09 -7.13 59.6 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t 70.9 -176.05 0.19 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.97 25.48 69.11 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.1 m -124.69 146.66 53.49 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HA ' HG12 ' A' ' 87' ' ' VAL . 71.8 Cg_endo -74.81 158.41 42.92 Favored 'Trans proline' 0 CA--C 1.496 -1.397 0 C-N-CA 121.959 1.773 . . . . 0.0 113.024 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.0 HG21 HD23 ' A' ' 28' ' ' LEU . 26.6 mm -86.09 131.31 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 20.0 m -130.64 166.72 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.95 142.33 27.6 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.19 34.85 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -60.7 145.08 50.65 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 139.5 57.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.478 0.656 . . . . 0.0 109.301 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -105.42 140.68 38.16 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -66.54 -34.58 78.23 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -135.27 159.93 39.99 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 60.59 41.74 15.0 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -99.5 16.74 22.28 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.66 84.51 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.2 m -70.6 -16.65 62.86 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -97.81 2.22 49.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.579 HD21 ' CZ ' ' A' ' 18' ' ' PHE . 25.3 mt -99.49 135.8 40.36 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -127.95 154.99 44.95 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -139.34 154.46 47.88 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -108.56 135.53 49.66 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -84.05 163.45 48.26 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.28 -23.34 45.41 Favored 'Trans proline' 0 CA--C 1.501 -1.146 0 C-N-CA 121.729 1.619 . . . . 0.0 112.46 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 p -84.29 -3.26 58.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.89 23.03 51.23 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -96.68 133.33 41.35 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.36 127.81 35.85 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.977 HG22 HG12 ' A' ' 72' ' ' VAL . 60.4 t -119.59 138.18 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -73.24 132.31 43.01 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -61.93 -40.94 97.21 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 122.102 -0.374 . . . . 0.0 111.294 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -84.89 -51.92 6.38 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.393 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.9 m -67.95 -39.05 83.49 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.916 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.46 5.21 89.74 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 106.401 -2.68 . . . . 0.0 106.401 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -92.93 161.29 14.53 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.977 HG12 HG22 ' A' ' 65' ' ' VAL . 22.0 m -115.58 161.18 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.5 mtt -73.31 140.48 46.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -157.26 168.02 28.63 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.0 143.0 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.05 -42.05 81.12 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.444 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.14 -33.4 70.04 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.13 -6.25 83.71 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 105.913 -2.875 . . . . 0.0 105.913 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.0 m -124.53 128.7 24.89 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.74 112.7 3.32 Favored 'Trans proline' 0 CA--C 1.498 -1.325 0 C-N-CA 121.19 1.26 . . . . 0.0 113.038 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -129.42 157.53 41.72 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.34 130.64 40.6 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.77 8.25 82.99 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG1' HD12 ' A' ' 140' ' ' LEU . 12.1 p -69.61 144.52 13.88 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-N 118.583 1.192 . . . . 0.0 108.199 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -85.62 155.85 20.96 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.406 HD11 ' HG ' ' A' ' 140' ' ' LEU . 48.9 mm -108.94 129.39 63.66 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 40' ' ' PRO . 35.3 m -129.74 170.05 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.34 141.49 28.5 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -142.85 169.08 18.24 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.2 m -73.25 149.15 43.0 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -67.78 153.19 44.25 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -131.86 -154.9 0.65 Allowed 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.57 -14.86 53.7 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.5 p -70.55 -37.59 74.04 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -130.72 17.81 5.21 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.85 130.75 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -61.39 139.08 58.26 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.49 -18.59 65.11 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -90.29 -4.75 56.95 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.8 mt -120.41 10.8 11.29 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -94.55 128.32 41.08 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -83.5 -7.25 59.57 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.316 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -75.84 -6.99 53.37 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -82.18 126.1 31.68 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -117.51 151.83 36.31 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.89 153.89 16.91 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.8 tp -114.6 120.66 40.95 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.416 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 10.5 t -80.87 137.21 50.39 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.58 -9.59 26.54 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.91 1.74 . . . . 0.0 112.782 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.66 -4.0 57.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.41 43.42 3.2 Favored Glycine 0 C--N 1.355 1.613 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -134.21 154.16 51.42 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -117.33 127.21 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.679 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -133.14 172.66 12.36 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.66 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 16.2 mt -84.19 150.34 25.55 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.94 -19.95 56.75 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -101.12 -28.75 12.52 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.66 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 14.1 mptt -131.86 85.17 51.89 Favored Pre-proline 0 CA--C 1.496 -1.109 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.32 -6.08 15.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.462 2.108 . . . . 0.0 112.458 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.9 m -86.84 -12.51 47.68 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.552 HD23 HD12 ' A' ' 142' ' ' LEU . 50.3 mt -106.44 130.68 54.2 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.679 HG22 ' HB3' ' A' ' 114' ' ' TYR . 29.0 pt -134.3 164.72 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.11 139.73 37.99 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.32 174.84 39.62 Favored Glycine 0 CA--C 1.494 -1.252 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.805 HD13 HD13 ' A' ' 136' ' ' LEU . 1.2 pp -134.39 159.36 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -96.35 116.86 29.71 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.95 125.76 29.82 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -150.68 146.83 26.72 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -92.34 -6.02 51.04 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -110.63 11.25 22.84 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -106.57 -6.45 18.03 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 70.85 129.89 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.849 0.833 . . . . 0.0 109.255 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -64.02 -36.89 85.46 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -87.9 85.46 7.01 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.32 3.7 0.85 Allowed Glycine 0 N--CA 1.435 -1.407 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.805 HD13 HD13 ' A' ' 125' ' ' ILE . 81.0 mt -62.94 122.56 16.32 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.553 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -86.09 153.53 22.03 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.726 0.774 . . . . 0.0 109.947 -177.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.79 140.51 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -146.51 167.47 23.59 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.452 HD12 ' CG1' ' A' ' 84' ' ' VAL . 89.2 mt -91.55 120.93 32.78 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -108.32 140.68 41.22 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.552 HD12 HD23 ' A' ' 121' ' ' LEU . 3.1 tp -70.06 135.11 48.94 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.31 143.45 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.247 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -147.61 104.23 3.6 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -67.14 -19.18 65.57 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.092 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -67.41 -24.68 65.68 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -131.69 79.72 1.89 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.6 mt -104.51 4.3 32.9 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -96.06 13.95 25.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -83.36 126.01 32.27 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -69.4 -24.77 63.9 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -73.12 -21.09 60.8 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -103.52 2.63 33.81 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.3 tpt85 -95.38 131.71 41.21 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -120.4 137.01 54.54 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -113.49 144.27 43.12 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -115.23 136.06 53.51 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.4 t -128.93 143.52 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt -108.8 151.22 41.67 Favored Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.75 148.48 65.25 Favored 'Trans proline' 0 CA--C 1.497 -1.344 0 C-N-CA 121.738 1.626 . . . . 0.0 113.057 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.54 158.06 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 C--O 1.262 1.723 0 CA-C-O 117.685 -1.15 . . . . 0.0 108.581 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.849 0.357 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.12 155.9 36.24 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.81 153.65 39.46 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.87 128.11 45.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.0 ptp -131.51 8.02 4.56 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.5 88.06 2.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -73.98 -23.35 59.46 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -81.67 138.56 35.27 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m -134.56 145.04 48.33 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -127.87 170.42 12.83 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -102.28 156.35 17.63 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-O 122.033 0.92 . . . . 0.0 108.747 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -90.33 157.77 44.43 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.49 156.29 66.74 Favored 'Trans proline' 0 CA--C 1.498 -1.306 0 C-N-CA 121.491 1.461 . . . . 0.0 111.953 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -113.47 164.89 13.04 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.19 -161.08 34.03 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.567 ' HB3' HD22 ' A' ' 55' ' ' LEU . 49.3 m0 -80.75 138.2 36.29 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -159.98 164.59 33.19 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -121.28 139.99 52.67 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 88.4 mt -108.78 120.32 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.281 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HB3' HG12 ' A' ' 27' ' ' VAL . 11.6 ptmt -122.44 147.38 46.39 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 121.997 0.903 . . . . 0.0 109.09 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -93.21 121.89 35.04 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.93 -25.95 63.92 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -63.64 -42.88 98.1 Favored 'General case' 0 CA--C 1.504 -0.795 0 O-C-N 121.222 -0.924 . . . . 0.0 110.628 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -106.82 -23.04 12.51 Favored 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.155 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.65 17.41 78.93 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -103.02 164.04 11.85 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 20' ' ' LYS . 22.5 m -114.45 159.35 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-O 121.557 0.694 . . . . 0.0 109.221 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.935 HD23 HG21 ' A' ' 41' ' ' ILE . 3.6 mp -67.73 132.55 47.66 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.915 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.8 ttp -146.1 166.91 24.73 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 31' ' ' ASP . 40.7 t -69.94 162.22 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.534 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.0 t70 -54.25 -40.51 67.81 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.85 -0.531 . . . . 0.0 110.578 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -161.92 45.36 0.16 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 55.73 47.54 20.26 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.5 m -87.8 98.94 11.75 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -75.9 -11.33 59.95 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -80.27 -6.66 58.27 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t 70.1 -169.38 0.17 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.61 25.06 75.06 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -131.42 148.98 72.26 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.45 ' HA ' HG12 ' A' ' 87' ' ' VAL . 71.8 Cg_endo -74.61 161.58 39.42 Favored 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 122.252 1.968 . . . . 0.0 112.977 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.935 HG21 HD23 ' A' ' 28' ' ' LEU . 29.9 mm -88.6 131.03 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 23.2 m -130.09 167.2 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.981 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.26 143.57 26.55 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.19 149.33 34.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -60.86 144.23 53.21 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.4 139.26 57.23 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -117.94 147.21 43.37 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.6 m -83.67 -19.49 35.23 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -126.49 149.39 49.37 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 58.69 42.89 19.61 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -93.37 5.18 52.46 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.56 87.74 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.4 p -73.09 -12.32 60.86 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -102.45 2.55 36.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 16' ' ' TRP . 28.5 mt -98.31 138.54 35.42 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -127.23 151.23 48.98 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -128.54 131.72 48.25 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -92.94 113.26 25.49 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -76.55 154.75 83.74 Favored Pre-proline 0 N--CA 1.439 -0.986 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.28 -17.82 61.91 Favored 'Trans proline' 0 CA--C 1.497 -1.351 0 C-N-CA 121.872 1.714 . . . . 0.0 112.858 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -73.87 -18.94 60.86 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.54 14.64 17.38 Favored Glycine 0 C--N 1.358 1.768 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.484 ' CD2' ' HB2' ' A' ' 103' ' ' GLN . 1.9 m-85 -107.34 160.3 15.73 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 118.22 1.01 . . . . 0.0 108.732 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.9 mt -110.05 128.83 55.65 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.903 HG22 HG12 ' A' ' 72' ' ' VAL . 86.1 t -115.67 136.5 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -80.84 128.87 34.15 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.59 -42.34 99.5 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 121.947 -0.471 . . . . 0.0 111.352 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -65.71 -50.43 64.9 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.3 p -89.14 -29.57 19.25 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.554 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.68 5.49 89.82 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -96.57 165.9 11.93 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.903 HG12 HG22 ' A' ' 65' ' ' VAL . 31.7 m -113.09 156.82 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 23.4 ptp -86.58 140.85 29.48 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -162.42 -177.86 5.92 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.8 142.34 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.981 0 CA-C-O 121.669 0.747 . . . . 0.0 109.005 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.472 ' HB2' HG13 ' A' ' 87' ' ' VAL . . . -70.58 -41.49 72.32 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.631 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -71.13 -32.9 69.56 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.92 -5.22 85.18 Favored Glycine 0 CA--C 1.494 -1.242 0 N-CA-C 105.802 -2.919 . . . . 0.0 105.802 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -123.66 127.42 25.5 Favored Pre-proline 0 N--CA 1.435 -1.207 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.05 117.42 5.15 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 C-N-CA 121.236 1.291 . . . . 0.0 113.135 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -135.93 162.27 33.31 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.68 128.92 35.58 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.95 11.51 81.27 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.85 143.54 14.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 CA-C-N 118.391 1.095 . . . . 0.0 108.414 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -82.0 157.42 24.22 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 121.494 0.664 . . . . 0.0 109.621 -178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.428 HD11 ' HG ' ' A' ' 140' ' ' LEU . 48.6 mm -112.82 127.77 69.88 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' A' ' 76' ' ' ALA . 33.3 m -132.0 170.42 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -99.69 143.49 29.87 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -146.08 -178.01 5.91 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 t -71.17 168.15 17.84 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.943 0.878 . . . . 0.0 108.877 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -84.35 134.97 34.48 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -101.75 -158.57 0.68 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.51 -13.78 59.56 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.1 p -68.62 -37.49 79.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -144.99 28.54 1.24 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.8 t -126.84 128.79 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -63.36 142.5 58.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -66.83 -19.8 65.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -90.03 -4.75 57.22 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.76 9.14 12.9 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -91.66 132.22 36.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.0 -7.69 48.17 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.625 ' NE2' HG21 ' A' ' 72' ' ' VAL . 35.3 mt-30 -70.23 -21.59 62.98 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.37 129.69 39.96 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -120.02 157.09 29.6 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.57 160.21 13.31 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.8 tp -135.19 129.81 34.34 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.8 p -102.12 159.3 29.79 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.91 -20.52 67.3 Favored 'Trans proline' 0 CA--C 1.499 -1.229 0 C-N-CA 122.323 2.015 . . . . 0.0 112.969 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -75.89 -13.75 60.26 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.39 5.69 60.28 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -82.72 138.62 34.01 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.12 124.72 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.747 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.9 OUTLIER -132.91 179.01 6.44 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.728 HD12 ' HB2' ' A' ' 118' ' ' LYS . 13.8 mt -85.55 149.03 25.65 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.17 -23.4 61.27 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -104.34 -17.73 14.7 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.734 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.728 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -134.55 84.28 40.36 Favored Pre-proline 0 CA--C 1.493 -1.231 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.71 -7.17 18.66 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.444 2.096 . . . . 0.0 112.466 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 71.0 m -88.65 -12.51 42.29 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 142' ' ' LEU . 46.4 mt -106.75 130.5 54.45 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.747 HG22 ' HB3' ' A' ' 114' ' ' TYR . 25.3 pt -134.07 165.0 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.28 138.95 35.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.82 176.06 39.14 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 107.146 -2.381 . . . . 0.0 107.146 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.7 pp -130.26 159.22 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -116.12 144.86 43.58 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -69.54 147.26 51.04 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.0 t -98.16 163.46 12.73 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -64.59 -37.1 86.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -96.78 5.09 51.28 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 51.4 45.02 28.59 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.952 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -77.47 104.86 8.25 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -65.34 -36.64 84.63 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -83.11 89.38 6.93 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 134.17 5.64 2.65 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.404 HD13 HD13 ' A' ' 125' ' ' ILE . 79.7 mt -67.61 125.8 27.33 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -89.0 154.43 20.22 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.474 0.654 . . . . 0.0 109.417 -177.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 p -97.66 144.99 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -146.73 166.52 26.36 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.428 ' HG ' HD11 ' A' ' 86' ' ' ILE . 86.6 mt -88.76 117.18 27.55 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -102.45 138.15 39.74 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.439 HD12 HD23 ' A' ' 121' ' ' LEU . 5.5 tp -72.72 137.54 46.0 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.077 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.85 147.58 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.132 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -145.53 107.33 4.29 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -64.89 -23.2 67.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.982 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -64.4 -28.18 69.51 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -140.45 85.9 2.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -106.48 3.95 27.75 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -98.38 16.48 21.49 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.403 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 97.9 mtt180 -76.93 135.62 38.77 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -70.82 -22.96 62.28 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 150' ' ' ARG . 8.3 pt-20 -72.05 -21.2 61.56 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -100.75 0.67 39.29 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -92.78 132.02 37.33 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -126.71 144.48 50.92 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -130.87 156.46 45.0 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -118.7 142.18 47.91 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.98 144.25 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.8 mt -108.67 155.75 40.05 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.98 141.67 98.56 Favored 'Trans proline' 0 CA--C 1.5 -1.189 0 C-N-CA 121.92 1.747 . . . . 0.0 113.401 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.6 t 61.0 63.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.263 1.774 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.455 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.147 0.499 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.66 156.06 37.18 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.23 136.99 52.35 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.4 95.09 7.44 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.0 ptp -81.09 -17.96 48.21 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.19 86.89 2.41 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -84.29 -35.6 23.23 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.86 142.05 37.17 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.7 m -133.15 145.76 50.96 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -101.55 170.99 7.83 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.29 162.39 25.59 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -90.15 146.92 35.86 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.86 -24.93 20.58 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.057 1.838 . . . . 0.0 113.843 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.94 150.74 49.41 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.06 -43.14 93.98 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -91.0 135.24 33.87 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -165.62 163.96 19.21 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.415 ' CE1' HD21 ' A' ' 55' ' ' LEU . 46.5 m-85 -116.28 137.36 52.21 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.98 120.6 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 29.8 pttt -125.68 146.62 49.65 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -87.82 130.93 34.71 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -64.67 -26.85 68.56 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 122.203 -0.311 . . . . 0.0 111.425 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 t -65.32 -42.02 93.41 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 121.79 -0.569 . . . . 0.0 110.672 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -104.98 -23.69 12.93 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.593 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.88 17.35 80.17 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 107.402 -2.279 . . . . 0.0 107.402 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -107.86 159.58 16.41 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 12.6 m -107.6 158.91 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.759 HD12 HG21 ' A' ' 41' ' ' ILE . 2.4 pt? -91.86 139.4 30.7 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.066 0.936 . . . . 0.0 109.468 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.6 ptm -147.57 178.7 8.24 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.584 HG11 ' H ' ' A' ' 34' ' ' SER . 43.8 t -64.5 156.49 5.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.635 ' HA ' HG22 ' A' ' 42' ' ' VAL . 43.0 t0 -57.36 -39.47 76.06 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.567 -0.708 . . . . 0.0 110.75 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -160.94 50.26 0.25 Allowed 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.861 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 53.9 51.95 13.83 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.584 ' H ' HG11 ' A' ' 30' ' ' VAL . 45.1 t -89.81 113.78 25.4 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -92.65 -4.62 53.01 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -91.36 0.47 57.51 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 t 69.56 -172.29 0.18 Allowed 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.61 29.26 72.82 Favored Glycine 0 C--N 1.355 1.605 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 28.4 t -128.59 129.37 23.53 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 87' ' ' VAL . 36.1 Cg_exo -61.7 155.3 54.69 Favored 'Trans proline' 0 CA--C 1.5 -1.219 0 C-N-CA 122.434 2.089 . . . . 0.0 113.433 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.759 HG21 HD12 ' A' ' 28' ' ' LEU . 24.0 mm -87.63 129.45 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 31' ' ' ASP . 14.8 m -130.99 163.15 37.71 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 CA-C-O 121.851 0.834 . . . . 0.0 109.474 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 136' ' ' LEU . 94.2 mt -82.72 144.45 30.21 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.232 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.99 148.35 29.65 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.3 t -66.87 154.73 40.22 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.83 138.65 58.51 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.41 147.87 52.39 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -86.62 -4.87 59.24 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -118.77 138.3 52.77 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 57.52 44.36 21.29 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -84.17 -5.5 59.26 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.63 84.72 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.0 m -69.07 -20.58 64.1 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -99.29 4.27 46.45 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.415 HD21 ' CE1' ' A' ' 18' ' ' PHE . 11.1 mt -99.6 136.53 39.4 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -126.2 148.69 49.4 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -124.26 128.52 49.29 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -91.36 109.86 21.15 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -75.15 155.53 86.2 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -58.78 -23.53 67.15 Favored 'Trans proline' 0 CA--C 1.498 -1.318 0 C-N-CA 122.037 1.825 . . . . 0.0 113.3 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.9 m -74.41 -15.64 60.91 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.35 11.75 30.66 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.77 155.25 17.45 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 118.4 1.1 . . . . 0.0 108.456 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.3 mt -107.8 123.91 49.27 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.834 HG22 HG12 ' A' ' 72' ' ' VAL . 92.7 t -109.72 136.85 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -80.97 125.67 30.43 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.45 -39.72 94.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.988 -0.445 . . . . 0.0 111.237 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -66.34 -50.9 62.0 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.1 p -90.82 -27.79 18.63 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.793 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.02 3.91 90.21 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.53 167.81 11.26 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.834 HG12 HG22 ' A' ' 65' ' ' VAL . 27.1 m -115.1 153.45 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.1 ptp -76.82 143.64 39.63 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -156.75 175.62 13.82 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.07 143.13 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.32 -43.21 74.19 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.763 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -71.89 -33.12 68.09 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.64 -7.29 81.54 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 105.652 -2.979 . . . . 0.0 105.652 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.2 m -114.05 119.19 41.22 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.33 113.53 3.8 Favored 'Trans proline' 0 CA--C 1.497 -1.328 0 C-N-CA 121.213 1.275 . . . . 0.0 112.922 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.67 165.03 30.81 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.688 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -74.15 138.3 43.75 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.66 6.87 82.56 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.537 ' HB ' HD12 ' A' ' 140' ' ' LEU . 83.8 t -83.05 133.45 29.05 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-N 119.13 1.465 . . . . 0.0 107.893 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.36 156.31 37.21 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.441 0.639 . . . . 0.0 109.592 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.4 mm -110.3 127.53 67.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.1 m -133.24 162.48 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -81.93 147.71 29.12 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -145.02 169.35 18.27 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.9 m -68.8 148.61 50.04 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -69.94 156.57 38.9 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.69 -159.92 1.01 Allowed 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.91 -18.86 48.63 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.4 m -67.92 -41.8 82.05 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -131.89 24.44 4.63 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.2 t -124.7 128.66 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -60.21 146.16 44.61 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.22 -20.53 66.1 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.46 -2.7 57.94 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -115.57 7.11 14.78 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -87.35 125.28 34.15 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -97.53 -8.13 29.82 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -83.08 -4.84 58.77 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.99 124.41 26.92 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.8 154.23 34.55 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -116.92 150.7 18.48 Favored Glycine 0 C--N 1.352 1.438 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.6 tp -111.51 120.36 41.87 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.413 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 8.8 t -77.7 143.78 67.95 Favored Pre-proline 0 N--CA 1.441 -0.912 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.99 -20.38 53.04 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.029 1.819 . . . . 0.0 112.801 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -85.26 -2.87 58.54 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.83 6.32 59.4 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -84.69 147.49 26.89 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.8 mt -111.85 124.01 68.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.564 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.1 p90 -132.27 171.18 14.02 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 2.3 mt -87.55 147.53 25.3 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.16 82.67 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.616 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -94.38 -17.3 22.68 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.281 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.582 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 0.6 OUTLIER -134.71 82.5 44.33 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -64.65 -15.02 47.9 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.595 2.197 . . . . 0.0 113.141 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 92.3 p -83.09 -17.17 44.06 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 140' ' ' LEU . 53.5 mt -98.41 130.68 45.04 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' A' ' 114' ' ' TYR . 36.4 pt -135.49 164.22 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.27 142.6 30.99 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.92 -173.14 32.25 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 106.564 -2.614 . . . . 0.0 106.564 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -136.54 161.64 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.53 ' O ' HD22 ' A' ' 136' ' ' LEU . 40.1 ttmt -110.18 143.41 40.32 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.77 149.4 46.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -107.71 157.2 18.31 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -60.8 -45.64 93.64 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -89.06 1.76 55.09 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 50.81 47.12 25.13 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.16 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -82.37 113.16 19.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.13 -35.72 80.35 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.6 85.66 6.95 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.88 -3.18 1.5 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 43' ' ' LEU . 88.1 mt -68.99 125.17 25.83 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.582 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -92.48 157.74 16.4 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.524 0.678 . . . . 0.0 109.486 -177.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.09 135.4 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.98 142.38 47.65 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.537 HD12 ' HB ' ' A' ' 84' ' ' VAL . 83.7 mt -79.68 128.85 33.91 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -119.91 152.48 37.31 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.688 HD13 ' HB2' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -88.52 139.29 30.63 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.715 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.18 144.24 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.862 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -149.82 103.86 3.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -67.43 -19.7 65.41 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.077 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.98 -24.94 66.09 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -133.96 82.43 1.98 Allowed 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.8 mt -103.05 4.7 37.5 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -93.45 15.81 14.99 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -87.43 115.5 24.9 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.584 ' HA ' ' HE ' ' A' ' 154' ' ' ARG . 60.9 pttt -66.06 -20.59 66.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.893 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -74.74 -18.29 60.52 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -96.91 -1.72 45.26 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.584 ' HE ' ' HA ' ' A' ' 151' ' ' LYS . 79.4 mtm180 -99.94 133.75 43.86 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -118.52 140.56 49.68 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -112.81 157.1 21.78 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -128.29 143.66 51.04 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.4 145.14 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.8 mt -107.77 151.59 41.2 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.83 149.1 72.33 Favored 'Trans proline' 0 CA--C 1.496 -1.399 0 C-N-CA 121.752 1.635 . . . . 0.0 113.058 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.673 HG12 HG23 ' A' ' 162' ' ' VAL . 67.4 t -119.94 124.81 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.673 HG23 HG12 ' A' ' 161' ' ' VAL . 59.5 t . . . . . 0 C--O 1.262 1.741 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.81 0.338 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.73 94.94 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.39 33.98 3.93 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.43 58.49 2.42 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.7 ttt -93.82 62.04 3.14 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 65.62 50.48 1.62 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -71.15 -19.4 62.43 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -119.74 159.36 24.65 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m -129.38 145.45 51.4 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -90.6 170.08 10.47 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -93.9 137.42 33.15 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.422 ' HB2' ' CD2' ' A' ' 58' ' ' HIS . 71.3 m-85 -78.53 157.38 77.45 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.71 149.33 83.77 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 C-N-CA 121.288 1.325 . . . . 0.0 112.069 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -98.75 164.27 12.29 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.89 -166.76 41.32 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.684 ' HB3' HD22 ' A' ' 55' ' ' LEU . 52.3 m0 -76.82 141.63 40.61 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -155.94 162.27 40.4 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.435 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 41.9 m-85 -119.59 140.67 50.2 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.565 HD11 ' CD2' ' A' ' 64' ' ' LEU . 82.8 mt -103.18 115.84 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -110.9 131.63 54.88 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -88.57 122.24 31.81 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -62.8 -20.06 64.65 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 t -63.62 -45.67 89.25 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 119.357 0.98 . . . . 0.0 110.916 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -116.94 -13.14 10.65 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.319 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.26 19.14 72.64 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -97.58 163.87 12.67 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.29 160.13 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.938 HD23 HG21 ' A' ' 41' ' ' ILE . 3.1 mp -67.61 133.18 48.92 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.468 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 37.3 ttp -145.28 163.66 33.79 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 31' ' ' ASP . 38.9 t -69.92 161.13 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' HG12 ' A' ' 30' ' ' VAL . 35.8 t70 -49.31 -38.09 26.43 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 122.188 -0.32 . . . . 0.0 111.015 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -161.26 48.57 0.21 Allowed 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.726 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 55.41 47.02 22.11 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -96.53 130.23 43.75 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -92.45 -3.21 55.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -85.44 142.37 29.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.5 p -72.6 161.03 31.3 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.52 7.58 69.09 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.1 m -92.45 128.73 43.43 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HA ' HG12 ' A' ' 87' ' ' VAL . 35.9 Cg_exo -60.0 151.8 69.47 Favored 'Trans proline' 0 CA--C 1.499 -1.242 0 C-N-CA 122.16 1.907 . . . . 0.0 113.127 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.938 HG21 HD23 ' A' ' 28' ' ' LEU . 25.0 mm -93.93 129.27 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 29.9 m -131.57 164.07 35.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.7 mt -94.51 142.6 27.25 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.11 150.33 35.72 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -60.46 145.22 49.08 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 139.58 57.23 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.24 146.3 47.4 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.7 m -85.53 -16.02 40.81 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -123.27 147.04 47.37 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 57.84 42.66 22.89 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -90.58 2.41 55.85 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 -36.79 84.74 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 m -69.72 -18.84 63.56 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -98.21 2.75 48.69 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.684 HD22 ' HB3' ' A' ' 16' ' ' TRP . 48.6 mt -98.61 136.22 39.01 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -126.1 150.12 48.44 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -128.58 130.89 48.0 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.435 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 52.0 t-80 -89.9 117.9 29.07 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -80.34 158.36 71.8 Favored Pre-proline 0 C--N 1.359 0.998 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.58 -17.68 55.55 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 121.77 1.647 . . . . 0.0 112.348 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -85.34 -2.52 58.17 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 58' ' ' HIS . . . 86.64 22.48 46.61 Favored Glycine 0 C--N 1.356 1.693 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -104.41 134.96 46.74 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.565 ' CD2' HD11 ' A' ' 19' ' ' ILE . 6.7 mp -94.28 123.17 37.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.958 HG22 HG12 ' A' ' 72' ' ' VAL . 65.2 t -110.6 135.33 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -79.29 128.0 32.77 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -63.27 -40.17 96.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.9 -0.5 . . . . 0.0 111.195 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -70.38 -50.29 40.36 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.962 -0.461 . . . . 0.0 112.116 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 88.5 p -87.43 -29.59 21.33 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.806 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.83 3.88 90.47 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -91.05 165.12 13.69 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.958 HG12 HG22 ' A' ' 65' ' ' VAL . 24.2 m -116.94 160.29 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 mtt -70.08 139.58 52.59 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -159.04 172.29 18.44 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.419 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -87.95 143.53 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.73 -44.56 81.24 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.788 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -73.26 -32.79 64.9 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.419 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.4 -7.91 80.68 Favored Glycine 0 CA--C 1.496 -1.118 0 N-CA-C 105.703 -2.959 . . . . 0.0 105.703 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.9 m -113.49 119.99 40.61 Favored Pre-proline 0 N--CA 1.436 -1.155 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HG3' ' CE2' ' A' ' 102' ' ' PHE . 72.3 Cg_endo -74.09 117.89 5.19 Favored 'Trans proline' 0 CA--C 1.496 -1.422 0 C-N-CA 121.291 1.327 . . . . 0.0 113.131 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -150.54 161.23 42.95 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -72.13 138.68 47.89 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.67 8.09 77.45 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.596 ' HB ' HD12 ' A' ' 140' ' ' LEU . 80.3 t -85.54 133.59 29.15 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-N 118.978 1.389 . . . . 0.0 107.648 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -73.74 153.8 39.88 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.593 0.711 . . . . 0.0 109.614 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.5 mm -107.61 128.4 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 40' ' ' PRO . 29.1 m -133.65 161.91 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -87.21 137.78 32.05 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -139.67 174.33 10.63 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -72.21 166.03 23.21 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -80.08 157.08 26.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -134.81 162.1 33.32 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.57 -22.05 0.41 Allowed Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.8 m -64.68 -40.81 96.04 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -128.61 16.75 6.43 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.87 127.97 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -65.09 140.32 58.8 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.61 -18.54 65.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -89.4 -5.7 57.2 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.7 mt -119.41 10.62 11.94 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -92.86 123.9 36.47 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' A' ' 80' ' ' PRO . 67.4 m-85 -77.65 -7.58 56.64 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.945 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -71.59 -12.21 61.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -76.7 126.8 31.61 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -117.3 155.56 29.3 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.3 151.61 18.08 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.0 tp -111.94 121.95 46.43 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.42 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.9 t -82.03 138.37 46.14 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.01 -8.97 25.07 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.768 1.645 . . . . 0.0 112.99 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.15 -0.3 57.68 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.3 41.55 4.51 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -132.18 151.13 51.96 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.9 mt -116.79 126.66 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.587 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.9 OUTLIER -132.14 173.63 11.04 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.665 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 13.7 mt -85.71 149.16 25.49 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.22 -21.04 59.97 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -102.25 -24.68 13.87 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.396 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 3.6 mptp? -133.46 85.06 44.42 Favored Pre-proline 0 CA--C 1.492 -1.264 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 114' ' ' TYR . 26.0 Cg_exo -66.35 -8.8 21.69 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.437 2.091 . . . . 0.0 112.591 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.3 m -82.92 -26.18 31.71 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.624 HD22 ' HB3' ' A' ' 140' ' ' LEU . 69.3 mt -93.07 131.35 38.16 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.587 HG22 ' HB3' ' A' ' 114' ' ' TYR . 38.9 pt -136.62 162.81 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.54 134.56 40.72 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.4 -169.02 19.37 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 106.988 -2.445 . . . . 0.0 106.988 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.446 ' CD1' HD13 ' A' ' 136' ' ' LEU . 8.8 pt -139.21 173.05 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.153 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -117.05 112.96 21.65 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -85.39 131.65 34.36 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 30.5 t -150.39 160.39 43.78 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.71 -30.93 68.68 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -100.78 34.63 2.4 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 128' ' ' SER . . . -119.66 99.45 6.66 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.48 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 16.8 tpt180 -62.22 131.54 49.76 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -62.55 -36.12 81.64 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.48 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 29.9 mt-10 -83.76 86.0 7.21 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.94 10.22 1.81 Allowed Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.446 HD13 ' CD1' ' A' ' 125' ' ' ILE . 18.7 mt -63.6 121.09 13.05 Favored 'General case' 0 C--N 1.363 1.155 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -83.12 155.37 23.85 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.546 0.689 . . . . 0.0 109.398 -178.099 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.27 134.16 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -130.09 139.6 50.92 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.624 ' HB3' HD22 ' A' ' 121' ' ' LEU . 77.0 mt -75.49 125.73 29.59 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -123.67 143.68 50.11 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.582 ' CD1' HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -84.41 148.99 26.29 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.68 151.67 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-O 121.767 0.794 . . . . 0.0 109.232 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -147.51 100.11 3.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -68.79 -20.07 64.32 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.794 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -68.39 -23.99 64.72 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -135.19 83.91 2.06 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.3 4.87 42.08 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -95.89 20.81 9.42 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -92.96 120.26 33.09 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -68.39 -22.93 64.61 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -70.97 -20.41 62.43 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -96.9 -1.68 45.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -98.84 133.13 43.57 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -123.19 140.35 53.11 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -123.51 156.2 36.09 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.7 141.02 49.0 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.06 144.68 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -108.38 152.75 42.15 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.4 149.19 74.84 Favored 'Trans proline' 0 CA--C 1.497 -1.347 0 C-N-CA 121.729 1.619 . . . . 0.0 113.053 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.678 HG12 HG23 ' A' ' 162' ' ' VAL . 65.6 t -120.02 124.55 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.678 HG23 HG12 ' A' ' 161' ' ' VAL . 60.5 t . . . . . 0 C--O 1.263 1.79 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.109 0.481 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.6 152.16 32.5 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.45 144.98 39.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.57 106.05 18.2 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.2 mtm -66.3 -38.87 88.74 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -95.2 64.32 2.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -65.66 -43.56 88.97 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -87.17 161.13 18.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -145.76 143.64 29.84 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -101.27 170.67 8.08 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -115.49 162.82 16.64 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -79.21 126.51 81.46 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.22 -23.22 24.66 Favored 'Trans proline' 0 CA--C 1.499 -1.247 0 C-N-CA 121.892 1.728 . . . . 0.0 114.131 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.64 162.36 18.53 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.35 -56.42 2.03 Favored Glycine 0 CA--C 1.494 -1.256 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -90.51 132.35 35.73 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -162.92 162.32 26.16 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.455 ' CE1' HD21 ' A' ' 55' ' ' LEU . 54.9 m-85 -117.84 137.37 52.81 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.521 HG22 ' CE3' ' A' ' 155' ' ' TRP . 80.4 mt -104.9 116.36 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -110.75 131.99 54.58 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -85.89 123.15 30.91 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.35 -16.33 63.98 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 122.27 -0.269 . . . . 0.0 111.532 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.2 t -63.16 -43.88 97.06 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 121.34 -0.85 . . . . 0.0 110.708 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -123.37 -5.68 8.25 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.623 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.25 21.93 76.99 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 45' ' ' THR . 10.9 m-30 -107.58 163.0 13.44 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -110.65 159.94 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.696 HD12 HG21 ' A' ' 41' ' ' ILE . 2.6 pt? -83.26 144.36 29.8 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 122.306 1.05 . . . . 0.0 108.994 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.9 tmm? -144.71 175.38 10.21 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 31' ' ' ASP . 15.8 t -68.93 170.22 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.609 ' H ' HG12 ' A' ' 30' ' ' VAL . 35.6 t70 -56.83 -40.8 76.7 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.318 -0.864 . . . . 0.0 110.487 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -166.59 58.67 0.09 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 53.97 48.06 22.01 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.0 m -88.44 128.2 35.52 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -92.92 -2.69 55.6 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -93.98 147.96 22.61 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.3 p -78.07 163.4 25.93 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.63 8.23 77.32 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -89.36 125.04 63.01 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.549 ' HA ' HG12 ' A' ' 87' ' ' VAL . 44.1 Cg_exo -58.97 149.93 75.94 Favored 'Trans proline' 0 CA--C 1.499 -1.264 0 C-N-CA 122.114 1.876 . . . . 0.0 113.221 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.696 HG21 HD12 ' A' ' 28' ' ' LEU . 26.2 mm -89.96 129.41 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.542 HG22 ' HA ' ' A' ' 31' ' ' ASP . 23.9 m -131.58 162.54 39.24 Favored 'Isoleucine or valine' 0 C--N 1.359 0.999 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -89.47 145.45 25.3 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.606 0.717 . . . . 0.0 109.136 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.25 148.77 32.81 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.409 ' HA ' ' CD2' ' A' ' 26' ' ' TYR . 12.3 t -63.16 156.99 23.55 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.74 137.1 56.41 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.698 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -145.85 129.31 16.91 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.6 m -60.69 -36.24 78.29 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -75.9 141.8 42.24 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 60.5 42.18 14.68 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.441 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -71.85 -27.41 62.86 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.71 90.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.1 m -67.9 -23.81 65.15 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -99.73 3.85 45.16 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 ' CE1' ' A' ' 18' ' ' PHE . 16.0 mt -99.5 135.39 40.98 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-O 121.894 0.855 . . . . 0.0 108.841 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.474 ' HB3' HD12 ' A' ' 64' ' ' LEU . 79.1 m95 -127.8 155.83 43.46 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -146.35 160.37 42.12 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -111.73 136.21 51.3 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.407 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 99.9 m-20 -84.78 161.04 54.53 Favored Pre-proline 0 N--CA 1.436 -1.148 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 59' ' ' ASP . 18.1 Cg_endo -60.01 -18.72 52.03 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.431 1.421 . . . . 0.0 112.97 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 66.6 m -82.43 -11.06 58.78 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.76 14.44 43.36 Favored Glycine 0 C--N 1.358 1.754 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.405 ' CE1' ' HB2' ' A' ' 61' ' ' SER . 9.7 m-85 -92.98 146.44 23.62 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 56' ' ' TRP . 3.0 mm? -92.7 132.17 37.15 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.908 HG22 HG12 ' A' ' 72' ' ' VAL . 67.0 t -124.67 137.24 58.05 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -81.11 129.78 34.72 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -62.5 -39.51 93.74 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 122.14 -0.35 . . . . 0.0 110.911 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -76.91 -54.89 6.0 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.882 -0.511 . . . . 0.0 111.043 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.0 m -68.85 -39.64 79.78 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.48 5.01 89.91 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 105.933 -2.867 . . . . 0.0 105.933 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -97.88 169.44 9.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.908 HG12 HG22 ' A' ' 65' ' ' VAL . 32.7 m -116.55 160.95 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.493 ' CE ' HD11 ' A' ' 28' ' ' LEU . 63.6 mtt -72.8 140.71 47.85 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -156.3 167.93 28.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.09 142.93 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.73 86.79 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.836 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -72.46 -32.92 66.65 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.01 -6.11 82.87 Favored Glycine 0 CA--C 1.495 -1.195 0 N-CA-C 105.736 -2.946 . . . . 0.0 105.736 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.7 m -117.89 122.92 30.07 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.73 117.16 5.0 Favored 'Trans proline' 0 CA--C 1.497 -1.374 0 C-N-CA 121.196 1.264 . . . . 0.0 112.945 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.39 166.36 26.58 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.47 135.9 39.37 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.0 4.27 82.1 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.89 131.02 35.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-N 119.099 1.45 . . . . 0.0 108.598 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -73.07 154.48 40.41 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-O 121.534 0.683 . . . . 0.0 109.447 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.866 HD11 HD13 ' A' ' 140' ' ' LEU . 47.9 mm -106.84 130.25 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.9 m -131.14 161.02 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -86.3 140.05 30.43 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -144.25 169.31 18.13 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 m -67.31 150.37 49.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -69.02 156.96 37.73 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.47 -155.07 0.67 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.65 -14.89 57.57 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.8 p -69.45 -36.93 77.09 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -143.63 31.32 1.32 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.2 t -125.49 129.22 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -62.42 145.19 54.7 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.24 -20.21 66.32 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -89.64 -3.48 58.24 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -115.93 8.06 14.58 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.55 121.13 27.81 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -98.35 -7.46 28.81 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -80.47 -8.88 59.72 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -77.43 126.22 30.56 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -116.32 154.02 30.94 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.45 161.89 12.63 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 106.541 -2.623 . . . . 0.0 106.541 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.5 tp -132.25 132.29 42.91 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.4 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 83.4 p -113.47 155.26 44.99 Favored Pre-proline 0 N--CA 1.443 -0.796 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 56.4 Cg_endo -70.51 -8.14 22.92 Favored 'Trans proline' 0 CA--C 1.499 -1.237 0 C-N-CA 122.132 1.888 . . . . 0.0 112.849 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -82.53 -3.75 56.45 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.44 23.02 52.55 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -110.42 136.5 49.48 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.8 mt -108.31 124.19 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.655 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.33 177.28 7.45 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.643 HD12 ' HB2' ' A' ' 118' ' ' LYS . 4.8 mt -86.98 150.95 23.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.18 86.37 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.714 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -97.75 -11.91 22.87 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.543 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.643 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.92 84.68 37.04 Favored Pre-proline 0 CA--C 1.493 -1.229 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -68.45 -9.82 27.16 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.255 1.97 . . . . 0.0 112.395 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.2 m -85.61 -27.59 25.35 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' ' 140' ' ' LEU . 57.2 mt -92.21 130.78 37.84 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.655 HG22 ' HB3' ' A' ' 114' ' ' TYR . 36.1 pt -136.39 164.99 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.2 mt -82.06 141.2 33.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.98 178.12 41.89 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 107.286 -2.326 . . . . 0.0 107.286 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.915 HD13 HD13 ' A' ' 136' ' ' LEU . 1.8 pp -129.36 158.81 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -104.89 135.26 46.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -97.53 135.3 39.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.1 t -150.09 155.67 40.27 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -69.72 -26.58 64.4 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -102.17 30.59 4.41 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.34 99.41 4.83 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.557 ' HG2' ' H ' ' A' ' 134' ' ' GLU . 54.6 ttt85 -62.7 145.25 55.14 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -59.98 -34.34 73.17 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.557 ' H ' ' HG2' ' A' ' 132' ' ' ARG . 88.8 tt0 -88.24 84.68 6.86 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.39 5.42 1.31 Allowed Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 125' ' ' ILE . 76.6 mt -63.0 127.7 32.43 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.549 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -87.7 153.42 21.38 Favored 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 121.621 0.724 . . . . 0.0 109.46 -177.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.64 138.36 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -145.52 163.83 33.5 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.866 HD13 HD11 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -90.41 126.2 35.81 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -126.77 161.86 27.19 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.533 ' CD1' HD23 ' A' ' 121' ' ' LEU . 1.1 mp -91.45 152.41 20.39 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.753 0.787 . . . . 0.0 109.207 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.75 155.57 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.919 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -141.1 101.23 3.99 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -66.18 -23.99 66.56 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.928 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -67.01 -25.95 66.55 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -141.85 85.84 1.96 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.6 mt -98.75 3.76 47.62 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -99.28 18.46 17.55 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -76.01 128.65 35.47 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -69.55 -23.27 63.55 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.17 -20.73 60.12 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -99.97 0.41 41.03 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -100.72 132.61 46.03 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.521 ' CE3' HG22 ' A' ' 19' ' ' ILE . 96.2 m95 -122.28 138.89 54.34 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -112.15 149.28 32.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.85 138.02 51.55 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.7 t -127.22 144.64 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.9 mt -109.54 152.66 42.9 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.91 150.66 73.54 Favored 'Trans proline' 0 CA--C 1.497 -1.364 0 C-N-CA 121.818 1.679 . . . . 0.0 112.86 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -117.7 125.23 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.262 1.723 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.749 0.309 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.17 134.63 55.22 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.7 156.93 34.23 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.89 64.06 7.05 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 98.5 mtp -95.99 60.39 2.06 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 65.2 60.71 0.77 Allowed 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.209 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.85 -39.97 83.73 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.29 149.48 33.52 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -143.3 157.62 44.32 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -119.32 171.91 7.98 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.83 162.28 13.03 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.473 ' HB2' ' CD2' ' A' ' 58' ' ' HIS . 75.2 m-85 -87.45 157.67 52.65 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.65 152.07 81.42 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 121.536 1.491 . . . . 0.0 112.209 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -97.52 164.31 12.49 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.4 -170.18 42.34 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 107.749 -2.141 . . . . 0.0 107.749 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.607 ' HB3' HD22 ' A' ' 55' ' ' LEU . 50.3 m0 -76.36 141.89 41.36 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -157.06 163.77 38.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.535 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 41.4 m-85 -120.4 138.89 53.52 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.6 mt -102.51 114.77 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -112.01 131.44 55.41 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -88.51 127.33 35.53 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.48 -19.86 65.83 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 151' ' ' LYS . 38.6 t -63.56 -44.01 95.37 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 119.114 0.87 . . . . 0.0 111.285 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -123.5 -7.51 8.07 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.822 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.14 20.25 79.3 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -100.15 166.88 10.79 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.66 160.56 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.945 HD23 HG21 ' A' ' 41' ' ' ILE . 2.8 mp -67.25 133.77 50.35 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.638 0.732 . . . . 0.0 109.956 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -145.46 166.16 26.47 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 31' ' ' ASP . 16.0 t -69.28 171.44 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 105.161 -2.162 . . . . 0.0 105.161 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 30' ' ' VAL . 35.8 t70 -54.8 -42.01 71.3 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.721 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -170.24 65.94 0.05 OUTLIER 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.815 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 53.16 46.82 25.8 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.0 m -97.44 123.76 41.4 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -94.27 -0.9 54.75 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.47 145.1 26.41 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.7 m -77.13 155.57 32.26 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.51 62.87 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.2 m -91.05 138.64 25.87 Favored Pre-proline 0 N--CA 1.438 -1.039 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.441 ' HA ' HG12 ' A' ' 87' ' ' VAL . 57.1 Cg_endo -70.3 154.09 65.89 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 121.67 1.58 . . . . 0.0 112.694 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.945 HG21 HD23 ' A' ' 28' ' ' LEU . 23.6 mm -92.6 131.13 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 24.6 m -131.95 167.44 26.37 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.79 144.03 26.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.26 36.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 m -61.03 143.93 54.41 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -59.83 139.69 57.14 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -108.73 142.22 39.57 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.7 m -66.8 -34.35 77.62 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -137.58 159.72 41.17 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.6 t0 61.64 46.05 7.53 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -105.97 17.49 23.54 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.26 86.47 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.7 p -71.56 -12.67 61.48 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -101.14 2.38 40.12 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 16' ' ' TRP . 59.8 mt -98.28 137.39 37.08 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.37 150.67 48.43 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -130.05 134.67 47.55 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 12' ' ' PHE . 55.9 t-80 -95.43 112.42 24.14 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -80.81 155.88 72.9 Favored Pre-proline 0 N--CA 1.439 -1.003 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.65 -19.69 46.76 Favored 'Trans proline' 0 CA--C 1.497 -1.363 0 C-N-CA 122.274 1.983 . . . . 0.0 113.675 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 63' ' ' TYR . 67.3 m -71.91 -19.59 61.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.67 15.21 19.48 Favored Glycine 0 C--N 1.355 1.622 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 61' ' ' SER . 1.1 m-85 -108.32 159.63 16.49 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 118.212 1.006 . . . . 0.0 108.726 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.94 125.78 51.41 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.963 HG22 HG12 ' A' ' 72' ' ' VAL . 66.5 t -114.48 134.05 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -76.46 129.79 37.04 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.01 -41.05 99.47 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 121.939 -0.475 . . . . 0.0 110.853 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -74.62 -53.92 8.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 122.052 -0.405 . . . . 0.0 111.088 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.0 m -70.32 -39.94 74.48 Favored 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.859 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.01 7.04 88.38 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 105.818 -2.913 . . . . 0.0 105.818 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.82 168.04 9.9 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.963 HG12 HG22 ' A' ' 65' ' ' VAL . 21.9 m -116.75 162.2 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 mtt -71.8 140.69 49.54 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -156.44 169.39 24.74 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -88.41 143.87 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.037 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.94 -42.19 85.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -71.65 -33.89 69.28 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 89.55 -8.29 80.13 Favored Glycine 0 CA--C 1.496 -1.147 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.5 m -126.25 124.46 24.49 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.65 130.94 41.28 Favored 'Trans proline' 0 CA--C 1.497 -1.339 0 C-N-CA 121.416 1.411 . . . . 0.0 112.99 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -149.27 150.15 32.09 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.16 130.09 40.58 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.1 7.92 82.75 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.06 144.11 13.8 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 CA-C-N 118.473 1.137 . . . . 0.0 108.302 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.29 156.35 20.97 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.8 mm -108.57 129.14 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.6 m -130.78 163.27 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -87.53 139.57 30.41 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -142.49 173.34 11.62 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -73.32 168.62 18.8 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -83.75 151.34 25.27 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.06 156.79 20.93 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.51 -166.74 42.83 Favored Glycine 0 C--N 1.349 1.291 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.3 p -89.91 7.08 39.1 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -101.97 17.43 23.18 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 p -100.05 142.32 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.4 tptp -66.07 141.72 58.05 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.64 -15.96 62.25 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -89.79 -6.82 55.58 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.3 mt -115.87 11.53 15.56 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -89.61 98.48 11.79 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -98.2 -7.39 29.42 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.274 -177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.453 ' HG2' HG21 ' A' ' 72' ' ' VAL . 26.6 mp0 -71.22 -18.55 62.45 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -70.76 135.36 48.15 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -129.43 152.68 48.71 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.08 163.79 12.38 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 106.635 -2.586 . . . . 0.0 106.635 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 67.0 tp -125.79 118.82 26.35 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.0 t -79.18 138.75 56.25 Favored Pre-proline 0 N--CA 1.441 -0.909 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.32 -9.55 26.26 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.802 1.668 . . . . 0.0 112.715 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -90.27 -0.77 57.78 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.62 40.29 4.75 Favored Glycine 0 C--N 1.356 1.675 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -129.55 149.69 51.21 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.1 mt -115.8 126.81 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.679 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.2 p90 -131.25 173.99 10.5 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.647 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 14.4 mt -83.92 150.58 25.59 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.05 -23.65 61.4 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -104.59 -19.98 13.81 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.767 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.647 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 1.3 mptm? -134.15 85.44 39.44 Favored Pre-proline 0 CA--C 1.495 -1.14 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.91 -9.19 23.98 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.605 2.204 . . . . 0.0 112.877 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.29 -29.46 28.35 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 140' ' ' LEU . 42.8 mt -89.18 130.89 35.53 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.679 HG22 ' HB3' ' A' ' 114' ' ' TYR . 24.6 pt -134.27 162.92 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.45 HD23 HD23 ' A' ' 140' ' ' LEU . 89.8 mt -81.09 136.6 35.95 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.64 175.96 38.16 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.647 HD13 HD13 ' A' ' 136' ' ' LEU . 1.9 pp -128.37 158.22 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.517 ' O ' HD22 ' A' ' 136' ' ' LEU . 47.9 tttt -107.19 147.79 29.69 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -124.53 144.91 49.86 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.8 t -149.97 161.82 41.56 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -69.15 -27.2 65.33 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -102.74 28.9 5.71 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -132.73 98.92 4.46 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -64.09 153.95 35.97 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.408 ' HA ' ' HG ' ' A' ' 136' ' ' LEU . 99.6 mtt180 -70.39 -16.84 63.01 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.15 84.59 5.7 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 131.1 13.68 1.92 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.647 HD13 HD13 ' A' ' 125' ' ' ILE . 82.5 mt -64.57 127.73 32.74 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -90.3 151.08 21.65 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.5 p -95.27 144.04 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -147.27 166.98 25.43 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.476 ' HB3' HD22 ' A' ' 121' ' ' LEU . 90.1 mt -90.85 119.92 31.46 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -118.25 143.21 46.74 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -74.03 146.29 43.85 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.053 -179.148 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.504 HG12 HD13 ' A' ' 122' ' ' ILE . 17.5 m -64.09 155.46 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.272 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -145.57 100.43 3.43 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -67.13 -20.23 65.74 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.027 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -67.8 -24.66 65.33 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -136.42 84.93 2.11 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.1 mt -101.3 5.18 42.28 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -93.43 17.46 11.39 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -90.56 109.48 20.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.453 ' HG3' ' HA ' ' A' ' 23' ' ' SER . 10.7 ptmt -66.47 -20.1 65.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.749 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -70.44 -19.25 62.99 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -95.31 -1.61 50.99 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -101.95 135.07 44.13 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -118.48 138.47 52.48 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -112.97 148.63 34.65 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.86 138.19 51.69 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.0 t -128.99 143.84 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.7 mt -108.41 152.48 42.04 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.2 149.96 76.49 Favored 'Trans proline' 0 CA--C 1.496 -1.401 0 C-N-CA 121.826 1.684 . . . . 0.0 113.234 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.9 t -119.22 125.71 74.69 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.262 1.728 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttm . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.154 0.502 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.78 148.58 28.03 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.89 154.66 28.28 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.69 76.55 8.05 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.4 mtt -70.47 -29.84 66.49 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.97 89.39 3.05 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -72.34 -23.24 61.12 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -81.06 146.97 30.36 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.3 p -140.11 150.73 44.64 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -134.81 171.34 14.52 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.29 159.55 15.31 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -83.53 157.18 64.94 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.45 141.31 89.98 Favored 'Trans proline' 0 CA--C 1.499 -1.241 0 C-N-CA 121.903 1.736 . . . . 0.0 112.891 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -90.48 155.83 18.63 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.89 -158.82 33.74 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.653 ' HB3' HD22 ' A' ' 55' ' ' LEU . 47.6 m0 -80.72 141.18 35.1 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -156.63 162.14 39.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.427 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 54.8 m-85 -120.92 140.01 52.43 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.1 mt -97.64 117.31 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.36 127.49 53.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.508 0.67 . . . . 0.0 109.992 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -87.33 114.38 23.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -60.12 -35.19 74.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 t -63.72 -43.86 95.3 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.685 -0.634 . . . . 0.0 111.5 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -99.36 -21.39 16.04 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.374 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.46 20.14 77.24 Favored Glycine 0 C--N 1.346 1.115 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -112.07 171.9 7.23 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.1 160.77 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.907 HD23 HG21 ' A' ' 41' ' ' ILE . 2.5 mp -69.18 133.81 48.45 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.592 0.711 . . . . 0.0 109.62 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.6 ttp -145.32 164.38 31.61 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.686 HG11 ' H ' ' A' ' 34' ' ' SER . 1.3 p -69.41 172.32 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' H ' HG22 ' A' ' 30' ' ' VAL . 19.0 t70 -53.22 -48.86 67.8 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.645 -0.659 . . . . 0.0 111.455 -176.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -172.55 75.21 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.04 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 51.75 47.72 24.24 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.686 ' H ' HG11 ' A' ' 30' ' ' VAL . 67.5 m -102.12 121.96 43.22 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.84 -1.51 49.38 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -82.77 150.4 26.67 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.0 t -80.65 149.45 29.81 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.57 8.73 60.71 Favored Glycine 0 C--N 1.355 1.625 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.5 t -83.46 124.61 75.48 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HA ' HG12 ' A' ' 87' ' ' VAL . 44.5 Cg_exo -59.2 148.75 84.52 Favored 'Trans proline' 0 CA--C 1.498 -1.324 0 C-N-CA 122.061 1.841 . . . . 0.0 113.016 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.907 HG21 HD23 ' A' ' 28' ' ' LEU . 24.1 mm -88.59 131.89 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 25.1 m -132.39 167.98 25.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.0 mt -96.45 144.24 26.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.85 149.77 33.95 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -62.8 144.06 56.91 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.85 138.98 57.02 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.412 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 46.4 ttt85 -117.98 138.16 52.37 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.1 m -64.52 -29.17 70.2 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.344 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 47' ' ' ARG . 17.4 ptpt -129.65 160.39 33.49 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 57.89 42.23 23.4 Favored 'General case' 0 C--N 1.361 1.076 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -98.25 11.55 37.53 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.55 87.7 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.0 p -73.73 -12.21 60.64 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -101.12 1.92 39.73 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.653 HD22 ' HB3' ' A' ' 16' ' ' TRP . 31.5 mt -99.58 137.5 37.98 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -128.57 154.85 45.76 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -138.44 153.91 48.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -105.0 118.55 36.81 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -85.05 156.44 60.48 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.26 -19.48 50.42 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 122.396 2.064 . . . . 0.0 113.742 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -73.23 -16.24 61.41 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.4 14.44 25.84 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -111.62 160.8 16.89 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 118.153 0.977 . . . . 0.0 108.667 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.77 135.39 47.29 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.992 HG22 HG12 ' A' ' 72' ' ' VAL . 59.4 t -120.65 140.45 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -88.92 123.42 33.26 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -63.34 -37.51 87.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 121.695 -0.628 . . . . 0.0 111.793 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -62.87 -49.41 74.96 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.977 -0.452 . . . . 0.0 111.383 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 87.7 p -91.07 -30.18 16.9 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.313 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.82 5.79 89.05 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 107.222 -2.351 . . . . 0.0 107.222 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -99.04 166.41 11.28 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 65' ' ' VAL . 16.5 m -116.17 164.15 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.0 139.16 50.44 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -156.97 170.84 21.61 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.406 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -87.44 143.22 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.37 83.63 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.346 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -71.28 -33.53 69.83 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.406 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.14 -8.12 80.39 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.6 m -123.06 127.17 25.77 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.33 126.91 13.45 Favored 'Trans proline' 0 CA--C 1.496 -1.411 0 C-N-CA 120.974 1.116 . . . . 0.0 112.906 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.0 157.81 43.87 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.88 132.65 43.79 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.51 7.11 85.07 Favored Glycine 0 C--N 1.345 1.034 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.431 ' CG1' HD12 ' A' ' 140' ' ' LEU . 10.1 p -71.82 143.77 13.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 CA-C-N 118.608 1.204 . . . . 0.0 108.094 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -84.13 154.49 23.1 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.466 HD11 ' HG ' ' A' ' 140' ' ' LEU . 48.3 mm -109.14 127.84 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.3 m -131.17 161.18 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -84.6 137.84 33.06 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -144.41 172.97 12.21 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.8 m -65.36 149.35 50.14 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -69.22 156.22 39.1 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 96' ' ' VAL . . . -71.36 148.4 47.06 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.85 -161.76 37.11 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -88.66 4.06 48.47 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -99.76 16.42 23.68 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.473 HG21 ' HB1' ' A' ' 92' ' ' ALA . 82.1 t -113.99 124.04 70.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -66.26 164.26 16.24 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.863 0.84 . . . . 0.0 109.972 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.98 -20.44 61.02 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -90.25 -5.04 56.79 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -113.06 6.59 17.7 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -88.97 98.56 11.82 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -96.79 -8.0 32.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -82.2 -9.87 59.35 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.95 128.83 34.13 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -117.48 152.24 35.46 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.51 152.75 17.33 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 105.971 -2.852 . . . . 0.0 105.971 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.2 tp -130.32 121.65 26.46 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 79.0 p -91.1 156.27 44.13 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 43.7 Cg_endo -68.25 -15.16 42.13 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 121.725 1.617 . . . . 0.0 112.451 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -72.68 -26.03 61.47 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.61 12.12 17.59 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -94.98 134.61 37.47 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.1 mt -107.35 125.3 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.74 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.8 p90 -135.71 176.1 8.99 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.634 HD12 ' HB2' ' A' ' 118' ' ' LYS . 3.5 mt -85.33 150.17 24.94 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.77 88.69 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.702 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -96.35 -11.12 26.25 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.569 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.634 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -135.25 84.9 34.47 Favored Pre-proline 0 CA--C 1.493 -1.213 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.8 -9.69 26.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.289 1.992 . . . . 0.0 112.205 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 79.7 p -88.64 -17.47 29.98 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.562 HD23 HD12 ' A' ' 142' ' ' LEU . 55.2 mt -102.91 129.95 49.79 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.74 HG22 ' HB3' ' A' ' 114' ' ' TYR . 37.9 pt -135.58 165.19 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.249 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.9 mt -77.74 138.51 39.07 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.68 176.94 36.37 Favored Glycine 0 CA--C 1.495 -1.216 0 N-CA-C 107.466 -2.254 . . . . 0.0 107.466 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -133.88 160.51 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -110.61 126.24 54.26 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -96.56 134.84 39.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.4 t -149.9 157.42 43.16 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -69.77 -26.58 64.36 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.13 31.41 3.96 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.96 103.02 6.3 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 27.9 tpt180 -62.0 137.51 58.26 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.47 -35.27 77.17 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 94.9 mt-10 -85.85 86.37 7.36 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.28 10.57 1.46 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 80.1 mt -64.53 126.74 28.82 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.577 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -83.22 151.2 25.76 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 121.696 0.76 . . . . 0.0 109.726 -177.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.44 139.15 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -146.52 166.42 26.5 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.466 ' HG ' HD11 ' A' ' 86' ' ' ILE . 90.6 mt -88.49 121.17 30.58 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -112.49 140.9 46.85 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.562 HD12 HD23 ' A' ' 121' ' ' LEU . 1.4 tp -69.68 138.91 53.35 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 119.116 -1.033 . . . . 0.0 108.821 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.3 134.18 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.349 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -119.26 88.18 2.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.435 ' HA ' HD21 ' A' ' 148' ' ' LEU . 23.5 pttp -63.65 -20.13 65.44 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.996 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.9 ptm180 -68.04 -21.47 65.01 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -139.05 86.64 2.15 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.435 HD21 ' HA ' ' A' ' 145' ' ' LYS . 95.2 mt -100.91 4.52 42.71 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -95.1 10.92 34.0 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -83.36 140.11 32.61 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -71.17 -23.96 62.15 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.33 -26.54 62.87 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -89.57 -1.06 57.91 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.34 133.72 52.7 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.67 0.747 . . . . 0.0 109.051 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -122.84 144.58 49.1 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -126.24 163.82 22.35 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -126.79 144.15 51.04 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.64 144.35 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -109.58 154.94 42.12 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.97 140.58 92.7 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 122.019 1.813 . . . . 0.0 113.198 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.6 t -118.61 125.86 74.72 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--O 1.263 1.782 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 121.205 0.526 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.73 40.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.78 149.13 32.75 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.79 143.63 23.73 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.7 tpp -83.28 -20.6 34.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 75.74 55.84 0.06 Allowed 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.31 -22.23 61.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -81.41 144.57 31.33 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.6 m -125.16 143.94 50.69 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -124.66 171.8 9.77 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 158.52 16.44 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -90.56 156.91 44.98 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.17 150.92 84.74 Favored 'Trans proline' 0 CA--C 1.498 -1.279 0 C-N-CA 121.53 1.487 . . . . 0.0 112.166 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -102.4 158.68 16.03 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.27 -165.39 31.4 Favored Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.655 ' HB3' HD22 ' A' ' 55' ' ' LEU . 50.1 m0 -77.3 140.36 40.0 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -158.41 164.49 36.23 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.427 ' CE1' HD21 ' A' ' 55' ' ' LEU . 44.9 m-85 -120.59 139.99 52.17 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.438 HD11 HD13 ' A' ' 64' ' ' LEU . 84.5 mt -102.26 115.52 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -114.06 131.55 56.34 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -85.5 124.25 31.86 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.15 -36.29 79.39 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.1 t -64.07 -42.68 96.89 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.601 -0.687 . . . . 0.0 111.214 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -96.52 -24.16 16.2 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.052 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.03 17.61 78.72 Favored Glycine 0 C--N 1.347 1.158 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -109.69 166.27 11.04 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.73 160.76 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.821 HD23 HG21 ' A' ' 41' ' ' ILE . 1.8 mp -70.68 135.19 48.14 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.54 0.686 . . . . 0.0 109.661 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.5 ttp -145.58 164.67 30.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.697 HG11 ' H ' ' A' ' 34' ' ' SER . 4.0 p -70.53 174.37 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.641 ' H ' HG22 ' A' ' 30' ' ' VAL . 35.9 t70 -54.21 -48.03 71.47 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.713 -0.617 . . . . 0.0 111.317 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -171.85 74.1 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 119.564 -0.854 . . . . 0.0 108.888 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 51.94 47.37 24.9 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.697 ' H ' HG11 ' A' ' 30' ' ' VAL . 66.8 m -99.17 117.71 34.24 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -91.86 -2.36 56.89 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -87.39 141.41 28.65 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.1 m -74.73 154.37 38.42 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.77 7.78 61.19 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 p -93.94 141.97 24.4 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HA ' HG12 ' A' ' 87' ' ' VAL . 35.6 Cg_exo -61.89 153.53 67.66 Favored 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 122.527 2.151 . . . . 0.0 113.945 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.821 HG21 HD23 ' A' ' 28' ' ' LEU . 30.8 mm -96.78 129.89 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 27.6 m -133.71 166.37 29.25 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.207 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 125' ' ' ILE . 91.5 mt -90.36 144.54 25.72 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.66 148.63 31.26 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.4 t -67.69 156.3 37.23 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.99 139.24 58.21 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.01 148.03 52.7 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -83.46 -10.45 58.36 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -125.14 146.79 49.32 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.96 42.67 22.46 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -91.94 -2.06 56.96 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.39 90.95 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.0 p -72.78 -13.22 61.27 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.18 1.82 42.37 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 16' ' ' TRP . 30.0 mt -98.28 138.41 35.58 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.6 150.99 48.57 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -127.59 133.39 49.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.417 ' HA ' HD23 ' A' ' 64' ' ' LEU . 83.5 t60 -89.18 110.47 21.21 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.34 141.6 83.46 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.1 -19.32 40.61 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 121.823 1.682 . . . . 0.0 114.076 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.409 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 68.9 m -73.67 -17.73 61.11 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.4 10.39 17.5 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 61' ' ' SER . 1.0 OUTLIER -104.93 164.9 11.44 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 118.607 1.203 . . . . 0.0 108.25 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD13 HD11 ' A' ' 19' ' ' ILE . 91.9 mt -112.73 129.94 56.24 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.951 HG22 HG12 ' A' ' 72' ' ' VAL . 80.4 t -114.8 134.04 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -77.8 129.34 35.33 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.58 -41.61 99.04 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 122.035 -0.416 . . . . 0.0 110.996 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -75.29 -53.68 8.36 Favored 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 122.039 -0.413 . . . . 0.0 111.171 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.6 m -70.34 -39.77 74.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.58 90.07 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -96.73 166.76 11.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.951 HG12 HG22 ' A' ' 65' ' ' VAL . 28.4 m -117.52 160.68 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.5 mtt -70.5 139.66 51.69 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -157.07 170.09 23.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.17 143.54 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.74 -42.26 86.52 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.29 -33.44 69.72 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.9 -7.73 81.17 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.1 m -124.88 128.72 24.8 Favored Pre-proline 0 N--CA 1.436 -1.135 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.53 126.59 13.65 Favored 'Trans proline' 0 CA--C 1.494 -1.476 0 C-N-CA 120.91 1.073 . . . . 0.0 112.865 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.7 167.09 23.01 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.03 128.1 33.08 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.21 76.52 Favored Glycine 0 C--N 1.345 1.037 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.34 143.31 14.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.71 155.98 25.26 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-O 121.46 0.648 . . . . 0.0 109.466 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.674 HD11 HD13 ' A' ' 140' ' ' LEU . 48.1 mm -113.71 128.78 70.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.3 m -133.22 161.58 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -85.72 137.68 32.64 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -142.38 175.22 9.94 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -71.83 165.18 24.64 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -84.53 156.98 21.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.05 159.01 44.35 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.26 -27.72 0.19 Allowed Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.8 t -64.19 -42.49 96.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -118.51 17.96 13.62 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -125.74 127.51 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -62.64 146.49 51.96 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -65.79 -19.38 65.87 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.36 -2.26 57.97 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -115.51 7.92 15.05 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -83.29 110.11 17.82 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -89.32 -7.96 54.27 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -80.11 -8.98 59.67 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -76.23 128.26 34.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.88 155.16 30.64 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.56 159.95 13.45 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 105.898 -2.881 . . . . 0.0 105.898 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 67.6 tp -132.98 125.25 29.34 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 97.8 p -93.02 157.57 38.93 Favored Pre-proline 0 N--CA 1.442 -0.841 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 56.5 Cg_endo -70.96 -8.5 23.76 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 C-N-CA 121.747 1.631 . . . . 0.0 112.539 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -87.52 -5.23 58.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.93 9.61 60.74 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -93.15 136.98 32.91 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -110.63 127.11 67.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.765 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.0 OUTLIER -133.8 178.52 6.88 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.71 HD12 ' HB2' ' A' ' 118' ' ' LYS . 4.3 mt -86.81 149.65 24.69 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.97 -36.42 84.34 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.765 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -99.8 -9.7 22.67 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.412 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.71 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.92 83.39 40.63 Favored Pre-proline 0 CA--C 1.493 -1.225 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -69.15 -8.73 24.39 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.206 1.938 . . . . 0.0 111.987 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.5 m -86.92 -14.65 41.24 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.57 HD23 HD12 ' A' ' 142' ' ' LEU . 75.6 mt -109.19 131.25 55.24 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.765 HG22 ' HB3' ' A' ' 114' ' ' TYR . 25.1 pt -134.22 166.5 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.7 mt -78.94 137.05 37.44 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.4 171.87 34.13 Favored Glycine 0 CA--C 1.494 -1.274 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.612 HG21 HD11 ' A' ' 43' ' ' LEU . 1.6 pp -135.36 160.19 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -118.35 141.89 48.07 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -134.75 149.69 50.47 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.672 ' H ' ' HB3' ' A' ' 131' ' ' ALA . 8.3 t -149.99 -179.52 7.22 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -71.67 -29.04 64.16 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.48 37.25 2.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.672 ' HB3' ' H ' ' A' ' 128' ' ' SER . . . -126.55 101.83 6.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.546 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 29.2 tpt180 -65.13 135.76 55.88 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -61.7 -35.86 79.26 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.546 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 14.8 mt-10 -85.55 86.02 7.39 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.55 4.64 1.62 Allowed Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.86 129.31 39.34 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.51 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -92.32 155.68 17.76 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.542 0.687 . . . . 0.0 109.399 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.11 146.92 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -146.6 166.4 26.64 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.674 HD13 HD11 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -91.12 114.22 26.69 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -103.95 142.93 33.56 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 121' ' ' LEU . 5.3 tp -70.3 137.06 50.36 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.66 143.21 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.36 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -138.03 96.56 3.23 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.08 -18.46 63.41 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.192 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -66.45 -27.79 68.09 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -133.53 84.7 2.15 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.4 mt -107.8 4.38 25.47 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -97.72 19.94 12.79 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -83.2 136.46 34.41 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -70.41 -22.19 62.76 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.15 -26.03 61.94 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -92.32 -0.79 57.37 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -92.52 132.97 36.38 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -124.54 140.12 53.24 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -123.92 155.75 37.56 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -118.06 139.25 51.48 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 t -127.93 144.15 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.116 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.0 mt -108.56 152.28 42.05 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.63 150.41 74.64 Favored 'Trans proline' 0 CA--C 1.497 -1.346 0 C-N-CA 121.745 1.63 . . . . 0.0 113.136 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.4 t -118.77 125.95 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.263 1.793 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 121.267 0.556 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.69 150.11 29.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.24 153.51 30.75 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.23 76.6 7.62 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 75.7 mtm -87.76 -11.78 47.09 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.24 85.24 2.32 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.43 -20.95 59.85 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -78.07 142.81 37.91 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -146.67 139.48 25.26 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -133.71 171.46 14.1 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.13 162.5 32.34 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -82.09 124.81 78.43 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.43 -21.84 19.24 Favored 'Trans proline' 0 CA--C 1.499 -1.234 0 C-N-CA 121.818 1.679 . . . . 0.0 113.043 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 155.07 17.43 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.98 -53.27 2.89 Favored Glycine 0 CA--C 1.494 -1.239 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -94.06 134.22 36.72 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -163.32 162.73 25.26 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.43 ' CE1' HD21 ' A' ' 55' ' ' LEU . 58.3 m-85 -118.86 138.87 52.43 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 80.9 mt -105.67 118.0 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -116.63 131.24 57.0 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -86.23 128.8 34.96 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -65.48 -24.64 67.21 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.0 p -67.47 -38.09 83.89 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 121.357 -0.84 . . . . 0.0 111.471 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -112.33 -20.1 11.95 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.043 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.32 22.07 76.58 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -109.81 163.15 13.79 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 m -115.04 161.25 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.953 HD23 HG21 ' A' ' 41' ' ' ILE . 3.2 mp -68.13 132.28 46.91 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.609 0.719 . . . . 0.0 109.438 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.7 ttp -145.71 163.67 34.19 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 31' ' ' ASP . 56.1 t -68.23 157.04 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.2 t70 -49.39 -39.9 34.04 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 122.133 -0.354 . . . . 0.0 111.714 -177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -150.94 36.13 0.61 Allowed 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.342 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 61.84 42.93 9.91 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 m -91.6 119.31 31.39 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -78.55 -12.13 60.0 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -86.07 145.96 26.83 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.8 m -76.34 162.23 28.06 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.07 11.26 34.69 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.0 p -117.68 147.69 41.48 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 73.0 Cg_endo -76.07 162.35 34.48 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.214 1.943 . . . . 0.0 113.401 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.953 HG21 HD23 ' A' ' 28' ' ' LEU . 22.9 mm -94.38 131.71 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 23.6 m -132.2 170.24 20.31 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.6 mt -99.14 143.46 29.39 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.53 150.95 36.53 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 m -59.99 145.26 46.85 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 139.84 58.2 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -126.8 147.61 50.0 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -88.5 -7.49 56.43 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.22 140.13 52.45 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.5 t0 57.6 44.96 20.05 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -86.49 -2.19 58.25 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.47 84.06 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.5 p -72.15 -14.74 61.9 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -103.07 3.32 35.88 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 18' ' ' PHE . 17.5 mt -97.16 135.41 39.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -128.83 154.74 46.15 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -136.54 152.34 50.39 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -103.11 116.41 32.45 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.59 157.05 67.85 Favored Pre-proline 0 N--CA 1.441 -0.913 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.64 -24.08 60.71 Favored 'Trans proline' 0 CA--C 1.498 -1.287 0 C-N-CA 122.296 1.997 . . . . 0.0 113.867 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -71.24 -19.58 62.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.54 10.37 31.29 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' CD2' ' HB2' ' A' ' 103' ' ' GLN . 2.1 m-85 -97.7 159.37 14.97 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.18 129.57 55.18 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.81 HG22 HG12 ' A' ' 72' ' ' VAL . 98.0 t -117.94 136.17 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -76.71 132.49 39.35 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -62.59 -42.81 99.79 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.053 -0.404 . . . . 0.0 111.184 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.9 -51.63 9.42 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.812 -0.555 . . . . 0.0 111.386 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.3 m -68.37 -39.76 81.67 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.43 5.38 90.01 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 106.422 -2.671 . . . . 0.0 106.422 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -99.39 161.46 13.6 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.81 HG12 HG22 ' A' ' 65' ' ' VAL . 1.1 m -108.05 165.98 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 63.3 mtt -80.2 133.2 36.0 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -152.04 175.93 12.03 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 118.876 -1.129 . . . . 0.0 108.913 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.94 142.25 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.73 -43.1 80.78 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.895 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -71.96 -33.04 67.86 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.14 -6.79 82.45 Favored Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 105.77 -2.932 . . . . 0.0 105.77 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.7 m -115.62 120.84 35.38 Favored Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.13 115.78 4.45 Favored 'Trans proline' 0 CA--C 1.497 -1.361 0 C-N-CA 121.211 1.274 . . . . 0.0 112.918 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.9 168.04 21.8 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.59 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -76.53 137.57 39.67 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.94 2.36 88.46 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.54 132.71 32.92 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 CA-C-N 119.355 1.577 . . . . 0.0 108.228 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -73.71 154.81 39.49 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 121.518 0.675 . . . . 0.0 109.74 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.5 mm -105.19 128.43 59.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.898 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 40' ' ' PRO . 26.7 m -130.6 166.3 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -100.95 141.83 33.28 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.32 169.97 13.58 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.3 m -73.17 129.18 37.49 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -131.25 161.59 31.91 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.485 0.66 . . . . 0.0 110.141 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 72.98 -159.41 0.09 Allowed 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.37 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.3 -166.21 37.59 Favored Glycine 0 CA--C 1.487 -1.662 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -68.82 -23.95 64.32 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -160.12 71.12 0.45 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.3 p -81.91 142.06 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 141.84 57.28 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -74.47 -15.53 60.88 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.38 -5.09 57.75 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -116.37 13.32 15.49 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -84.66 97.99 9.95 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -98.87 -9.95 23.55 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.457 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -94.37 -1.68 53.33 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -72.17 125.36 27.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -115.81 151.77 34.59 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.64 141.88 17.27 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 105.78 -2.928 . . . . 0.0 105.78 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.1 tp -105.6 124.92 50.36 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.404 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 0.9 OUTLIER -93.99 140.53 22.96 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.31 -8.17 22.96 Favored 'Trans proline' 0 CA--C 1.5 -1.214 0 C-N-CA 121.998 1.799 . . . . 0.0 112.916 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.8 0.11 55.4 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.69 35.0 8.04 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -127.08 147.99 50.15 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -118.51 126.86 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.058 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.645 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -137.74 174.03 11.02 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.637 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 13.3 mt -83.44 150.67 25.89 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.03 -22.91 58.16 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -104.69 -21.91 13.31 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.915 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.637 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 13.8 mptt -132.39 84.82 50.51 Favored Pre-proline 0 CA--C 1.498 -1.056 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -67.12 -9.24 24.39 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.542 2.161 . . . . 0.0 112.827 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.6 p -84.99 -14.76 46.46 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.802 HD13 HD13 ' A' ' 140' ' ' LEU . 80.4 mt -104.83 130.42 52.95 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.645 HG22 ' HB3' ' A' ' 114' ' ' TYR . 32.0 pt -135.27 166.47 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.6 mt -83.9 139.23 32.75 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.31 179.22 35.97 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 107.555 -2.218 . . . . 0.0 107.555 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 137' ' ' HIS . 2.0 pp -132.67 160.55 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -108.76 125.29 51.77 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -96.33 135.1 38.63 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.5 t -149.92 157.32 43.06 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -69.76 -26.63 64.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.12 32.14 3.63 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.07 103.67 6.65 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.561 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 28.0 tpt180 -61.73 136.38 57.97 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -61.84 -35.37 78.05 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.561 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 94.5 mt-10 -84.87 86.53 7.35 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.16 12.12 1.7 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.76 127.86 33.32 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.577 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -84.17 151.83 24.63 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 121.746 0.784 . . . . 0.0 109.763 -177.508 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.3 t -94.94 140.12 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -146.63 165.78 28.5 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.802 HD13 HD13 ' A' ' 121' ' ' LEU . 98.5 mt -78.99 122.94 26.8 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -110.97 139.11 46.58 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.658 HD12 HD23 ' A' ' 121' ' ' LEU . 3.7 tp -78.34 135.62 37.53 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 118.684 -1.206 . . . . 0.0 108.075 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.87 146.68 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.225 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -137.86 96.35 3.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -64.17 -19.59 65.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.664 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -70.12 -24.0 63.12 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -139.06 85.25 2.06 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -100.79 4.51 42.99 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.14 21.09 10.33 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -83.26 130.35 35.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -68.01 -22.24 64.99 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.48 -36.12 73.67 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -89.49 -1.41 58.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -94.76 131.41 40.63 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -119.62 137.88 53.59 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -112.09 154.77 24.92 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -128.57 143.43 50.96 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.99 144.69 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.64 153.76 42.04 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -58.08 141.06 96.15 Favored 'Trans proline' 0 CA--C 1.499 -1.271 0 C-N-CA 122.076 1.85 . . . . 0.0 113.14 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.8 t -118.73 125.73 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 C--O 1.262 1.727 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.201 0.524 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.98 154.11 35.38 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.22 153.96 34.83 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 64.84 53.76 1.42 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -76.61 -8.21 56.77 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -92.1 67.57 5.08 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.74 -22.21 61.65 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -99.62 152.33 20.17 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 t -146.21 138.42 25.17 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -94.55 170.9 9.14 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -104.78 162.67 13.11 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -83.3 156.83 66.01 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.49 151.5 82.88 Favored 'Trans proline' 0 CA--C 1.498 -1.286 0 C-N-CA 121.604 1.536 . . . . 0.0 112.395 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -88.61 156.7 18.9 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.777 0.798 . . . . 0.0 108.993 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.75 -168.42 37.75 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.7 ' HB3' HD22 ' A' ' 55' ' ' LEU . 46.5 m0 -77.73 146.1 36.15 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.17 160.83 41.2 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.49 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 47.9 m-85 -119.62 139.52 52.06 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.493 HG22 ' CE3' ' A' ' 155' ' ' TRP . 89.5 mt -107.27 114.65 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -109.99 132.7 53.92 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -83.47 122.95 29.21 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.83 -34.61 76.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 t -63.7 -43.55 96.29 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 121.653 -0.655 . . . . 0.0 111.399 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -101.62 -21.84 14.6 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.49 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.7 19.68 78.86 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -110.52 167.02 10.53 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 m -115.0 159.44 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.746 HD12 HG21 ' A' ' 41' ' ' ILE . 2.5 pt? -85.03 144.22 28.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.221 1.01 . . . . 0.0 109.259 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.524 ' HG2' ' H ' ' A' ' 30' ' ' VAL . 33.4 ttp -145.6 173.88 11.66 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.524 ' H ' ' HG2' ' A' ' 29' ' ' MET . 21.5 t -68.42 163.98 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.534 ' HA ' HG22 ' A' ' 42' ' ' VAL . 36.3 t70 -54.94 -40.47 69.95 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.741 -0.599 . . . . 0.0 110.433 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -160.2 48.32 0.26 Allowed 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 55.01 46.55 24.03 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.5 m -81.7 129.14 34.61 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -90.72 -2.12 57.83 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -97.54 152.44 19.02 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.0 p -80.29 166.73 21.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.6 12.51 75.07 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.2 t -94.18 123.51 58.75 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 87' ' ' VAL . 42.8 Cg_exo -59.17 148.94 83.49 Favored 'Trans proline' 0 CA--C 1.499 -1.267 0 C-N-CA 122.167 1.912 . . . . 0.0 113.414 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.746 HG21 HD12 ' A' ' 28' ' ' LEU . 26.1 mm -88.06 129.71 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG22 ' HA ' ' A' ' 31' ' ' ASP . 24.7 m -131.92 161.41 41.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 125' ' ' ILE . 92.3 mt -86.65 145.85 26.55 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.99 152.16 38.95 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -63.65 144.45 57.01 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.46 139.32 57.77 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -123.5 146.91 47.71 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 m -86.9 -14.4 42.04 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -125.41 147.27 49.25 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 58.49 41.27 22.92 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -90.37 0.35 57.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.03 85.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 t -67.48 -24.43 65.59 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.97 3.36 55.03 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.7 HD22 ' HB3' ' A' ' 16' ' ' TRP . 38.4 mt -98.1 138.01 36.04 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.948 0.88 . . . . 0.0 108.924 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -130.69 156.22 45.29 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -142.22 153.71 44.21 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -107.46 135.92 48.12 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.004 0.907 . . . . 0.0 108.754 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.35 158.92 54.3 Favored Pre-proline 0 N--CA 1.436 -1.152 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.0 -18.15 56.01 Favored 'Trans proline' 0 CA--C 1.499 -1.26 0 C-N-CA 121.616 1.544 . . . . 0.0 113.162 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.2 m -80.22 -13.08 59.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.6 39.97 Favored Glycine 0 C--N 1.358 1.763 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -96.77 147.68 23.68 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.46 134.38 43.5 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.914 HG22 HG12 ' A' ' 72' ' ' VAL . 61.2 t -120.16 137.56 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -76.82 130.95 38.36 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -62.55 -42.61 99.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.203 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -77.95 -52.36 8.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.845 -0.534 . . . . 0.0 111.418 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.7 m -70.4 -39.09 74.7 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.88 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.37 5.14 89.83 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 106.251 -2.739 . . . . 0.0 106.251 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -96.56 167.44 11.14 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.914 HG12 HG22 ' A' ' 65' ' ' VAL . 25.9 m -116.53 161.18 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.505 ' CE ' HD11 ' A' ' 28' ' ' LEU . 61.6 mtt -73.49 140.52 46.48 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -159.22 169.85 23.22 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.408 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -82.93 143.44 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.51 76.63 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.624 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -72.33 -32.84 66.86 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.15 -7.99 80.61 Favored Glycine 0 CA--C 1.495 -1.216 0 N-CA-C 105.871 -2.892 . . . . 0.0 105.871 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.6 m -119.67 126.23 27.04 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.59 117.21 5.03 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 121.17 1.247 . . . . 0.0 113.069 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -137.07 162.73 32.56 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.68 129.8 37.69 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.68 8.65 82.56 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' CG1' HD12 ' A' ' 140' ' ' LEU . 11.6 p -71.45 142.22 15.75 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 CA-C-N 118.619 1.21 . . . . 0.0 108.235 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -82.3 155.32 24.87 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.466 0.65 . . . . 0.0 109.495 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.444 HD11 ' HG ' ' A' ' 140' ' ' LEU . 48.3 mm -109.49 129.36 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.9 m -132.92 166.73 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -81.78 141.01 33.89 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -142.13 170.68 15.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.6 m -70.3 148.3 48.66 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -68.31 137.54 54.74 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.63 -158.74 0.69 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.56 -16.13 56.69 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.2 p -70.24 -39.36 75.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -133.3 21.0 4.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.7 t -126.67 129.32 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -62.07 141.93 57.83 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -69.23 -17.12 63.74 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -89.71 -6.25 56.26 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.5 mt -119.55 10.05 11.68 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -94.56 132.06 39.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.45 -6.78 49.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.78 -10.57 59.47 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.12 128.49 33.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.22 154.77 32.86 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.85 158.89 14.04 Favored Glycine 0 C--N 1.353 1.48 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.3 tp -118.43 120.07 36.46 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.431 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.1 t -82.07 140.55 46.25 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.48 -9.36 25.07 Favored 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 121.832 1.688 . . . . 0.0 112.768 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.68 2.34 56.03 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.98 20.25 40.08 Favored Glycine 0 C--N 1.356 1.684 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -108.91 150.23 28.01 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.7 mt -116.2 126.13 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.663 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -131.78 174.33 10.25 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.073 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.667 HD12 ' HB2' ' A' ' 118' ' ' LYS . 14.0 mt -84.11 150.01 25.83 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.38 -23.5 61.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -106.83 -18.86 13.81 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.149 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HB2' HD12 ' A' ' 115' ' ' LEU . 13.9 mptt -132.18 84.94 51.12 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.6 -9.22 24.69 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.506 2.137 . . . . 0.0 112.58 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.424 ' HA ' HG12 ' A' ' 143' ' ' VAL . 88.6 p -83.99 -15.99 45.66 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.603 HD23 HD12 ' A' ' 142' ' ' LEU . 73.3 mt -106.63 131.02 54.26 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.663 HG22 ' HB3' ' A' ' 114' ' ' TYR . 32.0 pt -134.21 164.44 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.7 mt -81.47 138.48 35.51 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.7 -179.52 38.1 Favored Glycine 0 CA--C 1.494 -1.25 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -130.35 161.41 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.517 ' O ' HD22 ' A' ' 136' ' ' LEU . 39.9 ttmt -113.75 144.42 43.0 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -66.95 156.82 34.88 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -110.97 160.47 16.78 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -65.26 -36.1 83.06 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -95.59 3.41 54.08 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 50.7 44.63 27.63 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.088 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -86.07 114.75 23.19 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -74.61 -20.12 60.03 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -91.32 90.05 7.55 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 134.06 2.46 3.41 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.517 HD22 ' O ' ' A' ' 126' ' ' LYS . 89.9 mt -66.96 131.18 45.34 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.609 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -90.85 156.62 17.89 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.602 0.715 . . . . 0.0 109.598 -177.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.67 139.55 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -148.14 167.59 24.65 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.454 HD12 ' CG1' ' A' ' 84' ' ' VAL . 90.7 mt -89.2 118.86 29.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -104.07 138.48 40.52 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.603 HD12 HD23 ' A' ' 121' ' ' LEU . 4.3 tp -72.27 135.02 45.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 118.924 -1.11 . . . . 0.0 108.115 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 120' ' ' SER . 7.7 p -61.72 141.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.189 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -131.35 101.88 5.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -64.78 -28.73 69.77 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -68.8 -18.42 64.18 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -132.97 77.29 1.73 Allowed 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.6 mt -99.99 3.74 44.44 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -97.35 31.79 2.41 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -102.3 116.57 32.91 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -68.33 -20.42 64.73 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.951 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -72.33 -19.37 61.66 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -96.91 -0.98 46.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -98.19 133.6 42.4 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.493 ' CE3' HG22 ' A' ' 19' ' ' ILE . 94.9 m95 -118.36 139.02 52.0 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -110.27 144.45 38.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -112.04 135.43 52.69 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.4 t -128.79 144.46 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.57 153.03 41.61 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.67 149.49 79.08 Favored 'Trans proline' 0 CA--C 1.496 -1.4 0 C-N-CA 121.764 1.643 . . . . 0.0 113.278 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.7 t -120.88 126.34 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.265 1.87 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.107 0.479 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 152.95 32.7 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.54 153.55 32.62 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.71 99.64 11.45 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 tpp -66.08 -40.11 90.59 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.07 88.51 2.9 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -72.69 -23.55 60.89 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.5 146.57 30.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -146.31 138.91 25.33 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -97.78 163.32 12.86 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -90.63 138.28 31.69 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -75.03 155.71 86.36 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.6 141.81 95.44 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 121.922 1.748 . . . . 0.0 112.691 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.55 157.48 16.18 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.25 -162.81 37.02 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.682 ' HB3' HD22 ' A' ' 55' ' ' LEU . 49.0 m0 -79.67 142.94 35.08 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -158.04 163.01 38.14 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.441 ' CE1' HD21 ' A' ' 55' ' ' LEU . 49.7 m-85 -119.8 139.82 51.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.562 HD11 ' CD2' ' A' ' 64' ' ' LEU . 84.7 mt -102.3 113.94 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -114.42 131.06 56.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -83.86 126.27 32.8 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -63.35 -28.28 69.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.8 p -71.0 -36.99 72.68 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 121.354 -0.841 . . . . 0.0 111.396 -176.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -105.05 -23.8 12.89 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.373 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.83 18.46 80.11 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -108.0 165.31 11.56 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -117.57 160.42 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.904 HD23 HG21 ' A' ' 41' ' ' ILE . 4.8 mp -68.63 133.76 48.94 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.956 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.6 ttp -145.43 163.25 35.22 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 31' ' ' ASP . 21.1 t -67.74 164.08 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' N ' HG12 ' A' ' 30' ' ' VAL . 18.6 t70 -53.62 -39.18 64.74 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 121.871 -0.518 . . . . 0.0 110.294 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -161.62 50.93 0.23 Allowed 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 54.87 41.59 31.78 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.9 m -75.19 132.96 41.5 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -96.81 1.38 50.66 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -103.02 150.27 23.73 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -77.01 158.42 30.59 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.66 8.59 62.11 Favored Glycine 0 C--N 1.356 1.661 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.2 t -93.35 126.14 51.61 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HA ' HG12 ' A' ' 87' ' ' VAL . 42.5 Cg_exo -59.23 150.63 72.92 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 122.251 1.968 . . . . 0.0 113.278 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.904 HG21 HD23 ' A' ' 28' ' ' LEU . 22.9 mm -90.62 130.09 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 25.6 m -132.19 164.2 35.49 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 121.701 0.762 . . . . 0.0 108.971 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.527 HD12 ' HB2' ' A' ' 136' ' ' LEU . 95.8 mt -85.42 145.29 27.52 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.95 148.73 32.04 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -62.91 143.5 57.6 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.4 139.45 57.67 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -121.35 146.56 46.73 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 p -87.34 -16.37 35.23 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -124.3 147.03 48.42 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 58.11 42.69 21.93 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -91.18 3.16 55.53 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.35 -37.41 87.16 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m -69.32 -17.37 63.71 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -100.64 3.88 42.85 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.682 HD22 ' HB3' ' A' ' 16' ' ' TRP . 25.8 mt -98.66 136.57 38.54 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -128.53 153.83 46.78 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -137.23 151.05 48.3 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -99.38 116.77 32.32 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -80.95 155.39 72.82 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.03 -15.75 45.56 Favored 'Trans proline' 0 CA--C 1.498 -1.286 0 C-N-CA 122.004 1.803 . . . . 0.0 113.256 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -77.94 -12.69 60.0 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.66 21.06 15.18 Favored Glycine 0 C--N 1.356 1.693 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -117.14 159.02 23.25 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 118.392 1.096 . . . . 0.0 108.215 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 19' ' ' ILE . 6.5 mp -106.01 126.29 52.02 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.725 HG22 HG22 ' A' ' 72' ' ' VAL . 98.1 t -115.57 137.34 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -74.07 131.3 41.21 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.21 -40.75 98.35 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 122.021 -0.424 . . . . 0.0 110.852 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -78.43 -56.33 4.52 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.305 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.415 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 68.0 m -70.22 -38.43 75.25 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -176.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.86 9.57 85.26 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 96.4 mm-40 -94.27 157.59 15.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.725 HG22 HG22 ' A' ' 65' ' ' VAL . 13.7 t -106.79 150.07 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 mtt -69.97 138.92 52.68 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -157.61 172.73 18.01 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.104 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.445 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -88.87 143.72 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.24 -42.8 88.11 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.44 -33.79 69.69 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.445 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 89.68 -8.42 79.85 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.5 m -124.73 122.29 25.68 Favored Pre-proline 0 N--CA 1.436 -1.159 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.03 129.21 32.03 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 121.389 1.392 . . . . 0.0 113.028 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 155.08 42.19 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.63 130.25 39.2 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.38 8.78 80.52 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.61 144.99 11.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -87.19 168.9 12.82 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.474 HD11 ' HG ' ' A' ' 140' ' ' LEU . 48.1 mm -116.92 128.64 74.27 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.2 m -130.24 160.08 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -86.22 138.41 31.89 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -140.16 167.88 21.11 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 91' ' ' GLN . 7.6 m -68.81 159.7 31.94 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.47 ' N ' HG22 ' A' ' 90' ' ' THR . 97.1 mt-30 -64.2 151.46 43.42 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.574 ' HB1' HG21 ' A' ' 96' ' ' VAL . . . -69.67 147.92 49.97 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.02 -167.02 43.29 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.8 p -85.63 1.59 48.6 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -98.82 21.25 11.74 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.574 HG21 ' HB1' ' A' ' 92' ' ' ALA . 98.2 t -115.08 123.25 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -65.25 150.11 48.79 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.7 -19.08 65.68 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -90.78 -2.31 57.8 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.8 mt -114.14 7.54 16.68 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -83.76 97.96 9.43 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -91.63 -6.64 51.88 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.289 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -74.26 -11.64 60.33 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -72.59 138.58 46.91 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -129.09 154.28 46.83 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.7 143.54 17.71 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 106.489 -2.644 . . . . 0.0 106.489 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.4 tp -109.54 123.95 50.28 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.459 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.6 t -89.15 139.16 28.69 Favored Pre-proline 0 N--CA 1.438 -1.047 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.93 -9.06 23.55 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.72 1.613 . . . . 0.0 112.722 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -88.07 -0.24 56.81 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.98 16.58 40.84 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -107.8 149.16 28.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.29 127.19 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.641 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -129.13 -178.67 4.74 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.659 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 15.2 mt -91.97 151.29 20.57 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.2 -22.98 60.34 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -104.39 -21.78 13.43 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.765 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.659 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 4.2 mptp? -133.39 85.59 43.27 Favored Pre-proline 0 CA--C 1.493 -1.232 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -66.89 -8.54 21.85 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.415 2.077 . . . . 0.0 112.281 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.415 ' HA ' HG12 ' A' ' 143' ' ' VAL . 90.0 p -87.19 -15.64 37.68 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.567 HD23 HD12 ' A' ' 142' ' ' LEU . 49.2 mt -103.59 130.98 51.11 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.641 HG22 ' HB3' ' A' ' 114' ' ' TYR . 32.7 pt -133.61 160.36 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.517 HD23 HG11 ' A' ' 138' ' ' VAL . 6.1 mp -82.69 138.15 34.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.28 179.85 38.18 Favored Glycine 0 CA--C 1.494 -1.234 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.9 pp -125.2 160.78 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.463 ' O ' HD22 ' A' ' 136' ' ' LEU . 86.8 tttt -118.02 145.85 44.47 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -75.55 164.67 26.1 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.9 p -128.88 167.54 17.24 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -65.52 -36.0 82.52 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.28 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -90.12 -1.64 57.97 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 48.57 48.33 19.7 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.752 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -84.18 110.26 18.39 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -75.69 -19.01 59.42 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.98 88.2 6.49 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 131.69 6.61 3.26 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.527 ' HB2' HD12 ' A' ' 43' ' ' LEU . 82.1 mt -65.64 129.22 38.99 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -90.87 155.49 18.72 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 121.663 0.744 . . . . 0.0 109.426 -177.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.517 HG11 HD23 ' A' ' 123' ' ' LEU . 30.9 t -94.33 140.28 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -147.18 167.66 23.62 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.474 ' HG ' HD11 ' A' ' 86' ' ' ILE . 88.7 mt -98.51 126.56 44.11 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -119.63 154.7 33.59 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.567 HD12 HD23 ' A' ' 121' ' ' LEU . 1.1 tp -75.63 136.57 40.45 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.562 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 120' ' ' SER . 11.1 p -62.22 144.89 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.59 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -139.13 97.59 3.33 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -64.45 -18.5 64.81 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.802 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -69.74 -22.41 63.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -133.87 83.81 2.07 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.6 mt -100.37 5.15 44.35 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -94.05 21.48 6.72 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -90.52 110.78 21.9 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.04 -21.13 65.93 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.903 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -74.39 -16.95 60.87 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -99.22 -0.53 41.25 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -98.42 133.88 42.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -116.73 137.85 51.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -112.38 146.25 38.66 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 136.31 52.1 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.6 t -127.35 145.0 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.1 mt -108.96 152.46 42.43 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.42 149.3 74.82 Favored 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 121.709 1.606 . . . . 0.0 113.114 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.55 158.83 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 C--O 1.262 1.727 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.728 0.299 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.96 98.31 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.74 47.07 8.36 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.42 71.52 10.79 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -106.47 12.92 29.09 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -120.84 91.57 3.56 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -86.54 -34.19 20.03 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -83.59 146.43 28.3 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.3 t -146.41 138.17 24.75 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.29 171.47 9.04 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.65 161.3 14.99 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.16 155.76 46.74 Favored Pre-proline 0 N--CA 1.441 -0.924 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.5 148.96 79.81 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 121.386 1.391 . . . . 0.0 112.17 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -91.94 157.83 16.61 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.815 0.817 . . . . 0.0 108.92 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.57 -165.65 35.47 Favored Glycine 0 CA--C 1.495 -1.18 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.691 ' HB3' HD22 ' A' ' 55' ' ' LEU . 52.7 m0 -75.83 141.91 42.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -156.1 162.34 40.27 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 41.2 m-85 -120.05 137.16 54.27 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.62 114.94 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -113.33 131.36 55.98 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -83.77 126.21 32.7 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -61.47 -35.98 79.14 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -67.1 -41.61 85.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.672 -0.642 . . . . 0.0 111.294 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -97.26 -24.6 15.61 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.331 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.28 17.8 79.0 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -111.0 168.57 9.39 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.18 161.11 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.854 HD23 HG21 ' A' ' 41' ' ' ILE . 5.2 mp -74.34 137.68 42.98 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.531 0.681 . . . . 0.0 110.874 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.4 ptm -147.09 176.06 10.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 31' ' ' ASP . 22.4 t -74.41 162.66 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.556 ' N ' HG12 ' A' ' 30' ' ' VAL . 39.5 t0 -56.01 -39.16 71.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 121.485 -0.76 . . . . 0.0 110.282 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -158.49 53.73 0.43 Allowed 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.054 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 51.64 48.93 21.91 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.0 m -98.23 127.48 44.19 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -92.59 -2.61 56.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -87.58 151.6 22.86 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.5 m -77.85 158.67 29.37 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.37 5.52 65.29 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.1 t -93.85 124.55 56.23 Favored Pre-proline 0 N--CA 1.438 -1.039 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -59.0 150.84 70.2 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 122.117 1.878 . . . . 0.0 113.433 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.854 HG21 HD23 ' A' ' 28' ' ' LEU . 23.5 mm -90.8 130.28 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 30.8 m -131.76 164.34 34.87 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.15 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.616 HD11 HG21 ' A' ' 125' ' ' ILE . 90.3 mt -91.57 147.74 22.79 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.04 151.6 29.52 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -66.11 159.56 25.87 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.023 0.916 . . . . 0.0 108.756 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.25 139.67 57.35 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.687 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.8 mmm-85 -127.65 147.17 50.37 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 m -87.85 -11.46 47.76 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -122.62 145.02 48.73 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 57.35 42.83 24.32 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 34.8 p90 -86.91 -1.38 57.78 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.08 89.59 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -70.65 -19.09 62.84 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 51' ' ' TYR . 8.4 mm100 -94.56 0.11 54.97 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.691 HD22 ' HB3' ' A' ' 16' ' ' TRP . 68.6 mt -99.86 140.53 33.94 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-O 121.936 0.874 . . . . 0.0 109.793 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -129.78 152.49 49.22 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -136.44 133.1 36.28 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -96.41 128.5 43.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.97 160.42 66.15 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.19 -27.91 58.76 Favored 'Trans proline' 0 CA--C 1.499 -1.255 0 C-N-CA 121.935 1.757 . . . . 0.0 113.675 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.4 m -73.65 -16.56 61.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.22 12.83 32.68 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -89.08 150.18 22.87 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.7 mt -105.47 129.06 53.84 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.995 HG22 HG12 ' A' ' 72' ' ' VAL . 68.0 t -114.58 135.21 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -84.33 128.31 34.5 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.38 -40.39 96.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.921 -0.487 . . . . 0.0 111.31 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -64.79 -49.63 69.95 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -89.52 -31.37 17.67 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.576 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.08 3.39 90.4 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 107.247 -2.341 . . . . 0.0 107.247 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -93.09 170.62 9.51 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.995 HG12 HG22 ' A' ' 65' ' ' VAL . 25.8 m -118.37 162.45 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.1 mtt -71.12 139.94 50.46 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -157.68 166.61 32.35 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.99 142.68 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.52 84.91 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.425 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.5 -33.27 69.1 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.02 84.06 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.2 m -124.25 126.84 25.47 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.91 116.7 4.79 Favored 'Trans proline' 0 CA--C 1.496 -1.399 0 C-N-CA 121.115 1.21 . . . . 0.0 112.765 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -136.69 162.54 32.89 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.56 130.34 38.67 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.17 8.28 78.73 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -71.74 145.21 12.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 118.586 1.193 . . . . 0.0 108.144 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -91.23 158.52 16.55 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.481 0.658 . . . . 0.0 109.25 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.654 HD11 HD13 ' A' ' 140' ' ' LEU . 48.8 mm -109.45 129.94 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 m -132.28 164.66 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -76.7 141.04 41.05 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -152.73 160.84 43.13 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 m -64.88 146.48 54.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -71.38 156.57 39.33 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.09 -154.3 0.54 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.03 -13.97 57.31 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.6 t -64.71 -45.08 88.08 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -136.78 21.69 3.09 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.4 t -125.11 130.23 73.14 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -61.22 141.76 57.28 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -67.75 -19.22 65.1 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.27 -5.03 56.78 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.3 mt -118.38 10.08 12.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -91.55 121.64 33.41 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -75.51 -8.57 57.09 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.275 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -73.55 -13.09 60.97 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -74.43 129.75 38.35 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -116.07 151.71 35.02 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.33 151.66 17.76 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.5 tp -118.91 121.85 40.93 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 8.6 t -84.81 140.62 37.76 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.85 -10.18 25.83 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.676 1.584 . . . . 0.0 112.689 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -86.87 -2.45 58.6 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.01 12.08 50.78 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -99.81 144.62 28.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.51 126.38 73.04 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.97 177.22 7.6 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.263 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.659 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 15.4 mt -87.41 150.59 23.7 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.24 -20.91 58.97 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -104.7 -24.39 12.95 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.561 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.659 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 13.8 mptt -131.9 84.45 53.9 Favored Pre-proline 0 CA--C 1.496 -1.099 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.05 -9.18 24.12 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.515 2.143 . . . . 0.0 113.014 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 88.2 p -83.22 -22.3 33.16 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.593 HD22 ' HB3' ' A' ' 140' ' ' LEU . 61.1 mt -96.24 131.68 42.47 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.586 HG22 ' HB3' ' A' ' 114' ' ' TYR . 22.7 pt -133.27 163.76 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.4 mt -81.52 139.67 35.0 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.71 176.34 40.55 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 106.909 -2.477 . . . . 0.0 106.909 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.616 HG21 HD11 ' A' ' 43' ' ' LEU . 1.9 pp -129.39 159.19 41.7 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' O ' HD22 ' A' ' 136' ' ' LEU . 47.8 tttt -102.04 145.77 28.85 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -116.77 140.6 49.24 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.4 t -149.35 155.87 41.18 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -69.52 -27.63 65.34 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.08 30.74 4.64 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -135.82 103.6 5.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -65.87 160.67 22.79 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -72.51 -13.11 61.34 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -95.62 89.25 5.29 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 127.31 7.81 4.74 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 126' ' ' LYS . 84.5 mt -67.46 133.55 49.74 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 118.987 1.394 . . . . 0.0 107.262 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.516 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -95.46 154.24 17.3 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.4 p -94.12 143.59 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -144.39 163.76 32.83 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.654 HD13 HD11 ' A' ' 86' ' ' ILE . 5.1 mp -94.33 124.22 38.22 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -122.11 156.24 34.02 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.56 HD12 HD23 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -80.36 149.69 30.15 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.165 -178.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.422 HG12 HD13 ' A' ' 122' ' ' ILE . 7.3 m -63.13 155.8 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.57 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -139.22 100.14 3.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -66.59 -21.53 66.14 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.004 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -67.29 -25.42 66.03 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -142.51 88.44 2.07 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.0 mt -100.78 3.77 42.4 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -99.32 25.31 7.05 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -83.46 125.63 31.93 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.7 -22.9 62.4 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -74.02 -21.88 59.8 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.71 2.17 38.28 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.1 ttp85 -102.81 132.38 49.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -119.59 142.89 47.98 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.541 0.686 . . . . 0.0 109.226 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -120.43 152.89 37.33 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.98 140.18 50.11 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.64 144.75 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.5 mt -109.86 152.46 42.98 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.41 149.06 74.7 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.731 1.621 . . . . 0.0 113.084 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.4 p -145.98 144.74 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.5 t . . . . . 0 C--O 1.262 1.75 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mmm . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.037 0.446 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -153.8 151.67 29.82 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 71.15 -169.04 0.15 Allowed 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.51 144.88 20.99 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -112.5 0.31 15.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.86 77.15 1.1 Allowed 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -71.32 -23.38 61.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -78.68 145.11 34.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.3 p -146.5 154.88 42.07 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -136.44 170.36 16.18 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -106.14 161.52 14.44 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -90.39 156.69 45.56 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.86 148.96 86.83 Favored 'Trans proline' 0 CA--C 1.499 -1.251 0 C-N-CA 121.411 1.407 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -95.02 158.57 15.41 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.76 -161.53 28.35 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.69 ' HB3' HD22 ' A' ' 55' ' ' LEU . 43.1 m0 -83.61 143.62 30.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.524 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 52.4 p90 -157.04 163.71 38.75 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.443 ' CE1' HD21 ' A' ' 55' ' ' LEU . 43.4 m-85 -121.76 139.76 53.18 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 64' ' ' LEU . 87.7 mt -106.86 119.2 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 27.9 pttt -122.66 147.05 46.9 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.644 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -89.24 127.98 35.8 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -62.9 -18.19 62.69 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 152' ' ' GLU . 45.5 t -62.29 -46.06 90.48 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 119.1 0.864 . . . . 0.0 110.883 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -125.8 -7.67 6.72 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.85 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.2 12.07 84.38 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CD2' ' HA ' ' A' ' 45' ' ' THR . 11.5 m-30 -84.68 156.18 21.62 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 22.2 m -111.9 159.29 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.624 0.726 . . . . 0.0 109.495 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.939 HD23 HG21 ' A' ' 41' ' ' ILE . 3.4 mp -66.38 131.6 46.44 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.566 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.0 ttp -145.88 166.39 26.11 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 31' ' ' ASP . 46.8 t -67.92 159.42 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.6 t70 -52.71 -40.61 63.15 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.926 -0.484 . . . . 0.0 110.68 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -163.27 50.64 0.16 Allowed 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.536 -0.866 . . . . 0.0 108.777 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 55.88 49.13 16.6 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.506 ' H ' HG11 ' A' ' 30' ' ' VAL . 66.5 m -94.45 109.32 21.2 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -91.12 -3.52 57.02 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -83.18 -6.4 59.46 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 t 69.07 -172.65 0.18 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.69 24.82 76.23 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.6 m -127.66 149.05 69.27 Favored Pre-proline 0 CA--C 1.501 -0.929 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 68.7 Cg_endo -72.6 158.58 50.56 Favored 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 122.161 1.908 . . . . 0.0 113.321 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.939 HG21 HD23 ' A' ' 28' ' ' LEU . 23.5 mm -88.0 131.41 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 24.5 m -130.84 166.13 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.99 142.77 27.81 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.37 151.25 39.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 26' ' ' TYR . 4.5 m -58.71 145.66 39.39 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.99 131.67 46.78 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -137.23 140.71 41.87 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -64.93 -36.09 83.25 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -75.19 142.37 43.49 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 60.32 43.22 13.85 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -70.17 -31.44 68.93 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.61 91.71 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.2 m -70.36 -22.05 62.82 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -100.43 4.23 43.65 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 16' ' ' TRP . 24.0 mt -102.3 138.74 38.83 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -125.42 151.54 46.05 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -128.51 135.24 49.16 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -91.58 112.99 25.14 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -85.42 156.38 59.43 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.94 -13.7 36.6 Favored 'Trans proline' 0 CA--C 1.497 -1.351 0 C-N-CA 122.216 1.944 . . . . 0.0 113.263 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.3 m -70.48 -20.58 62.85 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.15 8.82 33.08 Favored Glycine 0 C--N 1.356 1.674 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -121.95 161.97 21.93 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 118.513 1.156 . . . . 0.0 109.24 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.713 HD13 HD11 ' A' ' 19' ' ' ILE . 58.2 mt -99.81 135.14 41.69 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -177.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 72' ' ' VAL . 92.4 t -117.18 136.66 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -76.68 127.91 33.68 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -64.42 -37.33 87.14 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.321 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -75.54 -54.33 7.18 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.669 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.4 m -70.88 -39.96 72.52 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.67 10.25 84.54 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 105.932 -2.867 . . . . 0.0 105.932 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -98.99 162.62 12.97 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 65' ' ' VAL . 11.7 t -110.96 150.9 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.8 mtt -69.83 139.81 53.19 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -157.68 169.8 23.82 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.211 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.75 142.88 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.36 -41.11 76.98 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.476 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.45 -33.56 71.43 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.4 -6.79 83.06 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.9 m -123.82 125.88 25.82 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.41 115.83 4.23 Favored 'Trans proline' 0 CA--C 1.497 -1.365 0 C-N-CA 121.022 1.148 . . . . 0.0 112.758 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -135.75 162.65 32.18 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.21 38.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.34 7.42 82.72 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG1' HD12 ' A' ' 140' ' ' LEU . 12.0 p -70.83 142.9 15.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 CA-C-N 118.534 1.167 . . . . 0.0 107.942 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.21 155.39 20.74 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 mm -106.59 128.01 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 40' ' ' PRO . 34.1 m -130.59 168.48 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -80.33 142.08 34.82 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -145.21 171.24 14.83 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -71.45 169.18 15.93 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -84.04 156.47 22.21 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.49 150.99 42.77 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.7 -171.57 48.16 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 84.8 p -85.5 1.7 47.8 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -99.04 13.03 34.25 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.91 123.29 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -65.56 150.05 49.05 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.62 -20.4 66.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -90.66 -1.62 57.86 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.38 6.14 18.56 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.17 112.0 19.86 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -85.07 -10.74 56.56 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -84.26 -11.44 56.44 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.76 131.04 45.75 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.47 154.62 33.48 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.88 158.47 14.26 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.6 tp -129.53 130.91 46.38 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 91.7 p -104.16 155.92 36.5 Favored Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 57.3 Cg_endo -70.69 -8.5 23.76 Favored 'Trans proline' 0 CA--C 1.499 -1.239 0 C-N-CA 121.856 1.704 . . . . 0.0 112.61 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -82.62 -9.71 59.27 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.61 12.61 55.57 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -101.12 137.41 39.52 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.95 124.91 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.721 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -127.0 -179.62 4.93 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.641 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 7.7 mt -89.6 149.11 22.98 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.22 -24.23 61.36 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.27 -19.57 14.43 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.897 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.641 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 13.4 mptt -132.53 84.17 51.89 Favored Pre-proline 0 N--CA 1.438 -1.055 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -68.52 -9.75 26.98 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.605 2.203 . . . . 0.0 113.012 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.8 m -83.51 -22.88 32.35 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.546 HD23 HD12 ' A' ' 142' ' ' LEU . 54.4 mt -97.28 131.35 44.07 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.721 HG22 ' HB3' ' A' ' 114' ' ' TYR . 26.8 pt -133.19 163.21 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.9 mt -79.38 137.99 37.5 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.16 176.81 37.7 Favored Glycine 0 CA--C 1.493 -1.309 0 N-CA-C 107.415 -2.274 . . . . 0.0 107.415 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.759 HD13 HD13 ' A' ' 136' ' ' LEU . 1.4 pp -135.92 159.82 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.492 ' O ' HD22 ' A' ' 136' ' ' LEU . 88.2 tttt -108.48 145.59 34.46 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -134.54 144.71 48.15 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.59 ' H ' ' HB3' ' A' ' 131' ' ' ALA . 9.7 t -150.5 175.84 11.5 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -71.61 -28.58 63.9 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.9 37.51 2.04 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.59 ' HB3' ' H ' ' A' ' 128' ' ' SER . . . -124.77 104.46 8.65 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.44 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 32.2 tpt180 -63.68 129.93 42.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.16 -36.13 82.58 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 93.5 mt-10 -83.19 86.69 6.99 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.14 8.73 1.54 Allowed Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.759 HD13 HD13 ' A' ' 125' ' ' ILE . 84.2 mt -63.98 127.73 32.67 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.524 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -87.99 153.83 20.98 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.66 0.743 . . . . 0.0 109.706 -177.373 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.5 t -97.01 139.75 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -147.39 167.4 24.47 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.412 HD12 ' CG1' ' A' ' 84' ' ' VAL . 89.5 mt -91.91 125.02 36.45 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -116.74 142.18 47.25 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.546 HD12 HD23 ' A' ' 121' ' ' LEU . 1.1 tp -74.9 146.14 42.1 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.6 m -61.84 153.94 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 121.87 0.843 . . . . 0.0 109.443 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -148.24 102.16 3.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -70.08 -18.27 63.26 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.867 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -67.65 -25.58 65.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -135.6 84.24 2.07 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -102.55 4.36 38.41 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -97.78 22.31 9.31 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -90.9 115.33 27.86 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -68.5 -20.59 64.6 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 25.2 pt-20 -73.9 -17.32 61.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -100.63 0.88 40.05 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.55 133.35 39.67 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -118.43 139.8 50.85 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -123.14 158.28 31.09 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -119.91 142.37 48.76 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.2 t -128.58 144.12 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -109.49 152.64 42.85 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.74 150.13 73.86 Favored 'Trans proline' 0 CA--C 1.495 -1.453 0 C-N-CA 121.735 1.623 . . . . 0.0 113.07 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.7 t -118.71 125.83 74.74 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.261 1.7 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 ttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.784 0.326 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.16 142.4 46.13 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.24 156.95 36.51 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.35 101.85 14.54 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 60.4 ttm -65.21 -40.57 94.32 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -117.53 84.34 2.14 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.87 -22.16 61.56 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -99.48 148.0 24.7 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.9 m -139.14 145.45 39.43 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -103.46 162.15 13.27 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.9 161.02 17.71 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.978 0.894 . . . . 0.0 108.986 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -86.18 157.91 56.0 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.75 148.96 87.23 Favored 'Trans proline' 0 CA--C 1.499 -1.235 0 C-N-CA 121.321 1.348 . . . . 0.0 112.281 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.31 156.83 19.46 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.824 0.821 . . . . 0.0 109.179 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.52 -168.81 38.56 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.69 ' HB3' HD22 ' A' ' 55' ' ' LEU . 49.4 m0 -75.72 144.48 41.49 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.42 161.07 41.91 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 43.1 m-85 -119.59 138.65 53.08 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.508 HD11 ' CD2' ' A' ' 64' ' ' LEU . 85.6 mt -99.87 113.76 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -110.48 131.39 55.09 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.378 0.609 . . . . 0.0 109.429 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -83.66 123.95 30.34 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -61.03 -36.22 78.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 t -65.3 -43.32 91.48 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 121.557 -0.715 . . . . 0.0 111.56 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -99.18 -23.13 15.33 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.495 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.31 18.62 79.94 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.401 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 9.8 m-30 -107.23 167.09 10.15 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.25 160.94 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.96 HD23 HG21 ' A' ' 41' ' ' ILE . 2.5 mp -67.86 132.43 47.36 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.908 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.2 ttp -145.76 163.15 35.87 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 31' ' ' ASP . 21.0 t -68.33 165.57 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.562 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.0 t70 -49.37 -41.54 39.42 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 122.103 -0.373 . . . . 0.0 110.812 -177.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -162.21 51.53 0.21 Allowed 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 56.65 43.93 24.63 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -88.17 128.93 35.45 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -93.35 -2.0 55.28 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -88.31 142.32 27.83 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.7 m -74.98 156.57 36.13 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.18 7.26 62.42 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.3 m -93.03 137.23 23.84 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 56.5 Cg_endo -70.28 154.36 65.76 Favored 'Trans proline' 0 CA--C 1.496 -1.398 0 C-N-CA 121.661 1.574 . . . . 0.0 112.831 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.96 HG21 HD23 ' A' ' 28' ' ' LEU . 23.2 mm -91.81 130.84 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 27.6 m -131.65 164.39 34.65 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' CD1' HG21 ' A' ' 125' ' ' ILE . 92.8 mt -92.82 142.22 27.57 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.24 150.24 36.33 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.401 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 9.6 t -64.22 155.27 32.4 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.49 139.53 58.78 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.62 147.18 49.93 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -87.73 -12.15 46.09 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.29 143.92 48.91 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 57.66 40.08 26.89 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -85.68 -4.34 59.14 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.78 81.24 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -72.82 -13.4 61.29 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -102.31 2.49 36.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 16' ' ' TRP . 56.5 mt -98.02 138.07 35.88 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -126.51 149.94 49.06 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -133.01 129.6 38.34 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -92.25 129.39 38.21 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.13 159.8 56.09 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.29 -26.66 62.84 Favored 'Trans proline' 0 CA--C 1.499 -1.25 0 C-N-CA 122.021 1.814 . . . . 0.0 113.825 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.9 m -72.14 -19.55 61.76 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.88 11.25 28.73 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.472 ' CD2' ' HB2' ' A' ' 103' ' ' GLN . 2.6 m-85 -92.81 147.27 23.0 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.508 ' CD2' HD11 ' A' ' 19' ' ' ILE . 8.5 mp -103.1 128.36 50.04 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.969 HG22 HG12 ' A' ' 72' ' ' VAL . 58.2 t -114.23 135.44 53.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -75.73 131.02 39.57 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -62.18 -41.4 98.29 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 122.048 -0.407 . . . . 0.0 111.279 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -80.43 -52.09 8.07 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 121.691 -0.631 . . . . 0.0 111.379 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.6 m -68.24 -39.85 82.15 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.691 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.04 2.15 90.63 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -93.32 167.02 12.01 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.969 HG12 HG22 ' A' ' 65' ' ' VAL . 21.6 m -119.18 163.83 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.8 mtt -71.01 139.29 50.46 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -154.24 169.7 23.0 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.45 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -93.39 143.66 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.33 87.2 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -72.5 -33.01 66.64 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.45 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.32 -8.86 79.1 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 105.959 -2.856 . . . . 0.0 105.959 -177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.9 m -121.26 125.38 26.94 Favored Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.36 120.18 6.6 Favored 'Trans proline' 0 CA--C 1.497 -1.359 0 C-N-CA 121.205 1.27 . . . . 0.0 113.251 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -138.58 162.58 34.22 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.12 131.33 39.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.37 15.36 71.72 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.674 ' CG1' HD12 ' A' ' 140' ' ' LEU . 9.9 p -81.23 150.89 4.47 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -90.03 153.03 20.88 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.8 mm -109.8 128.25 66.03 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 40' ' ' PRO . 29.4 m -133.29 161.32 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -86.3 142.95 28.15 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.87 178.72 9.36 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 m -76.07 150.05 37.36 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -76.48 156.2 33.21 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -102.38 -148.08 0.38 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.563 ' H ' HG12 ' A' ' 96' ' ' VAL . . . 97.81 -6.03 62.22 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.9 p -67.96 -38.25 82.54 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -155.31 31.02 0.39 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 93' ' ' GLY . 7.4 p -133.35 147.97 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.22 157.02 38.42 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.81 0.814 . . . . 0.0 108.905 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -78.18 -21.54 50.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.44 -10.36 52.14 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -109.69 9.75 24.91 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -93.54 131.7 38.54 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -86.88 -7.72 57.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.641 ' NE2' HG21 ' A' ' 72' ' ' VAL . 33.5 mt-30 -70.16 -18.03 63.19 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -71.99 128.6 36.24 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.45 156.98 34.49 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.85 163.92 25.24 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 106.303 -2.719 . . . . 0.0 106.303 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -145.65 152.63 39.95 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 85.2 p -105.77 160.65 25.37 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.88 -14.61 33.46 Favored 'Trans proline' 0 CA--C 1.499 -1.268 0 C-N-CA 122.513 2.142 . . . . 0.0 113.424 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -74.79 -11.45 60.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.95 27.78 11.97 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -112.53 134.75 53.89 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -107.47 127.13 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.723 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.1 p90 -134.46 178.4 7.02 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.635 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 7.0 mt -89.23 146.67 24.6 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.59 -24.11 61.85 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -102.71 -19.19 14.86 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.657 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.635 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -134.57 82.71 44.62 Favored Pre-proline 0 N--CA 1.437 -1.116 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.54 -11.78 32.03 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.474 2.116 . . . . 0.0 113.05 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 88.9 p -79.94 -23.5 41.66 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.523 HD23 HD12 ' A' ' 142' ' ' LEU . 53.6 mt -95.81 131.79 41.74 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.723 HG22 ' HB3' ' A' ' 114' ' ' TYR . 23.8 pt -133.21 163.58 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.443 HD23 ' CD2' ' A' ' 140' ' ' LEU . 88.3 mt -81.68 141.99 33.11 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.78 -175.6 35.69 Favored Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 106.732 -2.547 . . . . 0.0 106.732 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.6 pp -135.45 161.02 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.421 ' O ' HD22 ' A' ' 136' ' ' LEU . 40.0 ttmt -117.32 143.09 46.3 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.98 151.54 44.54 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.8 m -104.51 166.48 10.36 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -65.14 -37.07 86.23 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -94.71 3.53 54.93 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 49.73 49.31 20.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.112 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -85.15 116.01 23.27 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.472 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -77.41 -22.57 51.36 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -90.49 87.4 6.74 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.5 6.1 2.15 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 126' ' ' LYS . 80.8 mt -66.37 125.48 25.79 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.526 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -89.02 154.87 19.86 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 121.491 0.662 . . . . 0.0 109.644 -177.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 52.5 t -79.16 136.28 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.91 140.58 44.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.674 HD12 ' CG1' ' A' ' 84' ' ' VAL . 88.5 mt -85.31 129.38 34.82 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -124.36 152.47 43.13 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.523 HD12 HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -81.66 152.79 26.95 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -61.19 141.03 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 121.808 0.813 . . . . 0.0 109.42 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -126.57 86.02 2.46 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.47 -20.52 66.39 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -71.34 -22.12 61.95 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -133.73 83.95 2.09 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.31 4.0 52.61 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -95.93 27.65 3.48 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -98.89 108.54 21.25 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -69.78 -21.53 63.41 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -69.82 -19.84 63.46 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -100.59 3.0 42.3 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -99.3 136.74 38.81 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -124.47 141.78 51.82 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -121.42 155.5 34.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.86 139.08 51.62 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.93 145.42 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.35 152.44 42.66 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.55 149.64 74.37 Favored 'Trans proline' 0 CA--C 1.496 -1.404 0 C-N-CA 121.809 1.673 . . . . 0.0 113.267 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.6 t -121.18 126.22 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--O 1.263 1.785 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.575 0.226 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.95 44.35 2.03 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.65 152.41 32.78 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.48 130.27 21.62 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.0 mtm -67.06 -37.46 84.08 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -112.34 74.73 0.88 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -72.53 -22.7 60.98 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -79.11 141.1 37.6 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.6 m -135.19 146.09 48.35 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -126.15 171.53 10.79 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 161.95 36.1 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -90.3 122.36 67.51 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.22 -24.61 23.08 Favored 'Trans proline' 0 CA--C 1.501 -1.135 0 C-N-CA 121.4 1.4 . . . . 0.0 112.492 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 pm0 -83.61 160.97 21.29 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.53 -61.99 0.87 Allowed Glycine 0 C--N 1.351 1.364 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.404 ' HB3' HD22 ' A' ' 55' ' ' LEU . 45.0 m0 -86.86 138.2 31.76 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -163.73 162.82 24.17 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.423 ' CE1' HD21 ' A' ' 55' ' ' LEU . 59.2 m-85 -119.15 138.12 53.13 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 64' ' ' LEU . 76.9 mt -104.01 117.69 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -117.08 129.6 56.1 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -85.33 127.16 34.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -67.16 -16.58 64.4 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 122.244 -0.285 . . . . 0.0 111.535 -177.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.8 t -62.93 -43.97 97.34 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 121.478 -0.764 . . . . 0.0 110.947 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -124.03 -6.52 7.82 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.535 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.46 23.75 76.46 Favored Glycine 0 C--N 1.349 1.305 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -103.33 162.96 12.57 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.81 160.81 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.887 HD23 HG21 ' A' ' 41' ' ' ILE . 2.4 mp -68.54 131.9 46.03 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.595 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 34.7 ttp -145.85 166.5 25.76 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 31' ' ' ASP . 24.0 t -68.03 164.94 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' N ' HG12 ' A' ' 30' ' ' VAL . 35.9 t70 -53.54 -40.97 65.95 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.747 -0.596 . . . . 0.0 110.458 -177.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -164.78 55.07 0.13 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 53.79 48.38 21.53 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.1 m -86.68 130.74 34.36 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.49 -2.01 52.49 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -94.02 152.34 18.88 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.9 m -81.36 157.89 24.87 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.78 8.39 65.39 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.0 t -88.53 124.68 65.45 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 87' ' ' VAL . 44.7 Cg_exo -58.77 148.72 81.87 Favored 'Trans proline' 0 CA--C 1.497 -1.329 0 C-N-CA 122.094 1.863 . . . . 0.0 113.163 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.887 HG21 HD23 ' A' ' 28' ' ' LEU . 25.1 mm -89.41 129.63 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 24.6 m -131.56 166.48 28.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.957 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.4 mt -94.36 141.65 28.33 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.11 151.81 40.09 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -60.44 146.28 45.15 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.3 139.07 58.73 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -127.66 140.85 51.83 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 90.2 m -66.47 -34.96 79.11 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.56 154.23 17.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 61.4 44.51 9.43 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 48' ' ' THR . 5.9 m-85 -67.15 -30.36 70.33 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.82 -38.05 84.08 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.891 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -70.95 -16.98 62.69 Favored 'General case' 0 CA--C 1.5 -0.98 0 O-C-N 121.897 -0.502 . . . . 0.0 109.723 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -109.29 7.64 25.3 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.423 HD21 ' CE1' ' A' ' 18' ' ' PHE . 10.5 mt -100.46 136.8 39.78 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -125.49 147.97 49.03 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -125.94 129.47 49.33 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -90.38 114.84 27.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -80.99 159.77 67.64 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.45 -21.73 55.39 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 122.135 1.89 . . . . 0.0 112.445 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.6 p -82.78 -2.84 55.6 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.46 20.4 54.58 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -100.82 138.93 37.21 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD2' HD11 ' A' ' 19' ' ' ILE . 5.9 mp -97.42 119.39 35.88 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.955 HG22 HG12 ' A' ' 72' ' ' VAL . 59.2 t -105.85 135.0 45.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -84.86 126.07 33.15 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -61.77 -40.64 95.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 122.011 -0.43 . . . . 0.0 111.514 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -65.09 -50.16 67.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 121.977 -0.452 . . . . 0.0 112.041 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.3 p -88.48 -29.66 19.97 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.333 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.19 4.37 90.24 Favored Glycine 0 C--N 1.352 1.445 0 N-CA-C 107.219 -2.352 . . . . 0.0 107.219 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -94.69 168.18 10.99 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.955 HG12 HG22 ' A' ' 65' ' ' VAL . 24.7 m -117.83 162.47 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.9 mtt -69.04 139.36 54.91 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -155.11 173.23 16.89 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.11 143.23 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.05 86.1 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.401 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.98 -33.05 67.82 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.27 -8.16 80.29 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 105.899 -2.88 . . . . 0.0 105.899 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.0 m -124.14 127.2 25.42 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.32 120.26 6.85 Favored 'Trans proline' 0 CA--C 1.495 -1.427 0 C-N-CA 121.115 1.21 . . . . 0.0 113.25 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -136.54 162.23 33.68 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.98 129.43 37.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.38 81.76 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.427 ' CG1' HD12 ' A' ' 140' ' ' LEU . 8.6 p -72.79 143.13 14.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-N 118.539 1.169 . . . . 0.0 108.268 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.5 154.69 24.96 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-O 121.468 0.651 . . . . 0.0 109.425 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.472 HD11 ' HG ' ' A' ' 140' ' ' LEU . 47.7 mm -109.82 127.06 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.0 m -132.08 160.86 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -84.43 139.63 32.08 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -146.87 171.59 14.97 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -66.51 149.43 50.45 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -69.67 156.41 39.0 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.578 ' HB1' HG21 ' A' ' 96' ' ' VAL . . . -72.35 148.04 45.7 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.35 -160.47 35.94 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 107.375 -2.29 . . . . 0.0 107.375 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.7 m -89.99 6.95 39.97 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -102.12 16.1 27.1 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.578 HG21 ' HB1' ' A' ' 92' ' ' ALA . 67.7 t -111.88 127.06 69.28 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -61.05 149.52 36.7 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -67.27 -18.47 65.22 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -90.36 -3.53 57.67 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.9 mt -114.6 6.78 15.87 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -87.1 98.63 11.4 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -96.0 -7.74 35.57 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.728 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -77.19 -9.33 58.71 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -77.52 125.47 29.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -118.51 152.77 35.32 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.51 145.09 17.24 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 106.86 -2.496 . . . . 0.0 106.86 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.0 tp -113.27 125.66 54.55 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.487 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . 86.5 p -89.81 158.38 45.0 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 53.2 Cg_endo -70.18 -8.48 23.7 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.659 1.573 . . . . 0.0 112.509 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -89.99 -4.12 57.62 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.39 4.96 65.74 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -89.65 145.05 25.5 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.8 mt -112.59 127.07 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.678 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -130.35 176.99 7.68 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.646 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 15.4 mt -82.37 150.08 27.35 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.66 -17.52 55.82 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -104.09 -26.12 12.7 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.379 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.646 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -133.27 86.02 42.68 Favored Pre-proline 0 N--CA 1.436 -1.137 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.98 -8.27 19.42 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.781 2.321 . . . . 0.0 113.236 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.6 m -88.23 -8.71 54.85 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.665 HD23 ' HB3' ' A' ' 140' ' ' LEU . 4.0 mp -107.24 130.93 54.68 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 114' ' ' TYR . 27.0 pt -134.93 168.2 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.66 138.78 37.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.06 177.8 34.62 Favored Glycine 0 CA--C 1.495 -1.17 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.2 pt -134.02 168.64 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -117.11 120.11 37.31 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -107.27 137.66 44.91 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 131' ' ' ALA . 86.3 p -150.9 172.34 15.82 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -69.9 -27.97 65.24 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -99.57 23.45 9.46 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.437 ' HB3' ' H ' ' A' ' 128' ' ' SER . . . -123.91 91.92 3.57 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -64.73 152.37 42.7 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.44 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -68.89 -14.55 63.1 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.043 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -92.73 85.03 5.1 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 126.9 13.57 2.96 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 mt -64.33 123.02 18.09 Favored 'General case' 0 C--N 1.36 1.058 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -90.0 152.72 21.05 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 121.515 0.674 . . . . 0.0 109.311 -177.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 p -99.38 144.9 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -147.79 166.95 25.99 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.665 ' HB3' HD23 ' A' ' 121' ' ' LEU . 87.8 mt -85.99 130.24 34.6 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -128.64 144.44 51.16 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 142' ' ' LEU . 0.7 OUTLIER -68.79 141.15 55.26 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.25 -178.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.66 129.77 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.29 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -124.18 92.08 3.59 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -67.2 -20.61 65.73 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -69.7 -19.29 63.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -128.39 77.46 1.77 Allowed 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.6 mt -103.55 4.41 35.76 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.02 22.23 9.64 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -98.92 125.65 44.41 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -68.51 -21.48 64.58 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -76.43 -19.61 57.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -92.16 -3.38 55.7 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.88 133.49 44.17 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -117.46 137.77 52.3 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.37 146.94 37.43 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -119.07 138.86 52.58 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.81 145.35 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.1 mt -109.71 154.58 42.4 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -58.39 141.21 96.86 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 C-N-CA 122.061 1.841 . . . . 0.0 113.08 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.8 t -119.93 126.12 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.261 1.702 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.643 0.259 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.26 155.76 39.45 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.69 156.29 41.63 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.93 108.65 19.84 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -128.54 9.53 6.02 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -105.01 70.89 0.93 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -73.08 -24.74 60.7 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -87.51 147.93 25.14 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 t -146.35 138.55 25.07 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -101.09 170.59 8.16 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -98.38 160.06 14.53 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -90.53 158.94 42.27 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.83 146.06 87.83 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 122.076 1.851 . . . . 0.0 112.687 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.67 156.74 16.4 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.47 -160.84 33.38 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.689 ' HB3' HD22 ' A' ' 55' ' ' LEU . 49.0 m0 -81.97 141.42 33.3 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -160.74 165.29 30.67 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -119.4 138.55 53.02 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.24 119.26 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HB3' HG12 ' A' ' 27' ' ' VAL . 11.1 ptmt -121.46 147.3 45.94 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.939 0.876 . . . . 0.0 108.986 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -91.41 123.65 35.0 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -59.33 -22.41 61.23 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.8 t -63.16 -45.55 91.31 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.278 -0.889 . . . . 0.0 110.882 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -114.05 -19.34 11.43 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.416 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.99 6.73 88.06 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.416 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 13.1 m-30 -83.8 160.14 21.27 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.456 HG12 ' HB3' ' A' ' 20' ' ' LYS . 29.9 m -114.71 160.12 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -177.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.921 HD23 HG21 ' A' ' 41' ' ' ILE . 4.2 mp -67.07 132.72 48.45 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.458 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.0 ttp -145.4 163.02 35.88 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 31' ' ' ASP . 31.4 t -67.62 162.7 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.0 t70 -48.65 -42.22 33.77 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 122.072 -0.393 . . . . 0.0 111.01 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -165.43 57.03 0.12 Allowed 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 119.555 -0.858 . . . . 0.0 108.708 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 54.23 49.25 19.02 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.7 m -97.07 126.93 42.57 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -91.47 -3.32 56.72 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -88.19 142.12 28.01 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 97.1 p -75.2 162.84 28.12 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.72 6.43 72.91 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.3 m -90.47 135.71 29.12 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.465 ' HA ' HG12 ' A' ' 87' ' ' VAL . 55.8 Cg_endo -69.51 154.14 69.13 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 C-N-CA 121.509 1.473 . . . . 0.0 112.763 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.921 HG21 HD23 ' A' ' 28' ' ' LEU . 23.4 mm -90.9 131.57 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 31.4 m -130.53 165.62 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 125' ' ' ILE . 92.1 mt -96.49 140.24 31.42 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.67 146.18 32.11 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.416 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 11.4 t -62.85 157.42 21.45 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.53 138.5 58.29 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -119.2 144.69 46.58 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -75.77 -16.55 60.1 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -118.04 154.26 32.32 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 61.54 48.85 5.48 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -68.58 -30.8 69.64 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.52 85.06 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 120.719 0.295 . . . . 0.0 110.563 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.1 m -66.86 -23.96 66.08 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -103.38 6.72 37.97 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.689 HD22 ' HB3' ' A' ' 16' ' ' TRP . 20.6 mt -99.94 137.38 38.47 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.901 0.857 . . . . 0.0 108.85 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -128.68 157.49 41.19 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -139.32 154.92 47.98 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -109.01 117.72 34.92 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.71 154.39 78.41 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.11 -17.86 58.71 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 121.867 1.712 . . . . 0.0 113.401 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -74.31 -19.01 60.62 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.36 19.26 10.09 Favored Glycine 0 C--N 1.357 1.705 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -109.7 154.79 22.38 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 118.296 1.048 . . . . 0.0 108.544 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 64' ' ' LEU . 1.7 mm? -102.97 131.56 49.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.045 HG22 HG12 ' A' ' 72' ' ' VAL . 64.3 t -119.75 136.15 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -79.87 130.08 35.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.78 -40.68 98.06 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 122.062 -0.399 . . . . 0.0 111.203 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -75.09 -53.11 9.44 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.076 -176.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.4 m -69.63 -40.03 76.81 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.1 5.26 89.84 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 105.754 -2.938 . . . . 0.0 105.754 -177.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.01 166.1 11.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.045 HG12 HG22 ' A' ' 65' ' ' VAL . 19.7 m -115.11 163.11 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.4 mtt -72.3 138.7 47.56 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -153.85 169.22 23.92 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.552 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -85.94 145.27 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.52 91.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.624 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -78.42 -31.7 48.31 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.552 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.56 -10.37 74.76 Favored Glycine 0 CA--C 1.495 -1.213 0 N-CA-C 105.903 -2.879 . . . . 0.0 105.903 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -116.02 122.91 31.69 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.22 128.79 16.09 Favored 'Trans proline' 0 CA--C 1.496 -1.383 0 C-N-CA 121.017 1.145 . . . . 0.0 113.158 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.02 158.96 44.09 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -73.16 133.41 44.06 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.88 84.63 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.5 p -74.7 142.54 14.52 Favored 'Isoleucine or valine' 0 C--N 1.358 0.942 0 CA-C-N 118.687 1.244 . . . . 0.0 108.191 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.89 155.46 24.08 Favored 'General case' 0 C--N 1.358 0.976 0 CA-C-O 121.427 0.632 . . . . 0.0 109.522 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.734 HD11 HD13 ' A' ' 140' ' ' LEU . 47.6 mm -110.05 129.11 65.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.0 m -130.64 161.68 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -83.24 142.55 31.06 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.52 175.3 12.45 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.4 m -69.36 148.6 49.44 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.6 pm0 -70.84 156.48 39.51 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.06 -154.06 0.61 Allowed 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.511 ' H ' HG12 ' A' ' 96' ' ' VAL . . . 95.73 3.97 60.67 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -95.88 -51.43 4.48 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -104.86 6.82 34.12 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 93' ' ' GLY . 9.4 p -133.74 147.26 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -64.11 142.47 58.4 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.61 -21.59 64.49 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.44 -7.45 58.42 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.42 9.79 18.2 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -87.86 129.51 35.19 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -85.74 -7.35 58.83 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -74.89 -11.02 60.03 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -78.26 128.18 33.34 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.16 153.89 33.08 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.45 155.17 16.51 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 106.623 -2.591 . . . . 0.0 106.623 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.5 tp -115.54 122.31 45.3 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.444 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.1 t -83.8 141.56 41.38 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 108' ' ' SER . 33.9 Cg_exo -59.46 -19.55 52.23 Favored 'Trans proline' 0 CA--C 1.503 -1.056 0 C-N-CA 122.036 1.824 . . . . 0.0 113.063 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.05 -3.51 57.34 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.17 10.8 55.69 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -94.51 147.18 23.52 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.6 mt -113.62 125.13 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.69 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -130.02 176.43 8.07 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.722 HD12 ' HB2' ' A' ' 118' ' ' LYS . 12.5 mt -85.45 151.12 24.22 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.07 -27.35 64.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -105.04 -15.7 15.02 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.277 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.722 ' HB2' HD12 ' A' ' 115' ' ' LEU . 3.7 mptp? -133.32 84.93 45.58 Favored Pre-proline 0 CA--C 1.494 -1.197 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.99 -8.56 23.01 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.432 2.088 . . . . 0.0 112.337 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.447 ' HA ' HG12 ' A' ' 143' ' ' VAL . 88.7 p -86.42 -15.88 38.93 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.592 HD13 HD23 ' A' ' 140' ' ' LEU . 57.0 mt -105.43 130.77 53.45 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' A' ' 114' ' ' TYR . 34.1 pt -134.51 164.18 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.404 HD23 ' CD1' ' A' ' 140' ' ' LEU . 82.9 mt -82.71 139.74 33.48 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.77 177.49 39.59 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.606 HD13 HD13 ' A' ' 136' ' ' LEU . 1.8 pp -131.88 159.3 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.449 ' O ' HD22 ' A' ' 136' ' ' LEU . 88.2 tttt -103.64 145.27 30.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.67 131.56 56.69 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.2 t -150.1 155.76 40.41 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -70.17 -26.52 63.95 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.15 32.74 3.36 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -129.77 107.35 9.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.447 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 32.0 tpt180 -59.74 130.55 47.33 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -63.12 -35.99 82.13 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.447 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 34.2 mt-10 -85.78 85.57 7.39 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 105.761 -1.941 . . . . 0.0 105.761 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.2 11.56 1.19 Allowed Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.606 HD13 HD13 ' A' ' 125' ' ' ILE . 82.6 mt -62.99 129.09 38.86 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.575 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -84.57 153.73 23.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 121.701 0.762 . . . . 0.0 109.592 -177.641 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.04 137.75 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -146.62 165.86 28.27 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.734 HD13 HD11 ' A' ' 86' ' ' ILE . 1.5 mp -88.22 130.63 35.02 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -117.78 150.79 38.54 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.574 HD12 HD23 ' A' ' 121' ' ' LEU . 1.7 tp -80.02 137.95 36.92 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 120' ' ' SER . 11.3 p -61.44 135.75 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.185 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -129.97 95.29 3.91 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -64.8 -19.56 65.9 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.02 -22.87 63.06 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -132.26 83.44 2.08 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -100.21 5.45 44.7 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -95.41 20.4 9.49 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -91.65 108.31 19.82 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -66.44 -20.52 66.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -73.82 -17.29 61.09 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -100.99 0.36 38.03 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -96.17 133.83 40.0 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -119.73 143.44 47.79 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -124.95 163.76 21.59 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -126.7 145.75 50.47 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.1 t -130.66 144.22 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.3 mt -107.56 152.29 41.35 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.9 150.35 73.27 Favored 'Trans proline' 0 CA--C 1.496 -1.406 0 C-N-CA 121.773 1.648 . . . . 0.0 113.18 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.0 t 61.96 73.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 80.0 t . . . . . 0 C--O 1.261 1.696 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mmt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.943 0.401 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.27 154.26 34.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.66 154.06 35.63 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.96 144.97 37.32 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.51 10.81 18.24 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -85.63 62.2 7.32 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -74.2 -22.9 59.19 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -78.9 140.51 38.09 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -126.27 144.28 50.85 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -126.0 171.74 10.53 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -104.96 161.12 14.48 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.039 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -90.19 157.44 45.26 Favored Pre-proline 0 N--CA 1.44 -0.955 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.4 145.93 92.04 Favored 'Trans proline' 0 CA--C 1.499 -1.231 0 C-N-CA 122.064 1.843 . . . . 0.0 112.688 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -95.8 161.35 14.05 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.5 -160.35 37.76 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.642 ' HB3' HD22 ' A' ' 55' ' ' LEU . 47.7 m0 -82.13 142.48 32.21 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -160.01 163.6 33.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.404 ' CE1' HD21 ' A' ' 55' ' ' LEU . 57.6 m-85 -120.92 139.09 53.71 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.4 mt -108.86 119.81 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 34.8 pttt -126.58 149.79 49.23 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.64 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.79 130.85 34.62 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.34 -33.55 75.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.091 -0.381 . . . . 0.0 110.229 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -65.18 -37.73 88.28 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 122.125 -0.359 . . . . 0.0 111.938 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -107.56 -23.12 12.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.141 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.06 19.65 79.76 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -108.63 154.92 21.29 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 14.1 m -106.8 158.44 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 121.798 0.808 . . . . 0.0 109.553 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.954 HD23 HG21 ' A' ' 41' ' ' ILE . 3.4 mp -71.65 133.7 45.85 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.39 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.2 ptm -147.02 175.47 10.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 31' ' ' ASP . 46.5 t -76.9 155.08 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.489 ' HA ' HG22 ' A' ' 42' ' ' VAL . 40.1 p-10 -52.28 -31.68 33.89 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.651 -0.656 . . . . 0.0 111.968 -177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -162.81 45.3 0.13 Allowed 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 54.67 49.24 18.51 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.447 ' H ' HG11 ' A' ' 30' ' ' VAL . 74.1 m -84.29 120.1 25.84 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -79.52 -11.62 59.89 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -93.23 142.63 27.09 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.6 p -78.82 167.24 21.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.55 8.77 58.23 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.6 p -105.13 148.55 36.39 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 56.0 Cg_endo -70.69 155.29 63.16 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 C-N-CA 122.042 1.828 . . . . 0.0 113.612 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.954 HG21 HD23 ' A' ' 28' ' ' LEU . 24.0 mm -94.04 132.88 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 23.1 m -130.9 163.78 35.85 Favored 'Isoleucine or valine' 0 C--N 1.36 1.027 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' CD1' HG21 ' A' ' 125' ' ' ILE . 87.4 mt -96.56 146.37 24.88 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.08 151.44 33.22 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -60.78 144.73 51.89 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.26 139.62 58.11 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -127.07 149.21 50.02 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -84.13 -9.45 58.57 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -124.6 145.73 49.45 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 58.53 39.32 25.02 Favored 'General case' 0 C--N 1.361 1.088 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -86.62 -4.93 59.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.48 -36.41 83.66 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -73.34 -14.43 61.29 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -101.03 2.02 40.09 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.642 HD22 ' HB3' ' A' ' 16' ' ' TRP . 26.5 mt -96.66 137.6 35.5 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -128.74 158.74 37.77 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -140.05 156.3 46.67 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -109.97 114.74 28.52 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.94 154.14 86.81 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.3 -16.75 56.48 Favored 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 121.948 1.765 . . . . 0.0 112.983 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 67.3 m -76.48 -16.52 59.64 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.61 23.54 8.28 Favored Glycine 0 C--N 1.356 1.681 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' CE1' ' HB2' ' A' ' 61' ' ' SER . 2.4 m-85 -115.39 154.6 28.92 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.695 1.247 . . . . 0.0 108.793 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.0 mm? -97.0 131.14 44.11 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.992 HG22 HG12 ' A' ' 72' ' ' VAL . 61.4 t -124.78 137.8 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -77.61 130.04 36.37 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -61.94 -44.01 97.66 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 121.915 -0.491 . . . . 0.0 111.337 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -79.72 -50.75 10.14 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.858 -0.526 . . . . 0.0 111.681 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 t -69.76 -39.72 76.54 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.94 3.28 90.56 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 107.253 -2.339 . . . . 0.0 107.253 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -94.8 164.38 12.96 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 65' ' ' VAL . 11.5 m -115.79 160.77 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.2 mtt -72.47 138.98 47.42 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -157.03 174.0 16.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.74 143.25 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.63 -43.53 76.12 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.835 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -72.8 -32.52 65.61 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.1 -7.43 80.92 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 105.704 -2.958 . . . . 0.0 105.704 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.5 m -115.34 120.59 36.24 Favored Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.44 106.76 2.32 Favored 'Trans proline' 0 CA--C 1.496 -1.384 0 C-N-CA 121.363 1.375 . . . . 0.0 113.559 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -137.8 165.46 26.4 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.617 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -72.41 136.56 46.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.61 4.58 79.67 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.697 ' HB ' HD12 ' A' ' 140' ' ' LEU . 79.5 t -81.48 132.8 30.67 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 CA-C-N 119.314 1.557 . . . . 0.0 108.055 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.71 151.94 41.93 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 121.526 0.679 . . . . 0.0 109.317 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.404 HD11 HD21 ' A' ' 140' ' ' LEU . 48.0 mm -104.19 127.88 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 40' ' ' PRO . 33.6 m -131.33 162.17 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -89.48 137.69 32.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.23 168.04 20.72 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 m -73.6 147.57 43.71 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -71.57 156.52 39.31 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.26 157.34 42.98 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.48 -29.96 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.18 0 N-CA-C 107.876 -2.09 . . . . 0.0 107.876 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.0 m -64.19 -40.96 97.18 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.73 16.54 17.4 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.09 127.22 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -63.45 146.62 53.24 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.28 -20.64 66.51 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.63 -2.11 57.86 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.0 mt -114.05 7.47 16.78 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.64 121.32 26.2 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -97.67 -8.7 28.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -3.23 48.55 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -75.33 140.34 43.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.42 151.19 51.98 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.58 153.24 17.38 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 106.388 -2.685 . . . . 0.0 106.388 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.5 tp -129.31 122.55 29.81 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.5 p -92.8 158.92 37.11 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.11 -19.98 68.24 Favored 'Trans proline' 0 CA--C 1.501 -1.137 0 C-N-CA 122.414 2.076 . . . . 0.0 113.031 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -78.28 -10.89 59.85 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.94 7.38 58.69 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -85.23 134.96 34.12 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.3 mt -108.08 123.02 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.578 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.9 OUTLIER -129.43 179.65 5.68 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.632 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 7.9 mt -85.89 148.51 25.76 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.86 -25.29 61.89 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -98.74 -22.61 15.79 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.651 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.632 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 1.7 mptm? -134.26 85.46 38.75 Favored Pre-proline 0 CA--C 1.496 -1.1 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -64.91 -11.01 27.51 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.648 2.232 . . . . 0.0 113.286 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 89.0 p -86.84 -15.19 39.89 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.712 HD23 HD13 ' A' ' 140' ' ' LEU . 4.1 mp -98.06 131.88 44.09 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 114' ' ' TYR . 26.8 pt -134.07 164.48 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -85.48 141.73 29.71 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.41 -176.14 32.18 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.531 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.9 pp -136.85 160.29 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.023 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.469 ' O ' HD22 ' A' ' 136' ' ' LEU . 51.8 tttt -93.06 143.55 26.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -119.66 127.66 53.11 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 34.7 t -150.57 156.55 41.61 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.24 -26.9 64.06 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -102.35 35.47 2.41 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 128' ' ' SER . . . -129.93 105.9 8.3 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.467 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 16.7 tpt180 -61.6 131.13 49.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -62.44 -36.81 83.58 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.467 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 13.6 mt-10 -82.93 85.82 7.07 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.73 7.88 1.54 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 126' ' ' LYS . 69.0 mt -66.06 127.46 32.19 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.531 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -88.81 154.73 20.03 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 121.517 0.675 . . . . 0.0 109.354 -177.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 50.6 t -77.78 135.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -130.92 137.06 49.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.712 HD13 HD23 ' A' ' 121' ' ' LEU . 72.3 mt -76.0 133.17 40.48 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -133.1 155.07 49.93 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.617 HD13 ' HB2' ' A' ' 82' ' ' ALA . 1.3 mp -94.11 151.91 19.14 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.23 154.1 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-O 121.821 0.819 . . . . 0.0 109.076 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -142.58 99.0 3.4 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -66.99 -20.61 65.91 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.045 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.76 -25.86 65.83 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -138.79 86.58 2.16 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.3 mt -100.82 4.65 43.05 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -96.28 21.32 9.15 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -88.07 124.7 34.03 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -68.17 -22.88 64.82 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -72.17 -20.34 61.61 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -96.02 -0.56 50.36 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -102.0 133.59 46.57 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -119.49 138.54 53.09 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -115.47 147.61 40.42 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -113.52 137.57 51.38 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.69 144.04 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.7 mt -108.87 154.93 41.56 Favored Pre-proline 0 N--CA 1.44 -0.943 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.5 140.85 94.54 Favored 'Trans proline' 0 CA--C 1.499 -1.237 0 C-N-CA 122.032 1.821 . . . . 0.0 113.266 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.5 p -143.53 143.68 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.0 t . . . . . 0 C--O 1.262 1.76 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.976 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.926 0.393 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.87 156.8 36.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.03 148.55 31.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 60.77 60.59 1.86 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 99.1 mtp -68.22 -28.28 67.1 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -134.97 90.48 2.64 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -73.01 -24.05 60.7 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -83.03 143.21 30.76 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 t -146.69 139.01 24.89 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -97.01 171.73 8.3 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -109.5 161.94 14.85 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -91.06 156.66 43.9 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.26 156.07 65.72 Favored 'Trans proline' 0 CA--C 1.501 -1.151 0 C-N-CA 121.797 1.665 . . . . 0.0 112.906 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 pm0 -75.57 159.78 30.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.62 -165.73 42.68 Favored Glycine 0 C--N 1.352 1.423 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.469 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.3 m95 -90.09 175.85 7.0 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -168.26 165.14 13.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.465 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 53.1 m-85 -118.01 135.23 54.29 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.6 mt -99.1 114.18 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -113.73 131.96 56.0 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.5 127.47 35.24 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.37 -21.55 66.67 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.1 p -68.22 -39.04 82.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 119.478 1.035 . . . . 0.0 111.704 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -116.86 -16.98 10.55 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.236 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.83 20.72 75.82 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 107.601 -2.199 . . . . 0.0 107.601 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -102.65 163.48 12.2 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.25 160.45 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.731 HD23 HG21 ' A' ' 41' ' ' ILE . 5.5 mp -67.03 133.49 50.01 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.793 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.5 ttp -145.82 163.01 36.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 31' ' ' ASP . 38.9 t -68.08 164.33 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.574 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.2 t70 -48.58 -44.32 36.69 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 122.042 -0.411 . . . . 0.0 110.946 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -167.37 62.41 0.08 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.582 -0.847 . . . . 0.0 108.734 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 54.39 47.64 22.43 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.6 m -95.41 124.71 39.58 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -93.28 -1.69 55.79 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -88.62 148.83 23.85 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.1 m -81.78 157.56 24.45 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.83 62.63 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.4 m -92.21 141.47 25.1 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 59.1 Cg_endo -71.3 154.66 61.28 Favored 'Trans proline' 0 CA--C 1.497 -1.364 0 C-N-CA 121.643 1.562 . . . . 0.0 112.861 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.731 HG21 HD23 ' A' ' 28' ' ' LEU . 25.5 mm -91.14 131.47 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 28.8 m -131.39 165.77 30.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 125' ' ' ILE . 90.0 mt -94.77 143.8 26.16 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.83 150.24 35.8 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 m -61.59 144.97 53.54 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.77 139.53 57.89 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -115.54 145.07 42.99 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -82.21 -20.31 38.0 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -128.84 149.58 50.69 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 59.13 44.28 16.13 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -97.22 10.3 39.85 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.18 86.3 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -73.06 -13.74 61.27 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -100.35 2.01 42.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.469 HD22 ' HB2' ' A' ' 16' ' ' TRP . 25.4 mt -97.41 136.08 38.37 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -127.97 158.7 37.15 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.9 ptm180 -141.88 158.44 43.79 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -111.52 115.41 29.15 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.92 154.47 86.86 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.02 -16.75 56.36 Favored 'Trans proline' 0 CA--C 1.496 -1.413 0 C-N-CA 121.871 1.714 . . . . 0.0 112.966 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.8 m -74.28 -20.17 60.23 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.23 21.15 8.19 Favored Glycine 0 C--N 1.356 1.679 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.37 155.81 25.6 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 118.724 1.262 . . . . 0.0 109.151 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.6 mm? -95.17 132.79 39.73 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.968 HG22 HG12 ' A' ' 72' ' ' VAL . 61.6 t -125.75 137.47 57.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -78.56 130.81 36.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -63.42 -41.67 98.72 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.939 -0.476 . . . . 0.0 111.503 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -73.3 -51.18 18.47 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.794 -0.566 . . . . 0.0 112.373 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.6 p -84.32 -29.64 26.18 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.565 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.06 4.6 90.49 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -89.61 166.1 13.84 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.968 HG12 HG22 ' A' ' 65' ' ' VAL . 32.5 m -118.12 160.81 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.1 mtt -72.55 140.86 48.36 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -154.94 169.46 24.01 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.462 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -91.56 143.55 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.33 87.78 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.32 -33.82 70.02 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 89.87 -8.49 79.72 Favored Glycine 0 CA--C 1.494 -1.219 0 N-CA-C 106.3 -2.72 . . . . 0.0 106.3 -178.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.3 m -124.59 121.57 25.8 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.39 128.43 27.34 Favored 'Trans proline' 0 CA--C 1.495 -1.429 0 C-N-CA 121.394 1.396 . . . . 0.0 112.837 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.42 153.51 38.64 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.62 132.74 44.13 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.07 16.41 69.77 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.671 ' CG1' HD12 ' A' ' 140' ' ' LEU . 7.5 p -82.8 149.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -90.8 153.09 20.49 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.42 HD11 HD11 ' A' ' 140' ' ' LEU . 49.2 mm -108.64 128.73 64.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.924 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 40' ' ' PRO . 34.2 m -131.53 161.47 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -89.04 140.96 28.91 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -145.45 171.67 14.3 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 m -71.17 150.92 44.89 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -70.95 157.26 38.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.95 162.35 38.9 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.58 -26.55 0.21 Allowed Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.1 m -64.9 -40.05 94.48 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -121.97 18.51 10.91 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 97' ' ' LYS . 84.1 t -126.37 129.01 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.402 ' O ' HG12 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -66.79 159.96 26.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -77.51 -16.96 58.4 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -89.55 -11.97 41.25 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.5 mt -112.05 11.58 20.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -91.68 115.29 27.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -97.82 -6.32 32.87 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.921 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -80.01 -7.81 59.02 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.97 127.04 31.48 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -119.42 153.5 35.13 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.66 148.84 17.69 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.7 tp -112.73 122.27 47.16 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.446 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 8.8 t -86.78 139.22 33.06 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.61 -9.81 27.21 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 C-N-CA 121.897 1.731 . . . . 0.0 113.006 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.51 -0.81 57.61 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.09 38.83 5.31 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -129.71 148.76 51.63 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.0 mt -118.71 126.17 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.604 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -130.88 176.6 8.09 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.638 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 12.1 mt -86.98 150.22 24.22 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.6 -25.21 61.24 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -103.33 -20.49 14.07 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.889 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.638 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 13.7 mptt -131.79 84.27 54.93 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.66 -9.23 24.78 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.542 2.162 . . . . 0.0 113.087 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 86.3 p -87.31 -16.95 33.6 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.657 HD12 ' HB3' ' A' ' 140' ' ' LEU . 4.6 mm? -97.14 130.72 44.36 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.604 HG22 ' HB3' ' A' ' 114' ' ' TYR . 25.0 pt -134.62 163.39 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.502 HD23 ' CD2' ' A' ' 140' ' ' LEU . 85.0 mt -80.4 143.1 33.74 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.66 -173.73 36.02 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -138.47 161.04 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.464 ' O ' HD22 ' A' ' 136' ' ' LEU . 39.7 ttmt -104.49 137.7 41.96 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -107.24 131.08 54.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.8 t -149.56 155.33 40.14 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -69.99 -24.87 63.38 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -101.02 25.95 7.52 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.03 100.48 5.45 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.619 ' HG2' ' H ' ' A' ' 134' ' ' GLU . 71.7 ttt180 -61.08 139.09 58.16 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -62.83 -21.77 66.17 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.619 ' H ' ' HG2' ' A' ' 132' ' ' ARG . 15.2 mt-10 -94.01 86.53 5.05 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 131.72 11.84 2.06 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 126' ' ' LYS . 78.7 mt -63.89 126.57 28.08 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -85.56 153.51 22.37 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.639 0.733 . . . . 0.0 109.7 -177.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.0 t -76.7 134.52 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.75 136.52 40.84 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -177.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.671 HD12 ' CG1' ' A' ' 84' ' ' VAL . 85.4 mt -83.55 132.31 34.93 Favored 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.757 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -125.22 152.87 43.99 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.451 HD12 HD13 ' A' ' 121' ' ' LEU . 1.4 mp -83.23 150.75 26.0 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.22 151.51 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 121.805 0.812 . . . . 0.0 109.474 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -140.59 94.61 2.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -70.48 -20.91 62.82 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -71.18 -19.71 62.37 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -142.49 85.36 1.9 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.8 mt -98.26 5.37 48.43 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -89.65 17.43 6.49 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -85.62 108.89 18.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -65.6 -20.23 66.23 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.784 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -74.1 -19.06 60.72 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -96.94 -1.49 45.61 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -98.24 133.4 42.72 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -119.83 139.46 52.33 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -117.48 160.25 21.52 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.81 142.86 51.18 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.25 143.3 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.0 mt -106.61 150.99 40.28 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.69 150.37 68.53 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 121.849 1.699 . . . . 0.0 112.934 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.4 t -118.26 125.56 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 C--O 1.261 1.668 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.705 0.288 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.42 154.04 34.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.26 156.44 39.68 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.57 142.87 29.54 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -135.3 7.71 3.37 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -102.79 69.02 1.04 Allowed 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -73.82 -23.87 59.71 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -88.76 148.45 23.94 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 t -146.43 138.9 25.18 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -116.4 170.37 8.6 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -91.14 161.13 15.22 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 121.971 0.891 . . . . 0.0 108.768 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -84.17 159.86 58.62 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -55.32 140.65 82.03 Favored 'Trans proline' 0 CA--C 1.5 -1.178 0 C-N-CA 121.826 1.684 . . . . 0.0 112.589 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -83.82 155.54 22.92 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.756 0.789 . . . . 0.0 109.092 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.19 -164.73 37.03 Favored Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.618 ' HB3' HD22 ' A' ' 55' ' ' LEU . 47.4 m0 -80.57 145.99 31.48 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.24 161.99 40.2 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 31.5 m-85 -117.65 135.83 53.73 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.456 HD11 ' CD2' ' A' ' 64' ' ' LEU . 82.4 mt -100.82 106.03 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -104.71 129.59 52.88 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.449 0.642 . . . . 0.0 109.381 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.01 119.95 24.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -62.08 -32.5 73.06 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.9 t -65.16 -43.02 93.12 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 121.594 -0.691 . . . . 0.0 111.101 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -100.02 -21.84 15.47 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.298 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.12 19.56 78.41 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 10.7 m-30 -109.8 162.27 14.63 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 28' ' ' LEU . 1.4 p -116.02 154.29 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.842 HD23 HG21 ' A' ' 41' ' ' ILE . 1.9 mp -61.6 133.71 55.97 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.998 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -144.77 166.35 25.48 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.661 HG11 ' H ' ' A' ' 34' ' ' SER . 2.6 p -70.79 179.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.633 ' H ' HG22 ' A' ' 30' ' ' VAL . 36.0 t70 -55.13 -47.91 74.41 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.289 -0.882 . . . . 0.0 111.479 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.411 ' H ' HG13 ' A' ' 30' ' ' VAL . 65.2 t30 -173.85 74.77 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.588 -0.845 . . . . 0.0 108.829 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 52.43 44.73 29.61 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.661 ' H ' HG11 ' A' ' 30' ' ' VAL . 57.2 m -103.08 118.84 37.7 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -93.64 -1.5 55.24 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -80.04 142.04 35.32 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t -75.56 149.07 38.42 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.48 5.83 60.09 Favored Glycine 0 C--N 1.355 1.614 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.3 m -83.97 138.22 40.18 Favored Pre-proline 0 N--CA 1.438 -1.032 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HA ' HG12 ' A' ' 87' ' ' VAL . 56.8 Cg_endo -70.31 155.25 64.53 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.597 1.531 . . . . 0.0 112.338 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.842 HG21 HD23 ' A' ' 28' ' ' LEU . 23.0 mm -94.36 131.63 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 20.6 m -133.93 169.03 22.54 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 125' ' ' ILE . 89.7 mt -95.7 143.15 27.21 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.66 151.59 37.49 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.405 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 9.1 t -65.34 153.5 41.01 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 139.42 57.62 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.109 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -106.78 138.58 42.68 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.3 m -66.04 -34.82 78.95 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -137.07 160.61 38.44 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 60.31 41.86 15.79 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -100.0 15.78 26.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.46 77.74 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.7 p -72.01 -13.12 61.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -101.65 2.94 39.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 16' ' ' TRP . 62.4 mt -98.61 133.53 42.82 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -126.84 152.73 46.59 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -134.93 150.05 50.34 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -99.13 115.14 28.36 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -83.08 154.96 67.44 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.52 -18.95 49.69 Favored 'Trans proline' 0 CA--C 1.496 -1.401 0 C-N-CA 122.386 2.057 . . . . 0.0 113.598 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.1 m -73.56 -16.25 61.27 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.23 15.4 21.66 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.07 158.07 21.72 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 118.427 1.113 . . . . 0.0 108.851 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.462 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.2 mp -105.0 124.34 49.36 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.6 t -113.95 138.4 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -75.34 132.06 40.69 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -62.59 -43.36 99.0 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.063 -0.398 . . . . 0.0 111.357 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -78.06 -52.35 8.89 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 121.81 -0.556 . . . . 0.0 111.421 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.6 m -68.4 -39.76 81.55 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.42 4.58 90.39 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 105.783 -2.927 . . . . 0.0 105.783 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.6 163.63 12.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 64' ' ' LEU . 2.2 p -115.28 154.56 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.404 ' N ' HG22 ' A' ' 72' ' ' VAL . 65.1 mtt -66.66 137.32 56.62 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -153.03 172.1 17.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.414 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -87.98 142.8 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.25 79.74 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.325 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -72.21 -33.27 67.47 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.41 -8.54 79.65 Favored Glycine 0 CA--C 1.495 -1.176 0 N-CA-C 105.924 -2.87 . . . . 0.0 105.924 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.5 m -119.7 124.01 28.23 Favored Pre-proline 0 N--CA 1.437 -1.089 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.4 116.53 4.73 Favored 'Trans proline' 0 CA--C 1.497 -1.375 0 C-N-CA 121.04 1.16 . . . . 0.0 112.901 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -136.27 161.82 34.72 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.68 131.2 40.68 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.69 7.85 83.68 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.489 ' CG1' HD12 ' A' ' 140' ' ' LEU . 9.4 p -72.75 143.38 14.0 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-N 118.652 1.226 . . . . 0.0 108.35 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -80.49 154.6 27.47 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 121.482 0.658 . . . . 0.0 109.267 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.492 HD11 ' HG ' ' A' ' 140' ' ' LEU . 47.7 mm -111.43 127.85 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.9 m -131.47 161.4 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -84.91 139.33 31.93 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -141.8 168.48 19.65 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.4 m -62.68 150.54 40.75 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.3 150.54 46.25 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.34 156.31 35.65 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.8 -166.82 42.62 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.5 p -88.01 7.46 31.11 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -93.79 7.38 45.11 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.52 123.52 71.26 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -67.25 144.0 56.17 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.38 -22.5 66.8 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.07 -3.87 57.7 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -117.81 10.25 13.2 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -99.64 139.11 35.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -91.78 -7.91 48.26 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -81.22 -7.84 59.64 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.34 129.77 35.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -123.97 154.48 39.74 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -116.29 153.7 17.29 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 106.858 -2.497 . . . . 0.0 106.858 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 tt -131.34 125.99 34.13 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 81.4 p -91.98 159.75 37.21 Favored Pre-proline 0 CA--C 1.506 -0.744 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.3 -19.82 59.68 Favored 'Trans proline' 0 CA--C 1.501 -1.171 0 C-N-CA 122.246 1.964 . . . . 0.0 112.986 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.63 -12.92 60.08 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 7.6 58.16 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -83.6 139.44 32.84 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.7 mt -109.4 124.72 66.32 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.711 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.4 p90 -135.59 175.85 9.21 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.633 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 7.5 mt -84.68 147.68 26.8 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.83 -23.14 60.73 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -102.77 -19.65 14.64 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.556 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.633 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 1.3 mptm? -134.46 83.51 43.03 Favored Pre-proline 0 CA--C 1.496 -1.102 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.99 -9.32 24.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.491 2.127 . . . . 0.0 113.246 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 88.1 p -86.06 -14.66 43.7 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.574 HD23 ' HB3' ' A' ' 140' ' ' LEU . 6.4 mp -102.22 131.18 48.93 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 114' ' ' TYR . 28.6 pt -134.58 167.46 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.44 137.7 35.62 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.13 176.63 34.3 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.9 pp -131.94 160.34 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -122.44 147.09 46.74 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -68.96 156.25 38.89 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.6 t -103.87 164.48 11.66 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -64.72 -37.14 86.59 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -97.79 7.17 46.85 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 51.05 47.81 24.2 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.985 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -83.44 110.24 18.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -74.02 -21.31 60.01 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -91.46 90.46 7.66 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 129.95 7.76 3.61 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.3 127.85 33.42 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -90.61 154.66 19.42 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.518 0.675 . . . . 0.0 109.543 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.21 145.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -147.84 165.93 29.12 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.574 ' HB3' HD23 ' A' ' 121' ' ' LEU . 89.7 mt -83.26 129.28 34.99 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -129.67 141.92 50.82 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.02 150.81 42.09 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.446 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.14 137.87 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 CA-C-O 121.917 0.865 . . . . 0.0 110.051 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -115.29 78.35 1.16 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -64.19 -18.45 64.5 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.06 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -68.06 -26.14 65.7 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -139.36 86.32 2.11 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.08 4.11 44.43 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -95.62 12.95 27.88 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -88.06 138.54 31.36 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -69.71 -22.82 63.37 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.19 -28.38 65.25 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -90.76 1.05 57.22 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -113.75 137.53 51.51 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.811 0.815 . . . . 0.0 109.17 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -119.64 143.39 47.72 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -118.01 143.22 46.58 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -112.41 135.54 52.98 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.0 145.49 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.76 152.24 42.79 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.52 151.13 70.42 Favored 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 121.728 1.619 . . . . 0.0 113.089 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.6 t 63.25 73.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.263 1.801 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.196 0.522 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.98 95.25 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.63 154.38 35.23 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 7' ' ' GLU . . . -99.58 131.19 45.74 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -20.24 30.74 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -106.46 33.88 3.66 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 24.9 pt-20 -72.11 -21.94 61.41 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -146.6 163.66 35.12 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.8 p -130.22 158.34 39.99 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -122.82 153.23 39.85 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.24 161.69 17.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -73.0 147.75 88.63 Favored Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.81 -30.9 32.98 Favored 'Trans proline' 0 CA--C 1.501 -1.171 0 C-N-CA 121.939 1.759 . . . . 0.0 114.205 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -142.82 159.45 42.21 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.67 -42.74 97.13 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -94.58 134.35 37.23 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -163.3 161.15 24.53 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -117.73 134.66 54.68 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 80.3 mt -98.21 115.25 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -113.0 131.11 55.89 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -84.98 121.4 27.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -61.81 -28.88 69.78 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.1 t -63.83 -43.68 95.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 121.443 -0.785 . . . . 0.0 110.87 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -104.55 -21.1 13.48 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.226 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.39 20.26 77.21 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -107.96 165.25 11.6 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.85 161.25 15.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.884 HD23 HG21 ' A' ' 41' ' ' ILE . 2.5 mp -70.29 134.24 47.77 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.605 0.717 . . . . 0.0 109.895 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 34.9 ttp -146.37 165.01 30.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 31' ' ' ASP . 32.4 t -70.4 164.84 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.569 ' N ' HG12 ' A' ' 30' ' ' VAL . 19.4 t70 -49.81 -43.03 48.37 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 122.016 -0.427 . . . . 0.0 110.599 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -164.51 57.04 0.14 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 54.57 47.93 21.55 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.7 m -87.88 127.45 35.35 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -93.32 -1.7 55.7 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -91.85 148.54 22.15 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.6 m -82.06 157.27 24.2 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.13 -3.83 64.64 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.4 m -82.92 143.71 46.62 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.58 155.41 54.73 Favored 'Trans proline' 0 CA--C 1.496 -1.42 0 C-N-CA 121.671 1.58 . . . . 0.0 112.793 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.884 HG21 HD23 ' A' ' 28' ' ' LEU . 26.8 mm -92.88 131.19 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 25.7 m -130.91 164.35 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.2 mt -93.03 143.18 26.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.99 151.33 38.42 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -66.86 155.04 39.4 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.2 139.47 58.11 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.8 147.65 51.59 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.5 m -83.97 -10.47 57.89 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -123.46 146.06 48.33 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 58.38 42.16 21.84 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -91.03 -1.85 57.74 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.04 89.64 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.9 p -75.04 -12.6 60.36 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -101.12 0.85 38.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 55' ' ' LEU . 9.1 mt -95.96 136.11 36.83 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -127.63 156.49 42.23 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -149.59 165.7 31.48 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -119.76 134.61 55.17 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 119.129 -1.028 . . . . 0.0 108.283 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 98.3 m-20 -75.24 162.05 74.57 Favored Pre-proline 0 N--CA 1.44 -0.966 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 59' ' ' ASP . 18.9 Cg_endo -58.54 -18.8 41.5 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.491 1.461 . . . . 0.0 113.198 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.6 m -84.12 -8.84 58.98 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.6 31.23 10.51 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -104.43 134.71 47.18 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.73 130.16 36.41 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.953 HG22 HG12 ' A' ' 72' ' ' VAL . 61.1 t -128.38 137.37 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -79.98 131.54 35.83 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.89 -43.05 99.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 122.06 -0.4 . . . . 0.0 111.348 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.42 -51.8 9.51 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 121.755 -0.591 . . . . 0.0 111.423 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -68.23 -39.49 82.31 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.49 4.89 90.3 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 106.094 -2.802 . . . . 0.0 106.094 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -96.28 167.23 11.31 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.953 HG12 HG22 ' A' ' 65' ' ' VAL . 20.1 m -117.22 161.35 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.5 mtt -72.76 139.94 47.44 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -154.12 169.43 23.58 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.45 142.41 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.48 -41.29 84.82 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -70.62 -34.07 71.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.83 -5.78 84.41 Favored Glycine 0 CA--C 1.495 -1.178 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.5 m -123.12 117.18 28.39 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.35 118.63 5.53 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 121.343 1.362 . . . . 0.0 112.831 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.25 161.46 42.4 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -75.01 133.22 41.7 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.13 8.29 64.84 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.3 t -81.69 131.84 32.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 CA-C-N 118.793 1.297 . . . . 0.0 108.151 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -72.43 149.13 44.51 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.862 HD11 HD13 ' A' ' 140' ' ' LEU . 48.8 mm -103.82 128.25 57.26 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.6 163.76 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -91.44 141.13 29.08 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -147.03 178.65 8.2 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.6 t -72.14 169.13 16.74 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -82.13 148.69 28.38 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.81 -143.15 0.24 Allowed 'General case' 0 C--N 1.357 0.932 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.49 -175.19 37.85 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.7 m -63.37 -40.15 96.46 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -155.38 69.75 0.71 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.0 t -119.34 124.92 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -67.34 145.99 54.53 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -68.82 -19.26 64.27 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -90.23 -6.38 55.29 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.6 mt -116.99 10.82 14.11 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -83.35 131.46 35.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -92.52 -5.46 51.71 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -72.75 -9.63 58.86 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -75.6 126.72 31.56 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.99 148.51 42.91 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.26 164.26 24.55 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 105.868 -2.893 . . . . 0.0 105.868 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -146.32 137.15 24.25 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 118.929 -1.108 . . . . 0.0 108.481 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.0 p -84.75 162.63 49.59 Favored Pre-proline 0 N--CA 1.442 -0.833 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.41 -16.93 37.83 Favored 'Trans proline' 0 CA--C 1.502 -1.102 0 C-N-CA 122.511 2.141 . . . . 0.0 113.295 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -72.93 -16.18 61.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.42 21.37 19.88 Favored Glycine 0 C--N 1.355 1.604 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -100.41 130.8 46.55 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.2 mt -101.93 127.28 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.503 ' HB3' HG22 ' A' ' 122' ' ' ILE . 4.9 p90 -140.06 171.88 13.56 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' A' ' 118' ' ' LYS . 4.2 mt -83.54 145.88 28.65 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.66 84.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.607 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -96.04 -14.28 23.07 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.296 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -134.56 83.09 43.66 Favored Pre-proline 0 CA--C 1.496 -1.131 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.88 -9.62 26.19 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.385 2.057 . . . . 0.0 112.952 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 85.0 p -88.88 -15.76 33.63 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.661 HD12 ' HG ' ' A' ' 140' ' ' LEU . 4.6 mm? -98.81 130.25 45.24 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.503 HG22 ' HB3' ' A' ' 114' ' ' TYR . 39.7 pt -141.44 164.26 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.631 HD22 ' H ' ' A' ' 123' ' ' LEU . 1.3 mm? -79.12 146.09 33.38 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.5 -169.49 24.87 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 106.258 -2.737 . . . . 0.0 106.258 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.8 pt -140.03 173.47 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -119.07 111.06 17.81 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.64 137.56 36.35 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.474 ' H ' ' HB2' ' A' ' 131' ' ' ALA . 10.8 t -150.0 174.31 12.86 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -71.47 -30.79 66.41 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.96 33.76 3.64 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.779 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -90.09 78.82 6.59 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.501 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 31.8 tpt180 -63.7 131.93 49.45 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.89 -35.73 77.41 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 30.6 mt-10 -84.55 84.48 7.65 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.4 3.29 2.76 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.779 HD21 ' HB1' ' A' ' 131' ' ' ALA . 8.6 mt -67.52 118.59 11.04 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 118.937 1.368 . . . . 0.0 107.415 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -85.06 156.0 21.28 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.521 HG13 ' HB ' ' A' ' 86' ' ' ILE . 0.4 OUTLIER -86.31 136.89 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.16 141.63 49.69 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.862 HD13 HD11 ' A' ' 86' ' ' ILE . 5.1 tp -80.77 114.69 19.83 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -115.35 151.74 34.08 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.563 HD12 HD13 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -88.67 151.13 22.64 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.6 m -66.43 150.09 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.019 0.914 . . . . 0.0 109.22 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -148.0 102.26 3.37 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -66.6 -20.48 66.01 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.277 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -80.36 -11.11 59.74 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.2 m170 -126.11 53.42 1.62 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.8 mt -91.06 4.06 53.11 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -92.96 12.2 24.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -90.12 125.27 35.38 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -69.32 -21.84 63.82 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -69.2 -20.0 63.97 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -92.68 -3.34 55.04 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -93.3 132.52 37.43 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -125.37 140.41 52.83 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -122.36 153.76 38.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -119.08 139.03 52.43 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 t -124.75 144.38 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.7 mt -109.43 155.24 41.55 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.28 139.98 91.62 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 122.035 1.823 . . . . 0.0 113.143 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 162' ' ' VAL . 11.8 p -146.5 145.57 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.508 HG23 HG22 ' A' ' 161' ' ' VAL . 50.7 t . . . . . 0 C--O 1.261 1.685 0 CA-C-O 117.634 -1.174 . . . . 0.0 108.416 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttm . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.887 0.375 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.08 154.91 34.47 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.64 151.25 34.65 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.22 89.48 4.78 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 75.6 mtm -89.58 -14.48 34.95 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.25 76.87 1.07 Allowed 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -73.17 -24.03 60.51 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.1 151.98 22.75 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.2 t -146.02 139.16 25.9 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -95.21 170.19 9.57 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.07 161.47 14.72 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -89.72 154.71 48.14 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.4 158.99 54.45 Favored 'Trans proline' 0 CA--C 1.5 -1.213 0 C-N-CA 122.012 1.808 . . . . 0.0 112.902 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -77.14 157.86 30.74 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 121.721 0.772 . . . . 0.0 109.08 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.0 -168.15 38.8 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 107.104 -2.399 . . . . 0.0 107.104 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.497 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.5 m95 -89.76 178.54 6.22 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -164.09 162.77 23.15 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.579 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 51.6 m-85 -118.66 134.7 54.92 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.0 mt -102.61 112.23 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -110.71 131.2 55.25 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.84 125.12 33.05 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -65.05 -21.38 66.82 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.5 t -63.33 -44.11 95.83 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.432 -0.793 . . . . 0.0 111.204 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -121.34 -6.61 9.32 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.789 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.72 25.01 75.07 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -106.0 164.55 11.88 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.38 160.87 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.0 HD23 HG21 ' A' ' 41' ' ' ILE . 2.5 mp -67.47 132.0 46.76 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.8 ttp -146.33 165.72 28.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 31' ' ' ASP . 75.0 t -69.81 158.26 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' N ' HG12 ' A' ' 30' ' ' VAL . 42.5 t0 -53.38 -40.65 65.18 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.765 -0.584 . . . . 0.0 110.668 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -156.26 27.06 0.35 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.307 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 61.44 45.48 8.42 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 m -85.99 117.46 24.85 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -88.05 -2.47 58.63 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -82.09 -7.13 59.6 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t 70.9 -176.05 0.19 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.97 25.48 69.11 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.1 m -124.69 146.66 53.49 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HA ' HG12 ' A' ' 87' ' ' VAL . 71.8 Cg_endo -74.81 158.41 42.92 Favored 'Trans proline' 0 CA--C 1.496 -1.397 0 C-N-CA 121.959 1.773 . . . . 0.0 113.024 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.0 HG21 HD23 ' A' ' 28' ' ' LEU . 26.6 mm -86.09 131.31 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 20.0 m -130.64 166.72 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.95 142.33 27.6 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.19 34.85 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -60.7 145.08 50.65 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 139.5 57.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.478 0.656 . . . . 0.0 109.301 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -105.42 140.68 38.16 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -66.54 -34.58 78.23 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -135.27 159.93 39.99 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 60.59 41.74 15.0 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -99.5 16.74 22.28 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.66 84.51 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.2 m -70.6 -16.65 62.86 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -97.81 2.22 49.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.579 HD21 ' CZ ' ' A' ' 18' ' ' PHE . 25.3 mt -99.49 135.8 40.36 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -127.95 154.99 44.95 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -139.34 154.46 47.88 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -108.56 135.53 49.66 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -84.05 163.45 48.26 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.28 -23.34 45.41 Favored 'Trans proline' 0 CA--C 1.501 -1.146 0 C-N-CA 121.729 1.619 . . . . 0.0 112.46 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 p -84.29 -3.26 58.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.89 23.03 51.23 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -96.68 133.33 41.35 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.36 127.81 35.85 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.977 HG22 HG12 ' A' ' 72' ' ' VAL . 60.4 t -119.59 138.18 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -73.24 132.31 43.01 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -61.93 -40.94 97.21 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 122.102 -0.374 . . . . 0.0 111.294 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -84.89 -51.92 6.38 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.393 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.9 m -67.95 -39.05 83.49 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.916 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.46 5.21 89.74 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 106.401 -2.68 . . . . 0.0 106.401 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -92.93 161.29 14.53 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.977 HG12 HG22 ' A' ' 65' ' ' VAL . 22.0 m -115.58 161.18 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.5 mtt -73.31 140.48 46.78 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -157.26 168.02 28.63 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.0 143.0 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.05 -42.05 81.12 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.444 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.14 -33.4 70.04 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.13 -6.25 83.71 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 105.913 -2.875 . . . . 0.0 105.913 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.0 m -124.53 128.7 24.89 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.74 112.7 3.32 Favored 'Trans proline' 0 CA--C 1.498 -1.325 0 C-N-CA 121.19 1.26 . . . . 0.0 113.038 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -129.42 157.53 41.72 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.34 130.64 40.6 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.77 8.25 82.99 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG1' HD12 ' A' ' 140' ' ' LEU . 12.1 p -69.61 144.52 13.88 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-N 118.583 1.192 . . . . 0.0 108.199 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -85.62 155.85 20.96 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.406 HD11 ' HG ' ' A' ' 140' ' ' LEU . 48.9 mm -108.94 129.39 63.66 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 40' ' ' PRO . 35.3 m -129.74 170.05 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.34 141.49 28.5 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -142.85 169.08 18.24 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.2 m -73.25 149.15 43.0 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -67.78 153.19 44.25 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -131.86 -154.9 0.65 Allowed 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.57 -14.86 53.7 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.5 p -70.55 -37.59 74.04 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -130.72 17.81 5.21 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.9 t -126.85 130.75 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -61.39 139.08 58.26 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.49 -18.59 65.11 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -90.29 -4.75 56.95 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.8 mt -120.41 10.8 11.29 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -94.55 128.32 41.08 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -83.5 -7.25 59.57 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.316 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -75.84 -6.99 53.37 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -82.18 126.1 31.68 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -117.51 151.83 36.31 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.89 153.89 16.91 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.8 tp -114.6 120.66 40.95 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.416 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 10.5 t -80.87 137.21 50.39 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.58 -9.59 26.54 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.91 1.74 . . . . 0.0 112.782 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.66 -4.0 57.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.41 43.42 3.2 Favored Glycine 0 C--N 1.355 1.613 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -134.21 154.16 51.42 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -117.33 127.21 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.679 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -133.14 172.66 12.36 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.66 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 16.2 mt -84.19 150.34 25.55 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.94 -19.95 56.75 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -101.12 -28.75 12.52 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.66 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 14.1 mptt -131.86 85.17 51.89 Favored Pre-proline 0 CA--C 1.496 -1.109 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.32 -6.08 15.46 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.462 2.108 . . . . 0.0 112.458 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.9 m -86.84 -12.51 47.68 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.552 HD23 HD12 ' A' ' 142' ' ' LEU . 50.3 mt -106.44 130.68 54.2 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.679 HG22 ' HB3' ' A' ' 114' ' ' TYR . 29.0 pt -134.3 164.72 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.11 139.73 37.99 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.32 174.84 39.62 Favored Glycine 0 CA--C 1.494 -1.252 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.805 HD13 HD13 ' A' ' 136' ' ' LEU . 1.2 pp -134.39 159.36 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -96.35 116.86 29.71 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.95 125.76 29.82 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -150.68 146.83 26.72 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -92.34 -6.02 51.04 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -110.63 11.25 22.84 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -106.57 -6.45 18.03 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 70.85 129.89 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.849 0.833 . . . . 0.0 109.255 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -64.02 -36.89 85.46 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -87.9 85.46 7.01 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.32 3.7 0.85 Allowed Glycine 0 N--CA 1.435 -1.407 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.805 HD13 HD13 ' A' ' 125' ' ' ILE . 81.0 mt -62.94 122.56 16.32 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.553 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -86.09 153.53 22.03 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.726 0.774 . . . . 0.0 109.947 -177.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.79 140.51 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -146.51 167.47 23.59 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.452 HD12 ' CG1' ' A' ' 84' ' ' VAL . 89.2 mt -91.55 120.93 32.78 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -108.32 140.68 41.22 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.552 HD12 HD23 ' A' ' 121' ' ' LEU . 3.1 tp -70.06 135.11 48.94 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.31 143.45 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.247 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -147.61 104.23 3.6 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -67.14 -19.18 65.57 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.092 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -67.41 -24.68 65.68 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -131.69 79.72 1.89 Allowed 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.6 mt -104.51 4.3 32.9 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -96.06 13.95 25.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -83.36 126.01 32.27 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -69.4 -24.77 63.9 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -73.12 -21.09 60.8 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -103.52 2.63 33.81 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.3 tpt85 -95.38 131.71 41.21 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -120.4 137.01 54.54 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -113.49 144.27 43.12 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -115.23 136.06 53.51 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.4 t -128.93 143.52 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt -108.8 151.22 41.67 Favored Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.75 148.48 65.25 Favored 'Trans proline' 0 CA--C 1.497 -1.344 0 C-N-CA 121.738 1.626 . . . . 0.0 113.057 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.54 158.06 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 C--O 1.262 1.723 0 CA-C-O 117.685 -1.15 . . . . 0.0 108.581 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.849 0.357 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.12 155.9 36.24 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.81 153.65 39.46 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.87 128.11 45.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.0 ptp -131.51 8.02 4.56 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.5 88.06 2.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -73.98 -23.35 59.46 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -81.67 138.56 35.27 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m -134.56 145.04 48.33 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -127.87 170.42 12.83 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -102.28 156.35 17.63 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-O 122.033 0.92 . . . . 0.0 108.747 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -90.33 157.77 44.43 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.49 156.29 66.74 Favored 'Trans proline' 0 CA--C 1.498 -1.306 0 C-N-CA 121.491 1.461 . . . . 0.0 111.953 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -113.47 164.89 13.04 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.19 -161.08 34.03 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.567 ' HB3' HD22 ' A' ' 55' ' ' LEU . 49.3 m0 -80.75 138.2 36.29 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -159.98 164.59 33.19 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -121.28 139.99 52.67 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 88.4 mt -108.78 120.32 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.281 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HB3' HG12 ' A' ' 27' ' ' VAL . 11.6 ptmt -122.44 147.38 46.39 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-O 121.997 0.903 . . . . 0.0 109.09 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -93.21 121.89 35.04 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.93 -25.95 63.92 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -63.64 -42.88 98.1 Favored 'General case' 0 CA--C 1.504 -0.795 0 O-C-N 121.222 -0.924 . . . . 0.0 110.628 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -106.82 -23.04 12.51 Favored 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.155 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.65 17.41 78.93 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -103.02 164.04 11.85 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 20' ' ' LYS . 22.5 m -114.45 159.35 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-O 121.557 0.694 . . . . 0.0 109.221 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.935 HD23 HG21 ' A' ' 41' ' ' ILE . 3.6 mp -67.73 132.55 47.66 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.915 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.8 ttp -146.1 166.91 24.73 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 31' ' ' ASP . 40.7 t -69.94 162.22 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.534 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.0 t70 -54.25 -40.51 67.81 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.85 -0.531 . . . . 0.0 110.578 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -161.92 45.36 0.16 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 55.73 47.54 20.26 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.5 m -87.8 98.94 11.75 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -75.9 -11.33 59.95 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -80.27 -6.66 58.27 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t 70.1 -169.38 0.17 Allowed 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.61 25.06 75.06 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -131.42 148.98 72.26 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.45 ' HA ' HG12 ' A' ' 87' ' ' VAL . 71.8 Cg_endo -74.61 161.58 39.42 Favored 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 122.252 1.968 . . . . 0.0 112.977 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.935 HG21 HD23 ' A' ' 28' ' ' LEU . 29.9 mm -88.6 131.03 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 23.2 m -130.09 167.2 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.981 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.26 143.57 26.55 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.19 149.33 34.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -60.86 144.23 53.21 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.4 139.26 57.23 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -117.94 147.21 43.37 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.6 m -83.67 -19.49 35.23 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -126.49 149.39 49.37 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 58.69 42.89 19.61 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -93.37 5.18 52.46 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.56 87.74 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.4 p -73.09 -12.32 60.86 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -102.45 2.55 36.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 16' ' ' TRP . 28.5 mt -98.31 138.54 35.42 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -127.23 151.23 48.98 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -128.54 131.72 48.25 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -92.94 113.26 25.49 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -76.55 154.75 83.74 Favored Pre-proline 0 N--CA 1.439 -0.986 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.28 -17.82 61.91 Favored 'Trans proline' 0 CA--C 1.497 -1.351 0 C-N-CA 121.872 1.714 . . . . 0.0 112.858 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -73.87 -18.94 60.86 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.54 14.64 17.38 Favored Glycine 0 C--N 1.358 1.768 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.484 ' CD2' ' HB2' ' A' ' 103' ' ' GLN . 1.9 m-85 -107.34 160.3 15.73 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 118.22 1.01 . . . . 0.0 108.732 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.9 mt -110.05 128.83 55.65 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.903 HG22 HG12 ' A' ' 72' ' ' VAL . 86.1 t -115.67 136.5 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -80.84 128.87 34.15 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.59 -42.34 99.5 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 121.947 -0.471 . . . . 0.0 111.352 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -65.71 -50.43 64.9 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.3 p -89.14 -29.57 19.25 Favored 'General case' 0 CA--C 1.498 -1.037 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.554 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.68 5.49 89.82 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -96.57 165.9 11.93 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.903 HG12 HG22 ' A' ' 65' ' ' VAL . 31.7 m -113.09 156.82 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 23.4 ptp -86.58 140.85 29.48 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -162.42 -177.86 5.92 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.8 142.34 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.981 0 CA-C-O 121.669 0.747 . . . . 0.0 109.005 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.472 ' HB2' HG13 ' A' ' 87' ' ' VAL . . . -70.58 -41.49 72.32 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.631 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -71.13 -32.9 69.56 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.92 -5.22 85.18 Favored Glycine 0 CA--C 1.494 -1.242 0 N-CA-C 105.802 -2.919 . . . . 0.0 105.802 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -123.66 127.42 25.5 Favored Pre-proline 0 N--CA 1.435 -1.207 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.05 117.42 5.15 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 C-N-CA 121.236 1.291 . . . . 0.0 113.135 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -135.93 162.27 33.31 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.68 128.92 35.58 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.95 11.51 81.27 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.85 143.54 14.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 CA-C-N 118.391 1.095 . . . . 0.0 108.414 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -82.0 157.42 24.22 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 121.494 0.664 . . . . 0.0 109.621 -178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.428 HD11 ' HG ' ' A' ' 140' ' ' LEU . 48.6 mm -112.82 127.77 69.88 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' A' ' 76' ' ' ALA . 33.3 m -132.0 170.42 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -99.69 143.49 29.87 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -146.08 -178.01 5.91 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 t -71.17 168.15 17.84 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.943 0.878 . . . . 0.0 108.877 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -84.35 134.97 34.48 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -101.75 -158.57 0.68 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.51 -13.78 59.56 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.1 p -68.62 -37.49 79.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -144.99 28.54 1.24 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.8 t -126.84 128.79 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -63.36 142.5 58.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -66.83 -19.8 65.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -90.03 -4.75 57.22 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.76 9.14 12.9 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -91.66 132.22 36.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.0 -7.69 48.17 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.625 ' NE2' HG21 ' A' ' 72' ' ' VAL . 35.3 mt-30 -70.23 -21.59 62.98 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.37 129.69 39.96 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -120.02 157.09 29.6 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.57 160.21 13.31 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.8 tp -135.19 129.81 34.34 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.8 p -102.12 159.3 29.79 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.91 -20.52 67.3 Favored 'Trans proline' 0 CA--C 1.499 -1.229 0 C-N-CA 122.323 2.015 . . . . 0.0 112.969 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -75.89 -13.75 60.26 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.39 5.69 60.28 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -82.72 138.62 34.01 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.12 124.72 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.747 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.9 OUTLIER -132.91 179.01 6.44 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.728 HD12 ' HB2' ' A' ' 118' ' ' LYS . 13.8 mt -85.55 149.03 25.65 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.17 -23.4 61.27 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -104.34 -17.73 14.7 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.734 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.728 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -134.55 84.28 40.36 Favored Pre-proline 0 CA--C 1.493 -1.231 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.71 -7.17 18.66 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.444 2.096 . . . . 0.0 112.466 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 71.0 m -88.65 -12.51 42.29 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 142' ' ' LEU . 46.4 mt -106.75 130.5 54.45 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.747 HG22 ' HB3' ' A' ' 114' ' ' TYR . 25.3 pt -134.07 165.0 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.28 138.95 35.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.82 176.06 39.14 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 107.146 -2.381 . . . . 0.0 107.146 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.7 pp -130.26 159.22 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -116.12 144.86 43.58 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -69.54 147.26 51.04 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.0 t -98.16 163.46 12.73 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -64.59 -37.1 86.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -96.78 5.09 51.28 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 51.4 45.02 28.59 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.952 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -77.47 104.86 8.25 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -65.34 -36.64 84.63 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -83.11 89.38 6.93 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 134.17 5.64 2.65 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.404 HD13 HD13 ' A' ' 125' ' ' ILE . 79.7 mt -67.61 125.8 27.33 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -89.0 154.43 20.22 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.474 0.654 . . . . 0.0 109.417 -177.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 p -97.66 144.99 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -146.73 166.52 26.36 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.428 ' HG ' HD11 ' A' ' 86' ' ' ILE . 86.6 mt -88.76 117.18 27.55 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -102.45 138.15 39.74 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.439 HD12 HD23 ' A' ' 121' ' ' LEU . 5.5 tp -72.72 137.54 46.0 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.077 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.85 147.58 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.132 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -145.53 107.33 4.29 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -64.89 -23.2 67.16 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.982 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -64.4 -28.18 69.51 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -140.45 85.9 2.03 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -106.48 3.95 27.75 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -98.38 16.48 21.49 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.403 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 97.9 mtt180 -76.93 135.62 38.77 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -70.82 -22.96 62.28 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 150' ' ' ARG . 8.3 pt-20 -72.05 -21.2 61.56 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -100.75 0.67 39.29 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -92.78 132.02 37.33 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -126.71 144.48 50.92 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -130.87 156.46 45.0 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -118.7 142.18 47.91 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.98 144.25 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.8 mt -108.67 155.75 40.05 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.98 141.67 98.56 Favored 'Trans proline' 0 CA--C 1.5 -1.189 0 C-N-CA 121.92 1.747 . . . . 0.0 113.401 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.6 t 61.0 63.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.263 1.774 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.455 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.147 0.499 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.66 156.06 37.18 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.23 136.99 52.35 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.4 95.09 7.44 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.0 ptp -81.09 -17.96 48.21 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.19 86.89 2.41 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -84.29 -35.6 23.23 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.86 142.05 37.17 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.7 m -133.15 145.76 50.96 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -101.55 170.99 7.83 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.29 162.39 25.59 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -90.15 146.92 35.86 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.86 -24.93 20.58 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.057 1.838 . . . . 0.0 113.843 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.94 150.74 49.41 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.06 -43.14 93.98 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -91.0 135.24 33.87 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -165.62 163.96 19.21 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.415 ' CE1' HD21 ' A' ' 55' ' ' LEU . 46.5 m-85 -116.28 137.36 52.21 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.98 120.6 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 29.8 pttt -125.68 146.62 49.65 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -87.82 130.93 34.71 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -64.67 -26.85 68.56 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 122.203 -0.311 . . . . 0.0 111.425 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 t -65.32 -42.02 93.41 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 121.79 -0.569 . . . . 0.0 110.672 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -104.98 -23.69 12.93 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.593 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.88 17.35 80.17 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 107.402 -2.279 . . . . 0.0 107.402 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -107.86 159.58 16.41 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 12.6 m -107.6 158.91 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.759 HD12 HG21 ' A' ' 41' ' ' ILE . 2.4 pt? -91.86 139.4 30.7 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.066 0.936 . . . . 0.0 109.468 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 16.6 ptm -147.57 178.7 8.24 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.584 HG11 ' H ' ' A' ' 34' ' ' SER . 43.8 t -64.5 156.49 5.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.635 ' HA ' HG22 ' A' ' 42' ' ' VAL . 43.0 t0 -57.36 -39.47 76.06 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.567 -0.708 . . . . 0.0 110.75 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -160.94 50.26 0.25 Allowed 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.861 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 53.9 51.95 13.83 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.584 ' H ' HG11 ' A' ' 30' ' ' VAL . 45.1 t -89.81 113.78 25.4 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -92.65 -4.62 53.01 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -91.36 0.47 57.51 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 t 69.56 -172.29 0.18 Allowed 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.61 29.26 72.82 Favored Glycine 0 C--N 1.355 1.605 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 28.4 t -128.59 129.37 23.53 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 87' ' ' VAL . 36.1 Cg_exo -61.7 155.3 54.69 Favored 'Trans proline' 0 CA--C 1.5 -1.219 0 C-N-CA 122.434 2.089 . . . . 0.0 113.433 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.759 HG21 HD12 ' A' ' 28' ' ' LEU . 24.0 mm -87.63 129.45 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 31' ' ' ASP . 14.8 m -130.99 163.15 37.71 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 CA-C-O 121.851 0.834 . . . . 0.0 109.474 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 136' ' ' LEU . 94.2 mt -82.72 144.45 30.21 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.232 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.99 148.35 29.65 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.3 t -66.87 154.73 40.22 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.83 138.65 58.51 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.41 147.87 52.39 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -86.62 -4.87 59.24 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -118.77 138.3 52.77 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 57.52 44.36 21.29 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -84.17 -5.5 59.26 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.63 84.72 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.0 m -69.07 -20.58 64.1 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -99.29 4.27 46.45 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.415 HD21 ' CE1' ' A' ' 18' ' ' PHE . 11.1 mt -99.6 136.53 39.4 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -126.2 148.69 49.4 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -124.26 128.52 49.29 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -91.36 109.86 21.15 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -75.15 155.53 86.2 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -58.78 -23.53 67.15 Favored 'Trans proline' 0 CA--C 1.498 -1.318 0 C-N-CA 122.037 1.825 . . . . 0.0 113.3 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.9 m -74.41 -15.64 60.91 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.35 11.75 30.66 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.77 155.25 17.45 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 118.4 1.1 . . . . 0.0 108.456 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.3 mt -107.8 123.91 49.27 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.834 HG22 HG12 ' A' ' 72' ' ' VAL . 92.7 t -109.72 136.85 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -80.97 125.67 30.43 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -62.45 -39.72 94.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.988 -0.445 . . . . 0.0 111.237 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -66.34 -50.9 62.0 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.1 p -90.82 -27.79 18.63 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.793 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.02 3.91 90.21 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.53 167.81 11.26 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.834 HG12 HG22 ' A' ' 65' ' ' VAL . 27.1 m -115.1 153.45 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.1 ptp -76.82 143.64 39.63 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -156.75 175.62 13.82 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.07 143.13 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.32 -43.21 74.19 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.763 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -71.89 -33.12 68.09 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.64 -7.29 81.54 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 105.652 -2.979 . . . . 0.0 105.652 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.2 m -114.05 119.19 41.22 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.33 113.53 3.8 Favored 'Trans proline' 0 CA--C 1.497 -1.328 0 C-N-CA 121.213 1.275 . . . . 0.0 112.922 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.67 165.03 30.81 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.688 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -74.15 138.3 43.75 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.66 6.87 82.56 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.537 ' HB ' HD12 ' A' ' 140' ' ' LEU . 83.8 t -83.05 133.45 29.05 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-N 119.13 1.465 . . . . 0.0 107.893 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.36 156.31 37.21 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.441 0.639 . . . . 0.0 109.592 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.4 mm -110.3 127.53 67.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.1 m -133.24 162.48 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -81.93 147.71 29.12 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -145.02 169.35 18.27 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.9 m -68.8 148.61 50.04 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -69.94 156.57 38.9 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.69 -159.92 1.01 Allowed 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.91 -18.86 48.63 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.4 m -67.92 -41.8 82.05 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -131.89 24.44 4.63 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.2 t -124.7 128.66 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -60.21 146.16 44.61 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.22 -20.53 66.1 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.46 -2.7 57.94 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -115.57 7.11 14.78 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.35 125.28 34.15 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -97.53 -8.13 29.82 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -83.08 -4.84 58.77 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.99 124.41 26.92 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -119.8 154.23 34.55 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -116.92 150.7 18.48 Favored Glycine 0 C--N 1.352 1.438 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.6 tp -111.51 120.36 41.87 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.413 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 8.8 t -77.7 143.78 67.95 Favored Pre-proline 0 N--CA 1.441 -0.912 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.99 -20.38 53.04 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.029 1.819 . . . . 0.0 112.801 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -85.26 -2.87 58.54 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.83 6.32 59.4 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -84.69 147.49 26.89 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.8 mt -111.85 124.01 68.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.564 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.1 p90 -132.27 171.18 14.02 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 2.3 mt -87.55 147.53 25.3 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.16 82.67 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.616 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -94.38 -17.3 22.68 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.281 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.582 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 0.6 OUTLIER -134.71 82.5 44.33 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -64.65 -15.02 47.9 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.595 2.197 . . . . 0.0 113.141 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 92.3 p -83.09 -17.17 44.06 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 140' ' ' LEU . 53.5 mt -98.41 130.68 45.04 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' A' ' 114' ' ' TYR . 36.4 pt -135.49 164.22 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.27 142.6 30.99 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.92 -173.14 32.25 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 106.564 -2.614 . . . . 0.0 106.564 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -136.54 161.64 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.53 ' O ' HD22 ' A' ' 136' ' ' LEU . 40.1 ttmt -110.18 143.41 40.32 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.77 149.4 46.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -107.71 157.2 18.31 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -60.8 -45.64 93.64 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -89.06 1.76 55.09 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 50.81 47.12 25.13 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.16 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -82.37 113.16 19.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.13 -35.72 80.35 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.6 85.66 6.95 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.88 -3.18 1.5 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 43' ' ' LEU . 88.1 mt -68.99 125.17 25.83 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.582 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -92.48 157.74 16.4 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.524 0.678 . . . . 0.0 109.486 -177.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.09 135.4 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.98 142.38 47.65 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.537 HD12 ' HB ' ' A' ' 84' ' ' VAL . 83.7 mt -79.68 128.85 33.91 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -119.91 152.48 37.31 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.688 HD13 ' HB2' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -88.52 139.29 30.63 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.715 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.18 144.24 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.862 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -149.82 103.86 3.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -67.43 -19.7 65.41 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.077 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.98 -24.94 66.09 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -133.96 82.43 1.98 Allowed 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.8 mt -103.05 4.7 37.5 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -93.45 15.81 14.99 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -87.43 115.5 24.9 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.584 ' HA ' ' HE ' ' A' ' 154' ' ' ARG . 60.9 pttt -66.06 -20.59 66.22 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.893 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -74.74 -18.29 60.52 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -96.91 -1.72 45.26 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.584 ' HE ' ' HA ' ' A' ' 151' ' ' LYS . 79.4 mtm180 -99.94 133.75 43.86 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -118.52 140.56 49.68 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -112.81 157.1 21.78 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -128.29 143.66 51.04 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.4 145.14 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.8 mt -107.77 151.59 41.2 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.83 149.1 72.33 Favored 'Trans proline' 0 CA--C 1.496 -1.399 0 C-N-CA 121.752 1.635 . . . . 0.0 113.058 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.673 HG12 HG23 ' A' ' 162' ' ' VAL . 67.4 t -119.94 124.81 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.673 HG23 HG12 ' A' ' 161' ' ' VAL . 59.5 t . . . . . 0 C--O 1.262 1.741 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.81 0.338 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.73 94.94 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.39 33.98 3.93 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.43 58.49 2.42 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.7 ttt -93.82 62.04 3.14 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 65.62 50.48 1.62 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -71.15 -19.4 62.43 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -119.74 159.36 24.65 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m -129.38 145.45 51.4 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -90.6 170.08 10.47 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -93.9 137.42 33.15 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.422 ' HB2' ' CD2' ' A' ' 58' ' ' HIS . 71.3 m-85 -78.53 157.38 77.45 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.71 149.33 83.77 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 C-N-CA 121.288 1.325 . . . . 0.0 112.069 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -98.75 164.27 12.29 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.89 -166.76 41.32 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.684 ' HB3' HD22 ' A' ' 55' ' ' LEU . 52.3 m0 -76.82 141.63 40.61 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -155.94 162.27 40.4 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.435 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 41.9 m-85 -119.59 140.67 50.2 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.565 HD11 ' CD2' ' A' ' 64' ' ' LEU . 82.8 mt -103.18 115.84 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -110.9 131.63 54.88 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -88.57 122.24 31.81 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -62.8 -20.06 64.65 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 t -63.62 -45.67 89.25 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 119.357 0.98 . . . . 0.0 110.916 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -116.94 -13.14 10.65 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.319 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.26 19.14 72.64 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -97.58 163.87 12.67 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.29 160.13 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.938 HD23 HG21 ' A' ' 41' ' ' ILE . 3.1 mp -67.61 133.18 48.92 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.468 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 37.3 ttp -145.28 163.66 33.79 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 31' ' ' ASP . 38.9 t -69.92 161.13 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' HG12 ' A' ' 30' ' ' VAL . 35.8 t70 -49.31 -38.09 26.43 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 122.188 -0.32 . . . . 0.0 111.015 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -161.26 48.57 0.21 Allowed 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.726 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 55.41 47.02 22.11 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -96.53 130.23 43.75 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -92.45 -3.21 55.55 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -85.44 142.37 29.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.5 p -72.6 161.03 31.3 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.52 7.58 69.09 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.1 m -92.45 128.73 43.43 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HA ' HG12 ' A' ' 87' ' ' VAL . 35.9 Cg_exo -60.0 151.8 69.47 Favored 'Trans proline' 0 CA--C 1.499 -1.242 0 C-N-CA 122.16 1.907 . . . . 0.0 113.127 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.938 HG21 HD23 ' A' ' 28' ' ' LEU . 25.0 mm -93.93 129.27 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 29.9 m -131.57 164.07 35.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.7 mt -94.51 142.6 27.25 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.11 150.33 35.72 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -60.46 145.22 49.08 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 139.58 57.23 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.24 146.3 47.4 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.7 m -85.53 -16.02 40.81 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -123.27 147.04 47.37 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 57.84 42.66 22.89 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -90.58 2.41 55.85 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 -36.79 84.74 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 m -69.72 -18.84 63.56 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -98.21 2.75 48.69 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.684 HD22 ' HB3' ' A' ' 16' ' ' TRP . 48.6 mt -98.61 136.22 39.01 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -126.1 150.12 48.44 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -128.58 130.89 48.0 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.435 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 52.0 t-80 -89.9 117.9 29.07 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -80.34 158.36 71.8 Favored Pre-proline 0 C--N 1.359 0.998 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.58 -17.68 55.55 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 121.77 1.647 . . . . 0.0 112.348 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -85.34 -2.52 58.17 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 58' ' ' HIS . . . 86.64 22.48 46.61 Favored Glycine 0 C--N 1.356 1.693 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -104.41 134.96 46.74 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.565 ' CD2' HD11 ' A' ' 19' ' ' ILE . 6.7 mp -94.28 123.17 37.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.958 HG22 HG12 ' A' ' 72' ' ' VAL . 65.2 t -110.6 135.33 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -79.29 128.0 32.77 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -63.27 -40.17 96.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.9 -0.5 . . . . 0.0 111.195 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -70.38 -50.29 40.36 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.962 -0.461 . . . . 0.0 112.116 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 88.5 p -87.43 -29.59 21.33 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.806 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.83 3.88 90.47 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -91.05 165.12 13.69 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.958 HG12 HG22 ' A' ' 65' ' ' VAL . 24.2 m -116.94 160.29 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 mtt -70.08 139.58 52.59 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -159.04 172.29 18.44 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.419 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -87.95 143.53 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.73 -44.56 81.24 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.788 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -73.26 -32.79 64.9 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.419 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.4 -7.91 80.68 Favored Glycine 0 CA--C 1.496 -1.118 0 N-CA-C 105.703 -2.959 . . . . 0.0 105.703 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.9 m -113.49 119.99 40.61 Favored Pre-proline 0 N--CA 1.436 -1.155 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HG3' ' CE2' ' A' ' 102' ' ' PHE . 72.3 Cg_endo -74.09 117.89 5.19 Favored 'Trans proline' 0 CA--C 1.496 -1.422 0 C-N-CA 121.291 1.327 . . . . 0.0 113.131 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -150.54 161.23 42.95 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -72.13 138.68 47.89 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.67 8.09 77.45 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.596 ' HB ' HD12 ' A' ' 140' ' ' LEU . 80.3 t -85.54 133.59 29.15 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-N 118.978 1.389 . . . . 0.0 107.648 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -73.74 153.8 39.88 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.593 0.711 . . . . 0.0 109.614 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.5 mm -107.61 128.4 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 40' ' ' PRO . 29.1 m -133.65 161.91 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -87.21 137.78 32.05 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -139.67 174.33 10.63 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -72.21 166.03 23.21 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -80.08 157.08 26.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -134.81 162.1 33.32 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.57 -22.05 0.41 Allowed Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.8 m -64.68 -40.81 96.04 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -128.61 16.75 6.43 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.87 127.97 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -65.09 140.32 58.8 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.61 -18.54 65.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -89.4 -5.7 57.2 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.7 mt -119.41 10.62 11.94 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -92.86 123.9 36.47 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' A' ' 80' ' ' PRO . 67.4 m-85 -77.65 -7.58 56.64 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.945 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -71.59 -12.21 61.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -76.7 126.8 31.61 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -117.3 155.56 29.3 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.3 151.61 18.08 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.0 tp -111.94 121.95 46.43 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.42 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.9 t -82.03 138.37 46.14 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.01 -8.97 25.07 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.768 1.645 . . . . 0.0 112.99 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.15 -0.3 57.68 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.3 41.55 4.51 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -132.18 151.13 51.96 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.9 mt -116.79 126.66 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.587 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.9 OUTLIER -132.14 173.63 11.04 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.665 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 13.7 mt -85.71 149.16 25.49 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.22 -21.04 59.97 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -102.25 -24.68 13.87 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.396 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 3.6 mptp? -133.46 85.06 44.42 Favored Pre-proline 0 CA--C 1.492 -1.264 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 114' ' ' TYR . 26.0 Cg_exo -66.35 -8.8 21.69 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.437 2.091 . . . . 0.0 112.591 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.3 m -82.92 -26.18 31.71 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.624 HD22 ' HB3' ' A' ' 140' ' ' LEU . 69.3 mt -93.07 131.35 38.16 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.587 HG22 ' HB3' ' A' ' 114' ' ' TYR . 38.9 pt -136.62 162.81 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.54 134.56 40.72 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.4 -169.02 19.37 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 106.988 -2.445 . . . . 0.0 106.988 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.446 ' CD1' HD13 ' A' ' 136' ' ' LEU . 8.8 pt -139.21 173.05 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.153 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -117.05 112.96 21.65 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -85.39 131.65 34.36 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 30.5 t -150.39 160.39 43.78 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.71 -30.93 68.68 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -100.78 34.63 2.4 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 128' ' ' SER . . . -119.66 99.45 6.66 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.48 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 16.8 tpt180 -62.22 131.54 49.76 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -62.55 -36.12 81.64 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.48 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 29.9 mt-10 -83.76 86.0 7.21 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.94 10.22 1.81 Allowed Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.446 HD13 ' CD1' ' A' ' 125' ' ' ILE . 18.7 mt -63.6 121.09 13.05 Favored 'General case' 0 C--N 1.363 1.155 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -83.12 155.37 23.85 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.546 0.689 . . . . 0.0 109.398 -178.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.27 134.16 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -130.09 139.6 50.92 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.624 ' HB3' HD22 ' A' ' 121' ' ' LEU . 77.0 mt -75.49 125.73 29.59 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -123.67 143.68 50.11 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.582 ' CD1' HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -84.41 148.99 26.29 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.68 151.67 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-O 121.767 0.794 . . . . 0.0 109.232 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -147.51 100.11 3.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -68.79 -20.07 64.32 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.794 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -68.39 -23.99 64.72 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -135.19 83.91 2.06 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.3 4.87 42.08 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -95.89 20.81 9.42 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -92.96 120.26 33.09 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -68.39 -22.93 64.61 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -70.97 -20.41 62.43 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -96.9 -1.68 45.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -98.84 133.13 43.57 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -123.19 140.35 53.11 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -123.51 156.2 36.09 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.7 141.02 49.0 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.06 144.68 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -108.38 152.75 42.15 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.4 149.19 74.84 Favored 'Trans proline' 0 CA--C 1.497 -1.347 0 C-N-CA 121.729 1.619 . . . . 0.0 113.053 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.678 HG12 HG23 ' A' ' 162' ' ' VAL . 65.6 t -120.02 124.55 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.678 HG23 HG12 ' A' ' 161' ' ' VAL . 60.5 t . . . . . 0 C--O 1.263 1.79 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 121.109 0.481 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.6 152.16 32.5 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.45 144.98 39.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.57 106.05 18.2 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.2 mtm -66.3 -38.87 88.74 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -95.2 64.32 2.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -65.66 -43.56 88.97 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -87.17 161.13 18.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -145.76 143.64 29.84 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -101.27 170.67 8.08 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -115.49 162.82 16.64 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -79.21 126.51 81.46 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.22 -23.22 24.66 Favored 'Trans proline' 0 CA--C 1.499 -1.247 0 C-N-CA 121.892 1.728 . . . . 0.0 114.131 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.64 162.36 18.53 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.35 -56.42 2.03 Favored Glycine 0 CA--C 1.494 -1.256 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -90.51 132.35 35.73 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -162.92 162.32 26.16 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.455 ' CE1' HD21 ' A' ' 55' ' ' LEU . 54.9 m-85 -117.84 137.37 52.81 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.521 HG22 ' CE3' ' A' ' 155' ' ' TRP . 80.4 mt -104.9 116.36 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -110.75 131.99 54.58 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -85.89 123.15 30.91 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.35 -16.33 63.98 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 122.27 -0.269 . . . . 0.0 111.532 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.2 t -63.16 -43.88 97.06 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 121.34 -0.85 . . . . 0.0 110.708 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -123.37 -5.68 8.25 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.623 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.25 21.93 76.99 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 45' ' ' THR . 10.9 m-30 -107.58 163.0 13.44 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -110.65 159.94 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.696 HD12 HG21 ' A' ' 41' ' ' ILE . 2.6 pt? -83.26 144.36 29.8 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 122.306 1.05 . . . . 0.0 108.994 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.9 tmm? -144.71 175.38 10.21 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 31' ' ' ASP . 15.8 t -68.93 170.22 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.609 ' H ' HG12 ' A' ' 30' ' ' VAL . 35.6 t70 -56.83 -40.8 76.7 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.318 -0.864 . . . . 0.0 110.487 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -166.59 58.67 0.09 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 53.97 48.06 22.01 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.0 m -88.44 128.2 35.52 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -92.92 -2.69 55.6 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -93.98 147.96 22.61 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.3 p -78.07 163.4 25.93 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.63 8.23 77.32 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -89.36 125.04 63.01 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.549 ' HA ' HG12 ' A' ' 87' ' ' VAL . 44.1 Cg_exo -58.97 149.93 75.94 Favored 'Trans proline' 0 CA--C 1.499 -1.264 0 C-N-CA 122.114 1.876 . . . . 0.0 113.221 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.696 HG21 HD12 ' A' ' 28' ' ' LEU . 26.2 mm -89.96 129.41 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.542 HG22 ' HA ' ' A' ' 31' ' ' ASP . 23.9 m -131.58 162.54 39.24 Favored 'Isoleucine or valine' 0 C--N 1.359 0.999 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -89.47 145.45 25.3 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.606 0.717 . . . . 0.0 109.136 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.25 148.77 32.81 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.409 ' HA ' ' CD2' ' A' ' 26' ' ' TYR . 12.3 t -63.16 156.99 23.55 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.74 137.1 56.41 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.698 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -145.85 129.31 16.91 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.6 m -60.69 -36.24 78.29 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -75.9 141.8 42.24 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 60.5 42.18 14.68 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.441 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -71.85 -27.41 62.86 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.71 90.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.1 m -67.9 -23.81 65.15 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -99.73 3.85 45.16 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 ' CE1' ' A' ' 18' ' ' PHE . 16.0 mt -99.5 135.39 40.98 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-O 121.894 0.855 . . . . 0.0 108.841 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.474 ' HB3' HD12 ' A' ' 64' ' ' LEU . 79.1 m95 -127.8 155.83 43.46 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -146.35 160.37 42.12 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -111.73 136.21 51.3 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -178.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.407 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 99.9 m-20 -84.78 161.04 54.53 Favored Pre-proline 0 N--CA 1.436 -1.148 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 59' ' ' ASP . 18.1 Cg_endo -60.01 -18.72 52.03 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.431 1.421 . . . . 0.0 112.97 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 66.6 m -82.43 -11.06 58.78 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.76 14.44 43.36 Favored Glycine 0 C--N 1.358 1.754 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.405 ' CE1' ' HB2' ' A' ' 61' ' ' SER . 9.7 m-85 -92.98 146.44 23.62 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 56' ' ' TRP . 3.0 mm? -92.7 132.17 37.15 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.908 HG22 HG12 ' A' ' 72' ' ' VAL . 67.0 t -124.67 137.24 58.05 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -81.11 129.78 34.72 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -62.5 -39.51 93.74 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 122.14 -0.35 . . . . 0.0 110.911 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -76.91 -54.89 6.0 Favored 'General case' 0 CA--C 1.501 -0.906 0 O-C-N 121.882 -0.511 . . . . 0.0 111.043 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.0 m -68.85 -39.64 79.78 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.48 5.01 89.91 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 105.933 -2.867 . . . . 0.0 105.933 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -97.88 169.44 9.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.908 HG12 HG22 ' A' ' 65' ' ' VAL . 32.7 m -116.55 160.95 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.493 ' CE ' HD11 ' A' ' 28' ' ' LEU . 63.6 mtt -72.8 140.71 47.85 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -156.3 167.93 28.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.09 142.93 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.73 86.79 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.836 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -72.46 -32.92 66.65 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.01 -6.11 82.87 Favored Glycine 0 CA--C 1.495 -1.195 0 N-CA-C 105.736 -2.946 . . . . 0.0 105.736 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.7 m -117.89 122.92 30.07 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.73 117.16 5.0 Favored 'Trans proline' 0 CA--C 1.497 -1.374 0 C-N-CA 121.196 1.264 . . . . 0.0 112.945 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.39 166.36 26.58 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.47 135.9 39.37 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.0 4.27 82.1 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.89 131.02 35.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-N 119.099 1.45 . . . . 0.0 108.598 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -73.07 154.48 40.41 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-O 121.534 0.683 . . . . 0.0 109.447 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.866 HD11 HD13 ' A' ' 140' ' ' LEU . 47.9 mm -106.84 130.25 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.9 m -131.14 161.02 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -86.3 140.05 30.43 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -144.25 169.31 18.13 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 m -67.31 150.37 49.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -69.02 156.96 37.73 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.47 -155.07 0.67 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.65 -14.89 57.57 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.8 p -69.45 -36.93 77.09 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -143.63 31.32 1.32 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.2 t -125.49 129.22 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -62.42 145.19 54.7 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.24 -20.21 66.32 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -89.64 -3.48 58.24 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -115.93 8.06 14.58 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.55 121.13 27.81 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -98.35 -7.46 28.81 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -80.47 -8.88 59.72 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -77.43 126.22 30.56 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -116.32 154.02 30.94 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.45 161.89 12.63 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 106.541 -2.623 . . . . 0.0 106.541 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.5 tp -132.25 132.29 42.91 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.4 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 83.4 p -113.47 155.26 44.99 Favored Pre-proline 0 N--CA 1.443 -0.796 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 56.4 Cg_endo -70.51 -8.14 22.92 Favored 'Trans proline' 0 CA--C 1.499 -1.237 0 C-N-CA 122.132 1.888 . . . . 0.0 112.849 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -82.53 -3.75 56.45 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.44 23.02 52.55 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -110.42 136.5 49.48 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.8 mt -108.31 124.19 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.655 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.33 177.28 7.45 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.643 HD12 ' HB2' ' A' ' 118' ' ' LYS . 4.8 mt -86.98 150.95 23.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.18 86.37 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.714 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -97.75 -11.91 22.87 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.543 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.643 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.92 84.68 37.04 Favored Pre-proline 0 CA--C 1.493 -1.229 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -68.45 -9.82 27.16 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.255 1.97 . . . . 0.0 112.395 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.2 m -85.61 -27.59 25.35 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' ' 140' ' ' LEU . 57.2 mt -92.21 130.78 37.84 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.655 HG22 ' HB3' ' A' ' 114' ' ' TYR . 36.1 pt -136.39 164.99 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.2 mt -82.06 141.2 33.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.98 178.12 41.89 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 107.286 -2.326 . . . . 0.0 107.286 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.915 HD13 HD13 ' A' ' 136' ' ' LEU . 1.8 pp -129.36 158.81 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -104.89 135.26 46.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -97.53 135.3 39.57 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.1 t -150.09 155.67 40.27 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -69.72 -26.58 64.4 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -102.17 30.59 4.41 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.34 99.41 4.83 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.557 ' HG2' ' H ' ' A' ' 134' ' ' GLU . 54.6 ttt85 -62.7 145.25 55.14 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -59.98 -34.34 73.17 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.557 ' H ' ' HG2' ' A' ' 132' ' ' ARG . 88.8 tt0 -88.24 84.68 6.86 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.39 5.42 1.31 Allowed Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 125' ' ' ILE . 76.6 mt -63.0 127.7 32.43 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 106.914 -1.514 . . . . 0.0 106.914 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.549 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -87.7 153.42 21.38 Favored 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 121.621 0.724 . . . . 0.0 109.46 -177.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 36.8 t -94.64 138.36 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -145.52 163.83 33.5 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.866 HD13 HD11 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -90.41 126.2 35.81 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -126.77 161.86 27.19 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.533 ' CD1' HD23 ' A' ' 121' ' ' LEU . 1.1 mp -91.45 152.41 20.39 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.753 0.787 . . . . 0.0 109.207 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.75 155.57 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.919 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -141.1 101.23 3.99 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -66.18 -23.99 66.56 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.928 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -67.01 -25.95 66.55 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -141.85 85.84 1.96 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.6 mt -98.75 3.76 47.62 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -99.28 18.46 17.55 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -76.01 128.65 35.47 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -69.55 -23.27 63.55 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.17 -20.73 60.12 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -99.97 0.41 41.03 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -100.72 132.61 46.03 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.521 ' CE3' HG22 ' A' ' 19' ' ' ILE . 96.2 m95 -122.28 138.89 54.34 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -112.15 149.28 32.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.85 138.02 51.55 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.7 t -127.22 144.64 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.9 mt -109.54 152.66 42.9 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.91 150.66 73.54 Favored 'Trans proline' 0 CA--C 1.497 -1.364 0 C-N-CA 121.818 1.679 . . . . 0.0 112.86 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -117.7 125.23 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.262 1.723 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.749 0.309 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.17 134.63 55.22 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.7 156.93 34.23 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.89 64.06 7.05 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 98.5 mtp -95.99 60.39 2.06 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 65.2 60.71 0.77 Allowed 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.209 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.85 -39.97 83.73 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.29 149.48 33.52 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -143.3 157.62 44.32 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -119.32 171.91 7.98 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.83 162.28 13.03 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.473 ' HB2' ' CD2' ' A' ' 58' ' ' HIS . 75.2 m-85 -87.45 157.67 52.65 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.65 152.07 81.42 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 121.536 1.491 . . . . 0.0 112.209 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -97.52 164.31 12.49 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.4 -170.18 42.34 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 107.749 -2.141 . . . . 0.0 107.749 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.607 ' HB3' HD22 ' A' ' 55' ' ' LEU . 50.3 m0 -76.36 141.89 41.36 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -157.06 163.77 38.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.535 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 41.4 m-85 -120.4 138.89 53.52 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.6 mt -102.51 114.77 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -112.01 131.44 55.41 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -88.51 127.33 35.53 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.48 -19.86 65.83 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 151' ' ' LYS . 38.6 t -63.56 -44.01 95.37 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 119.114 0.87 . . . . 0.0 111.285 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -123.5 -7.51 8.07 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.822 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.14 20.25 79.3 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -100.15 166.88 10.79 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.66 160.56 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.945 HD23 HG21 ' A' ' 41' ' ' ILE . 2.8 mp -67.25 133.77 50.35 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.638 0.732 . . . . 0.0 109.956 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -145.46 166.16 26.47 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 31' ' ' ASP . 16.0 t -69.28 171.44 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 105.161 -2.162 . . . . 0.0 105.161 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 30' ' ' VAL . 35.8 t70 -54.8 -42.01 71.3 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.721 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -170.24 65.94 0.05 OUTLIER 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.815 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 53.16 46.82 25.8 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.0 m -97.44 123.76 41.4 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -94.27 -0.9 54.75 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.47 145.1 26.41 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.7 m -77.13 155.57 32.26 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.51 62.87 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.2 m -91.05 138.64 25.87 Favored Pre-proline 0 N--CA 1.438 -1.039 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.441 ' HA ' HG12 ' A' ' 87' ' ' VAL . 57.1 Cg_endo -70.3 154.09 65.89 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 121.67 1.58 . . . . 0.0 112.694 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.945 HG21 HD23 ' A' ' 28' ' ' LEU . 23.6 mm -92.6 131.13 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 24.6 m -131.95 167.44 26.37 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.79 144.03 26.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.26 36.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 m -61.03 143.93 54.41 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -59.83 139.69 57.14 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -108.73 142.22 39.57 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.7 m -66.8 -34.35 77.62 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -137.58 159.72 41.17 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.6 t0 61.64 46.05 7.53 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -105.97 17.49 23.54 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.26 86.47 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.7 p -71.56 -12.67 61.48 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -101.14 2.38 40.12 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 16' ' ' TRP . 59.8 mt -98.28 137.39 37.08 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.37 150.67 48.43 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -130.05 134.67 47.55 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 12' ' ' PHE . 55.9 t-80 -95.43 112.42 24.14 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -80.81 155.88 72.9 Favored Pre-proline 0 N--CA 1.439 -1.003 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.65 -19.69 46.76 Favored 'Trans proline' 0 CA--C 1.497 -1.363 0 C-N-CA 122.274 1.983 . . . . 0.0 113.675 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 63' ' ' TYR . 67.3 m -71.91 -19.59 61.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.67 15.21 19.48 Favored Glycine 0 C--N 1.355 1.622 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 61' ' ' SER . 1.1 m-85 -108.32 159.63 16.49 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 118.212 1.006 . . . . 0.0 108.726 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.94 125.78 51.41 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.963 HG22 HG12 ' A' ' 72' ' ' VAL . 66.5 t -114.48 134.05 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -76.46 129.79 37.04 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.01 -41.05 99.47 Favored 'General case' 0 CA--C 1.509 -0.619 0 O-C-N 121.939 -0.475 . . . . 0.0 110.853 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -74.62 -53.92 8.44 Favored 'General case' 0 CA--C 1.501 -0.914 0 O-C-N 122.052 -0.405 . . . . 0.0 111.088 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.0 m -70.32 -39.94 74.48 Favored 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.859 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.01 7.04 88.38 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 105.818 -2.913 . . . . 0.0 105.818 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.82 168.04 9.9 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.963 HG12 HG22 ' A' ' 65' ' ' VAL . 21.9 m -116.75 162.2 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 mtt -71.8 140.69 49.54 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -156.44 169.39 24.74 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -88.41 143.87 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.037 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.94 -42.19 85.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -71.65 -33.89 69.28 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 89.55 -8.29 80.13 Favored Glycine 0 CA--C 1.496 -1.147 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.5 m -126.25 124.46 24.49 Favored Pre-proline 0 N--CA 1.437 -1.086 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.65 130.94 41.28 Favored 'Trans proline' 0 CA--C 1.497 -1.339 0 C-N-CA 121.416 1.411 . . . . 0.0 112.99 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -149.27 150.15 32.09 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.16 130.09 40.58 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.1 7.92 82.75 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.06 144.11 13.8 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 CA-C-N 118.473 1.137 . . . . 0.0 108.302 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.29 156.35 20.97 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.8 mm -108.57 129.14 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.6 m -130.78 163.27 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -87.53 139.57 30.41 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -142.49 173.34 11.62 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -73.32 168.62 18.8 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -83.75 151.34 25.27 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.06 156.79 20.93 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.51 -166.74 42.83 Favored Glycine 0 C--N 1.349 1.291 0 N-CA-C 107.531 -2.228 . . . . 0.0 107.531 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.3 p -89.91 7.08 39.1 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -101.97 17.43 23.18 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 p -100.05 142.32 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.4 tptp -66.07 141.72 58.05 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.64 -15.96 62.25 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -89.79 -6.82 55.58 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.3 mt -115.87 11.53 15.56 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -89.61 98.48 11.79 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -98.2 -7.39 29.42 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.274 -177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.453 ' HG2' HG21 ' A' ' 72' ' ' VAL . 26.6 mp0 -71.22 -18.55 62.45 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -70.76 135.36 48.15 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -129.43 152.68 48.71 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.08 163.79 12.38 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 106.635 -2.586 . . . . 0.0 106.635 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 67.0 tp -125.79 118.82 26.35 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.0 t -79.18 138.75 56.25 Favored Pre-proline 0 N--CA 1.441 -0.909 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.32 -9.55 26.26 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.802 1.668 . . . . 0.0 112.715 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -90.27 -0.77 57.78 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.62 40.29 4.75 Favored Glycine 0 C--N 1.356 1.675 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -129.55 149.69 51.21 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.1 mt -115.8 126.81 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.679 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.2 p90 -131.25 173.99 10.5 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.647 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 14.4 mt -83.92 150.58 25.59 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.05 -23.65 61.4 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -104.59 -19.98 13.81 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.767 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.647 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 1.3 mptm? -134.15 85.44 39.44 Favored Pre-proline 0 CA--C 1.495 -1.14 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.91 -9.19 23.98 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.605 2.204 . . . . 0.0 112.877 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.29 -29.46 28.35 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 140' ' ' LEU . 42.8 mt -89.18 130.89 35.53 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.679 HG22 ' HB3' ' A' ' 114' ' ' TYR . 24.6 pt -134.27 162.92 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.295 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.45 HD23 HD23 ' A' ' 140' ' ' LEU . 89.8 mt -81.09 136.6 35.95 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.64 175.96 38.16 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.647 HD13 HD13 ' A' ' 136' ' ' LEU . 1.9 pp -128.37 158.22 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.517 ' O ' HD22 ' A' ' 136' ' ' LEU . 47.9 tttt -107.19 147.79 29.69 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -124.53 144.91 49.86 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.8 t -149.97 161.82 41.56 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -69.15 -27.2 65.33 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -102.74 28.9 5.71 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -132.73 98.92 4.46 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -64.09 153.95 35.97 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.408 ' HA ' ' HG ' ' A' ' 136' ' ' LEU . 99.6 mtt180 -70.39 -16.84 63.01 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.15 84.59 5.7 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 131.1 13.68 1.92 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.647 HD13 HD13 ' A' ' 125' ' ' ILE . 82.5 mt -64.57 127.73 32.74 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -90.3 151.08 21.65 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.5 p -95.27 144.04 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -147.27 166.98 25.43 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.476 ' HB3' HD22 ' A' ' 121' ' ' LEU . 90.1 mt -90.85 119.92 31.46 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -118.25 143.21 46.74 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -74.03 146.29 43.85 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.053 -179.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.504 HG12 HD13 ' A' ' 122' ' ' ILE . 17.5 m -64.09 155.46 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.272 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -145.57 100.43 3.43 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -67.13 -20.23 65.74 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.027 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -67.8 -24.66 65.33 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -136.42 84.93 2.11 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.1 mt -101.3 5.18 42.28 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -93.43 17.46 11.39 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -90.56 109.48 20.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.453 ' HG3' ' HA ' ' A' ' 23' ' ' SER . 10.7 ptmt -66.47 -20.1 65.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.749 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -70.44 -19.25 62.99 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -95.31 -1.61 50.99 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -101.95 135.07 44.13 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -118.48 138.47 52.48 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -112.97 148.63 34.65 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.86 138.19 51.69 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.0 t -128.99 143.84 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.7 mt -108.41 152.48 42.04 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.2 149.96 76.49 Favored 'Trans proline' 0 CA--C 1.496 -1.401 0 C-N-CA 121.826 1.684 . . . . 0.0 113.234 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.9 t -119.22 125.71 74.69 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.262 1.728 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttm . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.154 0.502 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.78 148.58 28.03 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.89 154.66 28.28 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.69 76.55 8.05 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.4 mtt -70.47 -29.84 66.49 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.97 89.39 3.05 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -72.34 -23.24 61.12 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -81.06 146.97 30.36 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.3 p -140.11 150.73 44.64 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -134.81 171.34 14.52 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.29 159.55 15.31 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -83.53 157.18 64.94 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.45 141.31 89.98 Favored 'Trans proline' 0 CA--C 1.499 -1.241 0 C-N-CA 121.903 1.736 . . . . 0.0 112.891 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -90.48 155.83 18.63 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.89 -158.82 33.74 Favored Glycine 0 CA--C 1.496 -1.096 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.653 ' HB3' HD22 ' A' ' 55' ' ' LEU . 47.6 m0 -80.72 141.18 35.1 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -156.63 162.14 39.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.427 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 54.8 m-85 -120.92 140.01 52.43 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.1 mt -97.64 117.31 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.36 127.49 53.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.508 0.67 . . . . 0.0 109.992 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -87.33 114.38 23.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -60.12 -35.19 74.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 t -63.72 -43.86 95.3 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.685 -0.634 . . . . 0.0 111.5 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -99.36 -21.39 16.04 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.374 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.46 20.14 77.24 Favored Glycine 0 C--N 1.346 1.115 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -112.07 171.9 7.23 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.1 160.77 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.907 HD23 HG21 ' A' ' 41' ' ' ILE . 2.5 mp -69.18 133.81 48.45 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.592 0.711 . . . . 0.0 109.62 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.6 ttp -145.32 164.38 31.61 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.686 HG11 ' H ' ' A' ' 34' ' ' SER . 1.3 p -69.41 172.32 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' H ' HG22 ' A' ' 30' ' ' VAL . 19.0 t70 -53.22 -48.86 67.8 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.645 -0.659 . . . . 0.0 111.455 -176.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -172.55 75.21 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.04 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 51.75 47.72 24.24 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.686 ' H ' HG11 ' A' ' 30' ' ' VAL . 67.5 m -102.12 121.96 43.22 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.84 -1.51 49.38 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -82.77 150.4 26.67 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.0 t -80.65 149.45 29.81 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.57 8.73 60.71 Favored Glycine 0 C--N 1.355 1.625 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.5 t -83.46 124.61 75.48 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HA ' HG12 ' A' ' 87' ' ' VAL . 44.5 Cg_exo -59.2 148.75 84.52 Favored 'Trans proline' 0 CA--C 1.498 -1.324 0 C-N-CA 122.061 1.841 . . . . 0.0 113.016 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.907 HG21 HD23 ' A' ' 28' ' ' LEU . 24.1 mm -88.59 131.89 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 25.1 m -132.39 167.98 25.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.0 mt -96.45 144.24 26.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.85 149.77 33.95 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -62.8 144.06 56.91 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.85 138.98 57.02 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.412 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 46.4 ttt85 -117.98 138.16 52.37 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.1 m -64.52 -29.17 70.2 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.344 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 47' ' ' ARG . 17.4 ptpt -129.65 160.39 33.49 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 57.89 42.23 23.4 Favored 'General case' 0 C--N 1.361 1.076 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -98.25 11.55 37.53 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.55 87.7 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.0 p -73.73 -12.21 60.64 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -101.12 1.92 39.73 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.653 HD22 ' HB3' ' A' ' 16' ' ' TRP . 31.5 mt -99.58 137.5 37.98 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -128.57 154.85 45.76 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -138.44 153.91 48.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -105.0 118.55 36.81 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -85.05 156.44 60.48 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.26 -19.48 50.42 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 122.396 2.064 . . . . 0.0 113.742 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -73.23 -16.24 61.41 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.4 14.44 25.84 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -111.62 160.8 16.89 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 118.153 0.977 . . . . 0.0 108.667 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.77 135.39 47.29 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.992 HG22 HG12 ' A' ' 72' ' ' VAL . 59.4 t -120.65 140.45 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -88.92 123.42 33.26 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -63.34 -37.51 87.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 121.695 -0.628 . . . . 0.0 111.793 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -62.87 -49.41 74.96 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 121.977 -0.452 . . . . 0.0 111.383 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 87.7 p -91.07 -30.18 16.9 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.313 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.82 5.79 89.05 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 107.222 -2.351 . . . . 0.0 107.222 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -99.04 166.41 11.28 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 65' ' ' VAL . 16.5 m -116.17 164.15 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.0 139.16 50.44 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -156.97 170.84 21.61 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.406 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -87.44 143.22 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.37 83.63 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.346 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -71.28 -33.53 69.83 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.406 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.14 -8.12 80.39 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 105.863 -2.895 . . . . 0.0 105.863 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.6 m -123.06 127.17 25.77 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.33 126.91 13.45 Favored 'Trans proline' 0 CA--C 1.496 -1.411 0 C-N-CA 120.974 1.116 . . . . 0.0 112.906 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.0 157.81 43.87 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.88 132.65 43.79 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.51 7.11 85.07 Favored Glycine 0 C--N 1.345 1.034 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.431 ' CG1' HD12 ' A' ' 140' ' ' LEU . 10.1 p -71.82 143.77 13.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 CA-C-N 118.608 1.204 . . . . 0.0 108.094 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -84.13 154.49 23.1 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.466 HD11 ' HG ' ' A' ' 140' ' ' LEU . 48.3 mm -109.14 127.84 65.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.3 m -131.17 161.18 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -84.6 137.84 33.06 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -144.41 172.97 12.21 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.8 m -65.36 149.35 50.14 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -69.22 156.22 39.1 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 96' ' ' VAL . . . -71.36 148.4 47.06 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.85 -161.76 37.11 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -88.66 4.06 48.47 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -99.76 16.42 23.68 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.473 HG21 ' HB1' ' A' ' 92' ' ' ALA . 82.1 t -113.99 124.04 70.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -66.26 164.26 16.24 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.863 0.84 . . . . 0.0 109.972 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.98 -20.44 61.02 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -90.25 -5.04 56.79 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -113.06 6.59 17.7 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -88.97 98.56 11.82 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -96.79 -8.0 32.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -82.2 -9.87 59.35 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.95 128.83 34.13 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -117.48 152.24 35.46 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.51 152.75 17.33 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 105.971 -2.852 . . . . 0.0 105.971 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.2 tp -130.32 121.65 26.46 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 79.0 p -91.1 156.27 44.13 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 43.7 Cg_endo -68.25 -15.16 42.13 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 121.725 1.617 . . . . 0.0 112.451 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -72.68 -26.03 61.47 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.61 12.12 17.59 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -94.98 134.61 37.47 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.1 mt -107.35 125.3 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.74 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.8 p90 -135.71 176.1 8.99 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.634 HD12 ' HB2' ' A' ' 118' ' ' LYS . 3.5 mt -85.33 150.17 24.94 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.77 88.69 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.702 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -96.35 -11.12 26.25 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.569 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.634 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -135.25 84.9 34.47 Favored Pre-proline 0 CA--C 1.493 -1.213 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.8 -9.69 26.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.289 1.992 . . . . 0.0 112.205 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 79.7 p -88.64 -17.47 29.98 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.562 HD23 HD12 ' A' ' 142' ' ' LEU . 55.2 mt -102.91 129.95 49.79 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.74 HG22 ' HB3' ' A' ' 114' ' ' TYR . 37.9 pt -135.58 165.19 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.249 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.9 mt -77.74 138.51 39.07 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.68 176.94 36.37 Favored Glycine 0 CA--C 1.495 -1.216 0 N-CA-C 107.466 -2.254 . . . . 0.0 107.466 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -133.88 160.51 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -110.61 126.24 54.26 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -96.56 134.84 39.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.4 t -149.9 157.42 43.16 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -69.77 -26.58 64.36 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.13 31.41 3.96 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.96 103.02 6.3 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 27.9 tpt180 -62.0 137.51 58.26 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.47 -35.27 77.17 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 94.9 mt-10 -85.85 86.37 7.36 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.28 10.57 1.46 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 80.1 mt -64.53 126.74 28.82 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.577 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -83.22 151.2 25.76 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 121.696 0.76 . . . . 0.0 109.726 -177.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.44 139.15 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -146.52 166.42 26.5 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.466 ' HG ' HD11 ' A' ' 86' ' ' ILE . 90.6 mt -88.49 121.17 30.58 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -112.49 140.9 46.85 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.562 HD12 HD23 ' A' ' 121' ' ' LEU . 1.4 tp -69.68 138.91 53.35 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 119.116 -1.033 . . . . 0.0 108.821 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.3 134.18 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.349 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -119.26 88.18 2.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.435 ' HA ' HD21 ' A' ' 148' ' ' LEU . 23.5 pttp -63.65 -20.13 65.44 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.996 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.497 ' HG3' ' CD2' ' A' ' 147' ' ' HIS . 17.9 ptm180 -68.04 -21.47 65.01 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.497 ' CD2' ' HG3' ' A' ' 146' ' ' ARG . 99.4 m-70 -139.05 86.64 2.15 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.435 HD21 ' HA ' ' A' ' 145' ' ' LYS . 95.2 mt -100.91 4.52 42.71 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -95.1 10.92 34.0 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -83.36 140.11 32.61 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -71.17 -23.96 62.15 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.33 -26.54 62.87 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -89.57 -1.06 57.91 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.34 133.72 52.7 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.67 0.747 . . . . 0.0 109.051 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -122.84 144.58 49.1 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -126.24 163.82 22.35 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -126.79 144.15 51.04 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.64 144.35 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -109.58 154.94 42.12 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.97 140.58 92.7 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 122.019 1.813 . . . . 0.0 113.198 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.6 t -118.61 125.86 74.72 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--O 1.263 1.782 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 121.205 0.526 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.73 40.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.78 149.13 32.75 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.79 143.63 23.73 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.7 tpp -83.28 -20.6 34.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 75.74 55.84 0.06 Allowed 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.31 -22.23 61.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -81.41 144.57 31.33 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.6 m -125.16 143.94 50.69 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -124.66 171.8 9.77 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 158.52 16.44 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -90.56 156.91 44.98 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.17 150.92 84.74 Favored 'Trans proline' 0 CA--C 1.498 -1.279 0 C-N-CA 121.53 1.487 . . . . 0.0 112.166 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -102.4 158.68 16.03 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.27 -165.39 31.4 Favored Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.655 ' HB3' HD22 ' A' ' 55' ' ' LEU . 50.1 m0 -77.3 140.36 40.0 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -158.41 164.49 36.23 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.427 ' CE1' HD21 ' A' ' 55' ' ' LEU . 44.9 m-85 -120.59 139.99 52.17 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.438 HD11 HD13 ' A' ' 64' ' ' LEU . 84.5 mt -102.26 115.52 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -114.06 131.55 56.34 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -85.5 124.25 31.86 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.15 -36.29 79.39 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.1 t -64.07 -42.68 96.89 Favored 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 121.601 -0.687 . . . . 0.0 111.214 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -96.52 -24.16 16.2 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.052 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.03 17.61 78.72 Favored Glycine 0 C--N 1.347 1.158 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -109.69 166.27 11.04 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.73 160.76 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.821 HD23 HG21 ' A' ' 41' ' ' ILE . 1.8 mp -70.68 135.19 48.14 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.54 0.686 . . . . 0.0 109.661 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.5 ttp -145.58 164.67 30.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.697 HG11 ' H ' ' A' ' 34' ' ' SER . 4.0 p -70.53 174.37 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 177.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.641 ' H ' HG22 ' A' ' 30' ' ' VAL . 35.9 t70 -54.21 -48.03 71.47 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.713 -0.617 . . . . 0.0 111.317 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -171.85 74.1 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 119.564 -0.854 . . . . 0.0 108.888 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 51.94 47.37 24.9 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.697 ' H ' HG11 ' A' ' 30' ' ' VAL . 66.8 m -99.17 117.71 34.24 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -91.86 -2.36 56.89 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -87.39 141.41 28.65 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.1 m -74.73 154.37 38.42 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.77 7.78 61.19 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 p -93.94 141.97 24.4 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HA ' HG12 ' A' ' 87' ' ' VAL . 35.6 Cg_exo -61.89 153.53 67.66 Favored 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 122.527 2.151 . . . . 0.0 113.945 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.821 HG21 HD23 ' A' ' 28' ' ' LEU . 30.8 mm -96.78 129.89 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 27.6 m -133.71 166.37 29.25 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.207 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 125' ' ' ILE . 91.5 mt -90.36 144.54 25.72 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.66 148.63 31.26 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.4 t -67.69 156.3 37.23 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.99 139.24 58.21 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.01 148.03 52.7 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -83.46 -10.45 58.36 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -125.14 146.79 49.32 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 57.96 42.67 22.46 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -91.94 -2.06 56.96 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.61 -38.39 90.95 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.0 p -72.78 -13.22 61.27 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.18 1.82 42.37 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 16' ' ' TRP . 30.0 mt -98.28 138.41 35.58 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.6 150.99 48.57 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -127.59 133.39 49.73 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.417 ' HA ' HD23 ' A' ' 64' ' ' LEU . 83.5 t60 -89.18 110.47 21.21 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.34 141.6 83.46 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.1 -19.32 40.61 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 121.823 1.682 . . . . 0.0 114.076 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.409 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 68.9 m -73.67 -17.73 61.11 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.4 10.39 17.5 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 61' ' ' SER . 1.0 OUTLIER -104.93 164.9 11.44 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 118.607 1.203 . . . . 0.0 108.25 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD13 HD11 ' A' ' 19' ' ' ILE . 91.9 mt -112.73 129.94 56.24 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.951 HG22 HG12 ' A' ' 72' ' ' VAL . 80.4 t -114.8 134.04 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -77.8 129.34 35.33 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.58 -41.61 99.04 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 122.035 -0.416 . . . . 0.0 110.996 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -75.29 -53.68 8.36 Favored 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 122.039 -0.413 . . . . 0.0 111.171 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.6 m -70.34 -39.77 74.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.58 90.07 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -96.73 166.76 11.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.951 HG12 HG22 ' A' ' 65' ' ' VAL . 28.4 m -117.52 160.68 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.5 mtt -70.5 139.66 51.69 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -157.07 170.09 23.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.17 143.54 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.74 -42.26 86.52 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.29 -33.44 69.72 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.9 -7.73 81.17 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.1 m -124.88 128.72 24.8 Favored Pre-proline 0 N--CA 1.436 -1.135 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.53 126.59 13.65 Favored 'Trans proline' 0 CA--C 1.494 -1.476 0 C-N-CA 120.91 1.073 . . . . 0.0 112.865 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.7 167.09 23.01 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.03 128.1 33.08 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.21 76.52 Favored Glycine 0 C--N 1.345 1.037 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.34 143.31 14.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.71 155.98 25.26 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-O 121.46 0.648 . . . . 0.0 109.466 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.674 HD11 HD13 ' A' ' 140' ' ' LEU . 48.1 mm -113.71 128.78 70.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.3 m -133.22 161.58 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -85.72 137.68 32.64 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -142.38 175.22 9.94 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -71.83 165.18 24.64 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -84.53 156.98 21.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.05 159.01 44.35 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.26 -27.72 0.19 Allowed Glycine 0 CA--C 1.492 -1.344 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.8 t -64.19 -42.49 96.63 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -118.51 17.96 13.62 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -125.74 127.51 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -62.64 146.49 51.96 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -65.79 -19.38 65.87 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.36 -2.26 57.97 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -115.51 7.92 15.05 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -83.29 110.11 17.82 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -89.32 -7.96 54.27 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -80.11 -8.98 59.67 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -76.23 128.26 34.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.88 155.16 30.64 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.56 159.95 13.45 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 105.898 -2.881 . . . . 0.0 105.898 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 67.6 tp -132.98 125.25 29.34 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 97.8 p -93.02 157.57 38.93 Favored Pre-proline 0 N--CA 1.442 -0.841 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 56.5 Cg_endo -70.96 -8.5 23.76 Favored 'Trans proline' 0 CA--C 1.5 -1.21 0 C-N-CA 121.747 1.631 . . . . 0.0 112.539 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -87.52 -5.23 58.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.93 9.61 60.74 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -93.15 136.98 32.91 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -110.63 127.11 67.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.765 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.0 OUTLIER -133.8 178.52 6.88 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.71 HD12 ' HB2' ' A' ' 118' ' ' LYS . 4.3 mt -86.81 149.65 24.69 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.97 -36.42 84.34 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.765 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -99.8 -9.7 22.67 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.412 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.71 ' HB2' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.92 83.39 40.63 Favored Pre-proline 0 CA--C 1.493 -1.225 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -69.15 -8.73 24.39 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.206 1.938 . . . . 0.0 111.987 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.5 m -86.92 -14.65 41.24 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.57 HD23 HD12 ' A' ' 142' ' ' LEU . 75.6 mt -109.19 131.25 55.24 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.765 HG22 ' HB3' ' A' ' 114' ' ' TYR . 25.1 pt -134.22 166.5 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.7 mt -78.94 137.05 37.44 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.4 171.87 34.13 Favored Glycine 0 CA--C 1.494 -1.274 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.612 HG21 HD11 ' A' ' 43' ' ' LEU . 1.6 pp -135.36 160.19 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -118.35 141.89 48.07 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -134.75 149.69 50.47 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.672 ' H ' ' HB3' ' A' ' 131' ' ' ALA . 8.3 t -149.99 -179.52 7.22 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -71.67 -29.04 64.16 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.48 37.25 2.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.672 ' HB3' ' H ' ' A' ' 128' ' ' SER . . . -126.55 101.83 6.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.546 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 29.2 tpt180 -65.13 135.76 55.88 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -61.7 -35.86 79.26 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.546 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 14.8 mt-10 -85.55 86.02 7.39 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.55 4.64 1.62 Allowed Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.86 129.31 39.34 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.51 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -92.32 155.68 17.76 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.542 0.687 . . . . 0.0 109.399 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.11 146.92 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -146.6 166.4 26.64 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.674 HD13 HD11 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -91.12 114.22 26.69 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -103.95 142.93 33.56 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 121' ' ' LEU . 5.3 tp -70.3 137.06 50.36 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.66 143.21 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.36 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -138.03 96.56 3.23 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.08 -18.46 63.41 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.192 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -66.45 -27.79 68.09 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -133.53 84.7 2.15 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.4 mt -107.8 4.38 25.47 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -97.72 19.94 12.79 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -83.2 136.46 34.41 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -70.41 -22.19 62.76 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.15 -26.03 61.94 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -92.32 -0.79 57.37 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -92.52 132.97 36.38 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -124.54 140.12 53.24 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -123.92 155.75 37.56 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -118.06 139.25 51.48 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 t -127.93 144.15 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.116 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.0 mt -108.56 152.28 42.05 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.63 150.41 74.64 Favored 'Trans proline' 0 CA--C 1.497 -1.346 0 C-N-CA 121.745 1.63 . . . . 0.0 113.136 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.4 t -118.77 125.95 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.263 1.793 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 121.267 0.556 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.69 150.11 29.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.24 153.51 30.75 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.23 76.6 7.62 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 75.7 mtm -87.76 -11.78 47.09 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.24 85.24 2.32 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.43 -20.95 59.85 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -78.07 142.81 37.91 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -146.67 139.48 25.26 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -133.71 171.46 14.1 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.13 162.5 32.34 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -82.09 124.81 78.43 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.43 -21.84 19.24 Favored 'Trans proline' 0 CA--C 1.499 -1.234 0 C-N-CA 121.818 1.679 . . . . 0.0 113.043 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 155.07 17.43 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.98 -53.27 2.89 Favored Glycine 0 CA--C 1.494 -1.239 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -94.06 134.22 36.72 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -163.32 162.73 25.26 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.43 ' CE1' HD21 ' A' ' 55' ' ' LEU . 58.3 m-85 -118.86 138.87 52.43 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 80.9 mt -105.67 118.0 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -116.63 131.24 57.0 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -86.23 128.8 34.96 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -65.48 -24.64 67.21 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.0 p -67.47 -38.09 83.89 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 121.357 -0.84 . . . . 0.0 111.471 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -112.33 -20.1 11.95 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.043 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.32 22.07 76.58 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -109.81 163.15 13.79 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 m -115.04 161.25 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.953 HD23 HG21 ' A' ' 41' ' ' ILE . 3.2 mp -68.13 132.28 46.91 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.609 0.719 . . . . 0.0 109.438 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.7 ttp -145.71 163.67 34.19 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 31' ' ' ASP . 56.1 t -68.23 157.04 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.2 t70 -49.39 -39.9 34.04 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 122.133 -0.354 . . . . 0.0 111.714 -177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -150.94 36.13 0.61 Allowed 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.342 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 61.84 42.93 9.91 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.6 m -91.6 119.31 31.39 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -78.55 -12.13 60.0 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -86.07 145.96 26.83 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.8 m -76.34 162.23 28.06 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.07 11.26 34.69 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.0 p -117.68 147.69 41.48 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 73.0 Cg_endo -76.07 162.35 34.48 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.214 1.943 . . . . 0.0 113.401 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.953 HG21 HD23 ' A' ' 28' ' ' LEU . 22.9 mm -94.38 131.71 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 23.6 m -132.2 170.24 20.31 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.6 mt -99.14 143.46 29.39 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.53 150.95 36.53 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 m -59.99 145.26 46.85 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 139.84 58.2 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -126.8 147.61 50.0 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -88.5 -7.49 56.43 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.22 140.13 52.45 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.5 t0 57.6 44.96 20.05 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -86.49 -2.19 58.25 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.47 84.06 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.5 p -72.15 -14.74 61.9 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -103.07 3.32 35.88 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 18' ' ' PHE . 17.5 mt -97.16 135.41 39.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -128.83 154.74 46.15 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -136.54 152.34 50.39 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -103.11 116.41 32.45 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.59 157.05 67.85 Favored Pre-proline 0 N--CA 1.441 -0.913 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.64 -24.08 60.71 Favored 'Trans proline' 0 CA--C 1.498 -1.287 0 C-N-CA 122.296 1.997 . . . . 0.0 113.867 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -71.24 -19.58 62.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.54 10.37 31.29 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' CD2' ' HB2' ' A' ' 103' ' ' GLN . 2.1 m-85 -97.7 159.37 14.97 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.18 129.57 55.18 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.81 HG22 HG12 ' A' ' 72' ' ' VAL . 98.0 t -117.94 136.17 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -76.71 132.49 39.35 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -62.59 -42.81 99.79 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.053 -0.404 . . . . 0.0 111.184 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -78.9 -51.63 9.42 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.812 -0.555 . . . . 0.0 111.386 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.3 m -68.37 -39.76 81.67 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.43 5.38 90.01 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 106.422 -2.671 . . . . 0.0 106.422 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -99.39 161.46 13.6 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.81 HG12 HG22 ' A' ' 65' ' ' VAL . 1.1 m -108.05 165.98 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 63.3 mtt -80.2 133.2 36.0 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -152.04 175.93 12.03 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 118.876 -1.129 . . . . 0.0 108.913 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.94 142.25 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.73 -43.1 80.78 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.895 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -71.96 -33.04 67.86 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.14 -6.79 82.45 Favored Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 105.77 -2.932 . . . . 0.0 105.77 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.7 m -115.62 120.84 35.38 Favored Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.13 115.78 4.45 Favored 'Trans proline' 0 CA--C 1.497 -1.361 0 C-N-CA 121.211 1.274 . . . . 0.0 112.918 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.9 168.04 21.8 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.59 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -76.53 137.57 39.67 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.94 2.36 88.46 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.54 132.71 32.92 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 CA-C-N 119.355 1.577 . . . . 0.0 108.228 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -73.71 154.81 39.49 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 121.518 0.675 . . . . 0.0 109.74 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.5 mm -105.19 128.43 59.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.898 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 40' ' ' PRO . 26.7 m -130.6 166.3 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -100.95 141.83 33.28 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.32 169.97 13.58 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.3 m -73.17 129.18 37.49 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -131.25 161.59 31.91 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.485 0.66 . . . . 0.0 110.141 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 72.98 -159.41 0.09 Allowed 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.37 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.3 -166.21 37.59 Favored Glycine 0 CA--C 1.487 -1.662 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -68.82 -23.95 64.32 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -160.12 71.12 0.45 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.498 HG13 HD21 ' A' ' 101' ' ' ASN . 9.3 p -81.91 142.06 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 141.84 57.28 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -74.47 -15.53 60.88 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.38 -5.09 57.75 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -116.37 13.32 15.49 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.498 HD21 HG13 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -84.66 97.99 9.95 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -98.87 -9.95 23.55 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.457 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -94.37 -1.68 53.33 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -72.17 125.36 27.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -115.81 151.77 34.59 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.64 141.88 17.27 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 105.78 -2.928 . . . . 0.0 105.78 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.1 tp -105.6 124.92 50.36 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.404 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 0.9 OUTLIER -93.99 140.53 22.96 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.31 -8.17 22.96 Favored 'Trans proline' 0 CA--C 1.5 -1.214 0 C-N-CA 121.998 1.799 . . . . 0.0 112.916 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.8 0.11 55.4 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.69 35.0 8.04 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -127.08 147.99 50.15 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -118.51 126.86 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.058 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.645 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -137.74 174.03 11.02 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.637 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 13.3 mt -83.44 150.67 25.89 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.03 -22.91 58.16 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -104.69 -21.91 13.31 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.915 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.637 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 13.8 mptt -132.39 84.82 50.51 Favored Pre-proline 0 CA--C 1.498 -1.056 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -67.12 -9.24 24.39 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.542 2.161 . . . . 0.0 112.827 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.6 p -84.99 -14.76 46.46 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.802 HD13 HD13 ' A' ' 140' ' ' LEU . 80.4 mt -104.83 130.42 52.95 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.645 HG22 ' HB3' ' A' ' 114' ' ' TYR . 32.0 pt -135.27 166.47 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.6 mt -83.9 139.23 32.75 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.31 179.22 35.97 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 107.555 -2.218 . . . . 0.0 107.555 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 137' ' ' HIS . 2.0 pp -132.67 160.55 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -108.76 125.29 51.77 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -96.33 135.1 38.63 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.5 t -149.92 157.32 43.06 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -69.76 -26.63 64.39 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.12 32.14 3.63 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.07 103.67 6.65 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.561 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 28.0 tpt180 -61.73 136.38 57.97 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -61.84 -35.37 78.05 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.561 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 94.5 mt-10 -84.87 86.53 7.35 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.16 12.12 1.7 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.76 127.86 33.32 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.577 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -84.17 151.83 24.63 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 121.746 0.784 . . . . 0.0 109.763 -177.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.3 t -94.94 140.12 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -146.63 165.78 28.5 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.802 HD13 HD13 ' A' ' 121' ' ' LEU . 98.5 mt -78.99 122.94 26.8 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -110.97 139.11 46.58 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.658 HD12 HD23 ' A' ' 121' ' ' LEU . 3.7 tp -78.34 135.62 37.53 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 118.684 -1.206 . . . . 0.0 108.075 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.87 146.68 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.225 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -137.86 96.35 3.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -64.17 -19.59 65.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.664 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -70.12 -24.0 63.12 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -139.06 85.25 2.06 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -100.79 4.51 42.99 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.14 21.09 10.33 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -83.26 130.35 35.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -68.01 -22.24 64.99 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.48 -36.12 73.67 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -89.49 -1.41 58.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -94.76 131.41 40.63 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -119.62 137.88 53.59 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -112.09 154.77 24.92 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -128.57 143.43 50.96 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.99 144.69 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.64 153.76 42.04 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -58.08 141.06 96.15 Favored 'Trans proline' 0 CA--C 1.499 -1.271 0 C-N-CA 122.076 1.85 . . . . 0.0 113.14 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.8 t -118.73 125.73 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 C--O 1.262 1.727 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.201 0.524 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.98 154.11 35.38 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.22 153.96 34.83 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 64.84 53.76 1.42 Allowed 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -76.61 -8.21 56.77 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -92.1 67.57 5.08 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.74 -22.21 61.65 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -99.62 152.33 20.17 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.2 t -146.21 138.42 25.17 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -94.55 170.9 9.14 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -104.78 162.67 13.11 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -83.3 156.83 66.01 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.49 151.5 82.88 Favored 'Trans proline' 0 CA--C 1.498 -1.286 0 C-N-CA 121.604 1.536 . . . . 0.0 112.395 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -88.61 156.7 18.9 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.777 0.798 . . . . 0.0 108.993 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.75 -168.42 37.75 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.7 ' HB3' HD22 ' A' ' 55' ' ' LEU . 46.5 m0 -77.73 146.1 36.15 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.17 160.83 41.2 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.49 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 47.9 m-85 -119.62 139.52 52.06 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.493 HG22 ' CE3' ' A' ' 155' ' ' TRP . 89.5 mt -107.27 114.65 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -109.99 132.7 53.92 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -83.47 122.95 29.21 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -61.83 -34.61 76.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 t -63.7 -43.55 96.29 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 121.653 -0.655 . . . . 0.0 111.399 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -101.62 -21.84 14.6 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.49 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.7 19.68 78.86 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -110.52 167.02 10.53 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 m -115.0 159.44 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.167 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.746 HD12 HG21 ' A' ' 41' ' ' ILE . 2.5 pt? -85.03 144.22 28.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.221 1.01 . . . . 0.0 109.259 -178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.524 ' HG2' ' H ' ' A' ' 30' ' ' VAL . 33.4 ttp -145.6 173.88 11.66 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.524 ' H ' ' HG2' ' A' ' 29' ' ' MET . 21.5 t -68.42 163.98 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.534 ' HA ' HG22 ' A' ' 42' ' ' VAL . 36.3 t70 -54.94 -40.47 69.95 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.741 -0.599 . . . . 0.0 110.433 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -160.2 48.32 0.26 Allowed 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 55.01 46.55 24.03 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.5 m -81.7 129.14 34.61 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -90.72 -2.12 57.83 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -97.54 152.44 19.02 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.0 p -80.29 166.73 21.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.6 12.51 75.07 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.2 t -94.18 123.51 58.75 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 87' ' ' VAL . 42.8 Cg_exo -59.17 148.94 83.49 Favored 'Trans proline' 0 CA--C 1.499 -1.267 0 C-N-CA 122.167 1.912 . . . . 0.0 113.414 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.746 HG21 HD12 ' A' ' 28' ' ' LEU . 26.1 mm -88.06 129.71 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG22 ' HA ' ' A' ' 31' ' ' ASP . 24.7 m -131.92 161.41 41.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 125' ' ' ILE . 92.3 mt -86.65 145.85 26.55 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.99 152.16 38.95 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -63.65 144.45 57.01 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.46 139.32 57.77 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -123.5 146.91 47.71 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 m -86.9 -14.4 42.04 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -125.41 147.27 49.25 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 58.49 41.27 22.92 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -90.37 0.35 57.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.03 85.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 t -67.48 -24.43 65.59 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.97 3.36 55.03 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.7 HD22 ' HB3' ' A' ' 16' ' ' TRP . 38.4 mt -98.1 138.01 36.04 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.948 0.88 . . . . 0.0 108.924 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -130.69 156.22 45.29 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -142.22 153.71 44.21 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.453 ' CD2' ' O ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -107.46 135.92 48.12 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.004 0.907 . . . . 0.0 108.754 -178.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.35 158.92 54.3 Favored Pre-proline 0 N--CA 1.436 -1.152 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.0 -18.15 56.01 Favored 'Trans proline' 0 CA--C 1.499 -1.26 0 C-N-CA 121.616 1.544 . . . . 0.0 113.162 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.2 m -80.22 -13.08 59.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.6 39.97 Favored Glycine 0 C--N 1.358 1.763 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -96.77 147.68 23.68 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.46 134.38 43.5 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.914 HG22 HG12 ' A' ' 72' ' ' VAL . 61.2 t -120.16 137.56 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -76.82 130.95 38.36 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -62.55 -42.61 99.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.203 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -77.95 -52.36 8.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.845 -0.534 . . . . 0.0 111.418 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.7 m -70.4 -39.09 74.7 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.88 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.37 5.14 89.83 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 106.251 -2.739 . . . . 0.0 106.251 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -96.56 167.44 11.14 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.914 HG12 HG22 ' A' ' 65' ' ' VAL . 25.9 m -116.53 161.18 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.505 ' CE ' HD11 ' A' ' 28' ' ' LEU . 61.6 mtt -73.49 140.52 46.48 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -159.22 169.85 23.22 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.408 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -82.93 143.44 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.51 76.63 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.624 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -72.33 -32.84 66.86 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.15 -7.99 80.61 Favored Glycine 0 CA--C 1.495 -1.216 0 N-CA-C 105.871 -2.892 . . . . 0.0 105.871 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.6 m -119.67 126.23 27.04 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.59 117.21 5.03 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 121.17 1.247 . . . . 0.0 113.069 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -137.07 162.73 32.56 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.68 129.8 37.69 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.68 8.65 82.56 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' CG1' HD12 ' A' ' 140' ' ' LEU . 11.6 p -71.45 142.22 15.75 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 CA-C-N 118.619 1.21 . . . . 0.0 108.235 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -82.3 155.32 24.87 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.466 0.65 . . . . 0.0 109.495 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.444 HD11 ' HG ' ' A' ' 140' ' ' LEU . 48.3 mm -109.49 129.36 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.9 m -132.92 166.73 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -81.78 141.01 33.89 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -142.13 170.68 15.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.6 m -70.3 148.3 48.66 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -68.31 137.54 54.74 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.63 -158.74 0.69 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.56 -16.13 56.69 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.2 p -70.24 -39.36 75.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -133.3 21.0 4.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.7 t -126.67 129.32 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -62.07 141.93 57.83 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -69.23 -17.12 63.74 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -89.71 -6.25 56.26 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.5 mt -119.55 10.05 11.68 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -94.56 132.06 39.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.45 -6.78 49.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.78 -10.57 59.47 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.12 128.49 33.57 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.22 154.77 32.86 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.85 158.89 14.04 Favored Glycine 0 C--N 1.353 1.48 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.3 tp -118.43 120.07 36.46 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.431 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.1 t -82.07 140.55 46.25 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.48 -9.36 25.07 Favored 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 121.832 1.688 . . . . 0.0 112.768 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.68 2.34 56.03 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.98 20.25 40.08 Favored Glycine 0 C--N 1.356 1.684 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -108.91 150.23 28.01 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.7 mt -116.2 126.13 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.663 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -131.78 174.33 10.25 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.667 HD12 ' HB2' ' A' ' 118' ' ' LYS . 14.0 mt -84.11 150.01 25.83 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.38 -23.5 61.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -106.83 -18.86 13.81 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.149 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HB2' HD12 ' A' ' 115' ' ' LEU . 13.9 mptt -132.18 84.94 51.12 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.6 -9.22 24.69 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.506 2.137 . . . . 0.0 112.58 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.424 ' HA ' HG12 ' A' ' 143' ' ' VAL . 88.6 p -83.99 -15.99 45.66 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.603 HD23 HD12 ' A' ' 142' ' ' LEU . 73.3 mt -106.63 131.02 54.26 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.663 HG22 ' HB3' ' A' ' 114' ' ' TYR . 32.0 pt -134.21 164.44 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.7 mt -81.47 138.48 35.51 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.7 -179.52 38.1 Favored Glycine 0 CA--C 1.494 -1.25 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -130.35 161.41 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.517 ' O ' HD22 ' A' ' 136' ' ' LEU . 39.9 ttmt -113.75 144.42 43.0 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -66.95 156.82 34.88 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.7 t -110.97 160.47 16.78 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -65.26 -36.1 83.06 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -95.59 3.41 54.08 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 50.7 44.63 27.63 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.088 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -86.07 114.75 23.19 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -74.61 -20.12 60.03 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -91.32 90.05 7.55 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 134.06 2.46 3.41 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.517 HD22 ' O ' ' A' ' 126' ' ' LYS . 89.9 mt -66.96 131.18 45.34 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.609 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -90.85 156.62 17.89 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.602 0.715 . . . . 0.0 109.598 -177.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.67 139.55 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -148.14 167.59 24.65 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.454 HD12 ' CG1' ' A' ' 84' ' ' VAL . 90.7 mt -89.2 118.86 29.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -104.07 138.48 40.52 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.603 HD12 HD23 ' A' ' 121' ' ' LEU . 4.3 tp -72.27 135.02 45.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 118.924 -1.11 . . . . 0.0 108.115 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 120' ' ' SER . 7.7 p -61.72 141.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.189 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -131.35 101.88 5.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -64.78 -28.73 69.77 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.557 ' HG3' ' CD2' ' A' ' 147' ' ' HIS . 37.9 ptt180 -68.8 -18.42 64.18 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.557 ' CD2' ' HG3' ' A' ' 146' ' ' ARG . 97.4 m-70 -132.97 77.29 1.73 Allowed 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.6 mt -99.99 3.74 44.44 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -97.35 31.79 2.41 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -102.3 116.57 32.91 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -68.33 -20.42 64.73 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.951 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -72.33 -19.37 61.66 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -96.91 -0.98 46.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -98.19 133.6 42.4 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.493 ' CE3' HG22 ' A' ' 19' ' ' ILE . 94.9 m95 -118.36 139.02 52.0 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -110.27 144.45 38.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -112.04 135.43 52.69 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.4 t -128.79 144.46 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.57 153.03 41.61 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.67 149.49 79.08 Favored 'Trans proline' 0 CA--C 1.496 -1.4 0 C-N-CA 121.764 1.643 . . . . 0.0 113.278 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.7 t -120.88 126.34 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.265 1.87 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.107 0.479 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 152.95 32.7 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.54 153.55 32.62 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.71 99.64 11.45 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 tpp -66.08 -40.11 90.59 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.07 88.51 2.9 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -72.69 -23.55 60.89 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.5 146.57 30.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -146.31 138.91 25.33 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -97.78 163.32 12.86 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -90.63 138.28 31.69 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -75.03 155.71 86.36 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.6 141.81 95.44 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 121.922 1.748 . . . . 0.0 112.691 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.55 157.48 16.18 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.25 -162.81 37.02 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.682 ' HB3' HD22 ' A' ' 55' ' ' LEU . 49.0 m0 -79.67 142.94 35.08 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -158.04 163.01 38.14 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.441 ' CE1' HD21 ' A' ' 55' ' ' LEU . 49.7 m-85 -119.8 139.82 51.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.562 HD11 ' CD2' ' A' ' 64' ' ' LEU . 84.7 mt -102.3 113.94 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.166 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -114.42 131.06 56.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -83.86 126.27 32.8 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -63.35 -28.28 69.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.8 p -71.0 -36.99 72.68 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 121.354 -0.841 . . . . 0.0 111.396 -176.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -105.05 -23.8 12.89 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.373 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.83 18.46 80.11 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -108.0 165.31 11.56 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.4 m -117.57 160.42 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.904 HD23 HG21 ' A' ' 41' ' ' ILE . 4.8 mp -68.63 133.76 48.94 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.956 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.6 ttp -145.43 163.25 35.22 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 31' ' ' ASP . 21.1 t -67.74 164.08 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' N ' HG12 ' A' ' 30' ' ' VAL . 18.6 t70 -53.62 -39.18 64.74 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 121.871 -0.518 . . . . 0.0 110.294 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -161.62 50.93 0.23 Allowed 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 54.87 41.59 31.78 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.9 m -75.19 132.96 41.5 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -96.81 1.38 50.66 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -103.02 150.27 23.73 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -77.01 158.42 30.59 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.66 8.59 62.11 Favored Glycine 0 C--N 1.356 1.661 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.2 t -93.35 126.14 51.61 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HA ' HG12 ' A' ' 87' ' ' VAL . 42.5 Cg_exo -59.23 150.63 72.92 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 122.251 1.968 . . . . 0.0 113.278 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.904 HG21 HD23 ' A' ' 28' ' ' LEU . 22.9 mm -90.62 130.09 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 25.6 m -132.19 164.2 35.49 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 121.701 0.762 . . . . 0.0 108.971 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.527 HD12 ' HB2' ' A' ' 136' ' ' LEU . 95.8 mt -85.42 145.29 27.52 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.95 148.73 32.04 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -62.91 143.5 57.6 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.4 139.45 57.67 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -121.35 146.56 46.73 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.4 p -87.34 -16.37 35.23 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -124.3 147.03 48.42 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 58.11 42.69 21.93 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -91.18 3.16 55.53 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.35 -37.41 87.16 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m -69.32 -17.37 63.71 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -100.64 3.88 42.85 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.682 HD22 ' HB3' ' A' ' 16' ' ' TRP . 25.8 mt -98.66 136.57 38.54 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -128.53 153.83 46.78 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -137.23 151.05 48.3 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -99.38 116.77 32.32 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -80.95 155.39 72.82 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.03 -15.75 45.56 Favored 'Trans proline' 0 CA--C 1.498 -1.286 0 C-N-CA 122.004 1.803 . . . . 0.0 113.256 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.6 m -77.94 -12.69 60.0 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.66 21.06 15.18 Favored Glycine 0 C--N 1.356 1.693 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -117.14 159.02 23.25 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 118.392 1.096 . . . . 0.0 108.215 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 19' ' ' ILE . 6.5 mp -106.01 126.29 52.02 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.725 HG22 HG22 ' A' ' 72' ' ' VAL . 98.1 t -115.57 137.34 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.062 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -74.07 131.3 41.21 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.21 -40.75 98.35 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 122.021 -0.424 . . . . 0.0 110.852 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -78.43 -56.33 4.52 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.305 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.415 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 68.0 m -70.22 -38.43 75.25 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -176.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.86 9.57 85.26 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 96.4 mm-40 -94.27 157.59 15.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.725 HG22 HG22 ' A' ' 65' ' ' VAL . 13.7 t -106.79 150.07 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 mtt -69.97 138.92 52.68 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -157.61 172.73 18.01 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.104 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.445 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -88.87 143.72 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.24 -42.8 88.11 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.44 -33.79 69.69 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.445 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 89.68 -8.42 79.85 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.5 m -124.73 122.29 25.68 Favored Pre-proline 0 N--CA 1.436 -1.159 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.03 129.21 32.03 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 121.389 1.392 . . . . 0.0 113.028 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 155.08 42.19 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.63 130.25 39.2 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.38 8.78 80.52 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.61 144.99 11.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -87.19 168.9 12.82 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.474 HD11 ' HG ' ' A' ' 140' ' ' LEU . 48.1 mm -116.92 128.64 74.27 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.2 m -130.24 160.08 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -86.22 138.41 31.89 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -140.16 167.88 21.11 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 91' ' ' GLN . 7.6 m -68.81 159.7 31.94 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.47 ' N ' HG22 ' A' ' 90' ' ' THR . 97.1 mt-30 -64.2 151.46 43.42 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.574 ' HB1' HG21 ' A' ' 96' ' ' VAL . . . -69.67 147.92 49.97 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.02 -167.02 43.29 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.8 p -85.63 1.59 48.6 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -98.82 21.25 11.74 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.574 HG21 ' HB1' ' A' ' 92' ' ' ALA . 98.2 t -115.08 123.25 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -65.25 150.11 48.79 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.7 -19.08 65.68 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -90.78 -2.31 57.8 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.8 mt -114.14 7.54 16.68 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -83.76 97.96 9.43 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -91.63 -6.64 51.88 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.289 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -74.26 -11.64 60.33 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -72.59 138.58 46.91 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -129.09 154.28 46.83 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.7 143.54 17.71 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 106.489 -2.644 . . . . 0.0 106.489 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.4 tp -109.54 123.95 50.28 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.459 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.6 t -89.15 139.16 28.69 Favored Pre-proline 0 N--CA 1.438 -1.047 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.93 -9.06 23.55 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.72 1.613 . . . . 0.0 112.722 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -88.07 -0.24 56.81 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.98 16.58 40.84 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -107.8 149.16 28.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.29 127.19 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.641 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -129.13 -178.67 4.74 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.659 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 15.2 mt -91.97 151.29 20.57 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.2 -22.98 60.34 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -104.39 -21.78 13.43 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.765 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.659 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 4.2 mptp? -133.39 85.59 43.27 Favored Pre-proline 0 CA--C 1.493 -1.232 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -66.89 -8.54 21.85 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.415 2.077 . . . . 0.0 112.281 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.415 ' HA ' HG12 ' A' ' 143' ' ' VAL . 90.0 p -87.19 -15.64 37.68 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.567 HD23 HD12 ' A' ' 142' ' ' LEU . 49.2 mt -103.59 130.98 51.11 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.641 HG22 ' HB3' ' A' ' 114' ' ' TYR . 32.7 pt -133.61 160.36 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.517 HD23 HG11 ' A' ' 138' ' ' VAL . 6.1 mp -82.69 138.15 34.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.28 179.85 38.18 Favored Glycine 0 CA--C 1.494 -1.234 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.9 pp -125.2 160.78 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.463 ' O ' HD22 ' A' ' 136' ' ' LEU . 86.8 tttt -118.02 145.85 44.47 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -75.55 164.67 26.1 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.9 p -128.88 167.54 17.24 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -65.52 -36.0 82.52 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.28 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -90.12 -1.64 57.97 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 48.57 48.33 19.7 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.752 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -84.18 110.26 18.39 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -75.69 -19.01 59.42 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.98 88.2 6.49 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 131.69 6.61 3.26 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.527 ' HB2' HD12 ' A' ' 43' ' ' LEU . 82.1 mt -65.64 129.22 38.99 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -90.87 155.49 18.72 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 121.663 0.744 . . . . 0.0 109.426 -177.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.517 HG11 HD23 ' A' ' 123' ' ' LEU . 30.9 t -94.33 140.28 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -147.18 167.66 23.62 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.474 ' HG ' HD11 ' A' ' 86' ' ' ILE . 88.7 mt -98.51 126.56 44.11 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -119.63 154.7 33.59 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.567 HD12 HD23 ' A' ' 121' ' ' LEU . 1.1 tp -75.63 136.57 40.45 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.562 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 120' ' ' SER . 11.1 p -62.22 144.89 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.59 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -139.13 97.59 3.33 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -64.45 -18.5 64.81 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.802 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -69.74 -22.41 63.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -133.87 83.81 2.07 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.6 mt -100.37 5.15 44.35 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -94.05 21.48 6.72 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -90.52 110.78 21.9 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.04 -21.13 65.93 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.903 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -74.39 -16.95 60.87 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -99.22 -0.53 41.25 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -98.42 133.88 42.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -116.73 137.85 51.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -112.38 146.25 38.66 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 136.31 52.1 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.6 t -127.35 145.0 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.1 mt -108.96 152.46 42.43 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.42 149.3 74.82 Favored 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 121.709 1.606 . . . . 0.0 113.114 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.55 158.83 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 C--O 1.262 1.727 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.728 0.299 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.96 98.31 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.74 47.07 8.36 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.42 71.52 10.79 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -106.47 12.92 29.09 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -120.84 91.57 3.56 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -86.54 -34.19 20.03 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -83.59 146.43 28.3 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.3 t -146.41 138.17 24.75 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.29 171.47 9.04 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.65 161.3 14.99 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.16 155.76 46.74 Favored Pre-proline 0 N--CA 1.441 -0.924 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.5 148.96 79.81 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 121.386 1.391 . . . . 0.0 112.17 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -91.94 157.83 16.61 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.815 0.817 . . . . 0.0 108.92 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.57 -165.65 35.47 Favored Glycine 0 CA--C 1.495 -1.18 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.691 ' HB3' HD22 ' A' ' 55' ' ' LEU . 52.7 m0 -75.83 141.91 42.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -156.1 162.34 40.27 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 41.2 m-85 -120.05 137.16 54.27 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.9 mt -99.62 114.94 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -113.33 131.36 55.98 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -83.77 126.21 32.7 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -61.47 -35.98 79.14 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -67.1 -41.61 85.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 121.672 -0.642 . . . . 0.0 111.294 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -97.26 -24.6 15.61 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.331 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.28 17.8 79.0 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -111.0 168.57 9.39 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.18 161.11 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.854 HD23 HG21 ' A' ' 41' ' ' ILE . 5.2 mp -74.34 137.68 42.98 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.531 0.681 . . . . 0.0 110.874 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.4 ptm -147.09 176.06 10.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 31' ' ' ASP . 22.4 t -74.41 162.66 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.556 ' N ' HG12 ' A' ' 30' ' ' VAL . 39.5 t0 -56.01 -39.16 71.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 121.485 -0.76 . . . . 0.0 110.282 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -158.49 53.73 0.43 Allowed 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.054 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 51.64 48.93 21.91 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.0 m -98.23 127.48 44.19 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -92.59 -2.61 56.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -87.58 151.6 22.86 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.5 m -77.85 158.67 29.37 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.37 5.52 65.29 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.1 t -93.85 124.55 56.23 Favored Pre-proline 0 N--CA 1.438 -1.039 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -59.0 150.84 70.2 Favored 'Trans proline' 0 CA--C 1.498 -1.284 0 C-N-CA 122.117 1.878 . . . . 0.0 113.433 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.854 HG21 HD23 ' A' ' 28' ' ' LEU . 23.5 mm -90.8 130.28 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 30.8 m -131.76 164.34 34.87 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.15 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.616 HD11 HG21 ' A' ' 125' ' ' ILE . 90.3 mt -91.57 147.74 22.79 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.04 151.6 29.52 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -66.11 159.56 25.87 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.023 0.916 . . . . 0.0 108.756 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.25 139.67 57.35 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.687 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.8 mmm-85 -127.65 147.17 50.37 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 m -87.85 -11.46 47.76 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -122.62 145.02 48.73 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 57.35 42.83 24.32 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 34.8 p90 -86.91 -1.38 57.78 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.08 89.59 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -70.65 -19.09 62.84 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 51' ' ' TYR . 8.4 mm100 -94.56 0.11 54.97 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.691 HD22 ' HB3' ' A' ' 16' ' ' TRP . 68.6 mt -99.86 140.53 33.94 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-O 121.936 0.874 . . . . 0.0 109.793 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -129.78 152.49 49.22 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -136.44 133.1 36.28 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -96.41 128.5 43.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.97 160.42 66.15 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.19 -27.91 58.76 Favored 'Trans proline' 0 CA--C 1.499 -1.255 0 C-N-CA 121.935 1.757 . . . . 0.0 113.675 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.4 m -73.65 -16.56 61.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.22 12.83 32.68 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -89.08 150.18 22.87 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.7 mt -105.47 129.06 53.84 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.995 HG22 HG12 ' A' ' 72' ' ' VAL . 68.0 t -114.58 135.21 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -84.33 128.31 34.5 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.38 -40.39 96.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.921 -0.487 . . . . 0.0 111.31 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -64.79 -49.63 69.95 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -89.52 -31.37 17.67 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.576 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.08 3.39 90.4 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 107.247 -2.341 . . . . 0.0 107.247 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -93.09 170.62 9.51 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.995 HG12 HG22 ' A' ' 65' ' ' VAL . 25.8 m -118.37 162.45 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.1 mtt -71.12 139.94 50.46 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -157.68 166.61 32.35 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.99 142.68 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.37 -41.52 84.91 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.425 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.5 -33.27 69.1 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.02 84.06 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.2 m -124.25 126.84 25.47 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.91 116.7 4.79 Favored 'Trans proline' 0 CA--C 1.496 -1.399 0 C-N-CA 121.115 1.21 . . . . 0.0 112.765 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -136.69 162.54 32.89 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.56 130.34 38.67 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.17 8.28 78.73 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -71.74 145.21 12.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 118.586 1.193 . . . . 0.0 108.144 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -91.23 158.52 16.55 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.481 0.658 . . . . 0.0 109.25 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.654 HD11 HD13 ' A' ' 140' ' ' LEU . 48.8 mm -109.45 129.94 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 m -132.28 164.66 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.941 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -76.7 141.04 41.05 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -152.73 160.84 43.13 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 m -64.88 146.48 54.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -71.38 156.57 39.33 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.09 -154.3 0.54 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.03 -13.97 57.31 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.6 t -64.71 -45.08 88.08 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -136.78 21.69 3.09 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.4 t -125.11 130.23 73.14 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -61.22 141.76 57.28 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -67.75 -19.22 65.1 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.27 -5.03 56.78 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.3 mt -118.38 10.08 12.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -91.55 121.64 33.41 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -75.51 -8.57 57.09 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.275 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -73.55 -13.09 60.97 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -74.43 129.75 38.35 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -116.07 151.71 35.02 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.33 151.66 17.76 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.5 tp -118.91 121.85 40.93 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 8.6 t -84.81 140.62 37.76 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.85 -10.18 25.83 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.676 1.584 . . . . 0.0 112.689 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -86.87 -2.45 58.6 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.01 12.08 50.78 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -99.81 144.62 28.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.51 126.38 73.04 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.97 177.22 7.6 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.659 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 15.4 mt -87.41 150.59 23.7 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.24 -20.91 58.97 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -104.7 -24.39 12.95 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.561 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.659 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 13.8 mptt -131.9 84.45 53.9 Favored Pre-proline 0 CA--C 1.496 -1.099 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.05 -9.18 24.12 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.515 2.143 . . . . 0.0 113.014 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 88.2 p -83.22 -22.3 33.16 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.593 HD22 ' HB3' ' A' ' 140' ' ' LEU . 61.1 mt -96.24 131.68 42.47 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.586 HG22 ' HB3' ' A' ' 114' ' ' TYR . 22.7 pt -133.27 163.76 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.4 mt -81.52 139.67 35.0 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.71 176.34 40.55 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 106.909 -2.477 . . . . 0.0 106.909 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.616 HG21 HD11 ' A' ' 43' ' ' LEU . 1.9 pp -129.39 159.19 41.7 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' O ' HD22 ' A' ' 136' ' ' LEU . 47.8 tttt -102.04 145.77 28.85 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -116.77 140.6 49.24 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.4 t -149.35 155.87 41.18 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -69.52 -27.63 65.34 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.08 30.74 4.64 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -135.82 103.6 5.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -65.87 160.67 22.79 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -72.51 -13.11 61.34 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -95.62 89.25 5.29 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 127.31 7.81 4.74 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 126' ' ' LYS . 84.5 mt -67.46 133.55 49.74 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 118.987 1.394 . . . . 0.0 107.262 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.516 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -95.46 154.24 17.3 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.4 p -94.12 143.59 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -144.39 163.76 32.83 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.654 HD13 HD11 ' A' ' 86' ' ' ILE . 5.1 mp -94.33 124.22 38.22 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -122.11 156.24 34.02 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.56 HD12 HD23 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -80.36 149.69 30.15 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.165 -178.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.422 HG12 HD13 ' A' ' 122' ' ' ILE . 7.3 m -63.13 155.8 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.57 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -139.22 100.14 3.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -66.59 -21.53 66.14 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.004 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -67.29 -25.42 66.03 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -142.51 88.44 2.07 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.0 mt -100.78 3.77 42.4 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -99.32 25.31 7.05 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -83.46 125.63 31.93 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.7 -22.9 62.4 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -74.02 -21.88 59.8 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.71 2.17 38.28 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.1 ttp85 -102.81 132.38 49.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -119.59 142.89 47.98 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.541 0.686 . . . . 0.0 109.226 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -120.43 152.89 37.33 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.98 140.18 50.11 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.64 144.75 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.5 mt -109.86 152.46 42.98 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.41 149.06 74.7 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.731 1.621 . . . . 0.0 113.084 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.4 p -145.98 144.74 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.5 t . . . . . 0 C--O 1.262 1.75 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mmm . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.037 0.446 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -153.8 151.67 29.82 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 71.15 -169.04 0.15 Allowed 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.51 144.88 20.99 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -112.5 0.31 15.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -107.86 77.15 1.1 Allowed 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -71.32 -23.38 61.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -78.68 145.11 34.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.3 p -146.5 154.88 42.07 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -136.44 170.36 16.18 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -106.14 161.52 14.44 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -90.39 156.69 45.56 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.86 148.96 86.83 Favored 'Trans proline' 0 CA--C 1.499 -1.251 0 C-N-CA 121.411 1.407 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -95.02 158.57 15.41 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.76 -161.53 28.35 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.69 ' HB3' HD22 ' A' ' 55' ' ' LEU . 43.1 m0 -83.61 143.62 30.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.524 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 52.4 p90 -157.04 163.71 38.75 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.443 ' CE1' HD21 ' A' ' 55' ' ' LEU . 43.4 m-85 -121.76 139.76 53.18 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 64' ' ' LEU . 87.7 mt -106.86 119.2 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.437 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 27.9 pttt -122.66 147.05 46.9 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.644 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -89.24 127.98 35.8 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -62.9 -18.19 62.69 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 152' ' ' GLU . 45.5 t -62.29 -46.06 90.48 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 119.1 0.864 . . . . 0.0 110.883 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -125.8 -7.67 6.72 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.85 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.2 12.07 84.38 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CD2' ' HA ' ' A' ' 45' ' ' THR . 11.5 m-30 -84.68 156.18 21.62 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 22.2 m -111.9 159.29 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.624 0.726 . . . . 0.0 109.495 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.939 HD23 HG21 ' A' ' 41' ' ' ILE . 3.4 mp -66.38 131.6 46.44 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.566 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.0 ttp -145.88 166.39 26.11 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 31' ' ' ASP . 46.8 t -67.92 159.42 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.6 t70 -52.71 -40.61 63.15 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.926 -0.484 . . . . 0.0 110.68 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -163.27 50.64 0.16 Allowed 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.536 -0.866 . . . . 0.0 108.777 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 55.88 49.13 16.6 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.506 ' H ' HG11 ' A' ' 30' ' ' VAL . 66.5 m -94.45 109.32 21.2 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -91.12 -3.52 57.02 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -83.18 -6.4 59.46 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 t 69.07 -172.65 0.18 Allowed 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.69 24.82 76.23 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.6 m -127.66 149.05 69.27 Favored Pre-proline 0 CA--C 1.501 -0.929 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 68.7 Cg_endo -72.6 158.58 50.56 Favored 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 122.161 1.908 . . . . 0.0 113.321 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.939 HG21 HD23 ' A' ' 28' ' ' LEU . 23.5 mm -88.0 131.41 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 24.5 m -130.84 166.13 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.99 142.77 27.81 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.37 151.25 39.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 26' ' ' TYR . 4.5 m -58.71 145.66 39.39 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.99 131.67 46.78 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -137.23 140.71 41.87 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -64.93 -36.09 83.25 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -75.19 142.37 43.49 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 60.32 43.22 13.85 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -70.17 -31.44 68.93 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.61 91.71 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.2 m -70.36 -22.05 62.82 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -100.43 4.23 43.65 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 16' ' ' TRP . 24.0 mt -102.3 138.74 38.83 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -125.42 151.54 46.05 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -128.51 135.24 49.16 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -91.58 112.99 25.14 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -85.42 156.38 59.43 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.94 -13.7 36.6 Favored 'Trans proline' 0 CA--C 1.497 -1.351 0 C-N-CA 122.216 1.944 . . . . 0.0 113.263 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.3 m -70.48 -20.58 62.85 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.15 8.82 33.08 Favored Glycine 0 C--N 1.356 1.674 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -121.95 161.97 21.93 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 118.513 1.156 . . . . 0.0 109.24 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.713 HD13 HD11 ' A' ' 19' ' ' ILE . 58.2 mt -99.81 135.14 41.69 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -177.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 72' ' ' VAL . 92.4 t -117.18 136.66 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -76.68 127.91 33.68 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -64.42 -37.33 87.14 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.321 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -75.54 -54.33 7.18 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.669 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.4 m -70.88 -39.96 72.52 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.67 10.25 84.54 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 105.932 -2.867 . . . . 0.0 105.932 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -98.99 162.62 12.97 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 65' ' ' VAL . 11.7 t -110.96 150.9 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.8 mtt -69.83 139.81 53.19 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -157.68 169.8 23.82 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 118.947 -1.101 . . . . 0.0 108.211 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.75 142.88 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.36 -41.11 76.98 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.476 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.45 -33.56 71.43 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.4 -6.79 83.06 Favored Glycine 0 CA--C 1.495 -1.186 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.9 m -123.82 125.88 25.82 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.41 115.83 4.23 Favored 'Trans proline' 0 CA--C 1.497 -1.365 0 C-N-CA 121.022 1.148 . . . . 0.0 112.758 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -135.75 162.65 32.18 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.69 130.21 38.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.34 7.42 82.72 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG1' HD12 ' A' ' 140' ' ' LEU . 12.0 p -70.83 142.9 15.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 CA-C-N 118.534 1.167 . . . . 0.0 107.942 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.21 155.39 20.74 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 mm -106.59 128.01 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 40' ' ' PRO . 34.1 m -130.59 168.48 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -80.33 142.08 34.82 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -145.21 171.24 14.83 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -71.45 169.18 15.93 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -84.04 156.47 22.21 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.49 150.99 42.77 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.7 -171.57 48.16 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 84.8 p -85.5 1.7 47.8 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -99.04 13.03 34.25 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.91 123.29 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -65.56 150.05 49.05 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.62 -20.4 66.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -90.66 -1.62 57.86 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.38 6.14 18.56 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.17 112.0 19.86 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -85.07 -10.74 56.56 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -84.26 -11.44 56.44 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.76 131.04 45.75 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.47 154.62 33.48 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.88 158.47 14.26 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.6 tp -129.53 130.91 46.38 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 109' ' ' PRO . 91.7 p -104.16 155.92 36.5 Favored Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 57.3 Cg_endo -70.69 -8.5 23.76 Favored 'Trans proline' 0 CA--C 1.499 -1.239 0 C-N-CA 121.856 1.704 . . . . 0.0 112.61 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -82.62 -9.71 59.27 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.61 12.61 55.57 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -101.12 137.41 39.52 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.95 124.91 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.721 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -127.0 -179.62 4.93 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.641 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 7.7 mt -89.6 149.11 22.98 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.22 -24.23 61.36 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.27 -19.57 14.43 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.897 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.641 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 13.4 mptt -132.53 84.17 51.89 Favored Pre-proline 0 N--CA 1.438 -1.055 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -68.52 -9.75 26.98 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.605 2.203 . . . . 0.0 113.012 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.8 m -83.51 -22.88 32.35 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.546 HD23 HD12 ' A' ' 142' ' ' LEU . 54.4 mt -97.28 131.35 44.07 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.721 HG22 ' HB3' ' A' ' 114' ' ' TYR . 26.8 pt -133.19 163.21 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.9 mt -79.38 137.99 37.5 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.16 176.81 37.7 Favored Glycine 0 CA--C 1.493 -1.309 0 N-CA-C 107.415 -2.274 . . . . 0.0 107.415 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.759 HD13 HD13 ' A' ' 136' ' ' LEU . 1.4 pp -135.92 159.82 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.492 ' O ' HD22 ' A' ' 136' ' ' LEU . 88.2 tttt -108.48 145.59 34.46 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -134.54 144.71 48.15 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.59 ' H ' ' HB3' ' A' ' 131' ' ' ALA . 9.7 t -150.5 175.84 11.5 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -71.61 -28.58 63.9 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.9 37.51 2.04 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.59 ' HB3' ' H ' ' A' ' 128' ' ' SER . . . -124.77 104.46 8.65 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.44 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 32.2 tpt180 -63.68 129.93 42.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.16 -36.13 82.58 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 93.5 mt-10 -83.19 86.69 6.99 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.14 8.73 1.54 Allowed Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.759 HD13 HD13 ' A' ' 125' ' ' ILE . 84.2 mt -63.98 127.73 32.67 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.524 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -87.99 153.83 20.98 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.66 0.743 . . . . 0.0 109.706 -177.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.5 t -97.01 139.75 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -147.39 167.4 24.47 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.412 HD12 ' CG1' ' A' ' 84' ' ' VAL . 89.5 mt -91.91 125.02 36.45 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -116.74 142.18 47.25 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.546 HD12 HD23 ' A' ' 121' ' ' LEU . 1.1 tp -74.9 146.14 42.1 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.6 m -61.84 153.94 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 121.87 0.843 . . . . 0.0 109.443 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -148.24 102.16 3.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -70.08 -18.27 63.26 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.867 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -67.65 -25.58 65.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -135.6 84.24 2.07 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -102.55 4.36 38.41 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -97.78 22.31 9.31 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -90.9 115.33 27.86 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -68.5 -20.59 64.6 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 25.2 pt-20 -73.9 -17.32 61.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -100.63 0.88 40.05 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.55 133.35 39.67 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -118.43 139.8 50.85 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -123.14 158.28 31.09 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -119.91 142.37 48.76 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.2 t -128.58 144.12 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -109.49 152.64 42.85 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.74 150.13 73.86 Favored 'Trans proline' 0 CA--C 1.495 -1.453 0 C-N-CA 121.735 1.623 . . . . 0.0 113.07 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.7 t -118.71 125.83 74.74 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.261 1.7 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 ttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.784 0.326 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.16 142.4 46.13 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.24 156.95 36.51 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.35 101.85 14.54 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 60.4 ttm -65.21 -40.57 94.32 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -117.53 84.34 2.14 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -71.87 -22.16 61.56 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -99.48 148.0 24.7 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.9 m -139.14 145.45 39.43 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -103.46 162.15 13.27 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.9 161.02 17.71 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.978 0.894 . . . . 0.0 108.986 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -86.18 157.91 56.0 Favored Pre-proline 0 N--CA 1.441 -0.893 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.75 148.96 87.23 Favored 'Trans proline' 0 CA--C 1.499 -1.235 0 C-N-CA 121.321 1.348 . . . . 0.0 112.281 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -87.31 156.83 19.46 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 121.824 0.821 . . . . 0.0 109.179 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.52 -168.81 38.56 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.69 ' HB3' HD22 ' A' ' 55' ' ' LEU . 49.4 m0 -75.72 144.48 41.49 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.42 161.07 41.91 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 43.1 m-85 -119.59 138.65 53.08 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.508 HD11 ' CD2' ' A' ' 64' ' ' LEU . 85.6 mt -99.87 113.76 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -110.48 131.39 55.09 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.378 0.609 . . . . 0.0 109.429 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -83.66 123.95 30.34 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -61.03 -36.22 78.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 t -65.3 -43.32 91.48 Favored 'General case' 0 CA--C 1.504 -0.797 0 O-C-N 121.557 -0.715 . . . . 0.0 111.56 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -99.18 -23.13 15.33 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.495 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.31 18.62 79.94 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.401 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 9.8 m-30 -107.23 167.09 10.15 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.25 160.94 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.96 HD23 HG21 ' A' ' 41' ' ' ILE . 2.5 mp -67.86 132.43 47.36 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.908 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.2 ttp -145.76 163.15 35.87 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 31' ' ' ASP . 21.0 t -68.33 165.57 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.562 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.0 t70 -49.37 -41.54 39.42 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 122.103 -0.373 . . . . 0.0 110.812 -177.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -162.21 51.53 0.21 Allowed 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 56.65 43.93 24.63 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -88.17 128.93 35.45 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -93.35 -2.0 55.28 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -88.31 142.32 27.83 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.7 m -74.98 156.57 36.13 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.18 7.26 62.42 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.3 m -93.03 137.23 23.84 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 56.5 Cg_endo -70.28 154.36 65.76 Favored 'Trans proline' 0 CA--C 1.496 -1.398 0 C-N-CA 121.661 1.574 . . . . 0.0 112.831 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.96 HG21 HD23 ' A' ' 28' ' ' LEU . 23.2 mm -91.81 130.84 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 27.6 m -131.65 164.39 34.65 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' CD1' HG21 ' A' ' 125' ' ' ILE . 92.8 mt -92.82 142.22 27.57 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.24 150.24 36.33 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.401 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 9.6 t -64.22 155.27 32.4 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.49 139.53 58.78 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.62 147.18 49.93 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -87.73 -12.15 46.09 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.29 143.92 48.91 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 57.66 40.08 26.89 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -85.68 -4.34 59.14 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.78 81.24 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -72.82 -13.4 61.29 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -102.31 2.49 36.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 16' ' ' TRP . 56.5 mt -98.02 138.07 35.88 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -126.51 149.94 49.06 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -133.01 129.6 38.34 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 58' ' ' HIS . 0.1 OUTLIER -92.25 129.39 38.21 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.13 159.8 56.09 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.29 -26.66 62.84 Favored 'Trans proline' 0 CA--C 1.499 -1.25 0 C-N-CA 122.021 1.814 . . . . 0.0 113.825 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.9 m -72.14 -19.55 61.76 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.88 11.25 28.73 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.472 ' CD2' ' HB2' ' A' ' 103' ' ' GLN . 2.6 m-85 -92.81 147.27 23.0 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.508 ' CD2' HD11 ' A' ' 19' ' ' ILE . 8.5 mp -103.1 128.36 50.04 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.969 HG22 HG12 ' A' ' 72' ' ' VAL . 58.2 t -114.23 135.44 53.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -75.73 131.02 39.57 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -62.18 -41.4 98.29 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 122.048 -0.407 . . . . 0.0 111.279 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -80.43 -52.09 8.07 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 121.691 -0.631 . . . . 0.0 111.379 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.6 m -68.24 -39.85 82.15 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.691 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.04 2.15 90.63 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -93.32 167.02 12.01 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.969 HG12 HG22 ' A' ' 65' ' ' VAL . 21.6 m -119.18 163.83 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.8 mtt -71.01 139.29 50.46 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -154.24 169.7 23.0 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.45 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -93.39 143.66 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.33 87.2 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -72.5 -33.01 66.64 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.45 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.32 -8.86 79.1 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 105.959 -2.856 . . . . 0.0 105.959 -177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.9 m -121.26 125.38 26.94 Favored Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.36 120.18 6.6 Favored 'Trans proline' 0 CA--C 1.497 -1.359 0 C-N-CA 121.205 1.27 . . . . 0.0 113.251 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -138.58 162.58 34.22 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.12 131.33 39.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.37 15.36 71.72 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.674 ' CG1' HD12 ' A' ' 140' ' ' LEU . 9.9 p -81.23 150.89 4.47 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -90.03 153.03 20.88 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.8 mm -109.8 128.25 66.03 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 40' ' ' PRO . 29.4 m -133.29 161.32 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -86.3 142.95 28.15 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.87 178.72 9.36 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 m -76.07 150.05 37.36 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -76.48 156.2 33.21 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -102.38 -148.08 0.38 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.563 ' H ' HG12 ' A' ' 96' ' ' VAL . . . 97.81 -6.03 62.22 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.9 p -67.96 -38.25 82.54 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -155.31 31.02 0.39 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 93' ' ' GLY . 7.4 p -133.35 147.97 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.22 157.02 38.42 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.81 0.814 . . . . 0.0 108.905 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -78.18 -21.54 50.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.44 -10.36 52.14 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -109.69 9.75 24.91 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -93.54 131.7 38.54 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -86.88 -7.72 57.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.641 ' NE2' HG21 ' A' ' 72' ' ' VAL . 33.5 mt-30 -70.16 -18.03 63.19 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -71.99 128.6 36.24 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.45 156.98 34.49 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.85 163.92 25.24 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 106.303 -2.719 . . . . 0.0 106.303 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -145.65 152.63 39.95 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 85.2 p -105.77 160.65 25.37 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.88 -14.61 33.46 Favored 'Trans proline' 0 CA--C 1.499 -1.268 0 C-N-CA 122.513 2.142 . . . . 0.0 113.424 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -74.79 -11.45 60.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.95 27.78 11.97 Favored Glycine 0 C--N 1.355 1.602 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -112.53 134.75 53.89 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.4 mt -107.47 127.13 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.723 ' HB3' HG22 ' A' ' 122' ' ' ILE . 1.1 p90 -134.46 178.4 7.02 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.635 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 7.0 mt -89.23 146.67 24.6 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.59 -24.11 61.85 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -102.71 -19.19 14.86 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.657 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.635 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 0.9 OUTLIER -134.57 82.71 44.62 Favored Pre-proline 0 N--CA 1.437 -1.116 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.54 -11.78 32.03 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.474 2.116 . . . . 0.0 113.05 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 142' ' ' LEU . 88.9 p -79.94 -23.5 41.66 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.523 HD23 HD12 ' A' ' 142' ' ' LEU . 53.6 mt -95.81 131.79 41.74 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.723 HG22 ' HB3' ' A' ' 114' ' ' TYR . 23.8 pt -133.21 163.58 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.443 HD23 ' CD2' ' A' ' 140' ' ' LEU . 88.3 mt -81.68 141.99 33.11 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.78 -175.6 35.69 Favored Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 106.732 -2.547 . . . . 0.0 106.732 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.6 pp -135.45 161.02 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.421 ' O ' HD22 ' A' ' 136' ' ' LEU . 40.0 ttmt -117.32 143.09 46.3 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.98 151.54 44.54 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.8 m -104.51 166.48 10.36 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -65.14 -37.07 86.23 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -94.71 3.53 54.93 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 49.73 49.31 20.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.112 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -85.15 116.01 23.27 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.472 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -77.41 -22.57 51.36 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -90.49 87.4 6.74 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.5 6.1 2.15 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 126' ' ' LYS . 80.8 mt -66.37 125.48 25.79 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.526 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -89.02 154.87 19.86 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 121.491 0.662 . . . . 0.0 109.644 -177.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 52.5 t -79.16 136.28 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.91 140.58 44.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.674 HD12 ' CG1' ' A' ' 84' ' ' VAL . 88.5 mt -85.31 129.38 34.82 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -124.36 152.47 43.13 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.523 HD12 HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -81.66 152.79 26.95 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -61.19 141.03 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 121.808 0.813 . . . . 0.0 109.42 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -126.57 86.02 2.46 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.47 -20.52 66.39 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -71.34 -22.12 61.95 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -133.73 83.95 2.09 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.31 4.0 52.61 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -95.93 27.65 3.48 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -98.89 108.54 21.25 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -69.78 -21.53 63.41 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -69.82 -19.84 63.46 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -100.59 3.0 42.3 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -99.3 136.74 38.81 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -124.47 141.78 51.82 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -121.42 155.5 34.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.86 139.08 51.62 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.93 145.42 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.35 152.44 42.66 Favored Pre-proline 0 N--CA 1.441 -0.915 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.55 149.64 74.37 Favored 'Trans proline' 0 CA--C 1.496 -1.404 0 C-N-CA 121.809 1.673 . . . . 0.0 113.267 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.6 t -121.18 126.22 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--O 1.263 1.785 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.575 0.226 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.95 44.35 2.03 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.65 152.41 32.78 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.48 130.27 21.62 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.0 mtm -67.06 -37.46 84.08 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -112.34 74.73 0.88 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -72.53 -22.7 60.98 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -79.11 141.1 37.6 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.6 m -135.19 146.09 48.35 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -126.15 171.53 10.79 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 161.95 36.1 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -90.3 122.36 67.51 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.22 -24.61 23.08 Favored 'Trans proline' 0 CA--C 1.501 -1.135 0 C-N-CA 121.4 1.4 . . . . 0.0 112.492 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 pm0 -83.61 160.97 21.29 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.53 -61.99 0.87 Allowed Glycine 0 C--N 1.351 1.364 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.404 ' HB3' HD22 ' A' ' 55' ' ' LEU . 45.0 m0 -86.86 138.2 31.76 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -163.73 162.82 24.17 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.423 ' CE1' HD21 ' A' ' 55' ' ' LEU . 59.2 m-85 -119.15 138.12 53.13 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 64' ' ' LEU . 76.9 mt -104.01 117.69 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -117.08 129.6 56.1 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -85.33 127.16 34.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -67.16 -16.58 64.4 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 122.244 -0.285 . . . . 0.0 111.535 -177.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.8 t -62.93 -43.97 97.34 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 121.478 -0.764 . . . . 0.0 110.947 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -124.03 -6.52 7.82 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.535 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.46 23.75 76.46 Favored Glycine 0 C--N 1.349 1.305 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -103.33 162.96 12.57 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.81 160.81 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.887 HD23 HG21 ' A' ' 41' ' ' ILE . 2.4 mp -68.54 131.9 46.03 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.595 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 34.7 ttp -145.85 166.5 25.76 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 31' ' ' ASP . 24.0 t -68.03 164.94 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' N ' HG12 ' A' ' 30' ' ' VAL . 35.9 t70 -53.54 -40.97 65.95 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.747 -0.596 . . . . 0.0 110.458 -177.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -164.78 55.07 0.13 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 53.79 48.38 21.53 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.1 m -86.68 130.74 34.36 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.49 -2.01 52.49 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -94.02 152.34 18.88 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.9 m -81.36 157.89 24.87 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.78 8.39 65.39 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.0 t -88.53 124.68 65.45 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 87' ' ' VAL . 44.7 Cg_exo -58.77 148.72 81.87 Favored 'Trans proline' 0 CA--C 1.497 -1.329 0 C-N-CA 122.094 1.863 . . . . 0.0 113.163 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.887 HG21 HD23 ' A' ' 28' ' ' LEU . 25.1 mm -89.41 129.63 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 24.6 m -131.56 166.48 28.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.957 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.4 mt -94.36 141.65 28.33 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.11 151.81 40.09 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -60.44 146.28 45.15 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.3 139.07 58.73 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -127.66 140.85 51.83 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 90.2 m -66.47 -34.96 79.11 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.56 154.23 17.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 61.4 44.51 9.43 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 48' ' ' THR . 5.9 m-85 -67.15 -30.36 70.33 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.82 -38.05 84.08 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.891 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -70.95 -16.98 62.69 Favored 'General case' 0 CA--C 1.5 -0.98 0 O-C-N 121.897 -0.502 . . . . 0.0 109.723 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -109.29 7.64 25.3 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.423 HD21 ' CE1' ' A' ' 18' ' ' PHE . 10.5 mt -100.46 136.8 39.78 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -125.49 147.97 49.03 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -125.94 129.47 49.33 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -90.38 114.84 27.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -80.99 159.77 67.64 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.45 -21.73 55.39 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 122.135 1.89 . . . . 0.0 112.445 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.6 p -82.78 -2.84 55.6 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.46 20.4 54.58 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -100.82 138.93 37.21 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD2' HD11 ' A' ' 19' ' ' ILE . 5.9 mp -97.42 119.39 35.88 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.955 HG22 HG12 ' A' ' 72' ' ' VAL . 59.2 t -105.85 135.0 45.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -84.86 126.07 33.15 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -61.77 -40.64 95.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 122.011 -0.43 . . . . 0.0 111.514 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -65.09 -50.16 67.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 121.977 -0.452 . . . . 0.0 112.041 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.3 p -88.48 -29.66 19.97 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.333 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.19 4.37 90.24 Favored Glycine 0 C--N 1.352 1.445 0 N-CA-C 107.219 -2.352 . . . . 0.0 107.219 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -94.69 168.18 10.99 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.955 HG12 HG22 ' A' ' 65' ' ' VAL . 24.7 m -117.83 162.47 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.9 mtt -69.04 139.36 54.91 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -155.11 173.23 16.89 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.11 143.23 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.05 86.1 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.401 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.98 -33.05 67.82 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.27 -8.16 80.29 Favored Glycine 0 CA--C 1.495 -1.161 0 N-CA-C 105.899 -2.88 . . . . 0.0 105.899 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.0 m -124.14 127.2 25.42 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.32 120.26 6.85 Favored 'Trans proline' 0 CA--C 1.495 -1.427 0 C-N-CA 121.115 1.21 . . . . 0.0 113.25 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -136.54 162.23 33.68 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.98 129.43 37.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.38 81.76 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.427 ' CG1' HD12 ' A' ' 140' ' ' LEU . 8.6 p -72.79 143.13 14.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-N 118.539 1.169 . . . . 0.0 108.268 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.5 154.69 24.96 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-O 121.468 0.651 . . . . 0.0 109.425 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.472 HD11 ' HG ' ' A' ' 140' ' ' LEU . 47.7 mm -109.82 127.06 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 40' ' ' PRO . 34.0 m -132.08 160.86 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -84.43 139.63 32.08 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -146.87 171.59 14.97 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -66.51 149.43 50.45 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -69.67 156.41 39.0 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.578 ' HB1' HG21 ' A' ' 96' ' ' VAL . . . -72.35 148.04 45.7 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.35 -160.47 35.94 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 107.375 -2.29 . . . . 0.0 107.375 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.7 m -89.99 6.95 39.97 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -102.12 16.1 27.1 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.578 HG21 ' HB1' ' A' ' 92' ' ' ALA . 67.7 t -111.88 127.06 69.28 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -61.05 149.52 36.7 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -67.27 -18.47 65.22 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -90.36 -3.53 57.67 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.9 mt -114.6 6.78 15.87 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -87.1 98.63 11.4 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -96.0 -7.74 35.57 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.728 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -77.19 -9.33 58.71 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -77.52 125.47 29.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -118.51 152.77 35.32 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.51 145.09 17.24 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 106.86 -2.496 . . . . 0.0 106.86 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.0 tp -113.27 125.66 54.55 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.487 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . 86.5 p -89.81 158.38 45.0 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 108' ' ' SER . 53.2 Cg_endo -70.18 -8.48 23.7 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.659 1.573 . . . . 0.0 112.509 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -89.99 -4.12 57.62 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.39 4.96 65.74 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -89.65 145.05 25.5 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.8 mt -112.59 127.07 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.678 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -130.35 176.99 7.68 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.646 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 15.4 mt -82.37 150.08 27.35 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.66 -17.52 55.82 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -104.09 -26.12 12.7 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.379 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.646 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -133.27 86.02 42.68 Favored Pre-proline 0 N--CA 1.436 -1.137 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.98 -8.27 19.42 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.781 2.321 . . . . 0.0 113.236 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.6 m -88.23 -8.71 54.85 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.665 HD23 ' HB3' ' A' ' 140' ' ' LEU . 4.0 mp -107.24 130.93 54.68 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 114' ' ' TYR . 27.0 pt -134.93 168.2 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.66 138.78 37.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.06 177.8 34.62 Favored Glycine 0 CA--C 1.495 -1.17 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.2 pt -134.02 168.64 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -117.11 120.11 37.31 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -107.27 137.66 44.91 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 131' ' ' ALA . 86.3 p -150.9 172.34 15.82 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -69.9 -27.97 65.24 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -99.57 23.45 9.46 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.437 ' HB3' ' H ' ' A' ' 128' ' ' SER . . . -123.91 91.92 3.57 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -64.73 152.37 42.7 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.44 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -68.89 -14.55 63.1 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -92.73 85.03 5.1 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 126.9 13.57 2.96 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 mt -64.33 123.02 18.09 Favored 'General case' 0 C--N 1.36 1.058 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -90.0 152.72 21.05 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 121.515 0.674 . . . . 0.0 109.311 -177.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 p -99.38 144.9 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -147.79 166.95 25.99 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.665 ' HB3' HD23 ' A' ' 121' ' ' LEU . 87.8 mt -85.99 130.24 34.6 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -128.64 144.44 51.16 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 142' ' ' LEU . 0.7 OUTLIER -68.79 141.15 55.26 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.25 -178.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.66 129.77 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.491 -1.232 . . . . 0.0 109.29 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -124.18 92.08 3.59 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -67.2 -20.61 65.73 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.527 ' HG3' ' CD2' ' A' ' 147' ' ' HIS . 17.0 ptp180 -69.7 -19.29 63.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.527 ' CD2' ' HG3' ' A' ' 146' ' ' ARG . 98.0 m-70 -128.39 77.46 1.77 Allowed 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.6 mt -103.55 4.41 35.76 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.02 22.23 9.64 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -98.92 125.65 44.41 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -68.51 -21.48 64.58 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -76.43 -19.61 57.91 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -92.16 -3.38 55.7 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.88 133.49 44.17 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -117.46 137.77 52.3 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.37 146.94 37.43 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -119.07 138.86 52.58 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.81 145.35 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.1 mt -109.71 154.58 42.4 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -58.39 141.21 96.86 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 C-N-CA 122.061 1.841 . . . . 0.0 113.08 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.8 t -119.93 126.12 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.261 1.702 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.643 0.259 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.26 155.76 39.45 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.69 156.29 41.63 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.93 108.65 19.84 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -128.54 9.53 6.02 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -105.01 70.89 0.93 Allowed 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -73.08 -24.74 60.7 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -87.51 147.93 25.14 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 t -146.35 138.55 25.07 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -101.09 170.59 8.16 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -98.38 160.06 14.53 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -90.53 158.94 42.27 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.83 146.06 87.83 Favored 'Trans proline' 0 CA--C 1.499 -1.262 0 C-N-CA 122.076 1.851 . . . . 0.0 112.687 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.67 156.74 16.4 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.47 -160.84 33.38 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.689 ' HB3' HD22 ' A' ' 55' ' ' LEU . 49.0 m0 -81.97 141.42 33.3 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -160.74 165.29 30.67 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -119.4 138.55 53.02 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.24 119.26 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HB3' HG12 ' A' ' 27' ' ' VAL . 11.1 ptmt -121.46 147.3 45.94 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.939 0.876 . . . . 0.0 108.986 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -91.41 123.65 35.0 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -59.33 -22.41 61.23 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.8 t -63.16 -45.55 91.31 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 121.278 -0.889 . . . . 0.0 110.882 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -114.05 -19.34 11.43 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.416 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.99 6.73 88.06 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 107.732 -2.147 . . . . 0.0 107.732 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.416 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 13.1 m-30 -83.8 160.14 21.27 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.456 HG12 ' HB3' ' A' ' 20' ' ' LYS . 29.9 m -114.71 160.12 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -177.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.921 HD23 HG21 ' A' ' 41' ' ' ILE . 4.2 mp -67.07 132.72 48.45 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.458 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.0 ttp -145.4 163.02 35.88 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 31' ' ' ASP . 31.4 t -67.62 162.7 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.0 t70 -48.65 -42.22 33.77 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 122.072 -0.393 . . . . 0.0 111.01 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -165.43 57.03 0.12 Allowed 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 119.555 -0.858 . . . . 0.0 108.708 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 54.23 49.25 19.02 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.7 m -97.07 126.93 42.57 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -91.47 -3.32 56.72 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -88.19 142.12 28.01 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 97.1 p -75.2 162.84 28.12 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.72 6.43 72.91 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.3 m -90.47 135.71 29.12 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.465 ' HA ' HG12 ' A' ' 87' ' ' VAL . 55.8 Cg_endo -69.51 154.14 69.13 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 C-N-CA 121.509 1.473 . . . . 0.0 112.763 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.921 HG21 HD23 ' A' ' 28' ' ' LEU . 23.4 mm -90.9 131.57 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 31.4 m -130.53 165.62 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 125' ' ' ILE . 92.1 mt -96.49 140.24 31.42 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.67 146.18 32.11 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.416 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 11.4 t -62.85 157.42 21.45 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.53 138.5 58.29 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -119.2 144.69 46.58 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -75.77 -16.55 60.1 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -118.04 154.26 32.32 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 61.54 48.85 5.48 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -68.58 -30.8 69.64 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.52 85.06 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 120.719 0.295 . . . . 0.0 110.563 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.1 m -66.86 -23.96 66.08 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -103.38 6.72 37.97 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.689 HD22 ' HB3' ' A' ' 16' ' ' TRP . 20.6 mt -99.94 137.38 38.47 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.901 0.857 . . . . 0.0 108.85 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -128.68 157.49 41.19 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -139.32 154.92 47.98 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -109.01 117.72 34.92 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.71 154.39 78.41 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.11 -17.86 58.71 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 121.867 1.712 . . . . 0.0 113.401 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -74.31 -19.01 60.62 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.36 19.26 10.09 Favored Glycine 0 C--N 1.357 1.705 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -109.7 154.79 22.38 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 118.296 1.048 . . . . 0.0 108.544 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 64' ' ' LEU . 1.7 mm? -102.97 131.56 49.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.045 HG22 HG12 ' A' ' 72' ' ' VAL . 64.3 t -119.75 136.15 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -79.87 130.08 35.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.78 -40.68 98.06 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 122.062 -0.399 . . . . 0.0 111.203 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -75.09 -53.11 9.44 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.076 -176.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.4 m -69.63 -40.03 76.81 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.1 5.26 89.84 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 105.754 -2.938 . . . . 0.0 105.754 -177.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.01 166.1 11.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.045 HG12 HG22 ' A' ' 65' ' ' VAL . 19.7 m -115.11 163.11 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.4 mtt -72.3 138.7 47.56 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -153.85 169.22 23.92 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.552 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -85.94 145.27 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.52 91.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.624 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -78.42 -31.7 48.31 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.552 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 90.56 -10.37 74.76 Favored Glycine 0 CA--C 1.495 -1.213 0 N-CA-C 105.903 -2.879 . . . . 0.0 105.903 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -116.02 122.91 31.69 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.22 128.79 16.09 Favored 'Trans proline' 0 CA--C 1.496 -1.383 0 C-N-CA 121.017 1.145 . . . . 0.0 113.158 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.02 158.96 44.09 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -73.16 133.41 44.06 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.88 84.63 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.5 p -74.7 142.54 14.52 Favored 'Isoleucine or valine' 0 C--N 1.358 0.942 0 CA-C-N 118.687 1.244 . . . . 0.0 108.191 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -82.89 155.46 24.08 Favored 'General case' 0 C--N 1.358 0.976 0 CA-C-O 121.427 0.632 . . . . 0.0 109.522 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.734 HD11 HD13 ' A' ' 140' ' ' LEU . 47.6 mm -110.05 129.11 65.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 40' ' ' PRO . 33.0 m -130.64 161.68 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -83.24 142.55 31.06 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.52 175.3 12.45 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.4 m -69.36 148.6 49.44 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.6 pm0 -70.84 156.48 39.51 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.06 -154.06 0.61 Allowed 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.511 ' H ' HG12 ' A' ' 96' ' ' VAL . . . 95.73 3.97 60.67 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.5 m -95.88 -51.43 4.48 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -104.86 6.82 34.12 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 93' ' ' GLY . 9.4 p -133.74 147.26 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -64.11 142.47 58.4 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.61 -21.59 64.49 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.44 -7.45 58.42 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.42 9.79 18.2 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -87.86 129.51 35.19 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -85.74 -7.35 58.83 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -74.89 -11.02 60.03 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -78.26 128.18 33.34 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.16 153.89 33.08 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.45 155.17 16.51 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 106.623 -2.591 . . . . 0.0 106.623 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 66.5 tp -115.54 122.31 45.3 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.444 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 9.1 t -83.8 141.56 41.38 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 108' ' ' SER . 33.9 Cg_exo -59.46 -19.55 52.23 Favored 'Trans proline' 0 CA--C 1.503 -1.056 0 C-N-CA 122.036 1.824 . . . . 0.0 113.063 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.05 -3.51 57.34 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.17 10.8 55.69 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -94.51 147.18 23.52 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.6 mt -113.62 125.13 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.69 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -130.02 176.43 8.07 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.722 HD12 ' HB2' ' A' ' 118' ' ' LYS . 12.5 mt -85.45 151.12 24.22 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.07 -27.35 64.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -105.04 -15.7 15.02 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.277 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.722 ' HB2' HD12 ' A' ' 115' ' ' LEU . 3.7 mptp? -133.32 84.93 45.58 Favored Pre-proline 0 CA--C 1.494 -1.197 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.99 -8.56 23.01 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.432 2.088 . . . . 0.0 112.337 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.447 ' HA ' HG12 ' A' ' 143' ' ' VAL . 88.7 p -86.42 -15.88 38.93 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.592 HD13 HD23 ' A' ' 140' ' ' LEU . 57.0 mt -105.43 130.77 53.45 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' A' ' 114' ' ' TYR . 34.1 pt -134.51 164.18 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.404 HD23 ' CD1' ' A' ' 140' ' ' LEU . 82.9 mt -82.71 139.74 33.48 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.77 177.49 39.59 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.606 HD13 HD13 ' A' ' 136' ' ' LEU . 1.8 pp -131.88 159.3 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.449 ' O ' HD22 ' A' ' 136' ' ' LEU . 88.2 tttt -103.64 145.27 30.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.67 131.56 56.69 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.2 t -150.1 155.76 40.41 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -70.17 -26.52 63.95 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.15 32.74 3.36 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -129.77 107.35 9.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.447 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 32.0 tpt180 -59.74 130.55 47.33 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -63.12 -35.99 82.13 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.447 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 34.2 mt-10 -85.78 85.57 7.39 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 105.761 -1.941 . . . . 0.0 105.761 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.2 11.56 1.19 Allowed Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.606 HD13 HD13 ' A' ' 125' ' ' ILE . 82.6 mt -62.99 129.09 38.86 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.575 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -84.57 153.73 23.05 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 121.701 0.762 . . . . 0.0 109.592 -177.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.04 137.75 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -146.62 165.86 28.27 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.734 HD13 HD11 ' A' ' 86' ' ' ILE . 1.5 mp -88.22 130.63 35.02 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -117.78 150.79 38.54 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.574 HD12 HD23 ' A' ' 121' ' ' LEU . 1.7 tp -80.02 137.95 36.92 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 120' ' ' SER . 11.3 p -61.44 135.75 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.185 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -129.97 95.29 3.91 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -64.8 -19.56 65.9 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.02 -22.87 63.06 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -132.26 83.44 2.08 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -100.21 5.45 44.7 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -95.41 20.4 9.49 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -91.65 108.31 19.82 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -66.44 -20.52 66.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -73.82 -17.29 61.09 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -100.99 0.36 38.03 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -96.17 133.83 40.0 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -119.73 143.44 47.79 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -124.95 163.76 21.59 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -126.7 145.75 50.47 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 19.1 t -130.66 144.22 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.3 mt -107.56 152.29 41.35 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.9 150.35 73.27 Favored 'Trans proline' 0 CA--C 1.496 -1.406 0 C-N-CA 121.773 1.648 . . . . 0.0 113.18 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.0 t 61.96 73.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 80.0 t . . . . . 0 C--O 1.261 1.696 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mmt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.943 0.401 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.27 154.26 34.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.66 154.06 35.63 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.96 144.97 37.32 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.51 10.81 18.24 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -85.63 62.2 7.32 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -74.2 -22.9 59.19 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -78.9 140.51 38.09 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -126.27 144.28 50.85 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -126.0 171.74 10.53 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -104.96 161.12 14.48 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.039 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -90.19 157.44 45.26 Favored Pre-proline 0 N--CA 1.44 -0.955 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.4 145.93 92.04 Favored 'Trans proline' 0 CA--C 1.499 -1.231 0 C-N-CA 122.064 1.843 . . . . 0.0 112.688 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -95.8 161.35 14.05 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.5 -160.35 37.76 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.642 ' HB3' HD22 ' A' ' 55' ' ' LEU . 47.7 m0 -82.13 142.48 32.21 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -160.01 163.6 33.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.404 ' CE1' HD21 ' A' ' 55' ' ' LEU . 57.6 m-85 -120.92 139.09 53.71 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.4 mt -108.86 119.81 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 34.8 pttt -126.58 149.79 49.23 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.64 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.79 130.85 34.62 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.34 -33.55 75.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.091 -0.381 . . . . 0.0 110.229 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -65.18 -37.73 88.28 Favored 'General case' 0 CA--C 1.505 -0.756 0 O-C-N 122.125 -0.359 . . . . 0.0 111.938 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -107.56 -23.12 12.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.141 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.06 19.65 79.76 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -108.63 154.92 21.29 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 20' ' ' LYS . 14.1 m -106.8 158.44 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 121.798 0.808 . . . . 0.0 109.553 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.954 HD23 HG21 ' A' ' 41' ' ' ILE . 3.4 mp -71.65 133.7 45.85 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.39 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.2 ptm -147.02 175.47 10.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 31' ' ' ASP . 46.5 t -76.9 155.08 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.489 ' HA ' HG22 ' A' ' 42' ' ' VAL . 40.1 p-10 -52.28 -31.68 33.89 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.651 -0.656 . . . . 0.0 111.968 -177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -162.81 45.3 0.13 Allowed 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 54.67 49.24 18.51 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.447 ' H ' HG11 ' A' ' 30' ' ' VAL . 74.1 m -84.29 120.1 25.84 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -79.52 -11.62 59.89 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -93.23 142.63 27.09 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.6 p -78.82 167.24 21.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.55 8.77 58.23 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.6 p -105.13 148.55 36.39 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 56.0 Cg_endo -70.69 155.29 63.16 Favored 'Trans proline' 0 CA--C 1.499 -1.257 0 C-N-CA 122.042 1.828 . . . . 0.0 113.612 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.954 HG21 HD23 ' A' ' 28' ' ' LEU . 24.0 mm -94.04 132.88 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 23.1 m -130.9 163.78 35.85 Favored 'Isoleucine or valine' 0 C--N 1.36 1.027 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' CD1' HG21 ' A' ' 125' ' ' ILE . 87.4 mt -96.56 146.37 24.88 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.08 151.44 33.22 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -60.78 144.73 51.89 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.26 139.62 58.11 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -127.07 149.21 50.02 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -84.13 -9.45 58.57 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -124.6 145.73 49.45 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 58.53 39.32 25.02 Favored 'General case' 0 C--N 1.361 1.088 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -86.62 -4.93 59.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.48 -36.41 83.66 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -73.34 -14.43 61.29 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -101.03 2.02 40.09 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.642 HD22 ' HB3' ' A' ' 16' ' ' TRP . 26.5 mt -96.66 137.6 35.5 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -128.74 158.74 37.77 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -140.05 156.3 46.67 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -109.97 114.74 28.52 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.94 154.14 86.81 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.3 -16.75 56.48 Favored 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 121.948 1.765 . . . . 0.0 112.983 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 67.3 m -76.48 -16.52 59.64 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.61 23.54 8.28 Favored Glycine 0 C--N 1.356 1.681 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' CE1' ' HB2' ' A' ' 61' ' ' SER . 2.4 m-85 -115.39 154.6 28.92 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.695 1.247 . . . . 0.0 108.793 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.0 mm? -97.0 131.14 44.11 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.992 HG22 HG12 ' A' ' 72' ' ' VAL . 61.4 t -124.78 137.8 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -77.61 130.04 36.37 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -61.94 -44.01 97.66 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 121.915 -0.491 . . . . 0.0 111.337 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -79.72 -50.75 10.14 Favored 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 121.858 -0.526 . . . . 0.0 111.681 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 t -69.76 -39.72 76.54 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.94 3.28 90.56 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 107.253 -2.339 . . . . 0.0 107.253 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -94.8 164.38 12.96 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 65' ' ' VAL . 11.5 m -115.79 160.77 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.2 mtt -72.47 138.98 47.42 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -157.03 174.0 16.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.74 143.25 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.63 -43.53 76.12 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.835 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -72.8 -32.52 65.61 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.1 -7.43 80.92 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 105.704 -2.958 . . . . 0.0 105.704 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.5 m -115.34 120.59 36.24 Favored Pre-proline 0 N--CA 1.438 -1.037 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.44 106.76 2.32 Favored 'Trans proline' 0 CA--C 1.496 -1.384 0 C-N-CA 121.363 1.375 . . . . 0.0 113.559 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -137.8 165.46 26.4 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.617 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -72.41 136.56 46.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.61 4.58 79.67 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.697 ' HB ' HD12 ' A' ' 140' ' ' LEU . 79.5 t -81.48 132.8 30.67 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 CA-C-N 119.314 1.557 . . . . 0.0 108.055 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.71 151.94 41.93 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 121.526 0.679 . . . . 0.0 109.317 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.404 HD11 HD21 ' A' ' 140' ' ' LEU . 48.0 mm -104.19 127.88 58.08 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 40' ' ' PRO . 33.6 m -131.33 162.17 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -89.48 137.69 32.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.23 168.04 20.72 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 m -73.6 147.57 43.71 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -71.57 156.52 39.31 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.26 157.34 42.98 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.48 -29.96 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.18 0 N-CA-C 107.876 -2.09 . . . . 0.0 107.876 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.0 m -64.19 -40.96 97.18 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.73 16.54 17.4 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.09 127.22 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -63.45 146.62 53.24 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.28 -20.64 66.51 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -90.63 -2.11 57.86 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.0 mt -114.05 7.47 16.78 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.64 121.32 26.2 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -97.67 -8.7 28.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -3.23 48.55 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -75.33 140.34 43.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.42 151.19 51.98 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -111.58 153.24 17.38 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 106.388 -2.685 . . . . 0.0 106.388 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 65.5 tp -129.31 122.55 29.81 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.5 p -92.8 158.92 37.11 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.11 -19.98 68.24 Favored 'Trans proline' 0 CA--C 1.501 -1.137 0 C-N-CA 122.414 2.076 . . . . 0.0 113.031 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -78.28 -10.89 59.85 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.94 7.38 58.69 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -85.23 134.96 34.12 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.3 mt -108.08 123.02 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.578 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.9 OUTLIER -129.43 179.65 5.68 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.632 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 7.9 mt -85.89 148.51 25.76 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.86 -25.29 61.89 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -98.74 -22.61 15.79 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.651 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.632 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 1.7 mptm? -134.26 85.46 38.75 Favored Pre-proline 0 CA--C 1.496 -1.1 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -64.91 -11.01 27.51 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.648 2.232 . . . . 0.0 113.286 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 89.0 p -86.84 -15.19 39.89 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.712 HD23 HD13 ' A' ' 140' ' ' LEU . 4.1 mp -98.06 131.88 44.09 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 114' ' ' TYR . 26.8 pt -134.07 164.48 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -85.48 141.73 29.71 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.41 -176.14 32.18 Favored Glycine 0 CA--C 1.493 -1.301 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.531 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.9 pp -136.85 160.29 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.023 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.469 ' O ' HD22 ' A' ' 136' ' ' LEU . 51.8 tttt -93.06 143.55 26.13 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -119.66 127.66 53.11 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 34.7 t -150.57 156.55 41.61 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -70.24 -26.9 64.06 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -102.35 35.47 2.41 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 128' ' ' SER . . . -129.93 105.9 8.3 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.467 ' HG3' ' H ' ' A' ' 134' ' ' GLU . 16.7 tpt180 -61.6 131.13 49.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -62.44 -36.81 83.58 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.467 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 13.6 mt-10 -82.93 85.82 7.07 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.73 7.88 1.54 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 126' ' ' LYS . 69.0 mt -66.06 127.46 32.19 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.531 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -88.81 154.73 20.03 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 121.517 0.675 . . . . 0.0 109.354 -177.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 50.6 t -77.78 135.76 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -130.92 137.06 49.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.712 HD13 HD23 ' A' ' 121' ' ' LEU . 72.3 mt -76.0 133.17 40.48 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -133.1 155.07 49.93 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.617 HD13 ' HB2' ' A' ' 82' ' ' ALA . 1.3 mp -94.11 151.91 19.14 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.23 154.1 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-O 121.821 0.819 . . . . 0.0 109.076 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -142.58 99.0 3.4 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -66.99 -20.61 65.91 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.045 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.76 -25.86 65.83 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -138.79 86.58 2.16 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.3 mt -100.82 4.65 43.05 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -96.28 21.32 9.15 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -88.07 124.7 34.03 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -68.17 -22.88 64.82 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -72.17 -20.34 61.61 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -96.02 -0.56 50.36 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -102.0 133.59 46.57 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -119.49 138.54 53.09 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -115.47 147.61 40.42 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -113.52 137.57 51.38 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.3 t -127.69 144.04 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.7 mt -108.87 154.93 41.56 Favored Pre-proline 0 N--CA 1.44 -0.943 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.5 140.85 94.54 Favored 'Trans proline' 0 CA--C 1.499 -1.237 0 C-N-CA 122.032 1.821 . . . . 0.0 113.266 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.5 p -143.53 143.68 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.0 t . . . . . 0 C--O 1.262 1.76 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -179.976 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.926 0.393 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.87 156.8 36.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.03 148.55 31.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 60.77 60.59 1.86 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 99.1 mtp -68.22 -28.28 67.1 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -134.97 90.48 2.64 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -73.01 -24.05 60.7 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -83.03 143.21 30.76 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 t -146.69 139.01 24.89 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -97.01 171.73 8.3 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -109.5 161.94 14.85 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -91.06 156.66 43.9 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.26 156.07 65.72 Favored 'Trans proline' 0 CA--C 1.501 -1.151 0 C-N-CA 121.797 1.665 . . . . 0.0 112.906 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 pm0 -75.57 159.78 30.87 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.62 -165.73 42.68 Favored Glycine 0 C--N 1.352 1.423 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.469 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.3 m95 -90.09 175.85 7.0 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -168.26 165.14 13.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.465 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 53.1 m-85 -118.01 135.23 54.29 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.6 mt -99.1 114.18 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -113.73 131.96 56.0 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -87.5 127.47 35.24 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.37 -21.55 66.67 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.1 p -68.22 -39.04 82.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 119.478 1.035 . . . . 0.0 111.704 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -116.86 -16.98 10.55 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.236 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.83 20.72 75.82 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 107.601 -2.199 . . . . 0.0 107.601 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -102.65 163.48 12.2 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.25 160.45 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.731 HD23 HG21 ' A' ' 41' ' ' ILE . 5.5 mp -67.03 133.49 50.01 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.793 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.5 ttp -145.82 163.01 36.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 31' ' ' ASP . 38.9 t -68.08 164.33 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.574 ' N ' HG12 ' A' ' 30' ' ' VAL . 36.2 t70 -48.58 -44.32 36.69 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 122.042 -0.411 . . . . 0.0 110.946 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -167.37 62.41 0.08 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.582 -0.847 . . . . 0.0 108.734 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 54.39 47.64 22.43 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.6 m -95.41 124.71 39.58 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -93.28 -1.69 55.79 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -88.62 148.83 23.85 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.1 m -81.78 157.56 24.45 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.83 62.63 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.4 m -92.21 141.47 25.1 Favored Pre-proline 0 N--CA 1.438 -1.036 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 59.1 Cg_endo -71.3 154.66 61.28 Favored 'Trans proline' 0 CA--C 1.497 -1.364 0 C-N-CA 121.643 1.562 . . . . 0.0 112.861 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.731 HG21 HD23 ' A' ' 28' ' ' LEU . 25.5 mm -91.14 131.47 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 137' ' ' HIS . 28.8 m -131.39 165.77 30.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 125' ' ' ILE . 90.0 mt -94.77 143.8 26.16 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.83 150.24 35.8 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 m -61.59 144.97 53.54 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.77 139.53 57.89 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -115.54 145.07 42.99 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -82.21 -20.31 38.0 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -128.84 149.58 50.69 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 59.13 44.28 16.13 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -97.22 10.3 39.85 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.18 86.3 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -73.06 -13.74 61.27 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -100.35 2.01 42.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.469 HD22 ' HB2' ' A' ' 16' ' ' TRP . 25.4 mt -97.41 136.08 38.37 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -127.97 158.7 37.15 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.9 ptm180 -141.88 158.44 43.79 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -111.52 115.41 29.15 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.92 154.47 86.86 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.02 -16.75 56.36 Favored 'Trans proline' 0 CA--C 1.496 -1.413 0 C-N-CA 121.871 1.714 . . . . 0.0 112.966 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.8 m -74.28 -20.17 60.23 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.23 21.15 8.19 Favored Glycine 0 C--N 1.356 1.679 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.37 155.81 25.6 Favored 'General case' 0 C--N 1.357 0.892 0 CA-C-N 118.724 1.262 . . . . 0.0 109.151 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.6 mm? -95.17 132.79 39.73 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.968 HG22 HG12 ' A' ' 72' ' ' VAL . 61.6 t -125.75 137.47 57.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -78.56 130.81 36.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -63.42 -41.67 98.72 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.939 -0.476 . . . . 0.0 111.503 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -73.3 -51.18 18.47 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.794 -0.566 . . . . 0.0 112.373 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.6 p -84.32 -29.64 26.18 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 119.441 -0.903 . . . . 0.0 110.565 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.06 4.6 90.49 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -89.61 166.1 13.84 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.968 HG12 HG22 ' A' ' 65' ' ' VAL . 32.5 m -118.12 160.81 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.1 mtt -72.55 140.86 48.36 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -154.94 169.46 24.01 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.462 ' HB ' ' H ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -91.56 143.55 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.33 87.78 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.32 -33.82 70.02 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' H ' ' HB ' ' A' ' 75' ' ' ILE . . . 89.87 -8.49 79.72 Favored Glycine 0 CA--C 1.494 -1.219 0 N-CA-C 106.3 -2.72 . . . . 0.0 106.3 -178.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.3 m -124.59 121.57 25.8 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.39 128.43 27.34 Favored 'Trans proline' 0 CA--C 1.495 -1.429 0 C-N-CA 121.394 1.396 . . . . 0.0 112.837 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.42 153.51 38.64 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.62 132.74 44.13 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.07 16.41 69.77 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.671 ' CG1' HD12 ' A' ' 140' ' ' LEU . 7.5 p -82.8 149.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -90.8 153.09 20.49 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.42 HD11 HD11 ' A' ' 140' ' ' LEU . 49.2 mm -108.64 128.73 64.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.924 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 40' ' ' PRO . 34.2 m -131.53 161.47 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -89.04 140.96 28.91 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -145.45 171.67 14.3 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 m -71.17 150.92 44.89 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -70.95 157.26 38.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -146.95 162.35 38.9 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.58 -26.55 0.21 Allowed Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.1 m -64.9 -40.05 94.48 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -121.97 18.51 10.91 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 97' ' ' LYS . 84.1 t -126.37 129.01 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.402 ' O ' HG12 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -66.79 159.96 26.92 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -77.51 -16.96 58.4 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -89.55 -11.97 41.25 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.5 mt -112.05 11.58 20.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -91.68 115.29 27.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -97.82 -6.32 32.87 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.921 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -80.01 -7.81 59.02 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.97 127.04 31.48 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -119.42 153.5 35.13 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.66 148.84 17.69 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.7 tp -112.73 122.27 47.16 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.446 ' HB2' ' CE2' ' A' ' 114' ' ' TYR . 8.8 t -86.78 139.22 33.06 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.61 -9.81 27.21 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 C-N-CA 121.897 1.731 . . . . 0.0 113.006 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.51 -0.81 57.61 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.09 38.83 5.31 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -129.71 148.76 51.63 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.0 mt -118.71 126.17 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.604 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -130.88 176.6 8.09 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.638 ' HB2' ' H ' ' A' ' 118' ' ' LYS . 12.1 mt -86.98 150.22 24.22 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.6 -25.21 61.24 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -103.33 -20.49 14.07 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.889 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.638 ' H ' ' HB2' ' A' ' 115' ' ' LEU . 13.7 mptt -131.79 84.27 54.93 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.66 -9.23 24.78 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.542 2.162 . . . . 0.0 113.087 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 86.3 p -87.31 -16.95 33.6 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.657 HD12 ' HB3' ' A' ' 140' ' ' LEU . 4.6 mm? -97.14 130.72 44.36 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.604 HG22 ' HB3' ' A' ' 114' ' ' TYR . 25.0 pt -134.62 163.39 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.502 HD23 ' CD2' ' A' ' 140' ' ' LEU . 85.0 mt -80.4 143.1 33.74 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.66 -173.73 36.02 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 106.84 -2.504 . . . . 0.0 106.84 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 137' ' ' HIS . 1.8 pp -138.47 161.04 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.464 ' O ' HD22 ' A' ' 136' ' ' LEU . 39.7 ttmt -104.49 137.7 41.96 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -107.24 131.08 54.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.8 t -149.56 155.33 40.14 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -69.99 -24.87 63.38 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -101.02 25.95 7.52 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.03 100.48 5.45 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.619 ' HG2' ' H ' ' A' ' 134' ' ' GLU . 71.7 ttt180 -61.08 139.09 58.16 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -62.83 -21.77 66.17 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.619 ' H ' ' HG2' ' A' ' 132' ' ' ARG . 15.2 mt-10 -94.01 86.53 5.05 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 131.72 11.84 2.06 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 126' ' ' LYS . 78.7 mt -63.89 126.57 28.08 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -85.56 153.51 22.37 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.639 0.733 . . . . 0.0 109.7 -177.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.0 t -76.7 134.52 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.75 136.52 40.84 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -177.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.671 HD12 ' CG1' ' A' ' 84' ' ' VAL . 85.4 mt -83.55 132.31 34.93 Favored 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.757 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -125.22 152.87 43.99 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.451 HD12 HD13 ' A' ' 121' ' ' LEU . 1.4 mp -83.23 150.75 26.0 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.22 151.51 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 121.805 0.812 . . . . 0.0 109.474 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -140.59 94.61 2.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -70.48 -20.91 62.82 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -71.18 -19.71 62.37 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -142.49 85.36 1.9 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.8 mt -98.26 5.37 48.43 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -89.65 17.43 6.49 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -85.62 108.89 18.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -65.6 -20.23 66.23 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.784 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -74.1 -19.06 60.72 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -96.94 -1.49 45.61 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -98.24 133.4 42.72 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -119.83 139.46 52.33 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -117.48 160.25 21.52 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.81 142.86 51.18 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.25 143.3 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.0 mt -106.61 150.99 40.28 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.69 150.37 68.53 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 121.849 1.699 . . . . 0.0 112.934 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 71.4 t -118.26 125.56 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 C--O 1.261 1.668 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.888 . . . . . . . . 0 0 . 1 stop_ save_